Any feedback?
Please rate this page
(enzyme.php)
(0/150)

BRENDA support

Disease on EC 3.5.2.6 - beta-lactamase

Please use the Disease Search for a specific query.
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
DISEASE
TITLE OF PUBLICATION
LINK TO PUBMED
Abdominal Abscess
Efficacies of piperacillin-tazobactam and cefepime in rats with experimental intra-abdominal abscesses due to an extended-spectrum beta-lactamase-producing strain of Klebsiella pneumoniae.
Reversion to susceptibility of a carbapenem-resistant clinical isolate of Klebsiella pneumoniae producing KPC-3.
Successful medical treatment in a child with E. coli ESBL meningitis with acute communicating hydrocephalus and ventricular empyema: a case report.
Abscess
Bacteroides thetaiotaomicron in posthysterectomy infection.
beta-Lactamase activity in human pus.
Beta-lactamase production diminishes the prophylactic efficacy of ampicillin and cefazolin in a guinea pig model of Staphylococcus aureus wound infection.
Clinical evaluation of aztreonam therapy for serious infections due to gram-negative bacteria.
Effect of aspoxicillin on anaerobic bacteria.
Efficacy of ceftriaxone plus tazobactam in a rat model of intraabdominal abscess due to Bacteroides fragilis.
Efficacy of moxalactam in an animal model of subcutaneous abscesses: penetration into infected sites and in vivo activity against Bacteroides fragilis.
Emergence of Klebsiella pneumoniae ST273 Carrying blaNDM-7 and ST656 Carrying blaNDM-1 in Manila, Philippines.
Emergency surgery for tubo-ovarian abscess identified extended-spectrum beta-lactamase-producing Escherichia coli: the first case presentation revealing causative bacteria.
Haemophilus influenzae type b brain abscess complicating meningitis: case report.
In vivo protection of penicillin-susceptible Bacteroides melaninogenicus from penicillin by facultative bacteria which produce beta-lactamase.
Klebsiella Pneumoniae Visceral Organ Abscesses - Clinical Characteristics.
Long-term, low-dose tigecycline to treat relapsing bloodstream infection due to KPC-producing Klebsiella pneumoniae after major hepatic surgery.
Management of a post-operative multi-resistant infectious spondylitis associated with a kyphotic deformity.
Microbiology and management of peritonsillar, retropharyngeal, and parapharyngeal abscesses.
Microbiology of abscesses of the head and neck in children.
Piperacillin with and without tazobactam against extended-spectrum beta-lactamase-producing Pseudomonas aeruginosa in a rat thigh abscess model.
Post-appendectomy pelvic abscess with extended-spectrum beta-lactamase producing Escherichia coli: A case report and review of literature.
Presence of beta-lactamase-producing bacteria and beta-lactamase activity in abscesses.
Renal vein thrombosis complicating severe acute pyelonephritis with renal abscesses and associated bacteraemia caused by extended-spectrum beta-lactamase producing Escherichia coli.
[A SHV-derived extended-spectrum beta-lactamase (SHV-12) produced by an Escherichia coli recovered from wound abscess in post operative case with rectal carcinoma]
[Bacteriological study of oral open abscesses]
[Comparison of antimicrobial resistance patterns of enterotoxin gene positive and negative Bacteroides fragilis isolates]
[Peritonsillar abscess in a child caused by ampicillin resistant Haemophilus influenzae]
Acquired Immunodeficiency Syndrome
Expression in Escherichia coli of the AIDS virus aspartic protease through a protein fusion.
Long-Term Persistence of blaCTX-M-15 in Soil and Lettuce after Introducing Extended-Spectrum ?-Lactamase (ESBL)-Producing Escherichia coli via Manure or Water.
Pneumococcal bacterial peritonitis in aids patient following esophageal endoscopic variceal sclerotherapy. Case report and recommendations for antibiotic prophylaxis.
[Determination of antibodies to the AIDS virus and the viral antigen by an immunoenzyme method using peroxidase and beta-lactamase]
Acute Kidney Injury
Penicillinase treatment of acute renal insufficiency due to penicillin hypersensitivity.
Adenocarcinoma
Adenovirus-mediated expression of p33(ING1b) induces apoptosis and inhibits proliferation in gastric adenocarcinoma cells in vitro.
Antitumor activity of a Trans-thiosemicarbazone schiff base palladium (II) complex on human gastric adenocarcinoma cells.
Detection and characterization of VIM-31, a new variant of VIM-2 with Tyr224His and His252Arg mutations, in a clinical isolate of Enterobacter cloacae.
Evaluation of the toxicity of food additive silica nanoparticles on gastrointestinal cells.
Exosomes Serve as Nanoparticles to Deliver Anti-miR-214 to Reverse Chemoresistance to Cisplatin in Gastric Cancer.
Expression of miR-124 in gastric adenocarcinoma and the effect on proliferation and invasion of gastric adenocarcinoma SCG-7901 cells.
Frequent amplification of the bcl-1 locus in poorly differentiated squamous cell carcinoma of the lung. The Lung Cancer Study Group.
TMEM119 silencing inhibits cell viability and causes the apoptosis of gastric cancer SGC-7901 cells.
Upregulation of TMEFF2 is involved in the antiproliferative effects of vitamin C and tyrphostin AG490 on GES-1 and AGS cells.
[Effects of ginsenoside Rg5 on cell cycle and invasion of gastric cancer].
Adenocarcinoma of Lung
Cephalosporin derivatives of doxorubicin as prodrugs for activation by monoclonal antibody-beta-lactamase conjugates.
Adenoma
Increased expression of IGF II mRNA-binding protein 1 mRNA is associated with an advanced clinical stage and poor prognosis in patients with ovarian cancer.
Adenomatous Polyposis Coli
Flow cytometric DNA analysis is useful in detecting multiple genetic alterations in squamous cell carcinoma of the esophagus.
Adenoviridae Infections
Functional substitution identifies a cell survival promoting domain common to adenovirus E1B 19 kDa and Bcl-2 proteins.
Anaphylaxis
Anaphylactic shock after therapy with penicillinase.
Anemia
Abrogation of age-related resistance to chicken infectious anemia by embryonal bursectomy.
Depletion of CD4+ and CD8+ T lymphocyte subpopulations by CIA-1, a chicken infectious anemia virus.
Anemia, Hemolytic
Positive direct antiglobulin tests and haemolytic anaemia following therapy with beta-lactamase inhibitor containing drugs may be associated with nonimmunologic adsorption of protein onto red blood cells.
Positive direct antiglobulin tests and haemolytic anaemia following therapy with the beta-lactamase inhibitor, tazobactam, may also be associated with non-immunologic adsorption of protein onto red blood cells.
Aneurysm, Infected
First Initial community-acquired meningitis due to extended-spectrum beta-lactamase producing Escherichia coli complicated with multiple aortic mycotic aneurysms.
Recurrent Klebsiella pneumoniae mycotic aneurysm in a diabetic patient and emergence of an extended-spectrum beta-lactamase (CTX-M-24)-containing Klebsiella pneumoniae strain after prolonged treatment with first-generation cephalosporins for mycotic aneurysm.
Anthrax
Anthrax toxin uptake by primary immune cells as determined with a lethal factor-beta-lactamase fusion protein.
Imaging specific cell surface protease activity in living cells using reengineered bacterial cytotoxins.
PCR amplification on a microarray of gel-immobilized oligonucleotides: detection of bacterial toxin- and drug-resistant genes and their mutations.
Targeting the anthrax receptors, TEM-8 and CMG-2, for anti-angiogenic therapy.
Updated recommendations for antimicrobial prophylaxis among asymptomatic pregnant women after exposure to Bacillus anthracis.
[A METHOD FOR DIFFERENTIATION OF BACILLUS ANTHRACIS STRAINS AND PHYLOGENETICALLY RELATED SPECIES BASED ON DETERMINATION OF THE STRUCTURAL DIFFERENCESBETWEEN CHROMOSOMAL GENES FOR BIOSYNTHESIS OF FLAGELLIN AND METHIONINE].
Aortitis
Aortitis caused by beta-lactamase producing Haemophilus influenzae type b.
Appendicitis
A randomized comparative study of sulbactam plus ampicillin vs. metronidazole plus cefotaxime in the management of acute appendicitis in children.
Pharmacokinetics of parenteral sulbactam in patients with appendicitis.
[A contemporary situation in the antimicrobial treatment of the secondary peritonitis]
[Cefoperazone concentration in infected tissues and clinical effect for patients with peritonitis (author's transl)]
Arthritis, Infectious
Clinical evaluation of aztreonam therapy for serious infections due to gram-negative bacteria.
Septic arthritis caused by penicillinase producing Neisseria gonorrhea.
[Septic arthritis caused by beta-lactamase producing Haemophilus influenzae]
Asymptomatic Infections
Phenotypic characterization and whole genome analysis of extended-spectrum beta-lactamase-producing bacteria isolated from dogs in Germany.
Ataxia
Oxidative DNA damage is involved in ochratoxin A-induced G2 arrest through ataxia telangiectasia-mutated (ATM) pathways in human gastric epithelium GES-1 cells in vitro.
Sterigmatocystin-induced DNA damage triggers G2 arrest via an ATM/p53-related pathway in human gastric epithelium GES-1 cells in vitro.
Avian Leukosis
Expression of exogenous protein in the egg white of transgenic chickens.
Validating the hen as a bioreactor for the production of exogenous proteins in egg white.
Bacteremia
A Fatal Bacteremia Caused by Hypermucousviscous KPC-2 Producing Extensively Drug-Resistant K64-ST11 Klebsiella pneumoniae in Brazil.
A methodological comparison of risk scores versus decision trees for predicting drug-resistant infections: A case study using extended-spectrum beta-lactamase (ESBL) bacteremia.
Activity of ertapenem, ciprofloxacin, ceftriaxone, piperacillin-tazobactam, and ampicillin-sulbactam against 12 common clinical isolates of community-acquired bacteremia.
Association between dementia and reduced walking ability and 30-day mortality in patients with extended-spectrum beta-lactamase-producing Escherichia coli bacteremia.
Bacteremia caused by a beta-lactamase producing Haemophilus parainfluenzae strain of a new biotype. A case report.
Bacteremia caused by a beta-lactamase producing strain of Branhamella catarrhalis. A case report.
Bacteremia caused by Escherichia coli producing extended-spectrum beta-lactamase: a case-control study of risk factors and outcomes.
Bacteremia Caused by Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae in Vientiane, Lao PDR: A 5-Year Study.
Bacteremia due to Bacteroides fragilis group: distribution of species, beta-lactamase production, and antimicrobial susceptibility patterns.
Bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a pediatric oncology ward: clinical features and identification of different plasmids carrying both SHV-5 and TEM-1 genes.
Bacteremia due to Extended-Spectrum {beta}-Lactamase-Producing Klebsiella pneumoniae with or without Plasmid-Mediated AmpC {beta}-Lactamase (DHA-1): Microbiologic and Clinical Implications.
Bacteremia due to Klebsiella pneumoniae isolates producing the TEM-52 extended-spectrum beta-lactamase: treatment outcome of patients receiving imipenem or ciprofloxacin.
Bacteremia in patients undergoing oral procedures. Study following parenteral antimicrobial prophylaxis as recommended by the American Heart Association, 1977.
Beta-lactamase effect on ampicillin treatment of Haemophilus influenzae B bacteremia and meningitis in infant rats.
Bloodstream infections by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in children: epidemiology and clinical outcome.
Carbapenem therapy for bacteremia due to extended-spectrum-?-lactamase-producing Escherichia coli or Klebsiella pneumoniae: implications of ertapenem susceptibility.
Case report: Bacteremia due to Salmonella enterica Serotype Montevideo producing plasmid-mediated AmpC beta-lactamase (DHA-1).
Cefuroxime compared to piperacillin/tazobactam as empirical treatment of Escherichia coli bacteremia in a low Extended-spectrum beta-lactamase (ESBL) prevalence cohort.
Characteristics of bacteremia caused by extended-spectrum beta-lactamase-producing Proteus mirabilis.
Characterization of Klebsiella pneumoniae and Escherichia coli strains that produce CTX-M-2-type broad spectrum beta-lactamase isolated from a child with leukemia.
Citrobacter freundii bacteremia: Risk factors of mortality and prevalence of resistance genes.
Clinical and economic impact of bacteremia with extended- spectrum-beta-lactamase-producing Enterobacteriaceae.
Clinical and Microbiological Analysis of Risk Factors for Mortality in Patients with Carbapenem-Resistant Enterobacteriaceae Bacteremia.
Clinical epidemiology, risk factors and treatment outcomes of extended-spectrum beta-lactamase producing Enterobacteriaceae bacteremia among children in a Tertiary Care Hospital, Bangkok, Thailand.
Clinical evaluation of aztreonam therapy for serious infections due to gram-negative bacteria.
Clinical implications of inducible beta-lactamase activity in Gram-negative bacteremia in children.
Clinical outcome of empiric antimicrobial therapy of bacteremia due to extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae.
Clinical outcome of extended-spectrum beta-lactamase-producing Escherichia coli bacteremia in an area with high endemicity.
Clinical Outcomes of Ceftriaxone vs Penicillin G for Complicated Viridans Group Streptococci Bacteremia.
Clinical Risk Factors for Death Caused by Extended-Spectrum Beta-Lactamase: Producing Bacteria.
Clonal relationship and the association of the ST218 strain harboring blaOXA-72 gene to mortality in carbapenem-resistant Acinetobacter baumannii bacteremia.
Co-production of NDM-1 and OXA-232 by ST16 Klebsiella pneumoniae, Italy, 2016.
Comparison of outcome and clinical characteristics of bacteremia caused by methicillin-resistant, penicillin-resistant and penicillin-susceptible Staphylococcus aureus strains.
Discrepancy between effects of carbapenems and flomoxef in treating nosocomial hemodialysis access-related bacteremia secondary to extended spectrum beta-lactamase producing klebsiella pneumoniae in patients on maintenance hemodialysis.
Dissemination of bla NDM- 1 Gene Among Several Klebsiella pneumoniae Sequence Types in Mexico Associated With Horizontal Transfer Mediated by IncF-Like Plasmids.
Double-carbapenem regimen for carbapenemase-producing pandrug-resistant Klebsiella pneumoniae infections: Is it really effective in humans?
Drug-Resistant E. coli Bacteremia Transmitted by Fecal Microbiota Transplant.
E. coli bacteremia in comparison to K. pneumoniae bacteremia: influence of pathogen species and ESBL production on 7-day mortality.
Efficacy and Pharmacokinetics of the Combination of OP0595 and Cefepime in a Mouse Model of Pneumonia Caused by Extended-Spectrum-Beta-Lactamase-Producing Klebsiella pneumoniae.
Efficacy of Fosfomycin and Its Combination With Aminoglycosides in an Experimental Sepsis Model by Carbapenemase-Producing Klebsiella pneumoniae Clinical Strains.
Endocarditis caused by extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae: emergence of resistance to ciprofloxacin and piperacillin-tazobactam during treatment despite initial susceptibility.
Endometritis and Bacteremia With a New Delhi Metallo-Beta-Lactamase 1 (NDM-1)-containing Organism in a Remote Traveler.
Epidemiology and outcome of bacteremia caused by extended spectrum beta-lactamase (ESBL)-producing Escherichia coli and Klebsiella spp. in a tertiary care teaching hospital in south India.
Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum beta-lactamase production in Klebsiella pneumoniae isolates causing bacteremia.
Epidemiology of extended spectrum beta-lactamase producing Enterobacter bacteremia in a brazilian hospital.
Epidemiology, Risk Factors, and Clinical Outcomes of Bloodstream Infection due to Extended-Spectrum Beta-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae in Hematologic Malignancy: A Retrospective Study from Central South China.
Extended spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae bacteremia. Risk factors and outcome in the eastern region of Saudi Arabia.
Extended-spectrum beta-lactamase (ESBL)-producing and non-ESBL-producing Escherichia coli isolates causing bacteremia in the Netherlands (2014 - 2016) differ in clonal distribution, antimicrobial resistance gene and virulence gene content.
Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae bloodstream infection: risk factors and clinical outcome.
Extended-spectrum beta-lactamase-producing Klebsiella pneumoniae hospital acquired bacteremia. Risk factors and clinical outcome.
Extended-spectrum beta-lactamase-producing phenotype signifies a poor prognosis for patients with cefpodoxime-resistant Escherichia coli or Klebsiella pneumoniae bacteremia.
Failure of ceftazidime-amikacin therapy for bacteremia and meningitis due to Klebsiella pneumoniae producing an extended-spectrum beta-lactamase.
First reported nosocomial outbreak of Serratia marcescens harboring blaIMP-4 and blaVIM-2 in a neonatal intensive care unit in Cairo, Egypt.
Fosfomycin for Multidrug Treatment of Klebsiella pneumoniae Carbapenemase Bacteremia.
In vitro susceptibilities to 23 antimicrobial agents of Haemophilus influenzae from pediatric patients in Japan.
International prospective study of Klebsiella pneumoniae bacteremia: implications of extended-spectrum beta-lactamase production in nosocomial Infections.
Intra- and inter-species spread of carbapenemase genes in a non-hospitalized patient.
KPC-2 producing ST101 Klebsiella pneumoniae from bloodstream infection in India.
Meropenem-Vaborbactam as Salvage Therapy for Ceftazidime-Avibactam-, Cefiderocol-Resistant ST-512 Klebsiella pneumoniae-Producing KPC-31, a D179Y Variant of KPC-3.
Mima polymorpha bacteremia. False-positive cultures due to contaminated penicillinase.
Molecular epidemiology and clinical features of extended-spectrum beta-lactamase- or carbapenemase-producing Escherichia coli bacteremia in Japan.
Molecular epidemiology and risk factors of bloodstream infections caused by extended-spectrum beta-lactamase-producing Klebsiella pneumoniae A case-control study.
Nosocomial bacteremia and urinary tract infections caused by extended-spectrum beta -lactamase-producing Klebsiella pneumoniae with plasmids carrying both SHV-5 and TLA-1 genes.
Outcome of cephalosporin treatment of bacteremia due to CTX-M-type extended-spectrum beta-lactamase-producing Escherichia coli.
Outcomes analysis in patients with extended-spectrum beta-lactamase bacteremia empirically treated with piperacillin/tazobactam versus carbapenems.
Outcomes and risk factors for mortality in community-onset bacteremia caused by extended-spectrum beta-lactamase-producing Escherichia coli, with a special emphasis on antimicrobial therapy.
Predictors of mortality in patients with bacteremia of unknown source due to extended spectrum beta-lactamase producing Escherichia coli.
Presence of the KPC carbapenemase gene in Enterobacteriaceae causing bacteremia and its correlation with in vitro carbapenem susceptibility.
Pseudomonas aeruginosa bacteremia among liver transplant recipients.
Risk factors and outcome in extended spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae bacteremia.
Role of a cefoxitin-inducible beta-lactamase in a case of breakthrough bacteremia.
Ruptured Left Ventricular False Tendon Mimicking a Mural Vegetation.
The prediction values of carbapenemase detection methods and carbapenem susceptibility testing for clinical outcomes of patients with Acinetobacter bacteremia under carbapenem treatment.
Use of tigecycline for the treatment of prolonged bacteremia due to a multiresistant VIM-1 and SHV-12 beta--lactamase-producing Klebsiella pneumoniae epidemic clone.
Using Therapeutic Drug Monitoring to Treat KPC-Producing Klebsiella pneumoniae Central Nervous System Infection With Ceftazidime/Avibactam.
Validation of Available Extended-Spectrum-Beta-Lactamase Clinical Scoring Models in Predicting Drug Resistance in Patients with Enteric Gram-Negative Bacteremia Treated at South Texas Veterans Health Care System.
Virulence of metallo-beta-lactamase-producing Pseudomonas aeruginosa in vitro and in vivo.
[Clinical, epidemiological and microbiological characterization of bacteremia produced by carbapenem-resistant enterobacteria in a university hospital in Córdoba, Argentina].
[Frequency and risk factors for bacteremia caused by extendedspectrum beta-lactamase-producing enterobacteriaceae in patients of a public hospital in Lima, Peru].
[Mortality caused by bacteremia Escherichia coli and Klebsiella spp. extended-spectrum beta-lactamase- producers: a retrospective cohort from a hospital in Lima, Peru].
[Risk factors for extended espectrum beta-lactamase producer E.coli bacteremia from urinary origin.]
Bacterial Infections
1H, 13C, and 15N backbone resonance assignments for KPC-2, a class A serine-?-lactamase.
Applications of machine-learning methods for the discovery of NDM-1 inhibitors.
beta-Lactamase epidemiology and the utility of established and novel beta-lactamase inhibitors.
Beta-lactamase-inhibitor combinations in the 21st century: current agents and new developments.
Beta-lactamases and beta-lactamase inhibitors.
Characterization and plasmid elimination of NDM-1-producing Acinetobacter calcoaceticus from China.
Discovery of Baicalin as NDM-1 inhibitor: Virtual screening, biological evaluation and molecular simulation.
Discrepancy between effects of carbapenems and flomoxef in treating nosocomial hemodialysis access-related bacteremia secondary to extended spectrum beta-lactamase producing klebsiella pneumoniae in patients on maintenance hemodialysis.
Effective antimicrobial activity of Cbf-K16 and Cbf-A7 A13 against NDM-1-carrying Escherichia coli by DNA binding after penetrating the cytoplasmic membrane in vitro.
Epidemiology of VIM-1-imipenem resistant Pseudomonas aeruginosa in Iran: A systematic review and meta-analysis.
Multidrug-resistant organisms: A significant cause of severe sepsis in pediatric intestinal and multi-visceral transplantation.
New Delhi metallo-beta-lactamase: A weapon for the newly emerging drug-resistant bacteria.
New reactions in clavulanic acid biosynthesis.
Prevalence of Carbapenem Resistant Non-Fermenting Gram Negative Bacterial Infection and Identification of Carbapenemase Producing NFGNB Isolates by Simple Phenotypic Tests.
Rapid diagnosis of infections caused by beta-lactamase-producing bacteria by means of an enzyme radioisotopic assay.
Rational antibiotic therapy and the position of ampicillin/sulbactam.
Refined models of New Delhi metallo-beta-lactamase-1 with inhibitors: an QM/MM modeling study.
Structure-based functional fitness analyses of carbapenemase variants identified among pathogenic carbapenem-resistant Gram-negative bacteria.
Structure-based screening of inhibitors against KPC-2: designing potential drug candidates against multidrug-resistant bacteria.
Substrate selectivity and a novel role in inhibitor discrimination by position 237 in the KPC-2 {beta}-lactamase.
Sulbactam in combination with mezlocillin, piperacillin or cefotaxime: clinical and bacteriological findings in the treatment of serious bacterial infections.
The clinical development and launch of amoxicillin/clavulanate for the treatment of a range of community-acquired infections.
Ticarcillin/clavulanate compared with clindamycin/gentamicin (with or without ampicillin) for the treatment of intra-abdominal infections in pediatric and adult patients.
[Bacteriological and clinical evaluation tazobactam/piperacillin in infectious diseases in surgical field]
[Bacteriological study of chronic maxillary sinusitis in adults and observation of susceptibility to antibiotics]
[Clinical evaluation of sulbactam/ampicillin in children]
[Clinical evaluation of sultamicillin fine granules in pediatric patients]
[Clinical studies of sulbactam/cefoperazone therapy in pediatric bacterial infections]
[Pharmacokinetics and clinical efficacy of imipenem/cilastatin sodium in neonates]
[Recent intractable bacterial infections in otolaryngology]
[The new penicillins]
Bacteriuria
Emergence of community-acquired extended-spectrum beta-lactamase Escherichia coli (ESBLEC) in Honolulu: a case series of three individuals with community-acquired ESBLEC bacteriuria.
Key demographic characteristics of patients with bacteriuria due to extended spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae in a multiethnic community, in North West London.
Spinal Cord Injury Provider Knowledge and Attitudes Toward Bacteriuria Management and Antibiotic Stewardship.
Basal Cell Nevus Syndrome
Expression of cell cycle and apoptosis-related proteins in sporadic odontogenic keratocysts and odontogenic keratocysts associated with the nevoid basal cell carcinoma syndrome.
beta-lactamase deficiency
Multiple replicons constituting the genome of Pseudomonas cepacia 17616.
Response of Pseudomonas cepacia to beta-Lactam antibiotics: utilization of penicillin G as the carbon source.
Blindness
Degeneration of the cerebellar granule cell layer in transgenic mice expressing genes of human foamy virus.
Brain Abscess
Extended-Spectrum Beta-Lactamase-Producing Escherichia coli Meningitis and Cerebral Abscess in a Neonate: Therapeutic Challenge.
Neonatal Brain Abscess due to Extended-Spectrum Beta-Lactamase Producing Klebsiella pneumoniae.
Brain Diseases
Spectroscopic studies on Arabidopsis ETHE1, a glyoxalase II-like protein.
Brain Ischemia
Increased Neuronal Injury in Clock Gene Per-1 Deficient-Mice after Cerebral Ischemia.
Breast Neoplasms
Amplification and expression of the bcl-1 gene in human solid tumor cell lines.
Apoptosis induction of colorectal cancer cells HTL-9 in vitro by the transformed products of soybean isoflavones by Ganoderma lucidum.
BCL-1 participates in the 11q13 amplification found in breast cancer.
Chromosome 11q13, c-erbB-2, and c-myc amplification in invasive breast carcinoma: clinicopathologic correlations.
Elevated levels of tumour endothelial marker-8 in human breast cancer and its clinical significance.
High cell kinetics is associated with amplification of the int-2, bcl-1, myc and erbB-2 proto-oncogenes and loss of heterozygosity at the DF3 locus in primary breast cancers.
Hyaluronic acid-modified mesoporous silica-coated superparamagnetic Fe3O4 nanoparticles for targeted drug delivery.
Levels of expression of endothelial markers specific to tumour-associated endothelial cells and their correlation with prognosis in patients with breast cancer.
Novel beta-lactamase-random peptide fusion libraries for phage display selection of cancer cell-targeting agents suitable for enzyme prodrug therapy.
Synthesis and beta-lactamase-mediated activation of a cephalosporin-taxol prodrug.
The amplification unit on chromosome 11q13 in aggressive primary human breast tumors entails the bcl-1, int-2 and hst loci.
Bronchiectasis
Activities and sources of beta-lactamase in sputum from patients with bronchiectasis.
Role of beta-lactamases in the response of pulmonary infections to amoxycillin/clavulanate.
Bronchitis
Genetic diversity among strains of Moraxella catarrhalis: analysis using multiple DNA probes and a single-locus PCR-restriction fragment length polymorphism method.
Bronchitis, Chronic
Amoxycillin/clavulanate in acute purulent exacerbations of chronic bronchitis.
Augmentin in acute exacerbations of chronic bronchitis.
Bacteriology and beta-lactamase activity in acute exacerbation of chronic bronchitis.
Branhamella catarrhalis: antibiotic sensitivities and beta-lactamases.
The clinical relevance of in-vitro resistance to penicillin, ampicillin, amoxycillin and alternative agents, for the treatment of community-acquired pneumonia caused by Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis.
Burkitt Lymphoma
Molecular pathogenesis of non-Hodgkin lymphoma: a clinical perspective.
Overexpression of PRAD1 in a mantle zone lymphoma patient with a t(11;22)(q13;q11) translocation.
Utility of gene rearrangements in lymphoid malignancies.
[Molecular diagnosis of leukemia and lymphoma]
Carcinogenesis
Amplification and expression of the bcl-1 gene in human solid tumor cell lines.
Conversion of cadherin isoforms in cultured human gastric carcinoma cells.
miR-21 regulates N-methyl-N-nitro-N'-nitrosoguanidine-induced gastric tumorigenesis by targeting FASLG and BTG2.
Sterigmatocystin-induced checkpoint adaptation depends on Chk1 in immortalized human gastric epithelial cells in vitro.
The Gamma-glutamyltransferase gene of Helicobacter pylori can promote gastric carcinogenesis by activating Wnt signal pathway through up-regulating TET1.
[Activation of proto-oncogenes induced by MNNG on primary culture of human gastric epithelium and immortalized human gastric epithelial cell line]
[Expression of bcl-2 gene in EBV-transformed human gastric epithelial cell line GES-1]
[Study of APC, Rb, c-met gene copy numbers of human gastric mucosa epithelial cell line GES-1]
Carcinoma
Amplification of int-2 and bcl-1 genes in squamous cell carcinoma of the larynx.
Autophagy-mediated HMGB1 release promotes gastric cancer cell survival via RAGE activation of extracellular signal-regulated kinases 1/2.
BCL-1 participates in the 11q13 amplification found in breast cancer.
Coamplification of the hst and bcl-1 oncogenes in advanced squamous cell carcinomas of the head and neck.
Conversion of cadherin isoforms in cultured human gastric carcinoma cells.
Curcumin induces apoptosis in human gastric carcinoma AGS cells and colon carcinoma HT-29 cells through mitochondrial dysfunction and endoplasmic reticulum stress.
D11S287, a putative oncogene on chromosome 11q13, is amplified and expressed in squamous cell and mammary carcinomas and linked to BCL-1.
Evolution of a gastric carcinoma cell-specific DNA aptamer by live cell-SELEX.
Expression of cell cycle and apoptosis-related proteins in sporadic odontogenic keratocysts and odontogenic keratocysts associated with the nevoid basal cell carcinoma syndrome.
Fiber confocal back-scattering micro-spectral analysis for single cell.
Frequent amplification of 11q13 DNA markers is associated with lymph node involvement in human head and neck squamous cell carcinomas.
Frequent amplification of the bcl-1 locus in head and neck squamous cell carcinomas.
Frequent amplification of the bcl-1 locus in poorly differentiated squamous cell carcinoma of the lung. The Lung Cancer Study Group.
Genetic construction, expression, and characterization of a single chain anti-carcinoma antibody fused to beta-lactamase.
High cell kinetics is associated with amplification of the int-2, bcl-1, myc and erbB-2 proto-oncogenes and loss of heterozygosity at the DF3 locus in primary breast cancers.
Human intestinal circadian clock: expression of clock genes in colonocytes lining the crypt.
Oncogenes and tumour-suppressor genes in squamous cell carcinoma of the head and neck.
Overexpression of cyclin-D1, bcl-2, and bax proteins, proliferating cell nuclear antigen (PCNA), and DNA-ploidy in squamous cell carcinoma of the oral cavity.
PBX1 attributes as a determinant of connexin 32 downregulation in Helicobacter pylori-related gastric carcinogenesis.
Profiling and classification tree applied to renal epithelial tumours.
Pyruvate Kinase M2 Knockdown Suppresses Migration, Invasion, and Epithelial-Mesenchymal Transition of Gastric Carcinoma via Hypoxia-Inducible Factor Alpha/B-Cell Lymphoma 6 Pathway.
Serum Interleukin-33 Levels in Patients with Gastric Cancer.
The natural secolignan peperomin E induces apoptosis of human gastric carcinoma cells via the mitochondrial and PI3K/Akt signaling pathways in vitro and in vivo.
Therapeutic effects of monoclonal antibody-beta-lactamase conjugates in combination with a nitrogen mustard anticancer prodrug in models of human renal cell carcinoma.
TMEM119 silencing inhibits cell viability and causes the apoptosis of gastric cancer SGC-7901 cells.
[A SHV-derived extended-spectrum beta-lactamase (SHV-12) produced by an Escherichia coli recovered from wound abscess in post operative case with rectal carcinoma]
[Effect of MicroRNA-199 on Proliferation and Migration of Gastric Carcinoma Cells].
[Expression of bcl-2 gene in EBV-transformed human gastric epithelial cell line GES-1]
[Expression of OCT4 in gastric cancer cell lines and its significance].
Carcinoma, Basal Cell
Expression of cell cycle and apoptosis-related proteins in sporadic odontogenic keratocysts and odontogenic keratocysts associated with the nevoid basal cell carcinoma syndrome.
Carcinoma, Hepatocellular
Fiber confocal back-scattering micro-spectral analysis for single cell.
Carcinoma, Renal Cell
Profiling and classification tree applied to renal epithelial tumours.
Therapeutic effects of monoclonal antibody-beta-lactamase conjugates in combination with a nitrogen mustard anticancer prodrug in models of human renal cell carcinoma.
Carcinoma, Squamous Cell
Amplification of int-2 and bcl-1 genes in squamous cell carcinoma of the larynx.
Coamplification of the hst and bcl-1 oncogenes in advanced squamous cell carcinomas of the head and neck.
Frequent amplification of 11q13 DNA markers is associated with lymph node involvement in human head and neck squamous cell carcinomas.
Frequent amplification of the bcl-1 locus in head and neck squamous cell carcinomas.
Frequent amplification of the bcl-1 locus in poorly differentiated squamous cell carcinoma of the lung. The Lung Cancer Study Group.
Cardiovascular Diseases
Risk factors for fluoroquinolone resistance in Enterococcus urinary tract infections in hospitalized patients.
[Study of beta-lactamase activity of staphylococci from different sources]
Catheter-Related Infections
KPC-2 producing Klebsiella pneumoniae and Escherichia coli co-infection in a catheter-related infection.
Cellulitis
[The practice guideline 'Bacterial skin infections' (first revision) from the Dutch College of General Practitioners; a response from the perspective of dermatology]
Central Nervous System Diseases
Beta-lactamase inhibitors display anti-seizure properties in an invertebrate assay.
Cerebral Infarction
[Relationship between multi-locus fibrinogen polymorphisms and fibrinogen concentration, molecular reactivity and cerebral infarction]
Cerebrospinal Fluid Leak
Clinical characteristics of post-neurosurgical Klebsiella pneumoniae meningitis in adults and a clinical comparison to the spontaneous form in a Taiwanese population.
Chlamydophila Infections
[Epidemiology of community-acquired pneumonia in children. Current data]
Cholangitis
Extended Spectrum-?-Lactamase or Carbapenemase Producing Bacteria Isolated from Patients with Acute Cholangitis.
Successful medical treatment in a child with E. coli ESBL meningitis with acute communicating hydrocephalus and ventricular empyema: a case report.
[Bacteriological and clinical evaluation tazobactam/piperacillin in infectious diseases in surgical field]
[Clinical effect of cefmenoxime on cholecystitis; its clinical efficacy and tissue concentration]
[Clinical studies on 6059-S for biliary tract diseases. Clinical effect and tissue concentration (author's transl)]
[Studies on cefoperazone concentration in human biliary tract and clinical effect for acute cholecystitis and cholangitis (author's transl)]
Cholecystitis
[Clinical effect of cefmenoxime on cholecystitis; its clinical efficacy and tissue concentration]
[Studies on cefotaxime (HR 756) concentration in human biliary tract and clinical effect for acute or subacute cholecystitis with cholelithiasis (author's transl)]
Cholecystitis, Acute
Antibiotic resistance pattern and clinical outcomes in acute cholecystitis: 567 consecutive worldwide patients in a prospective cohort study.
[Clinical studies on 6059-S for biliary tract diseases. Clinical effect and tissue concentration (author's transl)]
[Studies on cefoperazone concentration in human biliary tract and clinical effect for acute cholecystitis and cholangitis (author's transl)]
Choledocholithiasis
Risk factors of organ failure in cholangitis with bacteriobilia.
Cholelithiasis
[Studies on cefoperazone concentration in human biliary tract and clinical effect for acute cholecystitis and cholangitis (author's transl)]
[Studies on cefotaxime (HR 756) concentration in human biliary tract and clinical effect for acute or subacute cholecystitis with cholelithiasis (author's transl)]
Cholera
Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study.
Chorioamnionitis
Successful prone positioning after recent caesarean section in severe ARDS with postpartum pulmonary haemorrhage.
Chronic Periodontitis
beta-Lactamase producing bacteria in adult periodontitis.
Prevalence of extended spectrum beta-lactamase producing anaerobic bacteria in chronic periodontitis.
Clostridium Infections
Adverse Reactions Associated with Penicillins, Carbapenems, Monobactams, and Clindamycin: A Retrospective Population-based Study.
Development of SYN-004, an oral beta-lactamase treatment to protect the gut microbiome from antibiotic-mediated damage and prevent Clostridium difficile infection.
Severe community onset healthcare-associated Clostridium difficile infection complicated by carbapenemase producing Klebsiella pneumoniae bloodstream infection.
Coinfection
beta-Lactamase produced by a highly beta-lactam-resistant strain of Bacteroides fragilis: an obstacle to the chemotherapy of experimental mixed infections.
Ceftaroline plus avibactam demonstrates bactericidal activity against pathogenic anaerobic bacteria in a one-compartment in vitro pharmacokinetic/pharmacodynamic model.
Co-infection With Chromosomally-Located bla CTX-M-14 and Plasmid-Encoding bla CTX-M-15 in Pathogenic Escherichia coli in the Republic of Korea.
Co-Infections of Two Strains of NDM-1 and OXA-232 Co-producing Klebsiella pneumoniae in a Kidney Transplant Patient.
Coinfection with Human Norovirus and Escherichia coli O25:H4 Harboring Two Chromosomal blaCTX-M-14 Genes in a Foodborne Norovirus Outbreak in Shizuoka Prefecture, Japan.
Dissemination of CTX-M-type extended-spectrum beta-lactamase genes to unusual hosts.
Ecological effects on the oro- and nasopharyngeal microflora in children after treatment of acute otitis media with cefuroxime axetil or amoxycillin-clavulanate as suspensions.
Effect of aspoxicillin on anaerobic bacteria.
In vitro susceptibility vs. in vivo efficacy of various antimicrobial agents against the Bacteroides fragilis group.
In vivo protection of penicillin-susceptible Bacteroides melaninogenicus from penicillin by facultative bacteria which produce beta-lactamase.
In-vivo protection of group A beta-haemolytic streptococci from penicillin by beta-lactamase-producing Bacteroides species.
Infectious morbidity in gynecologic cancer.
Klebsiella pneumoniae carrying bla NDM-1 gene in orthopedic practice.
KPC-2 producing Klebsiella pneumoniae and Escherichia coli co-infection in a catheter-related infection.
NDM-1 polymicrobial infections including Vibrio cholerae.
Oral streptococcal strains isolated from odontogenic infections and their susceptibility to antibiotics.
Patient costs for prophylaxis and treatment of obstetric and gynecologic surgical infections.
Simultaneous Infection with Enterobacteriaceae and Pseudomonas aeruginosa Harboring Multiple Carbapenemases in a Returning Traveler Colonized with Candida auris.
The role of beta-lactamase in mixed infections in mice in relation to treatment with ampicillin.
Ticarcillin disodium and clavulanate potassium in the treatment of post-cesarean-section endomyometritis.
[Bacteriological and clinical evaluation tazobactam/piperacillin in infectious diseases in surgical field]
[Clinically isolated bacterii seen in complicated infections]
[Pharmacokinetics and clinical efficacy of imipenem/cilastatin sodium in neonates]
Colitis
Anaerobic infections and Clostridium difficile colitis emerging during antibacterial therapy.
Comparison of adhesin genes expression among Klebsiella oxytoca ESBL-non-producers in planktonic and biofilm mode of growth, and imipenem sublethal exposure.
Colonic Neoplasms
High-throughput fluorescence anisotropy screen for inhibitors of the oncogenic mRNA binding protein, IMP-1.
IMP-1 Displays Cross-Talk with K-Ras and Modulates Colon Cancer Cell Survival through the Novel Proapoptotic Protein CYFIP2.
Prognostic values of tumor endothelial markers in patients with colorectal cancer.
The Preventive Effect of the Phenotype of Tumour-Associated Macrophages, Regulated by CD39, on Colon Cancer in Mice.
Tumour endothelial marker 8 (TEM-8) in human colon cancer and its association with tumour progression.
Colorectal Neoplasms
Apoptosis induction of colorectal cancer cells HTL-9 in vitro by the transformed products of soybean isoflavones by Ganoderma lucidum.
Detection of epithelial cells by RT-PCR targeting CEA, CK20, and TEM-8 in colorectal carcinoma patients using OncoQuick density gradient centrifugation system.
Flow cytometric DNA analysis is useful in detecting multiple genetic alterations in squamous cell carcinoma of the esophagus.
Influence of tumor microenvironment on prognosis in colorectal cancer: Tissue architecture-dependent signature of endosialin (TEM-1) and associated proteins.
Prognostic values of tumor endothelial markers in patients with colorectal cancer.
Quantitative analysis of TEM-8 and CEA tumor markers indicating free tumor cells in the peripheral blood of colorectal cancer patients.
Retraction RETRACTION of "Absolute quantification of free tumor cells in the peripheral blood of gastric cancer patients" by N. Bayat, M.M. Mokhtari, M. Rezaei-Tavirani, A. Baradaran-Rafii, S. Rahman Zadeh, S. Heidari-Keshel and F. Ghasemvand. Genet. Mol. Res. 13 (2): 4425-4432 (2014).
Coma
Longitudinal Analysis of Risk Factors for Clinical Outcomes of Enterobacteriaceae Meningitis/Encephalitis in Post-Neurosurgical Patients: A Comparative Cohort Study During 2014-2019.
Communicable Diseases
A novel chimeric peptide with antimicrobial activity.
An Evidence-Based Multidisciplinary Approach Focused at Creating Algorithms for Targeted Therapy of BSIs, cUTIs, and cIAIs Caused by Enterobacterales in Critically Ill Adult Patients.
Beta-lactamase inhibition: therapeutic implication in infectious diseases. St. Philip, Barbados, 20-21 January 1989.
Communication between the active site and the allosteric site in class A beta-lactamases.
Emergence of blaNDM-1 among Klebsiella pneumoniae ST15 and novel ST1031 clinical isolates in China.
Emergence of Carbapenem- and Tigecycline-Resistant Proteus cibarius of Animal Origin.
High Prevalence of Infectious Diseases and Drug-Resistant Microorganisms in Asylum Seekers Admitted to Hospital; No Carbapenemase Producing Enterobacteriaceae until September 2015.
Inhibitory effect of soy saponins on the activity of ?-lactamases, including New Delhi metallo-?-lactamase 1.
Long-term Follow-up of Preterm Infants Having Been Colonized With Extended Spectrum Beta-lactamase-producing Enterobacterales Over the First 6 Years of Life.
Penicillinase as a potential enzyme marker for enzyme linked immunosorbent assay and its application in immunodiagnostics.
Prevalence of multiresistant gram-negative organisms in a tertiary hospital in Mwanza, Tanzania.
The Life Cycle of a Virus: The Infectious Disease Narrative of NDM-1.
[A trial of simple and rapid carbapenemase big five gene analysis using LAMP method].
[Bacteriological and clinical evaluation tazobactam/piperacillin in infectious diseases in surgical field]
[Clinical evaluation of metallo-beta-lactamase producing bacterium]
[Clinical study of sultamicillin fine granules]
[Evaluation of beta-lactamase detection reagent with used HMRZ-86 for the detection of extended-spectrum beta-lactamase and metallo-beta-lactamase]
[In vitro activity of faropenem against beta-lactamase producing clinical isolates]
[Pharmacokinetic, bacteriological and clinical studies on cefpodoxime proxetil in the field of pediatrics]
[Role of beta-lactamase inhibitors in the etiotropic therapy of infectious diseases]
[Studies on sulbactam/ampicillin in the field of pediatrics]
[The taxonomic distribution, characteristic and susceptibility against antimicrobial agents of methicillin-resistant staphylococci isolated from blood]
[Use of antibiotics in general practice and at the Clinic for Infectious Diseases]
Community-Acquired Infections
An Outbreak of KPC-Producing Klebsiella pneumoniae Linked with an Index Case of Community-Acquired KPC-Producing Isolate: Epidemiological Investigation and Whole Genome Sequencing Analysis.
Antibacterial activity of Limonium brasiliense (Baicuru) against multidrug-resistant bacteria using a statistical mixture design.
Antibiogram, Prevalence of OXA Carbapenemase Encoding Genes, and RAPD-Genotyping of Multidrug-Resistant Acinetobacter baumannii Incriminated in Hidden Community-Acquired Infections.
Antibiotic resistance pattern and clinical outcomes in acute cholecystitis: 567 consecutive worldwide patients in a prospective cohort study.
Clinical characteristics of post-neurosurgical Klebsiella pneumoniae meningitis in adults and a clinical comparison to the spontaneous form in a Taiwanese population.
CTX-M type extended spectrum beta-lactamases in Escherichia coli isolates from community acquired upper urinary tract infections at a university in the European part of Turkey.
Emergency surgery for tubo-ovarian abscess identified extended-spectrum beta-lactamase-producing Escherichia coli: the first case presentation revealing causative bacteria.
Enterobacter cloacae infection of an expanded polytetrafluoroethylene femoral-popliteal bypass graft: a case report.
Escherichia coli producing SHV-type extended-spectrum beta-lactamase is a significant cause of community-acquired infection.
Extended spectrum beta-lactamases (ESBL) in Escherichia coli and Klebsiella pneumoniae: trends in the hospital and community settings.
Extended-Spectrum beta-Lactamase Genes of Klebsiella pneumoniae Strains in Taiwan: Recharacterization of shv-27, shv-41, and tem-116.
Extended-Spectrum Beta-Lactamase-Producing Escherichia coli in Drinking Water Samples From a Forcibly Displaced, Densely Populated Community Setting in Bangladesh.
Fecal carriage of extended-spectrum beta-lactamase and ampc beta-lactamase-producing enterobacteriaceae in a turkish community.
High prevalence of bla extended-spectrum beta(CTX-M)-lactamase genes in Escherichia coli isolates from pets and emergence of CTX-M-64 in China.
High rate of intestinal colonization with extended-spectrum-beta-lactamase-producing organisms in household contacts of infected community patients.
Incidence of beta-lactamase production among out patient clinical isolates in Middle Eastern countries and their antibiotic susceptibilities. Middle Eastern Study Group.
Increasing Prevalence of Escherichia coli and Klebsiella pneumoniae Producing CTX-M-Type Extended-Spectrum Beta-Lactamase, Carbapenemase, and NDM-1 in Patients from a Rural Community with Community Acquired Infections: A 3-Year Study.
Intra-abdominal infections: review of the bacteriology, antimicrobial susceptibility and the role of ertapenem in their therapy.
Phenotypic Detection of Carbapenemase Production in Carbapenem-Resistant Enterobacteriaceae by Modified Hodge Test and Modified Strip Carba NP Test.
Stability in the presence of widespread beta-lactamases. A prerequisite for the antibacterial activity of beta-lactam drugs.
The menace of beta-lactamase production on antibiotic prescription in community acquired-infections in Nigeria.
[Antimicrobial activities of sultamicillin against clinical isolates obtained from outpatients]
[Drug-resistant bacteria in clinical situations]
[Evaluation of the ChromID ESBL Agar for the Detection of ESBL-Positive Enterobacteriaceae and Vancomycin-Resistant Enterococcus Isolates from Urine Cultures].
[Investigation of beta-lactamase genes and clonal relationship among the extended-spectrum beta-lactamase producing nosocomial Escherichia coli isolates].
[Investigation of carbapenemase genes and molecular epidemiology of Enterobacteriaceae strains isolated between 2010-2014 in a university hospitals].
Confusion
B-cell lymphomas with coexpression of CD5 and CD10.
Conjunctivitis
Analysis of IMP-1 type metallo-?-lactamase-producing Acinetobacter radioresistens isolated from companion animals.
Increasing bacterial resistance in pediatric acute conjunctivitis (1997-1998).
PPNG conjunctivitis.
[Description and investigation of an outbreak of extended-spectrum beta-lactamase producing Escherichia coli strain in a neonatal unit]
COVID-19
Emerging Co-Pathogens: New Delhi Metallo-beta-lactamase producing Enterobacterales Infections in New York City COVID-19 Patients.
Outbreak of NDM-1-producing Klebsiella pneumoniae in the intensive care unit during the COVID-19 pandemic: Another nightmare.
Craniocerebral Trauma
First detection of VIM-4 metallo-?-lactamase-producing Escherichia coli in Russia.
Cross Infection
6-Halopyridylmethylidene Penicillin-Based Sulfones Efficiently Inactivate the Natural Resistance of Pseudomonas aeruginosa to ?-Lactam Antibiotics.
A new fimbrial antigen harbored by CAZ-5/SHV-4-producing Klebsiella pneumoniae strains involved in nosocomial infections.
Alliance of Efflux Pumps with ?-Lactamases in Multidrug-Resistant Klebsiella pneumoniae Isolates.
An observational study on bloodstream extended-spectrum beta-lactamase infection in critical care unit: incidence, risk factors and its impact on outcome.
Analysis of the molecular characteristics of a blaKPC-2-harbouring untypeable plasmid in Serratia marcescens.
Antibiotic resistance and genotype of beta-lactamase producing Escherichia coli in nosocomial infections in Cotonou, Benin.
Antibiotic Resistance Pattern and Evaluation of Metallo-Beta Lactamase Genes Including bla- IMP and bla- VIM Types in Pseudomonas aeruginosa Isolated from Patients in Tehran Hospitals.
Antimicrobial activity of doripenem (S-4661): a global surveillance report (2003).
Antimicrobial susceptibility and molecular epidemiological analysis of clinical strains of Pseudomonas aeruginosa.
bla(IMP) and bla(VIM) mediated carbapenem resistance in Pseudomonas and Acinetobacter species in India.
Carbapenem Resistant Aeromonas hydrophila Carrying bla cphA7 Isolated From Two Solid Organ Transplant Patients.
Carbapenemase among Clinical Bacterial Isolates in Nepal.
Cefepime and its role in pediatric infections.
Characterization of Carbapenemases in Extensively Drug Resistance Acinetobacter baumannii in a Burn Care Center in Iran.
Clinical outcome and risk factors related to extended-spectrum beta-lactamase-producing Klebsiella spp. infection among hospitalized patients.
Co-Carriage of blaKPC-2 and blaNDM-1 in Clinical Isolates of Pseudomonas aeruginosa Associated with Hospital Infections from India.
Complete Genome Sequence of an Acinetobacter Strain Harboring the NDM-1 Gene.
Detection and characterization of carbapenem resistant Gram-negative bacilli isolates recovered from hospitalized patients at Soba University Hospital, Sudan.
Detection of blaoxa genes and identification of biofilm-producing capacity of Acinetobacter baumannii in a tertiary teaching hospital, Klaten, Indonesia.
Detection of metallo-beta-lactamase producing Pseudomonas aeruginosa in intensive care units.
Development and Validation of a Single-Tube Multiple-Locus Variable Number Tandem Repeat Analysis for Klebsiella pneumoniae.
Dissemination of multi-resistant Gram-negative bacteria into German wastewater and surface waters.
Emergence and Expansion of a Carbapenem-Resistant Pseudomonas aeruginosa Clone Are Associated with Plasmid-Borne bla KPC-2 and Virulence-Related Genes.
Emergence and prevalence of beta-lactamase-producing Klebsiella pneumoniae resistant to cephems in Japan.
EMERGENCE OF CO-CARBAPENEMASE GENES, BLA(OXA23), BLA(VIM) AND BLA(NDM) IN CARBAPENEMRESISTANT ACINETOBACTER BAUMANNII CLINICAL ISOLATES.
Emergence of IncFIA Plasmid-Carrying blaNDM-1 Among Klebsiella pneumoniae and Enterobacter cloacae Isolates in a Tertiary Referral Hospital in Mexico.
Endemic dissemination of different sequence types of carbapenem-resistant Klebsiella pneumoniae strains harboring blaNDM and 16S rRNA methylase genes in Kerman hospitals, Iran, from 2015 to 2017.
Epidemic and endemic spread of Klebsiella pneumoniae producing SHV-5 beta-lactamase in Dubrava University Hospital, Zagreb, Croatia.
Extended spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae isolated in a rural hospital.
Extended-spectrum beta-lactamase producing Klebsiella pneumoniae in neonatal intensive care unit.
Extended-spectrum beta-lactamase-producing bacteria in a tertiary care hospital in Madrid: epidemiology, risk factors and antimicrobial susceptibility patterns.
Extended-spectrum beta-lactamases and clinical outcomes: current data.
Factors behind the prevalence of carbapenem-resistant Klebsiella pneumoniae in pediatric wards.
Genetic analysis of ESBL-producing Klebsiella pneumoniae isolated from UTI patients in Indonesia.
Genomic Analysis Of A KPC-2-Producing Klebsiella Pneumoniae ST11 Outbreak From A Teaching Hospital In Shandong Province, China.
Genomic analysis of a pan-resistant Klebsiella pneumoniae sequence type 11 identified in Japan in 2016.
Health and economic outcomes of the detection of Klebsiella pneumoniae-produced extended-spectrum beta-lactamase (ESBL) in a hospital with high prevalence of this infection.
High prevalence of extended spectrum beta-lactamase production among Klebsiella pneumoniae strains isolated at a University Hospital in Turkey.
Horizontal gene transfer-emerging multidrug resistance in hospital bacteria.
Identification of Klebsiella pneumoniae strains harboring inactive extended-spectrum beta-lactamase antibiotic-resistance genes.
Impact of beta-lactamases on the clinical use of beta-lactam antibiotics.
In vitro activity of cefiderocol against aerobic Gram-negative bacterial pathogens from Germany.
In vitro and in vivo potency of polymyxin B against IMP-type metallo-beta-lactamase-producing Pseudomonas aeruginosa.
Incidence of metallo-beta-lactamase-producing Pseudomonas aeruginosa in diabetes and cancer patients.
Infection control and antimicrobial restriction practices for antimicrobial-resistant organisms in Canadian tertiary care hospitals.
Intermolecular interactions of the extended recognition site of VIM-2 metallo-?-lactamase with 1,2,4-triazole-3-thione inhibitors. Validations of a polarizable molecular mechanics potential by ab initio QC.
International prospective study of Klebsiella pneumoniae bacteremia: implications of extended-spectrum beta-lactamase production in nosocomial Infections.
Low incidence of multidrug-resistant bacteria and nosocomial infection due to a preventive multimodal nosocomial infection control: a 10-year single centre prospective cohort study in neurocritical care.
Measuring the quality of infection control in Dutch nursing homes using a standardized method; the Infection prevention RIsk Scan (IRIS).
Microbiologic study of the pathogens isolated from wound culture among Wenchuan earthquake survivors.
Molecular characterization of carbapenem-resistant Klebsiella pneumoniae isolates from a university hospital in Brazil.
Molecular characterization of KPC-producing Klebsiella pneumoniae isolated from patients in a Public Hospital in Caracas, Venezuela.
Molecular epidemiology of KPC-producing Klebsiella pneumoniae isolated from patients in two public hospitals in Carabobo and Zulia states, Venezuela.
Mortality in patients with multidrug-resistant Pseudomonas aeruginosa infections: a meta-analysis.
Multidrug-resistant Klebsiella pneumoniae outbreak after endoscopic retrograde cholangiopancreatography.
Multiple antibiotic resistance (MAR) index and its reversion in Pseudomonas aeruginosa.
Nosocomial infection by VIM-2 metallo-beta-lactamase producing Pseudomonas putida.
Nosocomial infections by Klebsiella pneumoniae carbapenemase producing enterobacteria in a teaching hospital.
Nosocomial infections caused by multidrug-resistant isolates of pseudomonas putida producing VIM-1 metallo-beta-lactamase.
Nosocomial infections caused by multidrug-resistant Pseudomonas putida isolates producing VIM-2 and VIM-4 metallo-beta-lactamases.
Outbreak of nosocomial infections due to Klebsiella pneumoniae producing SHV-4 beta-lactamase.
Plasmid-mediated dissemination of the metallo-beta-lactamase gene blaIMP among clinically isolated strains of Serratia marcescens.
Prevalence and Molecular Characterization of Plasmid-mediated Extended-Spectrum ?-Lactamase Genes (balaTEM, blaCTX and blASHV) Among Urinary Escherichia coli Clinical Isolates in Mashhad, Iran.
Prevalence of extended-spectrum beta-lactamase genes in Acinetobacter baumannii strains isolated from nosocomial infections in Tehran, Iran.
Prevalence of metallo-beta-lactamase-producing Pseudomonas aeruginosa isolated from diabetic foot ulcer patients.
Prevalence of metallo?beta?lactamase producing Acinetobacter baumannii isolated from intensive care unit in tertiary care hospitals.
Pseudomonas aeruginosa - a phenomenon of bacterial resistance.
Quantitative detection of metallo-beta-lactamase of blaIMP-cluster-producing Pseudomonas aeruginosa by real-time polymerase chain reaction with melting curve analysis for rapid diagnosis and treatment of nosocomial infection.
Resistance patterns among nosocomial pathogens: trends over the past few years.
Risk factors and outcomes of bloodstream infections with metallo-beta-lactamase-producing Acinetobacter.
Risk factors and prognosis of nosocomial bloodstream infections caused by extended-spectrum-beta-lactamase-producing Escherichia coli.
Risk factors for extended-spectrum beta-lactamase-producing Escherichia coli infection in hospitalized patients.
Risk factors for infection by extended-spectrum beta-lactamase producing Klebsiella pneumoniae in a tertiary hospital in Salvador, Brazil.
Risk factors for nosocomial infections due to Pseudomonas aeruginosa producing metallo-{beta}-lactamase in two tertiary-care teaching hospitals.
Risk factors for the infection and/or colonization of extended-spectrum beta-lactamase-producing bacteria in a neonatal intensive care unit: a meta-analysis.
Risk factors of nosocomial infection with extended-spectrum Beta-lactamase-producing bacteria in a neonatal intensive care unit in china.
Role of Imipenem-resistant metallo-beta-lactamase positive pseudomonas aeruginosa carriers in nosocomial infections.
Suspected nosocomial infections with multi-drug resistant E. coli, including extended-spectrum beta-lactamase (ESBL)-producing strains, in an equine clinic.
The influence of Imipenem resistant metallo-beta-lactamase positive and negative Pseudomonas aeruginosa nosocomial infections on mortality and morbidity.
The influence of metallo-beta-lactamase production on mortality in nosocomial Pseudomonas aeruginosa infections.
Ventilator-associated pneumonia caused by colistin-resistant KPC-producing Klebsiella pneumoniae: a case report and literature review.
[Association of genotype of OXA-carbapenemases of Acinetobacter baumannii and antibiotic resistance]
[Beta-lactamase inhibitors]
[Change of ESBLs-KPN and ESBLs-ECO after antimicrobial intervention.]
[Evaluation of beta-lactamase detection reagent with used HMRZ-86 for the detection of extended-spectrum beta-lactamase and metallo-beta-lactamase]
[Evaluation of the ChromID ESBL Agar for the Detection of ESBL-Positive Enterobacteriaceae and Vancomycin-Resistant Enterococcus Isolates from Urine Cultures].
[Fluoroquinolone and aminoglycoside resistance in chromosomal cephalosporinase-overproducing gram-negative bacilli strains with inducible beta-lactamase]
[Implication of extended-spectrum beta-lactamase enterobacteriaceae in nosocomial infections in neonates]
[Investigation on the antibiotic resistance and risky factors of nosocomial infections caused by Stenotrophomonas maltophilia]
[Isolation and analysis of the drug resistance of the flavobacterium and its production of beta-lactamases]
[Microbiological aspects of antibiotics with immunomodulating action]
[Phenotypic and molecular identification of extended-spectrum beta-lactamase (ESBL) TEM and SHV produced by clinical isolates Escherichia coli and Klebsiella spp. in hospitals].
[Rapid and accurate detection of resistant bacteria for respiratory tract infection--present situation and future]
[The clinical significance of Pseudomonas aeruginosa typing and R-plasmid and DNA molecule hybridization in patients with cor pulmonale]
[Typing of extended-spectrum beta-lactamase-producing Salmonella typhimurium strains isolated in a pediatric unit]
Cystic Fibrosis
Activity of a novel combination against multidrug-resistant nonfermenters: ceftazidime plus NXL104.
Activity of BAL30376 (monobactam BAL19764 + BAL29880 + clavulanate) versus Gram-negative bacteria with characterized resistance mechanisms.
Antibodies against beta-lactamase can improve ceftazidime treatment of lung infection with beta-lactam-resistant Pseudomonas aeruginosa in a rat model of chronic lung infection.
Antibodies against chromosomal beta-lactamase.
Antibodies against Pseudomonas aeruginosa chromosomal beta-lactamase inpatients with cystic fibrosis are markers of the development of resistance of P. aeruginosa to beta-lactams.
Avidity of anti-P aeruginosa antibodies during chronic infection in patients with cystic fibrosis.
Characterization of paired mucoid/non-mucoid Pseudomonas aeruginosa isolates from Danish cystic fibrosis patients: antibiotic resistance, beta-lactamase activity and RiboPrinting.
Chronic infection sustained by a Pseudomonas aeruginosa High-Risk clone producing the VIM-1 metallo-?-lactamase in a cystic fibrosis patient after lung transplantation.
Clinically significant carbapenemases: an update.
Decreased baseline beta-lactamase production and inducibility associated with increased piperacillin susceptibility of Pseudomonas cepacia isolated from children with cystic fibrosis.
Derepressed beta-lactamase synthesis in strains of Pseudomonas aeruginosa isolated from patients with cystic fibrosis.
Differences in drug susceptibility between isolates of Pseudomonas cepacia recovered from patients with cystic fibrosis and other sources and its relationship to beta-lactamase focusing pattern.
Effect of pH and CO2 on in vitro susceptibility of Pseudomonas cepacia to beta-lactams.
Efflux pumps, OprD porin, AmpC beta-lactamase, and multiresistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
Enterobacter cloacae harbouring blaKPC-2 and qnrB-1 isolated from a cystic fibrosis patient: a case report.
Epidemiology of multi-drug-resistant gram-negative bacteria: data from an university hospital over a 36-month period.
Evaluation of phenotypic screening tests for carbapenemase production in Pseudomonas aeruginosa from patients with cystic fibrosis.
High-level beta-lactamase activity in sputum samples from cystic fibrosis patients during antipseudomonal treatment.
KPC-2 Carbapenemase-producing Klebsiella pneumoniae isolates from patients with Cystic Fibrosis.
Lack of efflux mechanism in a clinical isolate of Pseudomonas aeruginosa highly resistant to beta-lactams and imipenem.
Loss of activity of ceftazidime-avibactam due to MexAB-OprM efflux and overproduction of AmpC cephalosporinase in Pseudomonas aeruginosa isolated from patients suffering from cystic fibrosis.
Metallo-beta-lactamase VIM-2 in Pseudomonas aeruginosa isolates from a cystic fibrosis patient.
Molecular surveillance for carbapenemase genes in carbapenem-resistant Pseudomonas aeruginosa in Australian patients with cystic fibrosis.
Phenotypic and Genetic Characterization of Carbapenemase and ESBLs Producing Gram-negative Bacteria (GNB) Isolated from Patients with Cystic Fibrosis (CF) in Tehran Hospitals.
Pilot study of outcomes in pediatric rhinosinusitis.
Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response.
Pseudomonas aeruginosa infection in cystic fibrosis caused by an epidemic metallo-?-lactamase-producing clone with a heterogeneous carbapenem resistance phenotype.
Pseudomonas aeruginosa isolates from patients with cystic fibrosis have different beta-lactamase expression phenotypes but are homogeneous in the ampC-ampR genetic region.
Quantitative analysis of the IgG and IgG subclass immune responses to chromosomal Pseudomonas aeruginosa beta-lactamase in serum from patients with cystic fibrosis by western blotting and laser scanning densitometry.
Rapid development in vitro and in vivo of resistance to ceftazidime in biofilm-growing Pseudomonas aeruginosa due to chromosomal beta-lactamase.
Rapid emergence of resistance in Pseudomonas aeruginosa in cystic fibrosis patients due to in-vivo selection of stable partially derepressed beta-lactamase producing strains.
Role of efflux pumps: MexAB-OprM and MexXY(-OprA), AmpC cephalosporinase and OprD porin in non-metallo-?-lactamase producing Pseudomonas aeruginosa isolated from cystic fibrosis and burn patients.
The effect of augmentin on sputum beta-lactamase activity in patients with cystic fibrosis.
The influence of allotypes on the IgG subclass response to chromosomal beta-lactamase of Pseudomonas aeruginosa in cystic fibrosis patients.
[Surveillance of Pseudomonas aeruginosa sensitivity to antibiotics in France and distribution of beta-lactam resistance mechanisms: 1998 GERPB study]
Cystitis
A Pediatric Case of New Delhi Metallo-Beta-Lactamase (NDM-1)-Producing Enterobacteriaceae in the United States.
Analysis of IMP-1 type metallo-?-lactamase-producing Acinetobacter radioresistens isolated from companion animals.
Complete sequencing of the FII plasmid pHK01, encoding CTX-M-14, and molecular analysis of its variants among Escherichia coli from Hong Kong.
Emphysematous Cystitis.
[Clinical studies on sultamicillin fine granules in the urological field]
[Detection of beta-lactamase-producing bacteria from female patients with acute uncomplicated cystitis]
Cysts
Beta-lactam antibiotics resistant Rothia dentocariosa from infected postoperative maxillary cyst: studies on R-plasmid and beta-lactamase.
Dengue
The use of beta-lactamase in enzyme immunoassays for detection of microbial antigens.
Dermatitis, Phototoxic
Selective photodynamic inactivation of Helicobacter pylori by a cationic benzylidene cyclopentanone photosensitizer - an in vitro and ex vivo study.
Diabetes Mellitus
Bacterial Profiles and Their Associated Factors of Urinary Tract Infection and Detection of Extended Spectrum Beta-Lactamase Producing Gram-Negative Uropathogens Among Patients with Diabetes Mellitus at Dessie Referral Hospital, Northeastern Ethiopia.
Inverse association between use of broad spectrum penicllin with beta-lactamase inhibitors and prevalence of type 1 diabetes mellitus in Europe.
Diabetes Mellitus, Type 1
Inverse association between use of broad spectrum penicllin with beta-lactamase inhibitors and prevalence of type 1 diabetes mellitus in Europe.
Diabetic Foot
Detection of Escherichia coli and associated ?-lactamases genes from diabetic foot ulcers by multiplex PCR and molecular modeling and docking of SHV-1, TEM-1, and OXA-1 ?-lactamases with clindamycin and piperacillin-tazobactam.
Distribution of blaTEM, blaSHV, blaCTX-M, blaOXA, and blaDHA in Proteus mirabilis Isolated from Diabetic Foot Infections in Erbil, Iraq.
Infected foot ulcers in male and female diabetic patients: a clinico-bioinformative study.
Isolation of inducible amp C beta-lactamase producing Enterobacter aerogenes from a diabetic foot ulcer.
Diphtheria
Adjuvant activity of Mycobacterium bovis BCG expressing CRM197 on the immune response induced by BCG expressing tetanus toxin fragment C.
Dry Socket
Effects of 0.2% chlorhexidine gluconate and amoxicillin plus clavulanic acid on the prevention of alveolar osteitis following mandibular third molar extractions.
Dysentery
Cefotaximase and AmpC-producing Shigella flexneri in case of dysentery from southern India.
Outbreak of dysentery associated with ceftriaxone-resistant Shigella sonnei: First report of plasmid-mediated CMY-2-type AmpC beta-lactamase resistance in S. sonnei.
[Study of the penicillinase of the plague microbe, the synthesis of which is determined by the R-episome]
Dysentery, Bacillary
CTX-M-3 type beta-lactamase producing Shigella sonnei isolates from pediatric bacillary dysentery cases.
Inactivation of beta-lactamase from Shigella flexneri UCSF-129 by BRL 42715, a potent inhibitor.
Outbreak of dysentery associated with ceftriaxone-resistant Shigella sonnei: First report of plasmid-mediated CMY-2-type AmpC beta-lactamase resistance in S. sonnei.
Ecthyma
Beta-lactamase gonorrhoea with penile streptococcal ecthyma.
Elephantiasis, Filarial
Detection of antimicrofilarial ES antigen-antibody in immune complexes in Bancroftian filariasis by enzyme immunoassay.
Empyema
Bacteraemic Haemophilus influenzae pneumonia.
Empyema due to beta-lactamase-producing H. influenzae type b complicating severe laryngo-pharyngitis and cervical cellulitis.
Treatment of KPC-2 Enterobacter cloacae empyema with cefepime and levofloxacin.
Endocarditis
Activity of ampicillin plus sulbactam against beta-lactamase producing enterococci in experimental endocarditis.
Activity of isepamicin and selection of permeability mutants to beta-lactams during aminoglycoside therapy of experimental endocarditis due to Klebsiella pneumoniae CF104 producing an aminoglycoside acetyltransferase 6' modifying enzyme and a TEM-3 beta-lactamase.
Activity of sulbactam in combination with ceftriaxone in vitro and in experimental endocarditis caused by Escherichia coli producing SHV-2-like beta-lactamase.
Ampicillin, sulbactam, and rifampin combination treatment of experimental methicillin-resistant Staphylococcus aureus endocarditis in rabbits.
Bactericidal interactions of a beta-lactam and beta-lactamase inhibitors in experimental Pseudomonas aeruginosa endocarditis caused by a constitutive overproducer of type Id beta-lactamase.
beta-Lactamase production in experimental endocarditis due to aminoglycoside-resistant Streptococcus faecalis.
Beta-lactams against methicillin-resistant Staphylococcus aureus.
Ceftriaxone-sulbactam combination in rabbit endocarditis caused by a strain of Klebsiella pneumoniae producing extended-broad-spectrum TEM-3 beta-lactamase.
Chemoprophylactic efficacy against experimental endocarditis caused by beta-lactamase-producing, aminoglycoside-resistant enterococci is associated with prolonged serum inhibitory activity.
Clinical evaluation of aztreonam therapy for serious infections due to gram-negative bacteria.
Cutaneous Vasculitis and Generalized Lymphadenopathy Associated with Extended-Spectrum Beta-Lactamase (ESBL)-Producing Escherichia coli Endocarditis: A Rare Case Report.
Effects of inner-membrane-associated beta-lactamase on penicillin-binding protein assays. Study of stably derepressed Pseudomonas aeruginosa strains from experimental endocarditis.
Efficacy of amoxycillin/clavulanic acid in experimental Staphylococcus aureus endocarditis in the rat.
Efficacy of ampicillin plus a beta-lactamase inhibitor (CP-45,899) in experimental endocarditis due to Staphylococcus aureus.
Efficacy of cefoperazone in combination with sulbactam in experimental Staphylococcus aureus endocarditis in rabbits.
Efficacy of ciprofloxacin in experimental aortic valve endocarditis caused by a multiply beta-lactam-resistant variant of Pseudomonas aeruginosa stably derepressed for beta-lactamase production.
Emphysematous endocarditis caused by AmpC beta-lactamase-producing Escherichia coli: A case report.
Endocarditis caused by extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae: emergence of resistance to ciprofloxacin and piperacillin-tazobactam during treatment despite initial susceptibility.
Haemophilus parainfluenzae endocarditis in a patient with mitral valve prolapse.
Importance of beta-lactamase inactivation in treatment of experimental endocarditis caused by Staphylococcus aureus.
Importance of penicillinase production for activity of penicillin alone or in combination with sulbactam in experimental endocarditis due to methicillin-resistant Staphylococcus aureus.
In-vitro and in-vivo bacterocodal interactions of clindamycin and ceftazidime, by non-beta-lactamase mechanisms, in experimental Pseudomonas aeruginosa endocarditis caused by a constitutive beta-lactamase overproducing strain.
Killing curve activity of ciprofloxacin is comparable to synergistic effect of beta-lactam-tobramycin combinations against Haemophilus species endocarditis strains.
Native mitral valve endocarditis associated with KPC producing Serratia marcescens bacteremia successfully treated with mitral valve replacement and ceftazidime-avibactam.
Piperacillin, tazobactam, and gentamicin alone or combined in an endocarditis model of infection by a TEM-3-producing strain of Klebsiella pneumoniae or its susceptible variant.
Role of beta-lactamase in in vivo development of ceftazidime resistance in experimental Pseudomonas aeruginosa endocarditis.
The impact of penicillinase on cefamandole treatment and prophylaxis of experimental endocarditis due to methicillin-resistant Staphylococcus aureus.
Treatment of bacterial osteomyelitis and Staphylococcus aureus endocarditis and single-dose therapy for uncomplicated Neisseria gonorrhoeae infections: an overview.
[A fosfomycin-gentamicin combination in the treatment of experimental endocarditis caused by Klebsiella pneumoniae producing type TEM-3 beta-lactamase]
[Osler's endocarditis caused by Staphylococcus aureus. Temporary effect of penicillin G. Cure with the use of a synthetic penicillin insensitive to penicillinase.]
Endocarditis, Bacterial
The microbiological diagnosis of infective endocarditis.
Endometritis
Endometritis and Bacteremia With a New Delhi Metallo-Beta-Lactamase 1 (NDM-1)-containing Organism in a Remote Traveler.
Infectious disease relations to cesarean section.
Prevalence of beta-lactamase enzyme production in bacteria isolated from women with postpartum endometritis.
Sulbactam/ampicillin versus metronidazole/gentamicin in the treatment of post-cesarean section endometritis.
Ticarcillin disodium and clavulanate potassium in the treatment of post-cesarean-section endomyometritis.
Endophthalmitis
Criteria for intravitreal antibiotics during surgical removal of intraocular foreign bodies.
Enteritis
A case of pediatric patient with acute enteritis due to CTX-M-1 5 extended-spectrum ?-lactamase-producing Salmonella Blockley.
[Clinical Characteristics of Extended-spectrum beta-lactamase Producing Shigella sonnei Infection Outbreaked in Chungju Area.]
[Neurotoxic enteritis caused by penicillin; penicillinase activity of the brain tissue, a valuable protection.]
Enterobacteriaceae Infections
-
Clinical epidemiology, risk factors and treatment outcomes of extended-spectrum beta-lactamase producing Enterobacteriaceae bacteremia among children in a Tertiary Care Hospital, Bangkok, Thailand.
Clinical features of nosocomial infections by extended-spectrum beta-lactamase-producing Enterobacteriaceae in neonatal intensive care units.
Complex clonal and plasmid epidemiology in the first outbreak of Enterobacteriaceae infection involving VIM-1 metallo-beta-lactamase in Spain: toward endemicity?
Defining the Relationship Between Phenotypic and Genotypic Resistance Profiles of Multidrug-Resistant Enterobacterial Clinical Isolates.
Enterobacterial infection in Saudi Arabia: First record of Klebsiella pneumoniae with triple carbapenemase genes resistance.
First identification of coexistence of blaNDM-1 and blaCMY-42 among Escherichia coli ST167 clinical isolates.
Fluoroquinolone therapy for bloodstream infections caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae.
Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum beta-lactamase producing, Enterobacteriaceae infections: a systematic review.
High prevalence of CTX-M-1 group in ESBL-producing enterobacteriaceae infection in intensive care units in southern Chile.
In vitro activity of flomoxef against extended-spectrum ?-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Korea.
Increasing prevalence of ESBL production among Irish clinical Enterobacteriaceae from 2004 to 2008: an observational study.
Enterocolitis
ESBL-producing Enterobacterales in patients with traveller's diarrhoea - a cross sectional cohort study.
Piperacillin/tazobactam in comparison with clindamycin plus gentamicin in the treatment of intra-abdominal infections.
Enterocolitis, Necrotizing
Extended-spectrum beta-lactamase (ESBL) producing Enterobacterales in stool surveillance cultures of preterm infants are no risk factor for necrotizing enterocolitis: a retrospective case-control study over 12 years.
Infectious morbidity in gynecologic cancer.
Klebsiella pneumoniae with extended spectrum beta-lactamase activity associated with a necrotizing enterocolitis outbreak.
Epiglottitis
[Respiratory tract infections caused by Haemophilus influenzae in adults]
Epstein-Barr Virus Infections
Molecular characterization of primary mediastinal B cell lymphoma.
[Expression of bcl-2 gene in EBV-transformed human gastric epithelial cell line GES-1]
Erysipelas
[Recurrent erysipelas]
Escherichia coli Infections
Activity of imipenem/relebactam against carbapenem-resistant Escherichia coli isolates from the United States in relation to clonal background, resistance genes, co-resistance, and region.
Association of antibiotic utilization measures and reduced incidence of infections with extended-spectrum beta-lactamase-producing organisms.
Characterization of multidrug-resistant Escherichia coli isolates associated with nosocomial infections in dogs.
Chromosome-mediated OXA-48 carbapenemase in highly virulent Escherichia coli.
Clinical and molecular epidemiology of community-onset, extended-spectrum beta-lactamase-producing Escherichia coli infections in Thailand: a case-case-control study.
Clinical and Molecular Epidemiology of Extended-Spectrum Beta-Lactamase-Producing Escherichia Coli Infections in Metro Detroit: Early Dominance of the ST-131 Clone.
Clinical syndromes and treatment location predict utility of carbapenem sparing therapies in ceftriaxone-non-susceptible Escherichia coli bloodstream infection.
Complete nucleotide sequence of pSKLX3330, an IncI1 plasmid carrying blaCTX-M-55 isolated from community-onset Escherichia coli infection.
Epidemiology of CTX-M-type extended-spectrum beta-lactamase (ESBL)-producing nosocomial - Escherichia coli infection in China.
First case of New Delhi metallo-beta-lactamase 1-producing Escherichia coli infection in Japan.
High Prevalence of Escherichia coli-Producing CTX-M-15 Extended-Spectrum Beta-Lactamases in Poultry and Human Clinical Isolates in Romania.
Incidence and management of extended-spectrum beta-lactamase and quinolone-resistant Escherichia coli infections after prostate biopsy.
Infections due to Escherichia coli producing extended-spectrum beta-lactamase among hospitalised patients: factors influencing mortality.
Integrating forecast probabilities in antibiograms: a way to guide antimicrobial prescriptions more reliably?
Negative Pressure Wound Therapy in Infected Wound following Posterior Spinal Instrumentation using Simple Self-assembled System: A Case Report.
Oral fosfomycin for treatment of urinary tract infection: a retrospective cohort study.
Re: Incidence and Management of Extended-Spectrum Beta-Lactamase and Quinolone-Resistant Escherichia coli Infections after Prostate Biopsy.
Resistance to extended-spectrum beta-lactams by the emergence of SHV-12 and the loss of OmpK35 in Klebsiella pneumoniae and Escherichia coli in Malaysia.
Service evaluation of selected risk factors for extended-spectrum beta-lactamase Escherichia coli urinary tract infections: a case-control study.
Esophageal Neoplasms
Modulation of E-cadherin expression promotes migration ability of esophageal cancer cells.
Steroidal dimer by001 inhibits proliferation and migration of esophageal cancer cells via multiple mechanisms.
Exanthema
Piperacillin-tazobactam and netilmicin as a safe and efficacious empirical treatment of febrile neutropenic children.
Extensively Drug-Resistant Tuberculosis
Antitubercular and Antibacterial Activity of Quinonoid Natural Products Against Multi-Drug Resistant Clinical Isolates.
Eye Infections
Prevalence and antibacterial resistance patterns of extended-spectrum beta-lactamase producing Gram-negative bacteria isolated from ocular infections.
Fasciitis, Necrotizing
Aeromonas hydrophila with plasmid-borne class A extended-spectrum beta-lactamase TEM-24 and three chromosomal class B, C, and D beta-lactamases, isolated from a patient with necrotizing fasciitis.
Lower Extremity Wounds in Patients With Idiopathic Thrombocytopenic Purpura and Systemic Lupus Erythematosus.
Sequential necrotizing fasciitis caused by the monomicrobial pathogens Streptococcus equisimilis and extended-spectrum beta-lactamase-producing Escherichia coli.
Two non-otic cases of POM-1 metallo-?-lactamase-producing Pseudomonas otitidis infection: Necrotizing fasciitis and pan-peritonitis.
Foodborne Diseases
Determination of beta-lactamase activities and antibiotic susceptibility of some Bacillus strains causing food poisoning.
Inactivation, removal, and regrowth potential of opportunistic pathogens and antimicrobial resistance genes in recycled water systems.
Penicillinase production by Staphylococcus aureus strains from outbreaks of food poisoning.
Quinolone-resistant Escherichia coli O127a:K63 serotype with an extended-spectrum-beta-lactamase phenotype from a food poisoning outbreak in China.
Foot Ulcer
Detection of Escherichia coli and associated ?-lactamases genes from diabetic foot ulcers by multiplex PCR and molecular modeling and docking of SHV-1, TEM-1, and OXA-1 ?-lactamases with clindamycin and piperacillin-tazobactam.
Infected foot ulcers in male and female diabetic patients: a clinico-bioinformative study.
Isolation of inducible amp C beta-lactamase producing Enterobacter aerogenes from a diabetic foot ulcer.
Foot-and-Mouth Disease
[An immunoenzyme method of isolation of foot-and-mouth disease virus by using beta-lactamase conjugate with virus-specific antibodies]
Furunculosis
The 'hidden' carbapenemase of Aeromonas hydrophila.
Gastritis
A unique polysaccharide purified from Hericium erinaceus mycelium prevents oxidative stress induced by H2O2 in human gastric mucosa epithelium cell.
Up-Regulation of MiR-1915 Inhibits Proliferation, Invasion, and Migration of Helicobacter pylori-Infected Gastric Cancer Cells via Targeting RAGE.
Gastroenteritis
Extended Spectrum Beta-lactamase producing Salmonella Lindenberg gastroenteritis.
Extended-spectrum-beta-lactamase (TEM-52)-producing strains of Salmonella enterica of various serotypes isolated in France.
High prevalence of faecal carriage of ESBL-producing Enterobacteriaceae in Norwegian patients with gastroenteritis.
Imipenem resistance in a Salmonella clinical strain due to plasmid-mediated class A carbapenemase KPC-2.
Nosocomial outbreak of acute gastroenteritis in a neonatal intensive care unit in Tunisia caused by multiply drug resistant Salmonella wien producing SHV-2 beta-lactamase.
Nosocomial outbreak of pediatric gastroenteritis caused by CTX-M-14-type extended-spectrum beta-lactamase-producing strains of Salmonella enterica serovar London.
Possibility of CTX-M-14 Gene Transfer from Shigella sonnei to a Commensal Escherichia coli Strain of the Gastroenteritis Microbiome.
Serotype profile and molecular characterization of antimicrobial resistance in non-typhoidal Salmonella isolated from gastroenteritis cases over nine years.
The first description of the extended-spectrum beta-lactamase blaSHV-12 gene in a Salmonella monophasic Typhimurium strain isolated from acute gastroenteritis in a kidney transplant recipient in Southeast Spain.
Gastrointestinal Diseases
Long-term Follow-up of Preterm Infants Having Been Colonized With Extended Spectrum Beta-lactamase-producing Enterobacterales Over the First 6 Years of Life.
Glioma
Expression of metalloproteinases and metalloproteinase inhibitors by fetal astrocytes and glioma cells.
Gonorrhea
Beta-lactamase producing Neisseria gonorrhea strains in Karachi.
Cefoxitin as a single-dose treatment for urethritis caused by penicillinase-producing Neisseria gonorrhoeae.
Efficacy of pefloxacin in acute gonococcal urethritis.
Evaluation of a DNA-hybridization method for detection of African and Asian strains of Neisseria gonorrhoeae in men with urethritis.
Gonococcal infections.
Gonorrhea.
Long distance truck-drivers: 1. Prevalence of sexually transmitted diseases (STDs).
Multicenter, comparative study of enoxacin and ceftriaxone for treatment of uncomplicated gonorrhea.
Norfloxacin in the treatment of gonorrhea due to penicillinase and non-penicillinase producing Neisseria gonorrheae: a review.
Septic arthritis caused by penicillinase producing Neisseria gonorrhea.
[Critical remarks on gonorrhea therapy: netilmicin]
[Penicillinase activity of Staphylococci isolated from normal subjects (carriers) and also isolated from patients with dermatoses and gonorrhea]
[Therapy of acute gonorrhea]
Gout
"Roar" of blaNDM-1 and "silence" of blaOXA-58 co-exist in Acinetobacter pittii.
Graft vs Host Disease
Janus kinase 3 inhibitor WHI-P131/JANEX-1 prevents graft-versus-host disease but spares the graft-versus-leukemia function of the bone marrow allografts in a murine bone marrow transplantation model.
Gram-Negative Bacterial Infections
Carbapenem-Hydrolyzing Gram-Negative Bacteria: Current Options for Treatment and Review of Drugs in Development.
Conformational Intermediate That Controls KPC-2 Catalysis and Beta-Lactam Drug Resistance.
Increasing Prevalence of Escherichia coli and Klebsiella pneumoniae Producing CTX-M-Type Extended-Spectrum Beta-Lactamase, Carbapenemase, and NDM-1 in Patients from a Rural Community with Community Acquired Infections: A 3-Year Study.
Molecular Detection of blaIMP Genes in Metallo-Beta-Lactamase Producing Clinical Gram-Negative Isolates.
[Bacteriological and clinical evaluation tazobactam/piperacillin in infectious diseases in surgical field]
Gram-Positive Bacterial Infections
[Bacteriological and clinical evaluation tazobactam/piperacillin in infectious diseases in surgical field]
Granuloma
Determination of intracellular and extracellular beta-lactamase activities of Pseudomonas aeruginosa after exposure to beta-lactams in vitro and in vivo.
Significance of inducible cephalosporinase remaining in the experimentally infected rat granuloma pouch after beta-lactam therapy.
Specificity of beta-lactamase induction in Pseudomonas aeruginosa.
Haemophilus Infections
Haemophilus influenzae infections in adults: characterization of strains by serotypes, biotypes, and beta-lactamase production.
Unusual case of Haemophilus influenzae type b: Haemophilus influenzae type b meningitis cellulitis and subcutaneous abscess.
[Systemic infections due to type b Haemophilus influenzae. A retrospective study of 114 cases]
Healthcare-Associated Pneumonia
A change for the antibacterial treatment policy to decrease carbapenem consumption at a haematopoietic stem cell transplantation centre.
A novel type of AmpC beta-lactamase, ACC-1, produced by a Klebsiella pneumoniae strain causing nosocomial pneumonia.
An evaluation of meropenem/vaborbactam for the treatment of nosocomial pneumonia.
Doripenem: a review of its use in the treatment of bacterial infections.
In vivo efficacies of combinations of beta-lactams, beta-lactamase inhibitors, and rifampin against Acinetobacter baumannii in a mouse pneumonia model.
[Etiology of pneumonia and host defense]
Heart Defects, Congenital
Risk Factors for Acquisition of Extended-spectrum Beta-lactamase and AmpC Resistant Gram-negative Bacteria in Critically Ill Infants With Congenital Heart Disease.
Heart Diseases
Risk Factors for Community-Associated Clostridium difficile Infection in Adults: A Case-Control Study.
Heart Failure
[Matrix metalloproteinases and their inhibitors in lung cancer with malignant pleural effusion]
Hematologic Neoplasms
Balanoposthitis caused by Pseudomonas aeruginosa co-producing metallo-beta-lactamase and 16S rRNA methylase in children with hematological malignancies.
Bloodstream infections caused by qnr-positive Enterobacteriaceae: clinical and microbiologic characteristics and outcomes.
Cyclin D1 overexpression in non-Hodgkin's lymphoma with chromosome 11 bcl-1 rearrangement.
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies.
Large cell variants of CD5+, CD23- B-cell lymphoma/leukemia.
Oncogenes in multiple myeloma: point mutation of N-ras.
Hepatic Encephalopathy
Detection of High-Level Rifaximin Resistance in Enteric Bacteria by Agar Screen.
Hepatitis
[Expression of Bcl-2 and Bax proteins in liver tissues of chronic viral hepatitis]
Hepatitis B
Detection of hepatitis B surface antigen by Elisa technique using penicillinase (beta-lactamase) labelled caprine antibody to HBsAg.
Expression and secretion of hepatitis B viral surface antigen in E. coli.
Production and secretion in Escherichia coli of hepatitis B virus pre-S2 antigen as fusion proteins with beta-lactamase.
Hepatitis C
A cell-based beta-lactamase reporter gene assay for the identification of inhibitors of hepatitis C virus replication.
Persistent replication of hepatitis C virus replicons expressing the beta-lactamase reporter in subpopulations of highly permissive Huh7 cells.
Transport of viruses through fetal membranes: an in vitro model of perinatal transmission.
Hepatomegaly
Identification of the chicken anemia agent, reproduction of the disease, and serological survey in the United States.
Herpes Simplex
The antiviral spectrum of (E)-5-(2-bromovinyl)-2'-deoxyuridine.
[Expression in Chinese hamster transformant TK+-cells of the bacterial gene for beta-lactamase]
Hydrocephalus
Clinical characteristics of post-neurosurgical Klebsiella pneumoniae meningitis in adults and a clinical comparison to the spontaneous form in a Taiwanese population.
Hypersensitivity
Allergic Reactions and Cross-Reactivity Potential with Beta-Lactamase Inhibitors.
Endocarditis caused by Kingella denitrificans.
Penicillinase in the treatment of allergic reactions to penicillin
Penicillinase in the treatment of allergic reactions to penicillin.
Penicillinase treatment of acute renal insufficiency due to penicillin hypersensitivity.
Penicillinase treatment of fifty-two patients with allergic reactions to penicillin.
Piperacillin/Tazobactam-Associated Hypersensitivity Syndrome with Overlapping Features of Acute Generalized Exanthematous Pustulosis and Drug-Related Rash with Eosinophilia and Systemic Symptoms Syndrome.
The role of galacturonic acid in outer membrane stability in Klebsiella pneumoniae.
[Causal therapy of penicillin allergy with penicillinase]
[Characteristics of penicillinase plasmids from Staphylococcus aureus strains]
[Critical remarks on gonorrhea therapy: netilmicin]
[Development of surgical antibioprophylaxis kits: evaluation of the impact on prescribing habits]
[Experience with penicillinase therapy of penicillin allergy.]
[Experience with penicillinase treatment of penicillin allergy.]
[Penicillin allergy in the form of serum sickness; its treatment with penicillinase.]
[Penicillinase in the treatment of allergic reactions to penicillin.]
[The influence of penicillinase on hapten inhibitions in vitro and in vivo in experimental penicillin allergy]
[Treatment with penicillinase of 4 cases of penicillin allergy.]
Impetigo
Comparison of amoxicillin and clavulanic acid (augmentin) for the treatment of nonbullous impetigo.
Infections
"Double carbapenem" and oral fosfomycin for the treatment of complicated urinary tract infections caused by bla
(-)-Patchouli alcohol protects against Helicobacter pylori urease-induced apoptosis, oxidative stress and inflammatory response in human gastric epithelial cells.
5,5,6-Fused tricycles bearing imidazole and pyrazole 6-methylidene penems as broad-spectrum inhibitors of beta-lactamases.
6-(substituted methylene)penems, potent broad spectrum inhibitors of bacterial beta-lactamase. V. Chiral 1,2,3-triazolyl derivatives.
6-Acetylmethylenepenicillanic acid (Ro 15-1903), a potent beta-lactamase inhibitor. II. Antibacterial properties.
?-Lactamase inhibitor peptides as the new strategies to overcome bacterial resistance.
A case of New Delhi metallo-beta-lactamase 1 (NDM-1)-producing Klebsiella pneumoniae from the Balkan in the Netherlands with putative secondary transmission.
A case-control study of an outbreak of infections caused by Klebsiella pneumoniae strains producing CTX-1 (TEM-3) beta-lactamase.
A Cluster of Colistin- and Carbapenem-Resistant Klebsiella pneumoniae Carrying blaNDM-1 and mcr-8.2.
A combined disk test for direct differentiation of carbapenemase-producing enterobacteriaceae in surveillance rectal swabs.
A community-based outbreak of infection with penicillin-resistant Neisseria gonorrhoeae not producing penicillinase (chromosomally mediated resistance).
A comparison of ampicillin/sulbactam versus cefotaxime in the therapy of lower respiratory tract infections in hospitalized patients.
A convenient microbiological assay employing cell-free extracts for the rapid characterization of Gram-negative carbapenemase producers.
A coup d'état by NDM-producing Klebsiella pneumoniae overthrows the major bacterial population during KPC-directed therapy.
A hypervariable region in VP1 of chicken infectious anemia virus mediates rate of spread and cell tropism in tissue culture.
A large, refractory nosocomial outbreak of Klebsiella pneumoniae carbapenemase (KPC)-producing Escherichia coli demonstrates carbapenemase gene outbreaks involving sink sites require novel approaches to infection control.
A Matched Case-Case-Control Study of the Impact of Clinical Outcomes and Risk Factors of Patients with IMP-Type Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae in Japan.
A mechanistic approach to prove the efficacy of combination therapy against New Delhi metallo-?-lactamases producing bacterial strain: a molecular and biochemical approach.
A methodological comparison of risk scores versus decision trees for predicting drug-resistant infections: A case study using extended-spectrum beta-lactamase (ESBL) bacteremia.
A model to show the role of extracellular beta-lactamases in mediating staphylococcal resistance.
A multi-species cluster of GES-5 carbapenemase producing Enterobacterales linked by a geographically disseminated plasmid.
A Multicentered Study of the Clinical and Molecular Epidemiology of TEM- and SHV-type Extended-Spectrum Beta-Lactamase Producing Enterobacterales Infections in Children.
A multinational survey of risk factors for infection with extended-spectrum beta-lactamase-producing enterobacteriaceae in nonhospitalized patients.
A new case report of urinary tract infection due to KPC-3-producing klebsiella pneumoniae (ST258) in Spain.
A nosocomial outbreak of Pseudomonas aeruginosa isolates expressing the extended-spectrum beta-lactamase GES-2 in South Africa.
A Nosocomial Respiratory Infection Outbreak of Carbapenem-Resistant Escherichia coli ST131 With Multiple Transmissible bla KPC-2 Carrying Plasmids.
A novel GoldNano Carb test for rapid phenotypic detection of carbapenemases, particularly OXA type, in Enterobacteriaceae, Pseudomonas aeruginosa and Acinetobacter spp.
A novel incompatibility group X3 plasmid carrying blaNDM-1 encodes a small RNA that regulates host fucose metabolism and biofilm formation.
A novel plasmid-mediated beta-lactamase that hydrolyzes broad-spectrum cephalosporins in a clinical isolate of Klebsiella pneumoniae.
A Novel Role for Helicobacter pylori Gamma-Glutamyltranspeptidase in Regulating Autophagy and Bacterial Internalization in Human Gastric Cells.
A preliminary study on metallo-beta-lactamase producing Pseudomonas aeruginosa in hospitalized patients.
A prospective study of treatment of carbapenem-resistant Enterobacteriaceae infections and risk factors associated with outcome.
A Questionnaire-based Survey of Physician Perceptions of the Prevalence of Antimicrobial Resistance and Their Antibiotic Prescribing Patterns.
A rapid matrix-assisted laser desorption ionization-time of flight mass spectrometry-based method for single-plasmid tracking in an outbreak of carbapenem-resistant Enterobacteriaceae.
A rare emergence of resistance to ceftolozane/tazobactam in Klebsiella pneumoniae causing urinary tract infection.
A report on the presence of GES-5 extended spectrum beta-lactamase producing Pseudomonas aeruginosa associated with urinary tract infection from north-east India.
A silent outbreak due to Klebsiella pneumoniae that co-produced NDM-1 and OXA-48 carbapenemases, and infection control measures.
A State-of-Art Review on Multi-Drug Resistant Pathogens in Foods of Animal Origin: Risk Factors and Mitigation Strategies.
A Strain of Salmonella enterica serovar Virchow Isolated in Turkey and Carrying a CTX-M-3 Extended-Spectrum Beta-Lactamase.
A study of synergism between cloxacillin and gentamicin on resistant staphylococci (penicillinase producing and gentamicin resistant).
A Temporal Examination of the Planktonic and Biofilm Proteome of Whole Cell Pseudomonas aeruginosa PAO1 Using Quantitative Mass Spectrometry.
A threat of the Klebsiella pneumoniae carbapenemase-producing strains among transplant recipients.
A toolkit for the management of infection or colonization by extended-spectrum beta-lactamase producing Enterobacteriaceae in Italy: implementation and outcome of a European project.
A trial with IgY chicken antibodies to eradicate faecal carriage of Klebsiella pneumoniae and Escherichia coli producing extended-spectrum beta-lactamases.
A unique case report of a high-pressure paint injection injury of the hand with associated carbapenemase resistant Pseudomonas aeruginosa infection.
Accuracy of the ELITe MGB assays for the detection of carbapenemases, CTX-M, Staphylococcus aureus and mecA/C genes directly from respiratory samples.
Acinetobacter baumannii: biology and drug resistance - role of carbapenemases.
Activity of ertapenem and other antimicrobials against ESBL-producing enterobacteria isolated from urine in patients from Madrid.
Activity of erythromycin against Haemophilus influenzae from respiratory tract infections.
Activity of faropenem against cephalosporin-resistant Enterobacteriaceae.
Activity of faropenem tested against Neisseria gonorrhoeae isolates including fluoroquinolone-resistant strains.
Activity of fosfomycin alone or combined with cefoxitin in vitro and in vivo in a murine model of urinary tract infection due to Escherichia coli harbouring CTX-M-15-type extended-spectrum ?-lactamase.
Activity of imipenem against VIM-1 metallo-beta-lactamase-producing Klebsiella pneumoniae in the murine thigh infection model.
Activity of imipenem-relebactam against multi-drug and extensively-drug resistant Burkholderia cepacia complex and Burkholderia gladioli.
Activity of imipenem/relebactam against carbapenem-resistant Escherichia coli isolates from the United States in relation to clonal background, resistance genes, co-resistance, and region.
Activity of selected antimicrobial agents against strains of Staphylococcus aureus isolated from bovine intramammary infections that produce beta-lactamase.
Acute and chronic infection of H. pylori caused the difference in apoptosis of gastric epithelial cells.
Acute otitis media: making sense of recent guidelines on antimicrobial treatment.
Adverse Reactions Associated with Penicillins, Carbapenems, Monobactams, and Clindamycin: A Retrospective Population-based Study.
Aerobic and anaerobic microbiologic factors and recovery of beta-lactamase producing bacteria from obstetric and gynecologic infection.
AIDS patients with bacterial lower respiratory tract infections: treatment with ofloxacin versus sulbactam-ampicillin.
AmpC beta-lactamase producing multidrug resistant strains of Klebsiella spp. & Escherichia coli isolated from children under five in Chennai.
Ampicillin treatment failure of apparently beta-lactamase-negative Haemophilus influenzae type b meningitis due to novel beta-lactamase.
An ancient family of mobile genomic islands introducing cephalosporinase and carbapenemase genes in Enterobacteriaceae.
An effective intervention to limit the spread of an epidemic carbapenem-resistant Klebsiella pneumoniae strain in an acute care setting: From theory to practice.
An improved primer design for the loop-mediated isothermal amplification (LAMP) method to detect oxacillinase (OXA)-48 ?-lactamase genes in Gram-negative bacteria for clinical applications.
An in-vitro and in-vivo comparison of the activity of beta-lactamase inhibitor combinations with imipenem and cephalosporins against Escherichia coli producing TEM-1 or TEM-2 beta-lactamase.
An investigation of drug-resistant Acinetobacter baumannii infections in a comprehensive hospital of East China.
An Irish outbreak of New Delhi metallo-?-lactamase (NDM)-1 carbapenemase-producing Enterobacteriaceae: increasing but unrecognized prevalence.
An observational study on bloodstream extended-spectrum beta-lactamase infection in critical care unit: incidence, risk factors and its impact on outcome.
An Outbreak of Carbapenem-Resistant Klebsiella pneumoniae in an Intensive Care Unit of a Major Teaching Hospital in Chongqing, China.
An outbreak of extended spectrum beta-lactamase producing Klebsiella pneumoniae in a neonatal intensive care unit.
An outbreak of infection due to beta-Lactamase Klebsiella pneumoniae Carbapenemase 2-producing K. pneumoniae in a Greek University Hospital: molecular characterization, epidemiology, and outcomes.
Anaerobic bacteria in upper respiratory tract and other head and neck infections.
Anaerobic infections. The basics for primary care physicians.
Antibacterial activities of essential oils from Iranian medicinal plants on extended-spectrum ?-lactamase-producing Escherichia coli.
Antibacterial Activity of Some Plant Extracts Against Extended- Spectrum Beta-Lactamase Producing Escherichia coli Isolates.
Antibacterial activity of Syzygium aromaticum (clove) against uropathogens producing ESBL, MBL, and AmpC beta-lactamase: Are we close to getting a new antibacterial agent?
Antibacterial activity of ticarcillin in the presence of clavulanate potassium.
Antibacterial resistance.
Antibiogram and Genetic Characterization of Carbapenem-Resistant Gram-Negative Pathogens Incriminated in Healthcare-Associated Infections.
Antibiotic policy and prescribing strategies for therapy of extended-spectrum beta-lactamase-producing Enterobacteriaceae: the role of piperacillin-tazobactam.
Antibiotic resistance and prevalence of beta-lactamase in Haemophilus influenzae isolates-a surveillance study of patients with respiratory infection in Saudi Arabia.
Antibiotic resistance in Haemophilus influenzae: epidemiology, mechanisms, and therapeutic possibilities.
Antibiotic resistance in orthopaedic surgery: acute knee prosthetic joint infections due to extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae.
Antibiotic resistance of oral anaerobic bacteria and their effect on the management of upper respiratory tract and head and neck infections.
Antibiotic resistance pattern and clinical outcomes in acute cholecystitis: 567 consecutive worldwide patients in a prospective cohort study.
Antibiotic resistance patterns in gram-negative and gram-positive bacteria causing septicemia in newborns in León, Nicaragua: correlation with environmental samples.
Antibiotic Sensitivity Screening of Klebsiella spp. and Raoultella spp. Isolated from Marine Bivalve Molluscs Reveal Presence of CTX-M-Producing K. pneumoniae.
Antibiotic susceptibility of 33 Prevotella strains isolated from Romanian patients with abscesses in head and neck spaces.
Antibiotic usage in pelvic infections. An overview.
Antibiotic-dependent perturbations of extended spectrum beta-lactamase producing Klebsiella pneumoniae proteome.
Antibiotics in lung abscess.
Antibodies against beta-lactamase can improve ceftazidime treatment of lung infection with beta-lactam-resistant Pseudomonas aeruginosa in a rat model of chronic lung infection.
Antimicrobial resistance and beta-lactamase production of Escherichia coli causing canine urinary tract infections: Passive surveillance of laboratory isolates in Saskatoon, Canada, 2014.
Antimicrobial resistance. Its importance and efforts to control it.
Antimicrobial resistant Klebsiella pneumoniae carriage and infection in specialized geriatric care wards linked to acquisition in the referring hospital.
Antimicrobial susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in health care-associated urinary tract infection: focus on susceptibility to fosfomycin.
Antimicrobial susceptibility and beta-lactamase production of anaerobic and aerobic bacteria isolated from pus specimens from orofacial infections.
Antimicrobial susceptibility of anaerobic bacteria in Bulgaria.
Antimicrobial susceptibility of enterococci in vitro.
Antimicrobial susceptibility of metallo-beta-lactamase positive and negative Klebsiella pneumoniae strains isolated from intensive care unit patients.
Antimicrobial susceptibility pattern of extended-spectrum beta- lactamase producing Klebsiella pneumoniae clinical isolates in an Indian tertiary hospital.
Antimicrobial susceptibility, risk factors and prevalence of bla cefotaximase, temoneira, and sulfhydryl variable genes among Escherichia coli in community-acquired pediatric urinary tract infection.
Antimicrobial treatment of Capnocytophaga infections.
Antimicrobial treatment options in the management of odontogenic infections.
Antimicrobial use in European acute care hospitals: results from the second point prevalence survey (PPS) of healthcare-associated infections and antimicrobial use, 2016 to 2017.
Antimicrobial-resistant pathogens in animals and man: prescribing, practices and policies.
Are susceptibility tests enough, or should laboratories still seek ESBLs and carbapenemases directly?
Arrival of the rare carbapenemase OXA-204 in Canada causing a multispecies outbreak over 3?years.
Aspergillomarasmine A overcomes metallo-?-lactamase antibiotic resistance.
Assessment of antimicrobial prophylaxis to prevent perioperative infection in patients undergoing prostate brachytherapy: multicenter cohort study.
Assessment of biliary excretion of piperacillin-tazobactam in humans.
Assessment of two penicillins plus beta-lactamase inhibitors versus cefotaxime in treatment of murine Klebsiella pneumoniae infections.
Association between handling of pet treats and infection with Salmonella enterica serotype newport expressing the AmpC beta-lactamase, CMY-2.
Association of antibiotic utilization measures and reduced incidence of infections with extended-spectrum beta-lactamase-producing organisms.
Association of blaNDM-1 with blaKPC-2 and aminoglycoside-modifying enzymes genes among Klebsiella pneumoniae, Proteus mirabilis and Serratia marcescens clinical isolates in Brazil.
Association of Colistin-Resistant KPC Clonal Strains with Subsequent Infections and Colonization and Biofilm Production.
Augmentin (amoxycillin and clavulanic acid) therapy in complicated infections due to beta-lactamase producing bacteria.
Azidothymidine Produces Synergistic Activity in Combination with Colistin against Antibiotic-Resistant Enterobacteriaceae.
Aztreonam-Avibactam Susceptibility Testing Program for Metallo-Beta-Lactamase-Producing Enterobacterales in the Antibiotic Resistance Laboratory Network, March 2019 to December 2020.
Aztreonam-flucloxacillin double beta-lactam treatment as empirical therapy of serious infections in very elderly patients.
Bacteraemia due to extensively drug-resistant Pseudomonas aeruginosa sequence type 235 high-risk clone: Facing the perfect storm.
Bacteremia and other body site infection caused by hypervirulent and classic Klebsiella pneumoniae.
Bacteremia due to extended-spectrum beta-lactamase-producing Enterobacteriaceae other than Escherichia coli and Klebsiella.
Bacteremia due to extended-spectrum-beta-lactamase-producing Enterobacter cloacae: role of carbapenem therapy.
Bacteremia with ESBL-producing Enterobacterales is associated with IgG antibodies reacting with CTX-M-15 and/or CTX-M-27.
Bacterial agents of lower respiratory tract infections (LRTIs), beta-lactamase production, and resistance to antibiotics in elderly people. DEDALO Study Group.
Bacterial characteristics of carbapenem-resistant Enterobacteriaceae (CRE) colonized strains and their correlation with subsequent infection.
Bacterial infections of the upper respiratory airways and beta-lactam antibiotics.
Bacterial Profiles and Their Associated Factors of Urinary Tract Infection and Detection of Extended Spectrum Beta-Lactamase Producing Gram-Negative Uropathogens Among Patients with Diabetes Mellitus at Dessie Referral Hospital, Northeastern Ethiopia.
Bacterial resistance in South America.
Bactericidal activity of oral beta-lactam antibiotics in plasma and urine versus isogenic Escherichia coli strains producing broad- and extended-spectrum beta-lactamases.
Bactericidal and intracellular activity of ?-lactams against Mycobacterium abscessus.
Bactericidal killing activities of cefepime, ceftazidime, cefotaxime, and ceftriaxone against Staphylococcus aureus and beta-lactamase-producing strains of Enterobacter aerogenes and Klebsiella pneumoniae in an in vitro infection model.
Bacteriology and antimicrobial susceptibility of gram-positive cocci isolated from pus specimens of orofacial odontogenic infections.
Balanoposthitis caused by Pseudomonas aeruginosa co-producing metallo-beta-lactamase and 16S rRNA methylase in children with hematological malignancies.
Barrier Precautions in the Era of Multidrug Pathogens.
Beta-lactam resistance in clinical isolates of Escherichia coli caused by elevated production of the ampC-mediated chromosomal beta-lactamase.
Beta-lactam resistance in Nocardia brasiliensis is mediated by beta-lactamase and reversed in the presence of clavulanic acid.
Beta-lactam resistance mechanisms of methicillin-resistant Staphylococcus aureus.
Beta-lactam/beta-lactamase inhibitor combinations: pharmacodynamic considerations and possible role in the management of bacterial infections in the neutropenic host.
Beta-lactam/beta-lactamase inhibitors versus carbapenem for bloodstream infections due to extended-spectrum beta-lactamase-producing Enterobacteriaceae: systematic review and meta-analysis.
beta-Lactamase activities and resistance to antibiotics of Haemophilus influenzae, H. parainfluenzae and H. aphrophilus strains identified in throat cultures from children.
Beta-lactamase activity in bronchial sputum and treatment failure against penicillin-sensitive bacteria in pulmonary infections.
Beta-lactamase can function as a reporter of bacterial protein export during Mycobacterium tuberculosis infection of host cells.
Beta-lactamase inhibitor combinations with extended-spectrum penicillins: factors influencing antibacterial activity against enterobacteriaceae and Pseudomonas aeruginosa.
Beta-lactamase inhibitors: another approach to overcoming antimicrobial resistance.
beta-Lactamase Inhibitors: The Story so Far.
Beta-lactamase producing Haemophili occurrence in clinical materials and carriage in healthy children.
Beta-lactamase production and susceptibilities to amoxicillin, amoxicillin-clavulanate, ticarcillin, ticarcillin-clavulanate, cefoxitin, imipenem, and metronidazole of 320 non-Bacteroides fragilis Bacteroides isolates and 129 fusobacteria from 28 U.S. centers.
beta-lactamase production by strains of Escherichia coli of intermediate susceptibility to beta-lactam antibiotics. A study of their clinical significance in urinary tract infection.
Beta-lactamase-producing bacteria in mixed infections.
Beta-lactamases in clinical isolates. Spectrum implications of sulbactam/ampicillin.
Beta-lactamases, beta-lactamase inhibitors, and skin and skin-structure infections.
beta-Lactams without a suicide inhibitor.
Biochemical Characterization of the POM-1 Metallo-?-Lactamase from Pseudomonas otitidis.
Bla-OXA48 gene microorganisms outbreak, in a tertiary Children's Hospital, Over 3 years (2012-2014): Case Report.
Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase 2-producing K. pneumoniae at a Hematology Department in Wenzhou, China.
Boronic acid disk diffusion for the phenotypic detection of polymerase chain reaction-confirmed, carbapenem-resistant, gram-negative bacilli isolates.
Branhamella (Moraxella) catarrhalis: pathogenic significance in respiratory infections.
Branhamella catarrhalis prevalence in a hospital population.
Branhamella catarrhalis respiratory infections in The Netherlands.
Breakpoints for carbapenemase-producing Enterobacteriaceae: is the problem solved?
Broad-Spectrum ss-Lactam Antibiotics for Treating Experimental Peritonitis in Mice Due a Klebsiella pneumoniae Producing the Carbapenemase OXA-48.
Bronchopulmonary infection due to Branhamella catarrhalis.
Canine parvovirus and pseudorabies virus coinfection as a cause of death in a wolf (Canis lupus) from southern Italy.
Capnocytophaga canimorsus - a potent pathogen in immunocompetent humans - systematic review and retrospective observational study of case reports.
Carbapenem resistance in Acinetobacter baumannii clinical isolates from northwest Iran: high prevalence of OXA genes in sync.
Carbapenem versus fosfomycin tromethanol in the treatment of extended-spectrum beta-lactamase-producing Escherichia coli-related complicated lower urinary tract infection.
Carbapenem-Resistant Enterobacteriaceae in Solid Organ Transplantation: Management Principles.
Carbapenem-resistant enterobacteriaceae: an emerging problem in children.
Carbapenem-resistant Escherichia coli and Klebsiella pneumoniae isolates from Turkey with OXA-48-like carbapenemases and outer membrane protein loss.
Carbapenem-Susceptible OXA-23-Producing Proteus mirabilis in the French Community.
Carbapenemase IncF-borne blaNDM-5 gene in the E. coli ST167 high-risk clone from canine clinical infection, Italy.
Carbapenemase-producing Gram-negative bacteria: current epidemics, antimicrobial susceptibility and treatment options.
Carbapenemases: the versatile beta-lactamases.
Carriage of extended-spectrum beta-lactamase-producing enterobacteriacae among internal medicine patients in Switzerland.
Carriage of Extended-Spectrum-Beta-Lactamase- and AmpC Beta-Lactamase-Producing Escherichia coli Strains from Humans and Pets in the Same Households.
Carriage of two carbapenem-resistance genes in Pseudomonas aeruginosa isolated from hospital-acquired infections in children from Costa Rica: the importance of local epidemiology.
Cefdinir: an oral cephalosporin for the treatment of respiratory tract infections and skin and skin structure infections.
Cefepime pharmacodynamics in patients with extended spectrum beta-lactamase (ESBL) and non-ESBL infections.
Cefepime versus carbapenems for the treatment of urinary tract infections caused by extended-spectrum beta-lactamase producing enterobacteriaceae.
Cefepime, piperacillin-tazobactam, and the inoculum effect in tests with extended-spectrum beta-lactamase-producing Enterobacteriaceae.
Cefetamet pivoxil. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
Ceftazidime, an open randomized comparison of 3 dosages for genitourinary infections.
Ceftazidime-Avibactam Combination Therapy Compared to Ceftazidime-Avibactam Monotherapy for the Treatment of Severe Infections Due to Carbapenem-Resistant Pathogens: A Systematic Review and Network Meta-Analysis.
Ceftazidime/avibactam: a novel cephalosporin/nonbeta-lactam beta-lactamase inhibitor for the treatment of complicated urinary tract infections and complicated intra-abdominal infections.
Ceftizoxime in the treatment of uncomplicated gonorrhoea.
Ceftriaxone in acute purulent exacerbations of chronic bronchitis.
Cefuroxime axetil.
Cefuroxime: a review of its antibacterial activity, pharmacological properties and therapeutic use.
Cephalosporin resistance among animal-associated Enterobacteria: a current perspective.
Cephalosporins in overcoming beta-lactamase-producing bacteria and preservation of the interfering bacteria in the treatment of otitis, sinusitis and tonsillitis.
Challenges to Early Discharge of Patients with Upper Urinary Tract Infections by ESBL Producers: TMP/SMX as a Step-Down Therapy for Shorter Hospitalization and Lower Costs.
Changing epidemiology of infections due to extended spectrum beta-lactamase producing bacteria.
Characteristics and Evolution of Renal Transplant Recipients Infected by Carbapenemase-Producing Klebsiella pneumoniae.
Characteristics of aac(6')-Ib-cr gene in extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolated from Chungnam area.
Characterization of a large outbreak by CTX-M-1-producing Klebsiella pneumoniae and mechanisms leading to in vivo carbapenem resistance development.
Characterization of a NDM-7 carbapenemase-producing Escherichia coli ST410 clinical strain isolated from a urinary tract infection in China.
Characterization of a new plasmid-mediated extended-spectrum beta-lactamase from Serratia marcescens.
Characterization of blaCMY-11, an AmpC-type plasmid-mediated beta-lactamase gene in a Korean clinical isolate of Escherichia coli.
Characterization of Carbapenemase-Producing Enterobacteriaceae from Patients in Amman, Jordan.
Characterization of CMY-2-type beta-lactamase-producing Escherichia coli isolated from chicken carcasses and human infection in a city of South Brazil.
Characterization of CTX-M-14-producing Escherichia coli from food-producing animals.
Characterization of enteropathogenic Escherichia coli of clinical origin from the pediatric population in Pakistan.
Characterization of Escherichia coli NDM isolates with decreased susceptibility to aztreonam/avibactam: role of a novel insertion in PBP3.
Characterization of mobile genetic elements carrying VIM-1 and KPC-2 carbapenemases in Citrobacter freundii isolates in Madrid.
Characterization of multidrug-resistant Escherichia coli isolates associated with nosocomial infections in dogs.
Characterization of the AmpC ?-Lactamase from Burkholderia multivorans.
Characterization of the genetic environment of the blaKPC-2 gene among Klebsiella pneumoniae isolates from a Chinese Hospital.
Chemoprophylaxis and gonococcal infections in prostitutes.
Chromosomal Amplification of the blaOXA-58 Carbapenemase Gene in a Proteus mirabilis Clinical Isolate.
Chromosome Architecture and Gene Content of the Emergent Pathogen Acinetobacter haemolyticus.
Chromosome-mediated OXA-48 carbapenemase in highly virulent Escherichia coli.
Chronic CagA-positive Helicobacter pylori infection with MNNG stimulation synergistically induces mesenchymal and cancer stem cell-like properties in gastric mucosal epithelial cells.
Ciprofloxacin and co-trimoxazole resistance and extended spectrum beta-lactamase production in Escherichia coli strains isolated from urinary tract infections.
Ciprofloxacin versus ampicillin and probenecid in the treatment of uncomplicated gonorrhoea in men.
Clarithromycin. A review of its efficacy in the treatment of respiratory tract infections in immunocompetent patients.
Class A and D Extended-Spectrum ?-Lactamases in Imipenem Resistant Pseudomonas aeruginosa Isolated From Burn Patients in Iran.
Clavulanate combinations with mecillinam, cefixime or cefpodoxime against ESBL-producing Enterobacterales frequently associated with blaOXA-1 in a paediatric population with febrile urinary tract infections.
Clavulanate-potentiated amoxycillin: activity in vitro and bioavailability in the dog.
Clavulanic acid and penicillin treatment of Staphylococcus aureus renal infection in mice.
Clearance Rate of Carbapenemase-Producing Enterobacteriaceae Carriage Among Hospitalized Patients.
Clindamycin versus Unasyn in the treatment of facial cellulitis of odontogenic origin in children.
Clinical and bacteriological efficacy of amikacin in the treatment of lower urinary tract infection caused by extended-spectrum beta-lactamase-producing Escherichia coli or Klebsiella pneumoniae.
Clinical and bacteriological experience with cefodizime in acute purulent exacerbations of chronic bronchitis.
Clinical and Economic Impact of Community-Onset Urinary Tract Infections Caused by ESBL-Producing Klebsiella pneumoniae Requiring Hospitalization in Spain: An Observational Cohort Study.
Clinical and economic impact of urinary tract infections caused by ESBL-producing Escherichia coli requiring hospitalization: A matched cohort study.
Clinical and laboratory profiles of urinary tract infections caused by extended-spectrum beta-lactamase-producing Escherichia coli in a tertiary care center in central Saudi Arabia.
Clinical and microbiological implications of time-to-positivity of blood cultures in patients with Gram-negative bacilli bacteremia.
Clinical and molecular analysis of extended-spectrum {beta}-lactamase-producing enterobacteria in the community setting.
Clinical and molecular epidemiology of community-onset bacteremia caused by extended-spectrum ?-lactamase-producing Escherichia coli over a 6-year period.
Clinical and molecular epidemiology of community-onset, extended-spectrum beta-lactamase-producing Escherichia coli infections in Thailand: a case-case-control study.
Clinical and Molecular Epidemiology of Extended-Spectrum Beta-Lactamase-Producing Escherichia Coli Infections in Metro Detroit: Early Dominance of the ST-131 Clone.
Clinical and Molecular Epidemiology of Extended-Spectrum Beta-Lactamase-Producing Klebsiella spp.: A Systematic Review and Meta-Analyses.
Clinical and molecular epidemiology of healthcare-associated infections due to extended-spectrum beta-lactamase (ESBL)-producing strains of Escherichia coli and Klebsiella pneumoniae that harbor multiple ESBL genes.
Clinical Characteristics of Bacteremia Caused by Extended-spectrum Beta-lactamase-producing Escherichia coli at a Tertiary Hospital.
Clinical cure rate and cost-effectiveness of carbapenem sparing beta-lactams versus meropenem for Gram-negative infections: a systematic review, meta-analysis, and cost-effectiveness analysis.
Clinical evaluation of aztreonam therapy for serious infections due to gram-negative bacteria.
Clinical experience of serious infections caused by Enterobacteriaceae producing VIM-1 metallo-beta-lactamase in a Greek University Hospital.
Clinical experience with cefotaxime in the treatment of serious bone and joint infections.
Clinical features and molecular epidemiology of CMY-type beta-lactamase-producing Escherichia coli.
Clinical Features of Febrile Urinary Tract Infection Caused by Extended-spectrum Beta-lactamase-producing Escherichia Coli in Children.
Clinical features of multidrug-resistant organism infections in early postoperative solid organ transplantation in a single center.
Clinical features of patients with beta-lactamase producing Haemophilus influenzae isolated from sputum.
Clinical Impact of Extended-Spectrum ?-Lactamase-Producing Enterobacteriaceae in Patients with Biliary Tract Infection.
Clinical implications and risk factors of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae infection in children: a case-control retrospective study in a medical center in southern Taiwan.
Clinical laboratory detection of carbapenem-resistant and carbapenemase-producing Enterobacteriaceae.
Clinical Outcomes of Ceftriaxone vs Penicillin G for Complicated Viridans Group Streptococci Bacteremia.
Clinical outcomes of urinary tract infection caused by extended spectrum beta-lactamase producing Enterobacteriaceae: a retrospective observational study comparing patients with and without systemic inflammatory response syndrome.
Clinical patterns, epidemiology and risk factors of community-acquired urinary tract infection caused by extended-spectrum beta-lactamase producers: a prospective hospital case-control study.
Clinical Performance of Check-Direct CPE, a Multiplex PCR for Direct Detection of bla(KPC), bla(NDM) and/or bla(VIM), and bla(OXA)-48 from Perirectal Swabs.
Clinical Response and Outcome in Patients with Multidrug Resistant Gram-negative Infections.
Clinical significance of respiratory infection caused by Branhamella catarrhalis with special reference to beta-lactamase producing strains.
Clinical significance of serotype, biotype, and beta-lactamase production of respiratory isolates of Hemophilus influenzae.
Clinical syndromes and treatment location predict utility of carbapenem sparing therapies in ceftriaxone-non-susceptible Escherichia coli bloodstream infection.
Clinical trial of the efficacy and safety of ticarcillin and clavulanic acid.
Clinical Variants of New Delhi Metallo-?-Lactamase Are Evolving To Overcome Zinc Scarcity.
Clonal dissemination of highly virulent extended-spectrum beta-lactamase-producing Escherichia coli strains isolated from the urine of non-hospitalised patients in Zagreb region.
Clonal dissemination of Klebsiella pneumoniae carbapenemase KPC-3 in Long Beach, California.
Clonal spread and accumulation of ?-lactam resistance determinants in Enterobacter aerogenes and Enterobacter cloacae complex isolates from infection and colonization in patients at a public hospital in Recife, Pernambuco, Brazil.
Clonal spread of both oxyimino-cephalosporin- and cefoxitin-resistant Klebsiella pneumoniae isolates co-producing SHV-2a and DHA-1 beta-lactamase at a burns intensive care unit.
Clusters of imipenem-resistant Acinetobacter baumannii clones producing different carbapenemases in an intensive care unit.
Co-Carriage of blaKPC-2 and blaNDM-1 in Clinical Isolates of Pseudomonas aeruginosa Associated with Hospital Infections from India.
Co-existence of OXA-48 and NDM-1 in colistin resistant Pseudomonas aeruginosa ST235.
Co-Infections of Two Strains of NDM-1 and OXA-232 Co-producing Klebsiella pneumoniae in a Kidney Transplant Patient.
Co-occurrence of carbapenemase encoding genes in Acinetobacter baumannii, a dream or reality?
Co-production of MCR-1 and NDM-5 in Escherichia coli isolated from a colonization case of inpatient.
Coexistence of blaOXA-23 and armA in multidrug-resistant Acinetobacter baumannii isolated from hospital in South Korea.
Coexistence of SHV-4- and TEM-24-producing Enterobacter aerogenes strains before a large outbreak of TEM-24-producing strains in a French hospital.
Colonization and infection with extended spectrum beta-lactamase producing Enterobacteriaceae in high-risk patients - Review of the literature from a clinical perspective.
Colonization and infection with extended-spectrum beta-lactamase producing Enterobacteriaceae in patients with malignancy.
Combating bacterial resistance in skin and skin-structure infection: importance of beta-lactamase inhibition.
Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum beta-lactamases in the UK.
Comparative activities of novel beta-lactamase inhibitors, 6-exomethylene penamsulfones (CH1240, CH2140) in experimental mouse infection model.
Comparative clinical study of Sulbactam and ampicillin and clindamycin and tobramycin in infections of soft tissues.
Comparative efficacies of ticarcillin, ticarcillin/clavulanic acid, piperacillin and cefoxitin against polymicrobial infections in mice caused by Escherichia coli and Bacteroides fragilis.
Comparative evaluation of efficacy and safety of cefotaxime-sulbactam with amoxicillin-clavulanic acid in children with lower respiratory tract infections.
Comparative in vitro activity of amoxycillin/clavulanate (augmentin), ceftazidime and ceftriaxone against hospital strains of gram-negative and -positive bacteria.
Comparative study of a novel plasmid-mediated beta-lactamase, CAZ-2, and the CTX-1 and CAZ-1 enzymes conferring resistance to broad-spectrum cephalosporins.
Comparison of ampicillin-sulbactam with vancomycin for treatment of experimental endocarditis due to a beta-lactamase-producing, highly gentamicin-resistant isolate of Enterococcus faecalis.
Comparison of cefuroxime and penicillin in the treatment of uncomplicated gonorrhea.
Comparison of community-onset healthcare-associated and hospital-acquired urinary infections caused by extended-spectrum beta-lactamase-producing Escherichia coli and antimicrobial activities.
Comparison of ESBL contamination in organic and conventional retail chicken meat.
Comparison of minimum inhibitory concentrations to methicillin in heterogeneous and homogeneous methicillin resistant Staphylococcus aureus.
Comparison of the faecal colonization rates with extended-spectrum beta-lactamase producing enterobacteria among patients in different wards, outpatients and screened medical students.
Complete Assembly of Escherichia coli Sequence Type 131 Genomes Using Long Reads Demonstrates Antibiotic Resistance Gene Variation within Diverse Plasmid and Chromosomal Contexts.
Complete nucleotide sequence of pSKLX3330, an IncI1 plasmid carrying blaCTX-M-55 isolated from community-onset Escherichia coli infection.
Consequences of Extended Spectrum Beta-Lactamase-Producing Enterobacteriaceae and Methicillin-Resistant Staphylococcus aureus Carriage in Awaiting Liver Transplant Patients.
Control of carbapenemase-producing Klebsiella pneumoniae: a region-wide intervention.
Controversies in the treatment of streptococcal pharyngitis.
Conversion of benzylpenicillin to penicilloic acid in patients with chronic bronchial infections.
Correlation of in-vitro parameters of antimicrobial activity with prophylactic efficacy in an intradermal model of Staphylococcus aureus infection.
Cost-effectiveness analysis of vaborem for the treatment of carbapenem-resistant Enterobacteriaceae-Klebsiella pneumoniae carbapenemase (CRE-KPC) infections in the UK.
Critical issues for Klebsiella pneumoniae KPC-carbapenemase producing K. pneumoniae infections: a critical agenda.
Cross-infection of solid organ transplant recipients by a multidrug-resistant Klebsiella pneumoniae isolate producing the OXA-48 carbapenemase, likely derived from a multiorgan donor.
Crystallization and preliminary diffraction studies of GIM-1, a class B carbapenem-hydrolyzing ?-lactamase.
Crystallization and preliminary diffraction studies of SFC-1, a carbapenemase conferring antibiotic resistance.
CTX-M and PER-1 group extended spectrum ?-lactamases-producing Pseudomonas aeruginosa from the patients of lower respiratory tract infection.
CTX-M type extended spectrum beta-lactamases in Escherichia coli isolates from community acquired upper urinary tract infections at a university in the European part of Turkey.
CTX-M-producing Escherichia coli and Klebsiella pneumoniae isolated from community-acquired urinary tract infections in Valledupar, Colombia.
Daptomycin for a complicated urinary tract infection with vancomycin-resistant Enterococcus faecium in a renal transplant recipient.
Deadly Puppy Infection Caused by an MDR Escherichia coli O39 blaCTX-M-15, blaCMY-2, blaDHA-1, and aac(6)-Ib-cr - Positive in a Breeding Kennel in Central Italy.
Decreased baseline beta-lactamase production and inducibility associated with increased piperacillin susceptibility of Pseudomonas cepacia isolated from children with cystic fibrosis.
Decreasing level of resistance in invasive Klebsiella pneumoniae strains isolated in Marseille, January 2012-July 2015.
Decreasing prevalence of beta-lactamase production among respiratory tract isolates of Haemophilus influenzae in the United States.
Deep obstetrical and gynecological infections caused by non-typeable Haemophilus influenzae.
Depletion of CD4+ and CD8+ T lymphocyte subpopulations by CIA-1, a chicken infectious anemia virus.
Detection and Characterization of ESBL-Producing Escherichia coli From Humans and Poultry in Ghana.
Detection of BCL-6 rearrangements and p53 mutations in Malt-lymphomas.
Detection of bla KPC-2 in Proteus mirabilis in Brazil.
Detection of blaKPC and blaGES carbapenemase genes in Klebsiella pneumoniae isolated from hospitalized patients in Kashan, Iran.
Detection of cfxA and cfxA2, the beta-lactamase genes of Prevotella spp., in clinical samples from dentoalveolar infection by real-time PCR.
Detection of circulating antigens by ELISA using penicillinase in sera of mice infected with Toxoplasma gondii.
Detection of CMY-2 AmpC ?-lactamase-producing enterohemorrhagic Escherichia coli O157:H7 from outbreak strains in a nursery school in Japan.
Detection of ESBL bacteria from clinical specimens: evaluation of a new selective medium.
Detection of extended spectrum beta-lactamase from clinical isolates in Davangere.
Detection of extended-spectrum beta-lactamase production in Enterobacteriales from patients with suspected urinary tract infections, Tabora region, Rural Tanzania.
Detection of favorable oral cephalosporin-clavulanate interactions by in vitro disk approximation susceptibility testing of extended-spectrum-Beta-lactamase-producing members of the enterobacteriaceae.
Detection of Healthcare-Related Extended-Spectrum Beta-Lactamase-Producing Escherichia coli Transmission Events Using Combined Genetic and Phenotypic Epidemiology.
Detection of OXA-1 ?-Lactamase Gene of Klebsiella pneumoniae from Blood Stream Infections (BSI) by Conventional PCR and In-Silico Analysis to Understand the Mechanism of OXA Mediated Resistance.
Detection of OXA-48-like and NDM carbapenemases producing Klebsiella pneumoniae in Jordan: A pilot study.
Detection of the antimicrobial resistance genes blaTEM-1, cfxA, tetQ, tetM, tetW and ermC in endodontic infections of a Mexican population.
Detection systems for carbapenemase gene identification should include the SME serine carbapenemase.
Determinants of penicillinase producing Neisseria gonorrhoeae infections in heterosexuals in Amsterdam.
Determination of intracellular and extracellular beta-lactamase activities of Pseudomonas aeruginosa after exposure to beta-lactams in vitro and in vivo.
Determination of synergy between sulbactam, meropenem and colistin in carbapenem-resistant Klebsiella pneumoniae and Acinetobacter baumannii isolates and correlation with the molecular mechanism of resistance.
Development and validation of a method to determine amoxicillin in physiological fluids using micellar liquid chromatography.
Development and validation of a scoring system for predicting cancer patients at risk of extended-spectrum b-lactamase-producing Enterobacteriaceae infections.
Development of a multiplex PCR and SHV melting-curve mutation detection system for detection of some SHV and CTX-M beta-lactamases of Escherichia coli, Klebsiella pneumoniae, and Enterobacter cloacae in Taiwan.
Development of a rapid phenotypic test on a microfluidic device for carbapenemase detection using the chromogenic compound nitrocefin.
Development of a Two Triplex Real-Time Polymerase Chain Reaction for Rapid Detection of Six Carbapenemase Genes in Enterobacteriaceae.
Development of SYN-004, an oral beta-lactamase treatment to protect the gut microbiome from antibiotic-mediated damage and prevent Clostridium difficile infection.
Diagnosis and treatment of skin and soft tissue infections: clinical experience with ticarcillin disodium-clavulanate potassium.
Diagnostic accuracy of the BD Phoenix CPO Detect for carbapenemase production in 190 Enterobacteriaceae isolates.
Differences between clavulanic acid and sulbactam in induction and inhibition of cephalosporinases in enterobacteria.
Differences in the antibiotic susceptibility of human Escherichia coli with poultry-associated and non-poultry-associated extended-spectrum beta-lactamases.
Differential effects of chromosome and plasmid blaCTX-M-15 genes on antibiotic susceptibilities in extended-spectrum beta-lactamase-producing Escherichia coli isolates from patients with urinary tract infection.
Diffusion of 3-quaternary ammonium cephem antibiotics into cerebrospinal fluid of patients with bacterial meningitis.
Dipyridyl-substituted thiosemicarbazone as a potent broad-spectrum inhibitor of metallo-?-lactamases.
Direct and indirect pathogenicity of anaerobic bacteria in respiratory tract infections in children.
Discovery of thiosemicarbazone derivatives as effective New Delhi metallo-?-lactamase-1 (NDM-1) inhibitors against NDM-1 producing clinical isolates.
Dissemination of carbapenem-resistant Pseudomonas aeruginosa isolates and their susceptibilities to ceftolozane-tazobactam in Germany.
Dissemination of Escherichia coli with CTX-M type ESBL between humans and yellow-legged gulls in the south of France.
Dissemination of IncF plasmids carrying beta-lactamase genes in Gram-negative bacteria from Nigerian hospitals.
Dissemination of the metallo-beta-lactamase gene blaIMP-4 among gram-negative pathogens in a clinical setting in Australia.
Distribution of Class D Carbapenemase and Extended-Spectrum ?-Lactamase Genes among Acinetobacter Baumannii Isolated from Burn Wound and Ventilator Associated Pneumonia Infections.
Distribution of CRISPR-Cas Systems in Clinical Carbapenem-Resistant Klebsiella pneumoniae Strains in a Chinese Tertiary Hospital and Its Potential Relationship with Virulence.
Distribution of Pathogenicity Island Markers and H-Antigen Types of Escherichia coli O25b/ST131 Isolates from Patients with Urinary Tract Infection in Iran.
Distribution of the bla OXA , bla VEB-1 , and bla GES-1 genes and resistance patterns of ESBL-producing Pseudomonas aeruginosa isolated from hospitals in Tehran and Qazvin, Iran.
Diversity of clonal types of Klebsiella pneumoniae causing infections in intensive care neonatal patients in a large urban setting.
DNA replication in bacteriophage-infected Staphylococcus aureus.
Does broad-spectrum {beta}-lactam resistance due to NDM-1 herald the end of the antibiotic era for treatment of infections caused by Gram-negative bacteria?
Dosing nomograms for attaining optimum concentrations of meropenem by continuous infusion in critically ill patients with severe gram-negative infections: a pharmacokinetics/pharmacodynamics-based approach.
Double-disk synergy test positivity in Stenotrophomonas maltophilia clinical strains.
Doxycycline in respiratory infections: a re-assessment after 17 years.
Dual beta-lactam therapy for serious Gram-negative infections: is it time to revisit?
Dutch guideline for preventing nosocomial transmission of highly resistant microorganisms (HRMO).
Dutch patients, retail chicken meat and poultry share the same ESBL genes, plasmids and strains.
Early detection of metallo-?-lactamase NDM-1- and OXA-23 carbapenemase-producing Acinetobacter baumannii in Libyan hospitals.
Ebsulfur as a potent scaffold for inhibition and labelling of New Delhi metallo-?-lactamase-1 in vitro and in vivo.
Ecological effects on the oro- and nasopharyngeal microflora in children after treatment of acute otitis media with cefuroxime axetil or amoxycillin-clavulanate as suspensions.
Economic burden of inpatients infected with Klebsiella pneumoniae carbapenemase.
Editorial Comment to Differential effects of chromosome and plasmid blaCTX-M-15 genes on antibiotic susceptibilities in extended-spectrum beta-lactamase-producing Escherichia coli isolates from patients with urinary tract infection.
Effect of clavulanic acid and amoxycillin formulation against beta-lactamase producing Gram-negative bacteria in urinary tract infections.
Effect of Qiguiyin Decoction on multidrug-resistant Pseudomonas aeruginosa infection in rats.
Effect of tannin extract against Pseudomonas aeruginosa producing metallo beta-lactamase.
Effect of the ?-Lactamase Inhibitor Vaborbactam Combined with Meropenem against Serine Carbapenemase-Producing Enterobacteriaceae.
Effective Photodynamic Therapy with Ir(III) for Virulent Clinical Isolates of Extended-Spectrum Beta-Lactamase Klebsiella pneumoniae.
Effects of Helicobacter pylori on the expression levels of GATA-3 and connexin 32 and the GJIC function in gastric epithelial cells and their association by promoter analysis.
Effects of low ampicillin concentrations on penicillin sensitive and beta-lactamase producing strains of Neisseria gonorrhoeae.
Effects of morphine dependence on the pathogenesis of swine herpesvirus infection.
Effects of tazobactam on the frequency of the emergence of resistant strains from Enterobacter cloacae, Citrobacter freundii, and Proteus vulgaris (beta-lactamase derepressed mutants).
Efficacy and Pharmacokinetics of the Combination of OP0595 and Cefepime in a Mouse Model of Pneumonia Caused by Extended-Spectrum-Beta-Lactamase-Producing Klebsiella pneumoniae.
Efficacy and safety of de-escalation therapy to ertapenem for treatment of infections caused by extended-spectrum-?-lactamase-producing Enterobacteriaceae: an open-label randomized controlled trial.
Efficacy and Safety of Meropenem-Vaborbactam Versus Best Available Therapy for the Treatment of Carbapenem-Resistant Enterobacteriaceae Infections in Patients Without Prior Antimicrobial Failure: A Post Hoc Analysis.
Efficacy of ampicillin plus a beta-lactamase inhibitor (CP-45,899) in experimental endocarditis due to Staphylococcus aureus.
Efficacy of bacteriophage therapy in experimental sepsis and meningitis caused by a clone O25b:H4-ST131 Escherichia coli strain producing CTX-M-15.
Efficacy of BRL 25000 against Serratia marcescens, Enterobacter cloacae, and Citrobacter freundii in urinary tract infections.
Efficacy of cefoxitin for the treatment of urinary tract infection due to extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates.
Efficacy of cefoxitin versus carbapenem in febrile male urinary tract infections caused by extended spectrum beta-lactamase-producing Escherichia coli: a multicenter retrospective cohort study with propensity score analysis.
Efficacy of clavulanate-potentiated amoxycillin in experimental and clinical skin infections.
Efficacy of empirical therapy with non-carbapenems for urinary tract infections with extended-spectrum beta-lactamase-producing Enterobacteriaceae.
Efficacy of ertapenem for consolidation therapy of extended-spectrum beta-lactamase-producing gram-negative infections: a case series report.
Efficacy of Fosfomycin and Its Combination With Aminoglycosides in an Experimental Sepsis Model by Carbapenemase-Producing Klebsiella pneumoniae Clinical Strains.
Efficacy of humanized carbapenem and ceftazidime regimens against Enterobacteriaceae producing OXA-48 carbapenemase in a murine infection model.
Efficacy of non-carbapenem antibiotics for pediatric patients with first febrile urinary tract infection due to extended-spectrum beta-lactamase-producing Escherichia coli.
Efficacy of piperacillin combined with the Penem beta-lactamase inhibitor BLI-489 in murine models of systemic infection.
Efficacy of sulbactam-ampicillin in an induced Pasteurella haemolytica pneumonia model in calves.
Efforts towards the inhibitor design for New Delhi metallo-beta-lactamase (NDM-1).
Emergence and dissemination of extended-spectrum beta-lactamase-producing Escherichia coli in the community: lessons from the study of a remote and controlled population.
Emergence and Expansion of a Carbapenem-Resistant Pseudomonas aeruginosa Clone Are Associated with Plasmid-Borne bla KPC-2 and Virulence-Related Genes.
Emergence of a KPC Variant Conferring Resistance to Ceftazidime-Avibactam in a Widespread ST11 Carbapenem-Resistant Klebsiella pneumoniae Clone in China.
Emergence of a new group CTX-M enzyme in Romania and risk factors for extended spectrum beta-lactamase producing E. coli infections.
Emergence of antibiotic resistance during therapy for infections caused by Enterobacteriaceae producing AmpC beta-lactamase: implications for antibiotic use.
Emergence of antimicrobial resistance in gram-negative bacilli causing bacteremia during therapy.
Emergence of ceftazidime/avibactam non-susceptibility in an MDR Klebsiella pneumoniae isolate.
Emergence of clonally related Klebsiella pneumoniae isolates of sequence type 258 producing plasmid-mediated KPC carbapenemase in Norway and Sweden.
Emergence of colistin resistance in Enterobacteriaceae after the introduction of selective digestive tract decontamination in an intensive care unit.
Emergence of Klebsiella pneumoniae carbapenemase-producing bacteria.
Emergence of Klebsiella pneumoniae ST273 Carrying blaNDM-7 and ST656 Carrying blaNDM-1 in Manila, Philippines.
Emergence of metallo-beta-lactamase producing Pseudomonas aeruginosa in Pakistan.
Emergence of Mobile Colistin Resistance (mcr-8) in a Highly Successful Klebsiella pneumoniae Sequence Type 15 Clone from Clinical Infections in Bangladesh.
Emergence of NDM-1- and IMP-14a-producing Enterobacteriaceae in Thailand.
Emergence of NDM-1-producing Klebsiella pneumoniae in Greece: evidence of a widespread clonal outbreak.
Emergence of NDM-5-Producing Escherichia coli in a Teaching Hospital in Chongqing, China: IncF-Type Plasmids May Contribute to the Prevalence of blaNDM-5.
Emergence of New Delhi metallo-?-lactamase 1 (NDM-1) Producing and Multidrug Resistant Uropathogens Causing Urinary Tract Infections in Andaman Islands, India.
Emergence of Plasmid-Mediated Colistin Resistance Gene, mcr-1, in a Clinical Escherichia coli Isolate from Egypt.
Emerging Co-Pathogens: New Delhi Metallo-beta-lactamase producing Enterobacterales Infections in New York City COVID-19 Patients.
Enterobacter cloacae infection of an expanded polytetrafluoroethylene femoral-popliteal bypass graft: a case report.
Epidemic HI2 Plasmids Mobilising the Carbapenemase Gene blaIMP-4 in Australian Clinical Samples Identified in Multiple Sublineages of Escherichia coli ST216 Colonising Silver Gulls.
Epidemiological and clinical complexity of amoxicillin-clavulanate-resistant Escherichia coli.
Epidemiological investigation of fluoroquinolone resistance in infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae.
Epidemiological profile of healthcare-associated infections caused by Carbapenemase-producing Enterobacteriaceae.
Epidemiological study by pulsed-field gel electrophoresis of an outbreak of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a geriatric hospital.
Epidemiology and Burden of Bloodstream Infections Caused by Extended-Spectrum Beta-Lactamase Producing Enterobacteriaceae in a Pediatric Hospital in Senegal.
Epidemiology and clinical features of infections caused by extended-spectrum beta-lactamase-producing Escherichia coli in nonhospitalized patients.
Epidemiology and control of gonorrhoea in Sheffield.
Epidemiology and outcome of bacteremia caused by extended spectrum beta-lactamase (ESBL)-producing Escherichia coli and Klebsiella spp. in a tertiary care teaching hospital in south India.
Epidemiology and risk factors for extended-spectrum beta-lactamase-producing organisms: a case control study at a tertiary care center in Lebanon.
Epidemiology and treatment outcome of infection with antibiotic resistant strains of Neisseria gonorrhoeae in Scotland.
Epidemiology of colistin-resistant, carbapenemase-producing Enterobacteriaceae and Acinetobacter baumannii in Croatia.
Epidemiology of CTX-M-type extended-spectrum beta-lactamase (ESBL)-producing nosocomial - Escherichia coli infection in China.
Epidemiology of extended-spectrum beta-lactamase (ESBL) producing Escherichia coli in Japan: Characteristics of community-associated versus healthcare-associated ESBL E. coli.
Epidemiology of extended-spectrum beta-lactamase producing gram-negative bacilli at Siriraj Hospital, Thailand, 2003.
Epidemiology of metalloenzyme-producing Pseudomonas aeruginosa in a tertiary hospital in Greece.
Epidemiology of urinary tract infections caused by extended-spectrum beta-lactamase-producing Escherichia coli.
Epidemiology, risk factors and comorbidity for urinary tract infections caused by extended-spectrum beta-lactamase (ESBL)-producing enterobacteria.
Ertapenem susceptibility of extended spectrum beta-lactamase-producing Enterobacteriaceae at a tertiary care centre in India.
Ertapenem susceptibility of extended spectrum beta-lactamase-producing organisms.
Erythromycin for prokinesis: imprudent prescribing?
ESBL Escherichia coli Ventriculitis after Aneurysm Clipping: A Rare and Difficult Therapeutic Challenge.
ESBL-producing multidrug-resistant Providencia stuartii infections in a university hospital.
Escherichia coli belonging to ST131 rarely transfers blactx-m-15 to fecal Escherichia coli.
Escherichia coli ST167 carrying plasmid mobilisable mcr-1 and blaCTX-M-15 resistance determinants isolated from a human respiratory infection.
Evaluating the Efficacies of Carbapenem/?-Lactamase Inhibitors Against Carbapenem-Resistant Gram-Negative Bacteria in vitro and in vivo.
Evaluation of a chromogenic medium for detection of extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae strains.
Evaluation of a New Phenotypic OXA-48 Disk Test for the Differentiation of OXA-48 Carbapenemase-Producing Enterobacteriaceae Clinical Isolates.
Evaluation of a novel kit for the rapid detection of extended-spectrum beta-lactamases.
Evaluation of a novel procedure for rapid detection of carbapenemase-producing Enterobacteriaceae (CPE) using the LightMix® modular carbapenemase kits.
Evaluation of antibacterial activities of flomoxef against ESBL producing Enterobacteriaceae analyzed by Monte Carlo simulation.
Evaluation of antibiotic efficacy against infections caused by planktonic or biofilm cultures of Pseudomonas aeruginosa and Klebsiella pneumoniae in Galleria mellonella.
Evaluation of bacterial interference and beta-lactamase production in management of experimental infection with group A beta-hemolytic streptococci.
Evaluation of Hemophilus type B systemic isolates for beta-lactamase and non-beta-lactamase mediated ampicillin resistance and for susceptibility to other antimicrobial agents.
Evaluation of MBT STAR-Cepha and MBT STAR-Carba kits for the detection of extended-spectrum ?-lactamases and carbapenemase producing microorganisms using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
Evaluation of risk factors for the acquisition of bloodstream infections with extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species in the intensive care unit; antibiotic management and clinical outcome.
Evaluation of the Antimicrobial Activity of Sparfloxacin, Relative to Other Oral Antibiotics Against 1,125 Bacterial Isolates from 10 Medical Centers in Brazil.
Evaluation of the commercial combined disk test and minimum inhibitory concentration (MIC) determination for detection of carbapenemase producers among Gram-negative bacilli isolated in a region with high prevalence of blaOXA-48 and blaNDM.
Evaluation of the FilmArray Blood Culture Identification Panel on Detection of Pathogenic Microorganisms in Positive Blood Cultures: the First Clinical Report in Japan.
Evaluation of the Immunochromatographic NG-Test Carba 5, RESIST-5 O.O.K.N.V., and IMP K-SeT for Rapid Detection of KPC-, NDM-, IMP-, VIM-type, and OXA-48-like Carbapenemase Among Enterobacterales.
Evaluation of the NanoCHIP(®) Infection Control Panel test for direct detection and screening of methicillin-resistant Staphylococcus aureus (MRSA), Klebsiella pneumoniae carbapenemase (KPC)-producing bacteria and vancomycin-resistant Enterococcus (VRE).
Evaluation of ticarcillin/clavulanate potassium in the treatment of obstetric and gynecologic infections.
Evaluation of Xpert Carba-R Assay v.2 to Detect Carbapenemase Genes in Two Hospitals in Korea.
Evolution of beta-lactamase inhibitors.
Expanded-spectrum beta-lactamase producing Klebsiella pneumoniae-related peritonitis in a patient on peritoneal dialysis.
Expansion of the clavulanic acid gene cluster: identification and in vivo functional analysis of three new genes required for biosynthesis of clavulanic acid by Streptomyces clavuligerus.
Experience with fosfomycin in the treatment of complicated urinary tract infections caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae.
Experimental infections for the evaluation of beta-lactamase resistance.
Expression and purification of Suid Herpesvirus-1 glycoprotein E in the baculovirus system and its use to diagnose Aujeszky's disease in infected pigs.
Expression of CagL from Helicobacter pylori and Preliminary Study of its Biological Function.
Extended spectrum beta lactamase-producing Klebsiella pneumoniae infections: a review of the literature.
Extended spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae: considerations for diagnosis, prevention and drug treatment.
Extended Spectrum Beta-Lactamase Escherichia coli in River Waters Collected from Two Cities in Ghana, 2018-2020.
Extended spectrum beta-lactamase producing Enterobacterales faecal carriage in a medical intensive care unit: low rates of cross-transmission and infection.
Extended spectrum beta-lactamase production and fluorquinolone resistance in pathogens associated with community acquired urinary tract infection.
Extended spectrum beta-lactamase urinary tract infections.
Extended spectrum beta-lactamase-producing Enterobacteriaceae in international travelers and non-travelers in New York City.
Extended Spectrum Beta-Lactamase-Resistant Determinants among Carbapenem-Resistant Enterobacteriaceae from Beef Cattle in the North West Province, South Africa: A Critical Assessment of Their Possible Public Health Implications.
Extended-Spectrum ?-Lactamase and Carbapenemase Producing Gram-Negative Bacilli Infections Among Patients in Intensive Care Units of Felegehiwot Referral Hospital: A Prospective Cross-Sectional Study.
Extended-spectrum ?-lactamase, carbapenemase and AmpC producing Enterobacteriaceae in companion animals.
Extended-Spectrum ?-Lactamase- and Carbapenemase-Producing Enterobacteriaceae Isolated from Egyptian Patients with Suspected Blood Stream Infection.
Extended-spectrum and CMY-type beta-lactamase-producing Escherichia coli in clinical samples and retail meat from Pittsburgh, US, and Seville, Spain.
Extended-spectrum beta-lactamase (ESBL)-producing enterobacteria: factors associated with infection in the community setting, Auckland, New Zealand.
Extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae and urinary tract infections in pregnant/post-partum women: a systematic review and meta-analysis.
Extended-spectrum Beta-lactamase detection with different panels for automated susceptibility testing and with a chromogenic medium.
Extended-spectrum beta-lactamase Escherichia coli and Klebsiella pneumoniae urinary tract infections.
Extended-Spectrum Beta-Lactamase Infections in Orthopedic-Related Devices and Prosthetic Joints.
Extended-Spectrum Beta-lactamase Producers: Detection for the Diagnostic Laboratory.
Extended-spectrum beta-lactamase producing Enterobacteriaceae (ESBL-E) isolated from bean sprouts in the Netherlands.
Extended-spectrum beta-lactamase producing Enterobacteriaceae in the intensive care unit: persistent issues to understand the transition from colonization to infection.
Extended-spectrum beta-lactamase producing Klebsiella pneumoniae in neonatal intensive care unit.
Extended-spectrum beta-lactamase-positive Escherichia coli causing complicated upper urinary tract infection: Urologist should act in time.
Extended-spectrum beta-lactamase-producing Enterobacter cloacae in mobile dialysis units in the medical and surgical departments of a university hospital: a case-control study.
Extended-spectrum beta-lactamase-producing Enterobacteriaceae in hospital urinary tract infections: incidence and antibiotic susceptibility profile over 9 years.
Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae from urinary tract infections: Evolution of antimicrobial resistance and treatment options.
Extended-spectrum beta-lactamase-producing Escherichia coli infections in children: Are community-acquired strains different from nosocomial strains?
Extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in paediatric wards: a nested case-control study.
Extended-spectrum beta-lactamases in ambulatory care: a clinical perspective.
Extended-spectrum beta-lactamases in clinical isolates of Escherichia coli and Klebsiella spp. in a Singapore hospital: clinical spectrum.
Extended-spectrum beta-lactamases in urinary isolates of Escherichia coli, Klebsiella pneumoniae and other gram-negative bacteria in a hospital in Eastern Province, Saudi Arabia.
Extended-spectrum beta-lactamases: implications for the clinical laboratory and therapy.
Extended-spectrum cephalosporin-resistant gram-negative organisms in livestock: An emerging problem for human health?
Extended-spectrum-?-lactamase-producing Escherichia coli as a cause of pediatric infections: report of a neonatal intensive care unit outbreak due to a CTX-M-14-producing strain.
Extended-spectrum-Beta-lactamase producing bacteria related urinary tract infection in renal transplant recipients and effect on allograft function.
Factors associated with bacteraemia due to multidrug-resistant organisms among bacteraemic patients with multidrug-resistant organism carriage: a case control study.
Faecal microbiota transplant to ERadicate gastrointestinal carriage of Antibiotic Resistant Organisms (FERARO): a prospective, randomised placebo-controlled feasibility trial.
Failure of cephalosporins to prevent Staphylococcus aureus surgical wound infections.
Fatal sepsis due to a beta-lactamase-producing strain of Fusobacterium nucleatum subspecies polymorphum.
Fecal Colonization With Extended-spectrum Beta-lactamase-Producing Enterobacteriaceae and Risk Factors Among Healthy Individuals: A Systematic Review and Metaanalysis.
First case of New Delhi metallo-beta-lactamase 1-producing Escherichia coli infection in Japan.
First clinical cases of NDM-1-producing Klebsiella pneumoniae from two hospitals in Bulgaria.
First Description of an Extended Spectrum {beta}-Lactamase-Producing Multi-Drug Resistant Escherichia fergusonii in a Patient with Cystitis.
First detection of CTX-M and SHV extended-spectrum beta-lactamases in Escherichia coli urinary tract isolates from dogs and cats in the United States.
First nosocomial outbreak of Pseudomonas aeruginosa producing an integron-borne metallo-beta-lactamase (VIM-2) in the United States.
First outbreak of VIM-2 metallo-?-lactamase-producing Pseudomonas aeruginosa in The Netherlands: microbiology, epidemiology and clinical outcomes.
First report of the isolation of blaIMI-1-producing colistin-heteroresistant Enterobacter cloacae in Japan, September 2016.
Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum beta-lactamase producing, Enterobacteriaceae infections: a systematic review.
Fosfomycin: an oral agent for urinary infection caused by extended spectrum beta-lactamase producing organisms.
Frequency assessment of ?-lactamase enzymes in Escherichia coli and Klebsiella isolates in patients with urinary tract infection.
Frequency Distribution, Genotypes and the most Prevalent Sequence Types of New Delhi Metallo-beta-lactamase-Producing Escherichia coli among Clinical Isolates around the World; A Review.
Further experience with augmentin in the treatment of skin infections.
Gastrointestinal Tract Colonization Rate of Extended?-Spectrum Beta-Lactamase- and Carbapenemase-Producing Enterobacteriaceae and Associated Factors Among Hospitalized Patients in Arba Minch General Hospital, Arba Minch, Ethiopia.
Genes encoding TEM-4, SHV-2, and CTX-M-10 extended-spectrum beta-lactamases are carried by multiple Klebsiella pneumoniae clones in a single hospital (Madrid, 1989 to 2000).
Genetic characterization and virulence of a carbapenem-resistant Raoultella ornithinolytica isolated from well water carrying a novel megaplasmid containing blaNDM-1.
Genetic determinants for cfxA expression in Bacteroides strains isolated from human infections.
Genetic mapping identifies novel highly protective antigens for an apicomplexan parasite.
Genital infections in women attending a genito-urinary clinic in Harare, Zimbabwe.
Genome Sequence of Escherichia coli Clone O25:H4 Sequence Type 131, Isolated from a Sudanese Patient with Urinary Tract Infection.
Genomic analysis of carbapenemase-producing Enterobacteriaceae in Queensland reveals widespread transmission of blaIMP-4 on an IncHI2 plasmid.
Genomic Analysis of the Emergence and Rapid Global Dissemination of the Clonal Group 258 Klebsiella pneumoniae Pandemic.
Genomic characterisation of clinical and environmental Pseudomonas putida group strains and determination of their role in the transfer of antimicrobial resistance genes to Pseudomonas aeruginosa.
Genomic characterization of an colistin-resistant Klebsiella pneumoniae ST11 strain, co-producing KPC-2, FloR, CTX-M-55, SHV-12, FosA, and RmtB causing a lethal infection.
Genomic Characterization of Enterobacter cloacae Isolates from China That Coproduce KPC-3 and NDM-1 Carbapenemases.
Genomic Epidemiology of an Endoscope-Associated Outbreak of Klebsiella pneumoniae Carbapenemase (KPC)-Producing K. pneumoniae.
Genomics and Virulence of Klebsiella pneumoniae Kpnu95 ST1412 Harboring a Novel Incf Plasmid Encoding Blactx-M-15 and Qnrs1 Causing Community Urinary Tract Infection.
Genotypic and Phenotypic Characterization of IncX3 Plasmid Carrying blaNDM-7 in Escherichia coli Sequence Type 167 Isolated From a Patient With Urinary Tract Infection.
Genotypic to Phenotypic Resistance Discrepancies Identified Involving ?-Lactamase Genes, blaKPC, blaIMP, blaNDM-1, and blaVIM in Uropathogenic Klebsiella pneumoniae.
Genotypic versus phenotypic characterization, with respect to susceptibility and identification, of 17 clinical isolates of Staphylococcus lugdunensis.
Global dissemination of extensively drug-resistant carbapenemase-producing Enterobacteriaceae: clinical perspectives on detection, treatment and infection control.
Global distribution of TEM-1 and ROB-1 beta-lactamases in Haemophilus influenzae.
Group 1 beta-lactamases of Aeromonas caviae and their resistance to beta-lactam antibiotics.
Guidance for control of infections with carbapenem-resistant or carbapenemase-producing Enterobacteriaceae in acute care facilities.
Gut Microbiome Signatures are Predictive of Infectious Risk Following Induction Therapy for Acute Myeloid Leukemia.
Gut mucosal colonisation with extended-spectrum beta-lactamase producing Enterobacteriaceae in sub-Saharan Africa: a systematic review and meta-analysis.
H. pylori induces promoter hypermethylation and downregulates gene expression of IRX1 transcription factor on human gastric mucosa.
Haemophilus influenzae infections in adults: characterization of strains by serotypes, biotypes, and beta-lactamase production.
Health and economic outcomes of the detection of Klebsiella pneumoniae-produced extended-spectrum beta-lactamase (ESBL) in a hospital with high prevalence of this infection.
Healthcare costs doubled when children had urinary tract infections caused by extended-spectrum ?-lactamase-producing bacteria.
Helicobacter pylori induces epithelial-mesenchymal transition in gastric carcinogenesis via the AKT/GSK3? signaling pathway.
Helicobacter pylori induces malignant transformation of gastric epithelial cells in vitro.
Helicobacter pylori infection promotes Aquaporin 3 expression via the ROS-HIF-1?-AQP3-ROS loop in stomach mucosa: a potential novel mechanism for cancer pathogenesis.
Hemophilus influenzae respiratory infection in adults. 2. Treatment guidelines.
High carriage rate of extended-spectrum beta-lactamase-producing Enterobacteriaceae among patients admitted for surgery in Tanzanian hospitals with a low rate of endogenous surgical site infections.
High occurrence of blaCMY-1 AmpC lactamase producing Escherichia coli in cases of complicated urinary tract infection (UTI) from a tertiary health care centre in north India.
High plasmid variability, and the presence of IncFIB, IncQ, IncA/C, IncHI1B, and IncL/M in clinical isolates of Klebsiella pneumoniae with bla KPC and bla NDM from patients at a public hospital in Brazil.
High Prevalence of blaCTX-M-15 Gene among Extended-Spectrum ?-Lactamase-Producing Escherichia coli Isolates Causing Extraintestinal Infections in Bangladesh.
High prevalence of carbapenamase genes, AmpC genes and aminoglycoside resistance genes in extended spectrum ?-lactamase positive uropathogens from Northern India.
High prevalence of CTX-M-15 and first report of CTX-M-3, CTX-M-22, CTX-M-28 and plasmid-mediated AmpC beta-lactamase producing Enterobacteriaceae causing urinary tract infections in Bosnia and Herzegovina in hospital and community settings.
High Prevalence of Escherichia coli-Producing CTX-M-15 Extended-Spectrum Beta-Lactamases in Poultry and Human Clinical Isolates in Romania.
High Prevalence of Extended-Spectrum Beta-Lactamases in Escherichia coli Strains Collected From Strictly Defined Community-Acquired Urinary Tract Infections in Adults in China: A Multicenter Prospective Clinical Microbiological and Molecular Study.
High prevalence of Klebsiella pneumoniae carbapenemase-mediated resistance in K. pneumoniae isolates from Egypt.
High Prevalence of New Delhi Metallo-?-Lactamase-1 (NDM-1) Producers among Carbapenem-Resistant Enterobacteriaceae in Kuwait.
High proportion of intestinal colonization with successful epidemic clones of ESBL-producing Enterobacteriaceae in a neonatal intensive care unit in Ecuador.
Host immunology and rational immunotherapy for carbapenem-resistant Klebsiella pneumoniae infection.
Host-specific enzyme-substrate interactions in SPM-1 metallo-?-lactamase are modulated by second sphere residues.
How to detect NDM-1 producers.
Hydrotalcite Can Prevent the Damaging Effects of Helicobacter Pylori on Gastric Epithelial Cells.
Hyperproduction of TEM-1 beta-lactamase in clinical isolates of Escherichia coli serotype O15.
Identification and differentiation of carbapenemases in Klebsiella pneumoniae: a phenotypic test evaluation study from jaipur, India.
Identification of pharmacophore in bioactive metal complexes: Synthesis, spectroscopic characterization and application.
Identification of plasmid IncQ1 and NTEKPC-IId harboring bla KPC-2 in isolates from Klebsiella pneumoniae infections in patients from Recife-PE, Brazil.
Identification of the first imported KPC-3 Klebsiella pneumoniae from the USA to Taiwan.
Identity of blaCTX-M Carrying Plasmids in Sequential ESBL-E. coli Isolates from Patients with Recurrent Urinary Tract Infections.
Imaging tuberculosis with endogenous beta-lactamase reporter enzyme fluorescence in live mice.
Immunological and serological diversity of Neisseria gonorrhoeae: identification of new immunotypes and highly protective strains.
Impact and cost of infection control measures to reduce nosocomial transmission of extended-spectrum beta-lactamase-producing organisms in a non-outbreak setting.
Impact of beta-lactamases on the clinical use of beta-lactam antibiotics.
Impact of carbapenem resistance on epidemiology and outcomes of nonbacteremic Klebsiella pneumoniae infections.
Impact of cephalosporin restriction on incidence of infections with extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in an endemic setting.
Impact of early carbapenemase notification on infection control management and antimicrobial stewardship.
Impact of Empiric Antibiotic Use on Development of Infections caused by Extended-Spectrum beta-Lactamase Bacteria in a Neonatal Intensive Care Unit.
Impact of extended spectrum beta-lactamase producing Klebsiella pneumoniae infections in severely burned patients.
Impact of Helicobacter pylori Infection and Its Major Virulence Factor CagA on DNA Damage Repair.
Impact of host-pathogen-treatment tripartite components on early mortality of patients with Escherichia coli bloodstream infection: Prospective observational study.
Impact of reflex fosfomycin E-testing on the utilization of carbapenems for definitive extended-spectrum beta-lactamase Escherichia coli urinary tract infection treatment.
Impact of relebactam-mediated inhibition of Mycobacterium abscessus BlaMab ?-lactamase on the in vitro and intracellular efficacy of imipenem.
Impact of the New Delhi metallo-beta-lactamase on beta-lactam antibiotics.
Implications of beta-lactamase-inhibitor combinations.
Implications of faecal ESBL carriers undergoing TRUS-guided prostate biopsy (TRUSPB): role of screening prior to TRUSPB.
Importance of beta-lactamase inactivation in treatment of experimental endocarditis caused by Staphylococcus aureus.
Importance of beta-lactamase stability in treating today's respiratory tract infections.
Importance of extracellular and cell-bound beta-lactamase in mediating resistance of Staphylococcus aureus to mezlocillin.
Imported chicken meat as a potential source of quinolone-resistant Escherichia coli producing extended-spectrum beta-lactamases in the UK.
Improving detection of extended-spectrum Beta-lactamase-producing bacteria in a deployed setting.
Improving the Reprocessing Quality of Flexible Thermolabile Endoscopes: How to Learn from Mistakes.
In vitro activities of 16 antimicrobial agents against clinical isolates of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in two regional hospitals in Taiwan.
In vitro activity of beta-lactam antibiotics against CTX-M-producing Escherichia coli.
In vitro activity of cefpirome against beta-lactamase-inducible and stably derepressed Enterobacteriaceae.
In vitro activity of cefpodoxime in comparison with other oral beta-lactam antibiotics.
In vitro activity of fosfomycin and other antimicrobials against uropathogenic Escherichia coli and Klebsiella pneumoniae at a tertiary care center in Lebanon.
In vitro Activity of Meropenem-Vaborbactam versus Other Antibiotics Against Carbapenem-Resistant Escherichia coli from Southeastern China.
In vitro activity of oral antimicrobial agents against clinical isolates of Pasteurella multocida.
In vitro activity of temocillin against extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae strains isolated from urinary tract infections in France.
In vitro activity of the {beta}-lactamase inhibitor NXL104 against KPC-2 carbapenemase and Enterobacteriaceae expressing KPC carbapenemases.
In vitro and in vivo antibacterial activity assays of carvacrol: A candidate for development of innovative treatments against KPC-producing Klebsiella pneumoniae.
In vitro and in vivo antibacterial activity of moxalactam, an oxa-beta-lactam antibiotic.
In Vitro Discordance with In Vivo Activity: Humanized Exposures of Ceftazidime-Avibactam, Aztreonam, and Tigecycline Alone and in Combination against New Delhi Metallo-?-Lactamase-Producing Klebsiella pneumoniae in a Murine Lung Infection Model.
In vitro efficacy of beta-lactam/beta-lactamase inhibitor combinations against bacteria involved in mixed infections.
In vitro released antigens in diagnosis and immunomonitoring of filaria and tuberculosis.
In vitro susceptibilities of Capnocytophaga isolates to beta-lactam antibiotics and beta-lactamase inhibitors.
In vitro synergy of ?-lactam combinations against KPC-producing Klebsiella pneumoniae strains.
In vivo effect of cefazolin, daptomycin, and nafcillin in experimental endocarditis with a methicillin-susceptible Staphylococcus aureus strain showing an inoculum effect against cefazolin.
In vivo pharmacodynamics of piperacillin/tazobactam: implications for antimicrobial efficacy and resistance suppression with innovator and generic products.
In vivo protection of penicillin-susceptible Bacteroides melaninogenicus from penicillin by facultative bacteria which produce beta-lactamase.
In Vivo Studies on Staphylococcal Penicillinase.
In-vitro activity of FCE 22101 against respiratory tract pathogens with reference to production of beta-lactamases.
Inactivation of the glycoside hydrolase NagZ attenuates antipseudomonal {beta}-lactam resistance in Pseudomonas aeruginosa.
Incidence and management of extended-spectrum beta-lactamase and quinolone-resistant Escherichia coli infections after prostate biopsy.
Incidence of a subsequent carbapenem-resistant Enterobacteriaceae infection after previous colonisation or infection: a prospective cohort study.
Incidence of beta-lactamase producing E. coli in urinary tract infections.
Incidence of beta-lactamase production and antimicrobial susceptibility of anaerobic gram-negative rods isolated from pus specimens of orofacial odontogenic infections.
Incidence of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in patients with urinary tract infection.
Incidence of multidrug resistance and extended-spectrum beta-lactamase expression in community-acquired urinary tract infection among different age groups of patients.
Increase resistant rates and ESBL production between E. coli isolates causing urinary tract infection in young patients from Iran.
Increased beta-lactamase activity in Branhamella catarrhalis after exposure to amoxicillin and clavulanic acid.
Increasing prevalence of ampicillin- resistant, non-beta-lactamase-producing strains of Haemophilus influenzae in children in Japan.
Increasing Prevalence of Escherichia coli and Klebsiella pneumoniae Producing CTX-M-Type Extended-Spectrum Beta-Lactamase, Carbapenemase, and NDM-1 in Patients from a Rural Community with Community Acquired Infections: A 3-Year Study.
Inducible amp C beta-lactamase producing gram-negative bacilli from blood stream infections: frequency, antimicrobial susceptibility, and molecular epidemiology in a national surveillance program (SCOPE).
Infection and chronic colonization of an intensive care unit patient's respiratory tract by a Klebsiella pneumoniae strain producing a novel AmpC beta-lactamase different from that known.
Infection control and antimicrobial restriction practices for antimicrobial-resistant organisms in Canadian tertiary care hospitals.
Infection Control Following an Outbreak of Extended-Spectrum Beta-Lactamase-Producing Klebsiella pneumoniae Isolated from Catheter-Associated Urinary Tract Infection.
Infection in women. Clinical experience with beta-lactamase inhibitors.
Infection related to Klebsiella pneumoniae producing carbapenemase in renal transplant patients.
Infection with Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae in solid organ transplantation.
Infection with Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae in cancer patients.
Infection with penicillinase producing Neisseria gonorrhoeae in Catalonia.
Infections by OXA-48-like-producing Klebsiella pneumoniae non-co-producing extended-spectrum beta-lactamase: Can they be successfully treated with cephalosporins?
Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study.
Infections due to Escherichia coli producing extended-spectrum beta-lactamase among hospitalised patients: factors influencing mortality.
Infections in Cancer Patients with Solid Tumors: A Review.
Infections in gynaecology and obstetrics and cefotaxime.
Infections of the upper respiratory tract, head, and neck. The role of anaerobic bacteria.
Infections with extended-spectrum beta-lactamase-producing enterobacteriaceae: changing epidemiology and drug treatment choices.
Infectious diseases in the critically ill patients.
Infective endocarditis caused by Neisseria flavescens.
Infezioni delle vie urinarie: appropriatezza in antibioticoterapia.
Influence of beta-lactamase inhibitors on the potency of their companion drug with organisms possessing class I enzymes.
Influence of clindamycin on derepression of beta-lactamases in Enterobacter spp. and Pseudomonas aeruginosa.
Integrating forecast probabilities in antibiograms: a way to guide antimicrobial prescriptions more reliably?
Intensive care unit outbreak of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae controlled by cohorting patients and reinforcing infection control measures.
Intestinal carriage of Extended Spectrum Beta-Lactamase producing E. coli in women with urinary tract infections, Cameroon.
Invasive device-related infections after heart surgery.
Invasive Haemophilus influenzae disease in Alaskan residents aged 10 years and older before and after infant vaccination programs.
Investigation and management of an A. Baumannii outbreak in ICU.
Investigation of a nosocomial outbreak of Acinetobacter baumannii producing PER-1 extended-spectrum beta-lactamase in an intensive care unit.
Investigation of a nosocomial outbreak of imipenem-resistant Acinetobacter baumannii producing the OXA-23 beta-lactamase in korea.
Investigation of risk factors for community-acquired urinary tract infections caused by extended-spectrum beta-lactamase Escherichia coli and Klebsiella species.
In vitro effect of an antimicrobial combination therapy without colistin and tigecycline for CPE and non-CPE.
Is treatment of acute exacerbations of chronic bronchitis with intramuscular mezlocillin justifiable?
Isolation and plasmid characterization of carbapenemase (IMP-4) producing Salmonella enterica Typhimurium from cats.
Italian nationwide survey on Pseudomonas aeruginosa from invasive infections: activity of ceftolozane/tazobactam and comparators, and molecular epidemiology of carbapenemase producers.
Klebsiella pneumoniae carbapenemase (KPC) in urinary infection isolates.
Klebsiella pneumoniae infections in Greek hospitals. Dissemination of plasmids encoding an SHV-5 type beta-lactamase.
Klebsiella pneumoniae with extended spectrum beta-lactamase activity associated with a necrotizing enterocolitis outbreak.
KPC - 3 Klebsiella pneumoniae ST258 clone infection in postoperative abdominal surgery patients in an intensive care setting: analysis of a case series of 30 patients.
KPC-2 producing Klebsiella pneumoniae and Escherichia coli co-infection in a catheter-related infection.
KPC-2-producing Klebsiella pneumoniae infections in Greek hospitals are mainly due to a hyperepidemic clone.
Laboratory diagnosis of bloodstream infections caused by extended-spectrum beta-lactamase-producing E. coli and Klebsiella species.
Lack of association of Staphylococcus aureus type A beta-lactamase with cefazolin combined with antimicrobial spacer placement prosthetic joint infection treatment failure.
Large Dissemination of VIM-2 Metallo-{beta}-Lactamase-Producing Pseudomonas aeruginosa Causing Healthcare-Associated Community-Onset Infections.
Large hospital outbreak of KPC-2-producing Klebsiella pneumoniae: investigating mortality and the impact of screening for KPC-2 with polymerase chain reaction.
Large outbreak of infection and colonization with gram-negative pathogens carrying the metallo- beta -lactamase gene blaIMP-4 at a 320-bed tertiary hospital in Australia.
Long-term outcomes of inappropriate antibiotic therapy for upper urinary tract infections caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae: a retrospective cohort study.
Loss of plasmid DNA coding for beta-lactamase during experimental infection with Haemophilus influenzae type b.
Low expression of the long non-coding RNA NR_026827 in gastric cancer.
Low Frequency of Ceftazidime-Avibactam Resistance among Enterobacteriaceae Isolates Carrying blaKPC Collected in U.S. Hospitals from 2012 to 2015.
Low relapse rate of urinary tract infections from extended-spectrum beta-lactamase-producing bacteria in young children.
Lumbar arthrodesis infection by multi-resistant Klebsiella pneumoniae, successfully treated with implant retention and ceftazidime/avibactam.
Macrolide susceptibility and beta-lactamase production among haemophilus influenzae isolates in the United States, 1996-1997.
MALDI-TOF MS based procedure to detect KPC-2 directly from positive blood culture bottles and colonies.
Management of a post-operative multi-resistant infectious spondylitis associated with a kyphotic deformity.
Management of Extended-Spectrum Beta-Lactamase Urinary Tract Infections: Diagnostic and Treatment Considerations for the Older Adult.
Management of infections in the neutropenic child with cancer.
Management of KPC-Producing Klebsiella pneumoniae Infections.
Managing ESBL-producing Enterobacteriaceae-related urinary tract infection in primary care: a tool kit for general practitioners.
Maternal antibiotic exposure during pregnancy is a risk factor for community-acquired urinary tract infection caused by extended-spectrum beta-lactamase-producing bacteria in infants.
MCR: modern colistin resistance.
Measuring the quality of infection control in Dutch nursing homes using a standardized method; the Infection prevention RIsk Scan (IRIS).
Mechanical ventilation-associated pneumonia caused by Acinetobacter baumannii in Northeast China region: analysis of genotype and drug resistance of bacteria and patients' clinical features over 7 years.
Mechanisms responsible for the emergence of carbapenem resistance in Pseudomonas aeruginosa.
Meropenem-nacubactam activity against AmpC-overproducing and KPC-expressing Pseudomonas aeruginosa in a neutropenic murine lung infection model.
Meropenem-vaborbactam for adults with complicated urinary tract and other invasive infections.
Meta-analysis of proportion estimates of Extended-Spectrum-Beta-Lactamase-producing Enterobacteriaceae in East Africa hospitals.
Metallo beta-lactamase producing pseudomonas species--a major cause of concern among hospital associated urinary tract infection.
Methicillin-resistant S. aureus (MRSA), extended-spectrum (ESBL)- and plasmid-mediated AmpC ß-lactamase -producing Gram-negative bacteria associated with skin and soft tissue infections in hospital and community settings.
Mezlocillin and azlocillin: an evaluation of two new beta-lactam antibiotics.
Microarray analysis of Long non-coding RNA expression profiles in human gastric cells and tissues with Helicobacter pylori Infection.
Microbial factors leading to recurrent upper respiratory tract infections.
Microbial infection pattern, pathogenic features and resistance mechanism of carbapenem-resistant Gram negative bacilli during long-term hospitalization.
Microbial pathogenicity and virulence mediated by integrons on Gram-positive microorganisms.
Microbiological examinations and in-vitro testing of different antibiotics in therapeutic endoscopy of the biliary system.
Microbiology and management of sinusitis.
Microbiology of abscesses of the head and neck in children.
Microbiology of common infections in the upper respiratory tract.
Microbiology of gastrostomy site wound infections in children.
Microbiology of Meropenem-Vaborbactam: A Novel Carbapenem Beta-Lactamase Inhibitor Combination for Carbapenem-Resistant Enterobacterales Infections.
microRNA-29a-3p, Up-Regulated in Human Gastric Cells and Tissues with H.Pylori Infection, Promotes the Migration of GES-1 Cells via A20-Mediated EMT Pathway.
Minimum inhibitory concentration of carbapenems and tigecycline against Salmonella spp.
Mir-30d increases intracellular survival of Helicobacter pylori through inhibition of autophagy pathway.
Mobilization of Carbapenemase-Mediated Resistance in Enterobacteriaceae.
Modeling Meropenem Treatment, Alone and in Combination with Daptomycin, for KPC-Producing Klebsiella pneumoniae Strains with Unusually Low Carbapenem MICs.
Modulation of neutrophil extracellular traps release by Klebsiella pneumoniae.
Molecular Analysis of the Antibiotic Resistant NDM-1 Gene in Clinical Isolates of Enterobacteriaceae.
Molecular and Epidemiological Characterization of IMP-type Metallo-?-lactamase-producing Enterobacter cloacae in a Large Tertiary Care Hospital in Japan.
Molecular Basis of Class A ?-Lactamase Inhibition by Relebactam.
Molecular basis of NDM-1, a new antibiotic resistance determinant.
Molecular characteristics of extended spectrum ?-lactamase and carbapenemase genes carried by carbapenem-resistant Enterobacter cloacae in a Chinese university hospital.
Molecular characteristics of extended-spectrum beta-lactamase-producing Escherichia coli from the Chicago area: high prevalence of ST131 producing CTX-M-15 in community hospitals.
Molecular Characteristics of Travel-Related Extended-Spectrum {beta}-lactamase producing Escherchia coli from the Calgary Health Region.
Molecular characterization and epidemiology of extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates causing health care-associated infection in Thailand, where the CTX-M family is endemic.
Molecular Characterization by Using Next-Generation Sequencing of Plasmids Containing blaNDM-7 in Enterobacteriaceae from Calgary, Canada.
Molecular characterization of carbapenem-resistant Enterobacteriaceae at a tertiary care laboratory in Mumbai.
Molecular Characterization of Carbapenem-Resistant Serratia marcescens Clinical Isolates in a Tertiary Hospital in Hangzhou, China.
Molecular Characterization of Carbapenemase Production Among Gram-Negative Bacteria in Saudi Arabia.
Molecular characterization of carbapenemases of clinical Acinetobacter baumannii-calcoaceticus complex isolates from a University Hospital in Tunisia.
Molecular Characterization of Extended-Spectrum ?-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae Among the Pediatric Population in Qatar.
Molecular correlation between in vitro and in vivo activity of beta-lactam and beta-lactamase inhibitor combinations against methicillin-resistant Staphylococcus aureus.
Molecular detection and antibiotic resistance pattern of extended-spectrum beta-lactamase producing Escherichia coli in a Tertiary Hospital in Enugu, Nigeria.
Molecular detection of blaNDM-1 (New Delhi metallobetalactamase-1) in nosocomial Enterobacteriaceae isolates by nested, multiplex polymerase chain reaction.
Molecular epidemiology and genome dynamics of New Delhi metallo-beta-lactamase (NDM) producing extraintestinal pathogenic E. coli (ExPEC) strains from India.
Molecular epidemiology and spatiotemporal analysis of hospital-acquired Acinetobacter baumannii infection in a tertiary care hospital in southern Thailand.
Molecular epidemiology of a clonal outbreak of multidrug-resistant Acinetobacter baumannii in a university hospital in Italy.
Molecular epidemiology of carbapenem-resistant Enterobacterales in Thailand, 2016-2018.
Molecular epidemiology of multiresistant Escherichia coli isolates from community-onset urinary tract infections in Cornwall, England.
Molecular features of primary mediastinal B-cell lymphoma: involvement of p16INK4A, p53 and c-myc.
Molecular typing, biofilm production, and detection of carbapenemase genes in multidrug-resistant Acinetobacter baumannii isolated from different infection sites using ERIC-PCR in Hamadan, west of Iran.
Monitoring Ceftazidime-Avibactam (CAZ-AVI) and Aztreonam (ATM) Concentrations in the Treatment of a Bloodstream Infection Caused by a Multidrug-Resistant Enterobacter sp. Carrying both KPC-4 and NDM-1 Carbapenemases.
Monitoring Effector Translocation using the TEM-1 Beta-Lactamase Reporter System.
Monitoring the antimicrobial susceptibility of Gram-negative organisms involved in intraabdominal and urinary tract infections recovered during the SMART study (Spain, 2016 and 2017).
Moraxella catarrhalis in upper respiratory tract of healthy Yemeni children/adults and paediatric patients: detection and significance.
Morganella morganii, a non-negligent opportunistic pathogen.
Mortality following bacteraemic infection caused by extended spectrum beta-lactamase (ESBL) producing E. coli compared to non-ESBL producing E. coli.
Multi-antibiotic resistant extended-spectrum beta-lactamase producing bacteria pose a challenge to the effective treatment of wound and skin infections.
Multi-Drug Resistant Escherichia coli Causing Early-Onset Neonatal Sepsis - a Single Center Experience from China.
Multi-drug resistant escherichia coli with extended-spectrum beta-lactamase activity and fluoroquinolone resistance isolated from clinical infections in dogs.
Multicategory interpretive reporting of susceptibility testing with selected antimicrobial concentrations. Ten years of laboratory and clinical experience.
Multicenter surveillance of antimicrobial susceptibilities and resistance mechanisms among Enterobacterales species and non-fermenting Gram-negative bacteria from different infection sources in Taiwan from 2016 to 2018.
Multidrug resistant and carbapenemase producing Enterobacteriaceae among patients with urinary tract infection at referral Hospital, Northwest Ethiopia.
Multidrug-resistant and extended-spectrum beta-lactamase-producing uropathogens in children in Bhaktapur, Nepal.
Multidrug-Resistant Bacterial Infections in U.S. Hospitalized Patients, 2012-2017.
Multidrug-resistant NDM-1 Klebsiella outbreak and infection control in endoscopic urology.
Multidrug-resistant opportunistic pathogens challenging veterinary infection control.
Multiomics Assessment of Gene Expression in a Clinical Strain of CTX-M-15-Producing ST131 Escherichia coli.
Multiple antibiotic-resistance mechanisms including a novel combination of extended-spectrum beta-lactamases in a Klebsiella pneumoniae clinical strain isolated in Argentina.
Native mitral valve endocarditis associated with KPC producing Serratia marcescens bacteremia successfully treated with mitral valve replacement and ceftazidime-avibactam.
NDM-1 Carbapenemase-Producing Enterobacteriaceae are Highly Susceptible to Ceragenins CSA-13, CSA-44, and CSA-131.
NDM-1 Infection and colonisation in critically ill patients from Delhi: A glimpse of the community scenario.
NDM-1 producers as causative agents of nosocomial urinary tract infections.
Negative Pressure Wound Therapy in Infected Wound following Posterior Spinal Instrumentation using Simple Self-assembled System: A Case Report.
Neonatal Risk Factors for Colonization with Extended-Spectrum Beta-Lactamase-Producing Bacteria in the Neonatal Intensive Care Unit.
New Delhi metallo-?-lactamase in Jamaica.
New Delhi Metallo-?-Lactamase-Mediated Carbapenem Resistance: Origin, Diagnosis, Treatment and Public Health Concern.
New Delhi Metallo-beta lactamase-1 containing enterobacteriaceae: origin, diagnosis, treatment and public health concern.
New Delhi Metallo-Beta-Lactamase (NDM-1)-Producing Klebsiella Pneumoniae Isolated from a Burned Patient.
New Delhi Metallo-beta-lactamase around the world: an eReview using Google Maps.
New guidelines for hospital-acquired pneumonia/ventilator-associated pneumonia: USA vs. Europe.
New perspectives for reassessing fosfomycin: applicability in current clinical practice.
NitroSpeed-Carba NP Test for Rapid Detection and Differentiation between Different Classes of Carbapenemases in Enterobacterales.
Norfloxacin in the treatment of gonorrhea due to penicillinase and non-penicillinase producing Neisseria gonorrheae: a review.
Nosocomial bacteremia and urinary tract infections caused by extended-spectrum beta -lactamase-producing Klebsiella pneumoniae with plasmids carrying both SHV-5 and TLA-1 genes.
Nosocomial blood stream infection in intensive care units at Assiut University Hospitals (Upper Egypt) with special reference to extended spectrum beta-lactamase producing organisms.
Nosocomial outbreak by imipenem-resistant metallo-beta-lactamase-producing Pseudomonas aeruginosa in an adult intensive care unit in a Brazilian teaching hospital.
Nosocomial outbreak of infections by Proteus mirabilis that produces extended-spectrum CTX-M-2 type beta-lactamase.
Nosocomial Outbreak of New Delhi Metallo-?-Lactamase-1-Producing Gram-Negative Bacteria in South Africa: A Case-Control Study.
Nosocomial Outbreak of VIM-2 Metallo-Beta-Lactamase Producing Pseudomonas aeruginosa Associated With Retrograde Urography.
Nosocomial urinary tract infections caused by extended-spectrum beta-lactamase uropathogens: Prevalence, pathogens, risk factors, and strategies for infection control.
Novel bacteriophage therapy for controlling metallo-beta-lactamase producing Pseudomonas aeruginosa infection in catfish.
Occurrence of carbapenemase-producing bacteria in coastal recreational waters.
Occurrence of CTX-M Producing Escherichia coli in Soils, Cattle, and Farm Environment in France (Burgundy Region).
Occurrence of extended-spectrum beta-lactamases in members of the family Enterobacteriaceae in Italy: implications for resistance to beta-lactams and other antimicrobial drugs.
Occurrence of false positive results for the detection of carbapenemases in carbapenemase-negative Escherichia coli and Klebsiella pneumoniae isolates.
Occurrence of PER-1 producing clinical isolates of Pseudomonas aeruginosa in Japan and their susceptibility to doripenem.
Oligopeptides as full-length New Delhi metallo-?-lactamase-1 (NDM-1) inhibitors.
One-Step Detection and Classification of Bacterial Carbapenemases in 10 Minutes Using Fluorescence Identification of ?-Lactamase Activity.
One-Step Differential Detection of OXA-48-Like Variants Using High-Resolution Melting (HRM) Analysis.
Optimization of the MALDIxin test for the rapid identification of colistin resistance in Klebsiella pneumoniae using MALDI-TOF MS.
Optimized Detection of Acute MHV68 Infection With a Reporter System Identifies Large Peritoneal Macrophages as a Dominant Target of Primary Infection.
Oral fosfomycin for treatment of urinary tract infection: a retrospective cohort study.
Oral streptococcal strains isolated from odontogenic infections and their susceptibility to antibiotics.
Orally administered beta-lactamase enzymes represent a novel strategy to prevent colonization by Clostridium difficile.
Other antimicrobials of interest in the era of extended-spectrum beta-lactamases: fosfomycin, nitrofurantoin and tigecycline.
Outbreak of carbapenem-resistant Klebsiella pneumoniae producing KPC-3 in a tertiary medical centre in Israel.
Outbreak of ceftazidime-resistant Klebsiella pneumoniae in a pediatric hospital in Warsaw, Poland: clonal spread of the TEM-47 extended-spectrum beta-lactamase (ESBL)-producing strain and transfer of a plasmid carrying the SHV-5-like ESBL-encoding gene.
Outbreak of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a neonatal intensive care unit linked to artificial nails.
Outbreak of infection by carbapenem-resistant Acinetobacter baumannii producing the carbapenemase OXA-58 in Belgium.
Outbreak of infection by extended-spectrum beta-lactamase SHV-5-producing Serratia marcescens in a Mexican hospital.
Outbreak of infection caused by Enterobacter cloacae producing the novel VEB-3 beta-lactamase in China.
Outbreak of infection with Klebsiella pneumoniae sequence type 258 producing Klebsiella pneumoniae Carbapenemase 3 in an intensive care unit in Italy.
Outbreak of infections caused by Enterobacter cloacae producing the integron-associated beta-lactamase IBC-1 in a neonatal intensive care unit of a Greek hospital.
Outbreak of infections caused by Pseudomonas aeruginosa producing VIM-1 carbapenemase in Greece.
Outbreak of KPC-3-producing ST15 and ST348 Klebsiella pneumoniae in a Portuguese hospital.
Outbreak of Multidrug-Resistant Acinetobacter baumannii ST208 Producing OXA-23-Like Carbapenemase in a Children's Hospital in Shanghai, China.
Outbreak of NDM-1-Producing Klebsiella pneumoniae in a Dutch Hospital, with Interspecies Transfer of the Resistance Plasmid and Unexpected Occurrence in Unrelated Health Care Centers.
Outbreak of Pseudomonas aeruginosa infections with PER-1 extended-spectrum beta-lactamase in Warsaw, Poland: further evidence for an international clonal complex.
Outbreak of pulmonary infection caused by Klebsiella pneumoniae isolates harbouring blaIMP-4 and blaDHA-1 in a neonatal intensive care unit in China.
Outbreak of Serratia marcescens colonization and infection traced to a healthcare worker with long-term carriage on the hands.
Outbreaks of imipenem-resistant Acinetobacter baumannii producing carbapenemases in Korea.
Outcomes analysis in patients with extended-spectrum beta-lactamase bacteremia empirically treated with piperacillin/tazobactam versus carbapenems.
Outcomes of transplantation using organs from a donor infected with Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae.
Overexpression of AmpC and Efflux Pumps in P. aeruginosa from Blood Stream Infections: Prevalence and Linkage to Resistance in a Spanish Multicenter Study.
Overexpression of the Ubiquilin-4 (UBQLN4) is Associated with Cell Cycle Arrest and Apoptosis in Human Normal Gastric Epithelial Cell Lines GES-1 Cells by Activation of the ERK Signaling Pathway.
Paradoxical activity of beta-lactam antibiotics against Proteus vulgaris in experimental infection in mice.
Parenteral carbapenems.
Pathophysiologic basis for the use of third-generation cephalosporins.
Patient specific risk stratification for antimicrobial resistance and possible treatment strategies in gram-negative bacterial infections.
Patient-to-patient transmission is important in extended-spectrum beta-lactamase-producing Klebsiella pneumoniae acquisition.
Patterns of Antimicrobial Prescribing in a Tertiary Care Hospital in Oman.
Patterns of antimicrobial therapy in severe nosocomial infections: empiric choices, proportion of appropriate therapy, and adaptation rates--a multicentre, observational survey in critically ill patients.
PCR-Dipstick-Oriented Surveillance and Characterization of mcr-1- and Carbapenemase-Carrying Enterobacteriaceae in a Thai Hospital.
Penicillin resistant Staphylococcus aureus in Port Moresby.
Performance accuracy of antibacterial and antifungal susceptibility test methods: report from the College of American Pathologists Microbiology Surveys Program (2001-2003).
Performance evaluation of the PANA RealTyper™ CRE Kit for detecting carbapenemase genes in gram-negative bacilli.
Performance of a loop-mediated isothermal amplification assay (Isoplex CRE-ART) to detect common carbapenemase-encoding genes in Gram-negative bacteria.
Persistence of related bla-IMP-4 metallo-beta-lactamase producing Enterobacteriaceae from clinical and environmental specimens within a burns unit in Australia - a six-year retrospective study.
Persistent carriage and infection by multidrug-resistant Escherichia coli ST405 producing NDM-1 carbapenemase: report on the first Italian cases.
Persistent extended-spectrum beta-lactamase urinary tract infection.
Persistent infection with metallo-beta-lactamase and extended spectrum ?-lactamase producer Morganella morganii in a patient with urinary tract infection after kidney transplantation.
Perspectives of beta-lactamases inhibitors in therapy of infections caused by Escherichia coli or Klebsiella with plasmidic resistance to third generation cephalosporins.
Pharmacokinetics and distribution of ticarcillin-clavulanic acid (Timentin) in experimental animals.
Pharmacokinetics of intravenous amoxycillin and potassium clavulanate in seriously ill children.
Pharmacokinetics-Pharmacodynamics of a Novel Beta-Lactamase Inhibitor, CB-618, in Combination with Meropenem in an In Vitro Infection Model.
Pharmacokinetics/Pharmacodynamics of Vaborbactam, a Novel Beta-Lactamase Inhibitor, in Combination with Meropenem.
Pharmacological aspects and spectrum of action of ceftazidime-avibactam: a systematic review.
Phenotypic and genotypic evaluation of beta-lactamases (ESBL and KPC) among enterobacteria isolated from community-acquired monomicrobial urinary tract infections.
Phenotypic and molecular detection of metallo-?-lactamase-producing Pseudomonas aeruginosa isolates from patients with burns in Tehran, Iran.
Phenotypic and Molecular Survey of Metallo-beta-lactamase-producing Pseudomonas aeruginosa Isolated from Patients with Nosocomial and Non-Nosocomial Infections.
Phenotypic Detection of Carbapenemase-Producing Organisms from Clinical Isolates.
Phenotypic detection of extended-spectrum beta-lactamase production in Enterobacteriaceae: review and bench guide.
Phenotypic identification & molecular detection of bla (ndm-1) gene in multidrug resistant Gram-negative bacilli in a tertiary care centre.
Piperacillin-Tazobactam Versus Carbapenems for the Treatment of Nonbacteremic Urinary Tract Infections due to Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae.
Piperacillin/tazobactam in the treatment of polymicrobial infections.
Pivmecillinam compared to other antimicrobials for community-acquired urinary tract infections with Escherichia coli, ESBL-producing or not - a retrospective cohort study.
Placental transfer of cefmenoxime in late pregnancy.
Pneumococcal infection in children: rational antibiotic choice for drug-resistant Streptococcus pneumoniae.
Point-Counterpoint: Piperacillin-Tazobactam Should Be Used To Treat Infections with Extended-Spectrum-Beta-Lactamase-Positive Organisms.
Polymyxins: To Combine or Not to Combine?
Population Analysis and Epidemiological Features of inhibitor-resistant-TEM (IRT) {beta}-lactamases Producing Escherichia coli from both Community and Hospital Settings in Madrid, Spain.
Population Genomic Analysis of 1,777 Extended-Spectrum Beta-Lactamase-Producing Klebsiella pneumoniae Isolates, Houston, Texas: Unexpected Abundance of Clonal Group 307.
Population Pharmacokinetics of High-Dose Continuous-Infusion Meropenem and Considerations for Use in the Treatment of Infections Due to KPC-Producing Klebsiella pneumoniae.
Population-based epidemiological study of infections caused by carbapenem-resistant Pseudomonas aeruginosa in the Calgary Health Region: importance of metallo-beta-lactamase (MBL)-producing strains.
Potency and antimicrobial spectrum update for piperacillin/tazobactam (2000): emphasis on its activity against resistant organism populations and generally untested species causing community-acquired respiratory tract infections.
Potential Inhibitors Against NDM-1 Type Metallo-?-Lactamases: An Overview.
Potentiation of human polymorphonuclear leukocyte phagocytosis and intracellular bactericidal activity by amoxycillin/clavulanic acid.
Prediction of infection caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae: development of a clinical decision-making nomogram.
Predictive factors for extended-spectrum beta-lactamase producing Enterobacteriaceae causing infection among intensive care unit patients with prior colonization.
Predictive utility of prior positive urine culture of extended- spectrum ? -lactamase producing strains.
Predictors of blaCTX-M-15 in varieties of Escherichia coli genotypes from humans in community settings in Mwanza, Tanzania.
Predictors of mortality from community-onset bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae.
Predominance of CTX-M-15 among ESBL Producers from Environment and Fish Gut from the Shores of Lake Victoria in Mwanza, Tanzania.
Predominance of Non-carbapenemase Producing Carbapenem-Resistant Enterobacterales in South Texas.
Predominance of SHV-5 beta-lactamase in enteric bacteria causing community-acquired urinary tract infections in Bosnia and Herzegovina.
Preparation, crystallization and preliminary X-ray crystallographic analysis of OXA-23, a carbapenemase conferring widespread antibiotic resistance.
Presence of different beta-lactamase classes among clinical isolates of Pseudomonas aeruginosa expressing AmpC beta-lactamase enzyme.
Presence of ESBL/AmpC-producing Escherichia coli in the broiler production pyramid: a descriptive study.
Prevalence and Clinical Burden of NDM-1 Positive Infections in Pediatric and Neonatal Patients in Pakistan.
Prevalence and pathogenesis of extended-spectrum beta-lactamase producing Escherichia coli causing urinary tract infection in hospitalized patients.
Prevalence and phenotypic characterization of carbapenem-resistant Klebsiella pneumoniae strains recovered from sputum and fecal samples of ICU patients in Zhejiang Province, China.
Prevalence and risk factors for Enterobacteriaceae in patients hospitalized with community-acquired pneumonia.
Prevalence and risk factors for extended spectrum Beta-lactamase-producing uropathogens in patients with urinary tract infection.
Prevalence and risk factors of MRSA, ESBL and MDR bacterial colonization upon admission to an Egyptian medical ICU.
Prevalence of beta-lactamase enzyme production in bacteria isolated from women with postpartum endometritis.
Prevalence of carbapenemase-producing Enterobacteriaceae and its impact on clinical outcomes at a teaching hospital in Taiwan.
Prevalence of extended spectrum beta lactamase producing Escherichia coli and Klebsiella pneumoniae urinary isolates in a tertiary care hospital in Kathmandu, Nepal.
Prevalence of Extended Spectrum Beta-Lactamase Producing Klebsiella Pneumoniae Isolated From Urinary Tract Infected Patients.
Prevalence of extended-spectrum beta-lactamase producing Escherichia coli in community-onset urinary tract infections in France in 2013.
Prevalence of Extended-Spectrum Beta-Lactamase/Carbapenemase Genes and Quinolone-Resistance Determinants in Klebsiella pneumoniae Clinical Isolates from Respiratory Infections in Myanmar.
Prevalence of extended-spectrum beta-lactamases among Enterobacteriaceae isolated from blood culture in a tertiary care hospital.
Prevalence of gonorrhoea and knowledge of sexually transmitted infections in a farming community in Zimbabwe.
Prevalence of H.influenzae biotypes and their clinical significance in a University Hospital.
Prevalence of oropharyngeal beta-lactamase-producing Capnocytophaga spp. in pediatric oncology patients over a ten-year period.
Prevalence of PER and VEB Type Extended Spectrum Betalactamases among Multidrug Resistant Acinetobacter baumannii Isolates in North-West of Iran.
Prevalence of ST1193 clone and IncI1/ST16 plasmid in E-coli isolates carrying blaCTX-M-55 gene from urinary tract infections patients in China.
Prevalence of the NTEKPC-I on IncF Plasmids Among Hypervirulent Klebsiella pneumoniae Isolates in Jiangxi Province, South China.
Prevalence of two multidrug-resistant Klebsiella species in an Indian teaching hospital and adjoining community.
Prevalence, antimicrobial properties and beta-lactamase production of haemolytic enterobacteria in patients with diarrhoea and urinary tract infections in Legos, Nigeria.
Prevalence, microbiology, and clinical characteristics of extended-spectrum beta-lactamase-producing Enterobacter spp., Serratia marcescens, Citrobacter freundii, and Morganella morganii in Korea.
Prevotella and Porphyromonas infections in children.
Probability of achieving requisite pharmacodynamic exposure for oral beta-lactam regimens against Haemophilus influenzae in children.
Probiotics for intestinal decolonization of ESBL-producing enterobacteriaceae; a randomized, placebo-controlled clinical trial.
Prospective cohort study of risk factors for extended-spectrum ß-lactamase-producing Escherichia coli urinary tract infections in elderly patients admitted to hospital.
Prospective survey of colonization and infection caused by SHV-4 producing Klebsiella pneumoniae in a neurosurgical intensive care unit.
Prosthetic valve endocarditis caused by metallo-beta-lactamase-producing Pseudomonas aeruginosa.
Protocol for a randomised trial of early kangaroo mother care compared to standard care on survival of pre-stabilised preterm neonates in The Gambia (eKMC).
Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response.
Pseudomonas aeruginosa Coharboring BlaKPC-2 and BlaVIM-2 Carbapenemase Genes.
Pseudomonas aeruginosa infection in cystic fibrosis caused by an epidemic metallo-?-lactamase-producing clone with a heterogeneous carbapenem resistance phenotype.
Quantifying the clinical virulence of Klebsiella pneumoniae producing carbapenemase Klebsiella pneumoniae with a Galleria mellonella model and a pilot study to translate to patient outcomes.
Quantitative analysis of the IgG and IgG subclass immune responses to chromosomal Pseudomonas aeruginosa beta-lactamase in serum from patients with cystic fibrosis by western blotting and laser scanning densitometry.
Randomised observer blind comparative trial of ceftriaxone and penicillin in treating uncomplicated gonorrhoea in men and women.
Rapid and widespread dissemination of multidrug-resistant blaCMY-2 Salmonella Typhimurium in Mexico.
Rapid Carbapenemase Detection With Xpert Carba-R V2 Directly On Positive Blood Vials.
Rapid containment of coincident outbreaks with 2 carbapenem-resistant Klebsiella pneumoniae strains in an intensive care unit.
Rapid detection and characterization of carbapenemases in Enterobacterales with a new modified carbapenem inactivation method: mCIMplus.
Rapid detection and evaluation of clinical characteristics of emerging multiple-drug-resistant gram-negative rods carrying the metallo-beta-lactamase gene blaIMP.
Rapid detection of colistin resistance in Acinetobacter baumannii using MALDI-TOF-based lipidomics on intact bacteria.
Rapid detection of Klebsiella pneumoniae carbapenemase genes in enterobacteriaceae directly from blood culture bottles by real-time PCR.
Rapid discrimination of klebsiella pneumoniae carbapenemase 2 - producing and non-producing klebsiella pneumoniae strains using near-infrared spectroscopy (NIRS) and multivariate analysis.
Rapid identification of carbapenemase genes in gram-negative bacteria with an oligonucleotide microarray-based assay.
Rapidec Carba NP for Detection of Carbapenemase-Producing Enterobacteriaceae in Clinical Isolates: Cross-Sectional Study.
Rate of bactericidal activity for Branhamella catarrhalis of a new macrolide, CP-62,993, compared with that of amoxicillin-clavulanic acid.
Rational use of aminoglycosides--review and recommendations by the Swedish Reference Group for Antibiotics (SRGA).
Re: Incidence and Management of Extended-Spectrum Beta-Lactamase and Quinolone-Resistant Escherichia coli Infections after Prostate Biopsy.
Real-Time PCR Typing of Escherichia coli Based on Multiple Single Nucleotide Polymorphisms--a Convenient and Rapid Method.
Recovery of beta-lactamase producing bacteria in pediatric infections.
Recurrent healthcare-associated community-onset infections due to Klebsiella pneumoniae producing VIM-1 metallo-{beta}-lactamase.
Redefining extended-spectrum beta-lactamases: balancing science and clinical need.
Reduced use of third-generation cephalosporins decreases the acquisition of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae.
Refractory vertebral osteomyelitis due to CTX-M-14-producing Escherichia coli at ertapenem treatment in a patient with a coexisting urinary tract infection caused by the same pathogen.
Relationship between adverse drug reactions to antibacterial agents and the Klebsiella pneumoniae carbapenemase-producing (KPC) Klebsiella pneumoniae outbreak: insight from a pharmacovigilance study.
Relationship between ciprofloxacin resistance and extended-spectrum beta-lactamase production in Escherichia coli and Klebsiella pneumoniae strains.
Repeated local emergence of carbapenem-resistant Acinetobacter baumannii in a single hospital ward.
Resistance evolution of hypervirulent carbapenem-resistant Klebsiella pneumoniae ST11 during treatment with tigecycline and polymyxin.
Resistance of Haemophilus influenzae isolates in children under 5 years old with acute respiratory infections in China between 2000 and 2002.
Resistance to extended-spectrum beta-lactams by the emergence of SHV-12 and the loss of OmpK35 in Klebsiella pneumoniae and Escherichia coli in Malaysia.
Resistome and microbial profiling of pediatric patient's gut infected with multidrug-resistant diarrhoeagenic Enterobacteriaceae using next-generation sequencing; the first study from Pakistan.
Respiratory tract infections caused by beta-lactamase producing organisms treated with augmentin.
Restriction of cephalosporins and control of extended spectrum Beta lactamase producing gram negative bacteria in a neonatal intensive care unit.
Retrospective evaluation of the patients with urinary tract infections due to carbapenemase producing Enterobacteriaceae.
Risk Factor Analysis in Clinical Isolates of ESBL and MBL (Including NDM-1) Producing Escherichia coli and Klebsiella Species in a Tertiary Care Hospital.
Risk factors and clinical features of infections caused by plasmid-mediated AmpC beta-lactamase-producing Enterobacteriaceae.
Risk Factors and Clinical Impact of Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae.
Risk factors and epidemiologic predictors of blood stream infections with New Delhi Metallo-b-lactamase (NDM-1) producing Enterobacteriaceae.
Risk factors and molecular epidemiology of community-onset, multidrug resistance extended-spectrum ?-lactamase-producing Escherichia coli infections.
Risk factors and molecular features of extended-spectrum beta-lactamase producing bacteria at southwest of Saudi Arabia.
Risk factors for bloodstream infections due to extended-spectrum ?-lactamase producing Enterobacteriaceae in cancer patients.
Risk factors for carbapenem-resistant Enterobacteriaceae infections: a French case-control-control study.
Risk factors for extended-spectrum beta-lactamase positivity in uropathogenic Escherichia coli isolated from community-acquired urinary tract infections.
Risk factors for extended-spectrum beta-lactamase-producing Enterobacterales bloodstream infection among solid organ transplant recipients.
Risk factors for extended-spectrum beta-lactamase-producing Enterobacteriaceae in a neonatal intensive care unit.
Risk factors for extended-spectrum beta-lactamase-producing Escherichia coli urinary tract infection in the community in Denmark: a case-control study.
Risk factors for fecal carriage of extended-spectrum beta-lactamase-producing and carbapenem-resistant Escherichia coli and Klebsiella pneumoniae strains among patients at hospital admission.
Risk factors for infection and predictors of mortality among patients with KPC-producing Klebsiella pneumoniae bloodstream infections in the intensive care unit.
Risk factors for infection by extended-spectrum beta-lactamase producing Klebsiella pneumoniae in a tertiary hospital in Salvador, Brazil.
Risk factors for infection with extended-spectrum and AmpC beta-lactamase-producing gram-negative rods in renal transplantation.
Risk factors for the development of extended-spectrum beta-lactamase-producing bacteria in nonhospitalized patients.
Risk factors for the infection and/or colonization of extended-spectrum beta-lactamase-producing bacteria in a neonatal intensive care unit: a meta-analysis.
Risk factors for urinary tract infection caused by Enterobacteriaceae with extended-spectrum beta-lactamase resistance in patients admitted to internal medicine departments.
Risk factors in community-acquired/onset urinary tract infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae.
Role of beta-lactamases in the resistance of gram-negative bacilli to beta-lactam antibiotics.
Role of cephalosporins in gonorrhoea and other sexually transmitted diseases.
Role of cephamycins in obstetrics and gynecology.
Role of Double-Carbapenem Regimen in the Treatment of Infections due to Carbapenemase Producing Carbapenem-Resistant Enterobacteriaceae: A Single-Center, Observational Study.
Role of Imipenem-resistant metallo-beta-lactamase positive pseudomonas aeruginosa carriers in nosocomial infections.
Role of infection control measures in limiting morbidity associated with multi-resistant organisms in critically ill patients.
Role of newer antimicrobial agents in the treatment of mixed aerobic and anaerobic infections.
Role of sultamicillin and ampicillin/sulbactam in the treatment of upper and lower bacterial respiratory tract infections.
Roultella ornithinolytica infection in infancy: a case of febrile urinary tract infection.
Ruthenium complexes as prospective inhibitors of metallo-?-lactamases to reverse carbapenem resistance.
Search and Contain: Impact of an integrated genomic and epidemiological surveillance and response program for control of carbapenemase-producing Enterobacterales.
Selection during cefepime treatment of a new cephalosporinase variant with extended-spectrum resistance to cefepime in an Enterobacter aerogenes clinical isolate.
Selection of beta-lactamase producers during cephalosporin and penicillin therapy.
Selection of TNF-alpha binding affibody molecules using a beta-lactamase protein fragment complementation assay.
Selective digestive decontamination by erythromycin-base in a polyvalent intensive care unit.
Sepsis due to fluoroquinolone-resistant Escherichia coli after transrectal ultrasound-guided prostate needle biopsy.
Septic shock caused by Klebsiella pneumoniae carbapenemase-producing Enterobacter gergoviae in a neutropenic patient with leukemia.
Serotyping clinical isolates of Pseudomonas aeruginosa in relation to infection site antibiotic susceptibility and beta-lactamase production.
Service evaluation of selected risk factors for extended-spectrum beta-lactamase Escherichia coli urinary tract infections: a case-control study.
Severe community onset healthcare-associated Clostridium difficile infection complicated by carbapenemase producing Klebsiella pneumoniae bloodstream infection.
Significance of inducible cephalosporinase remaining in the experimentally infected rat granuloma pouch after beta-lactam therapy.
Simulation of human serum pharmacokinetics of cefazolin, piperacillin, and BRL 42715 in rats and efficacy against experimental intraperitoneal infections.
Single dose cefoxitin in treating uncomplicated gonorrhoea caused by penicillinase producing Neisseria gonorrhoeae (PPNG) and non-PPNG strains.
Single dose ciprofloxacin for treating gonococcal infections in men.
Single dose enoxacin for the treatment of uncomplicated urogenital gonorrhea.
Single-dose amikacin plus 7 days of amoxicillin/clavulanate to treat acute cystitis caused by extended-spectrum beta-lactamase-producing Escherichia coli: A retrospective cohort study.
Sites of colonization in hospitalized patients with infections caused by extended-spectrum beta-lactamase organisms: a prospective cohort study.
Spread of Klebsiella pneumoniae producing SHV-5 beta-lactamase among hospitalized patients.
Stability of Meropenem and Piperacillin/Tazobactam with Heparin in Various Peritoneal Dialysis Solutions.
Staphylococcal resistance revisited: community-acquired methicillin resistant Staphylococcus aureus--an emerging problem for the management of skin and soft tissue infections.
Status Epilepticus and Delirium Associated with Ertapenem in a Very Elderly Patient with Chronic Kidney Disease and Silent Ischaemic Cerebrovascular Disease.
Stenotrophomonas maltophilia infections.
Stepwise upregulation of the Pseudomonas aeruginosa chromosomal cephalosporinase conferring high-level beta-lactam resistance involves three AmpD homologues.
Stigmasterol: An adjuvant for beta lactam antibiotics against beta-lactamase positive clinical isolates.
Structure, Genetics and Worldwide Spread of New Delhi Metallo-?-lactamase (NDM): a threat to public health.
Structures of the class D carbapenemase OXA-24 from Acinetobacter baumannii in complex with doripenem.
Study of family physicians' practices in case of urinary tract infections caused by enterobacteriaceae secreting extended-spectrum-beta-lactamase.
Study of immune function in inbred miniature pigs vaccinated and challenged with suid herpesvirus 1.
Success of an infection control program to reduce the spread of carbapenem-resistant Klebsiella pneumoniae.
Successful containment of carbapenem-resistant Enterobacteriaceae by strict contact precautions without active surveillance.
Successful control of an outbreak of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae at a long-term acute care hospital.
Successful medical treatment in a child with E. coli ESBL meningitis with acute communicating hydrocephalus and ventricular empyema: a case report.
Successful Treatment of
Successful treatment of lower urinary tract infections with oral fosfomycin: a report of three cases.
Successful treatment of NDM-1 Klebsiella pneumoniae bacteraemia in a neutropenic patient.
Successful Treatment of Urinary Tract Infection in Kidney Transplant Recipients Caused by Multiresistant Klebsiella pneumoniae Producing New Delhi Metallo-Beta-Lactamase (NDM-1) With Strains Genotyping.
Sulbactam/ampicillin in the treatment of lower respiratory infections.
Sultamicillin (CP-49, 952): evaluation of two dosage schedules in urinary infection.
Superior effect of tazobactam/piperacillin compared to piperacillin on beta-lactamase-producing Pseudomonas aeruginosa.
Surveillance of healthcare-associated infections in a neonatal intensive care unit in Italy during 2006-2010.
Susceptibility to penicillins and cephalosporins in beta-lactamase producing strains of E. coli and relative amount of beta-lactamase produced from these strains.
Symposium on antimicrobial therapy. IV. The cephalosporins.
Synergistic antibiotic combinations for colistin-resistant Klebsiella pneumoniae.
Synthesis and Characterization of Carbon Dots Coated CaCO3 Nanocarrier for Levofloxacin Against Multidrug Resistance Extended-Spectrum Beta-Lactamase Escherichia coli of Urinary Tract Infection Origin.
Synthesis of silver nanoparticles using the Streptomyces coelicolor klmp33 pigment: an antimicrobial agent against extended-spectrum beta-lactamase (ESBL) producing Escherichia coli.
Systematic Review and Meta-analysis of Clinical and Economic Outcomes from the Implementation of Hospital-Based Antimicrobial Stewardship Programs.
Systemic antibiotics for treating diabetic foot infections.
Systemic Haemophilus influenzae infection in childhood.
Targeting Multidrug-Resistant Acinetobacter spp.: Sulbactam and the Diazabicyclooctenone ?-Lactamase Inhibitor ETX2514 as a Novel Therapeutic Agent.
Tazobactam inactivation of SHV-1 and the inhibitor-resistant Ser130 -->Gly SHV-1 beta-lactamase: insights into the mechanism of inhibition.
Temporal trends and risk factors for extended-spectrum beta-lactamase-producing Escherichia coli in adults with catheter-associated urinary tract infections.
The addition of avibactam renders piperacillin an effective treatment for Mycobacterium abscessus infection in an in vivo model.
The Amino Acid Changes T55A, A273P and R277C in the Beta-Lactamase CTX-M-14 Render E. coli Resistant to the Antibiotic Nitrofurantoin, a First-Line Treatment of Urinary Tract Infections.
The antibiotic susceptibilities and beta-lactamase production of clinical isolated Branhamella catarrhalis from acute otitis media in children.
The beta-lactamases of Moraxella (Branhamella) catarrhalis isolated from Danish children.
The characteristics of NDM-1-producing Escherichia coli that belong to the successful and virulent clone ST131.
The clinical significance of anaerobic bacteria in acute orofacial odontogenic infections.
The concept of indirect pathogenicity by beta-lactamase production, especially in ear, nose and throat infection.
The Current Burden of Carbapenemases: Review of Significant Properties and Dissemination among Gram-Negative Bacteria.
The detection and verification of carbapenemases using ertapenem and Matrix Assisted Laser Desorption Ionization-Time of Flight.
The development of efflux pump inhibitors to treat Gram-negative infections.
The distribution of pathogens and their antimicrobial susceptibility patterns among canine surgical wound infections in Sweden in relation to different risk factors.
The efficacy of cefmetazole against pyelonephritis caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae.
The emergence of a novel ceftazidime-resistant CTX-M extended-spectrum beta-lactamase, CTX-M-55, in both community-onset and hospital-acquired infections in Thailand.
The emergence of bacterial resistance and its influence on empiric therapy.
The emergence of resistance to beta-lactam antibiotics during treatment of Pseudomonas aeruginosa lower respiratory tract infections: is combination therapy the solution?
The epidemic of extended-spectrum-?-lactamase-producing Escherichia coli ST131 is driven by a single highly pathogenic subclone, H30-Rx.
The Epidemiology, Evolution, and Treatment of KPC-Producing Organisms.
The frequency of Klebsiella pneumonia encoding genes for CTX-M, TEM-1 and SHV-1 extended-spectrum beta lactamases enzymes isolated from urinary tract infection.
The Gut of Healthy Infants in the Community as a Reservoir of ESBL and Carbapenemase-Producing Bacteria.
The Helicobacter pylori Protein CagM is Located in the Transmembrane Channel That is Required for CagA Translocation.
The impact of carbapenemases on antimicrobial development and therapy.
The importance of beta-lactamase resistance in surgical infections.
The importance of black-pigmented gram-negative anaerobes in human infections.
The Importance of Long-term Acute Care Hospitals in the Regional Epidemiology of Klebsiella pneumoniae Carbapenemase-Producing Enterobacteriaceae.
The influence of metallo-beta-lactamase production on mortality in nosocomial Pseudomonas aeruginosa infections.
The involvement of Helicobacter pylori thioredoxin-1 in gastric carcinogenesis.
The microbiologic aspects, including diagnosis, of beta-hemolytic streptococcal and enterococcal infections.
The need for and choice of chemotherapy for anaerobic infections.
The occurrence, virulence, and antimicrobial resistance of anaerobes in polymicrobial infections.
The perils of medical tourism: NDM-1-positive Escherichia coli causing febrile neutropenia in a medical tourist.
The population biology of suid herpesvirus 1.
The role of antibiotics in pediatric chronic rhinosinusitis.
The role of beta-lactamase in mixed infections in mice in relation to treatment with ampicillin.
The role of beta-lactamase-producing-bacteria in mixed infections.
The Role of Cefepime in the Treatment of Extended-Spectrum Beta-Lactamase Infections.
The Role of Ceftiofur in the Selection and Dissemination of blaCMY-2 - Mediated Cephalosporin Resistance in Salmonella enterica and Commensal Escherichia coli Isolated from Cattle.
The role of epidemic resistance plasmids and international high-risk clones in the spread of multidrug-resistant Enterobacteriaceae.
The role of the blaKPC gene in antimicrobial resistance of Klebsiella pneumoniae.
The tyrosine kinase inhibitor genistein blocks HIV-1 infection in primary human macrophages.
The use of aztreonam in the treatment of uncomplicated gonorrhoea.
The use of oral antibiotics in daily clinical practice.
Therapeutic challenges associated with extended-spectrum, beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae.
Therapeutic effect of SF-2103A, a novel carbapenem antibiotic, in combination with cefotaxime, cefoperazone and other cephalosporins.
Therapy of soft tissue infections with piperacillin/tazobactam.
Third-generation cephalosporin-resistant non-typhoidal Salmonella isolated from human feces in Japan.
Three regimens of procaine penicillin G, Augmentin, and probenecid compared for treating acute gonorrhoea in men.
Transmission in the community of clonal Proteus mirabilis carrying VIM-1 metallo-beta-lactamase.
Transmission of Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae: the role of infection control.
Transmission of meropenem in breast milk.
Transplant tourism complicated by life-threatening New Delhi metallo-beta-lactamase-1 infection.
Transport of viruses through fetal membranes: an in vitro model of perinatal transmission.
Treatment and clinical outcomes of urinary tract infections caused by KPC-producing Enterobacteriaceae in a retrospective cohort.
Treatment and Outcomes of Infections Caused by Diverse Carbapenemase-Producing Carbapenem-Resistant Enterobacterales.
Treatment duration of complicated urinary tract infections by extended-spectrum beta-lactamases producing enterobacterales.
Treatment Failure in Urinary Tract Infections: A Warning Witness for Virulent Multi-Drug Resistant ESBL- Producing Escherichia coli.
Treatment of acute bacterial rhinosinusitis caused by antimicrobial-resistant Streptococcus pneumoniae.
Treatment of acute uncomplicated urinary tract infections with single daily doses of cefuroxime axetil.
Treatment of bacterial osteomyelitis and Staphylococcus aureus endocarditis and single-dose therapy for uncomplicated Neisseria gonorrhoeae infections: an overview.
Treatment of beta-hemolytic streptococcal pharyngitis with cefaclor or penicillin. Efficacy and interaction with beta-lactamase-producing organisms in the pharynx.
Treatment of infections caused by metallo-beta-lactamase-producing Pseudomonas aeruginosa in the Calgary Health Region.
Treatment of Klebsiella pneumoniae carbapenemase (KPC) infections: a review of published case series and case reports.
Treatment of non-complicated urogenital, rectal and oropharyngeal gonorrhoea with intramuscular cefotaxime 1.0 g or cefuroxime 1.5 g.
Treatment of polymicrobial intra-abdominal, pelvic, and diabetic foot infections.
Treatment of respiratory tract infections with cephalosporin antibiotics.
Treatment of skin and soft-tissue infections.
Treatment options for infections caused by carbapenem-resistant Enterobacteriaceae: can we apply "precision medicine" to antimicrobial chemotherapy?
Treatment options for K. pneumoniae, P. aeruginosa and A. baumannii co-resistant to carbapenems, aminoglycosides, polymyxins and tigecycline: an approach based on the mechanisms of resistance to carbapenems.
Treatment options for new delhi metallo-Beta-lactamase-harboring enterobacteriaceae.
Trends in prevalence of extended-spectrum beta-lactamase-producing Escherichia coli isolated from patients with community- and healthcare-associated bacteriuria: results from 2014 to 2020 in an urban safety-net healthcare system.
Trends in the development of beta-lactam antibiotics.
Trimethoprim-sulfamethoxazole therapy for patients with carbapenemase-producing Klebsiella pneumoniae infections: retrospective single-center case series.
Two dose Augmentin treatment of acute gonorrhoea in men.
Two non-otic cases of POM-1 metallo-?-lactamase-producing Pseudomonas otitidis infection: Necrotizing fasciitis and pan-peritonitis.
Two-year prospective evaluation of colonization with extended-spectrum beta-lactamase-producing Enterobacteriaceae: time course and risk factors.
Ultrastructural changes caused by polymyxin B and meropenem in multiresistant Klebsiella pneumoniae carrying blaKPC-2 gene.
Uncovering novel susceptibility targets to enhance the efficacy of third-generation cephalosporins against ESBL-producing uropathogenic Escherichia coli.
Unexpected advanced generation cephalosporinase activity of the M69F variant of SHV beta-lactamase.
Unusual case of Haemophilus influenzae type b: Haemophilus influenzae type b meningitis cellulitis and subcutaneous abscess.
Updated Guidelines for the Management of Acute Otitis Media in Children by the Italian Society of Pediatrics: Treatment.
Upper respiratory tract infections. Ecological and therapeutic aspects of beta-lactamase production with special reference to Branhamella catarrhalis.
Urethral gonococcal infection by co-existing beta-lactamase and "resistant" strains of gonococci.
Urinary tract infection caused by ESBL- producing bacteria: Risk factors and antibiotic resistance.
Urinary tract infection in infants caused by extended-spectrum beta-lactamase-producing Escherichia coli: comparison between urban and rural hospitals.
Urinary tract infections caused by extended-spectrum betalactamase-producing bacteria in children: a matched casecontrol study.
Use of a non-radioactive hybridisation assay for direct detection of gram-negative bacteria carrying TEM beta-lactamase genes in infected urine.
USE OF AMOXICILLIN AND CLAVULANIC ACID (AUGMENTIN) IN THE TREATMENT OF SKIN AND SOFT TISSUE INFECTIONS IN CHILDREN.
Use of cefepime for the treatment of infections caused by extended spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli.
Use of cefotaxime, a beta-lactamase stable cephalosporin, in the therapy of serious infections, including those due to multiresistant organisms.
Use of fractionated urinary filarial antigen in the diagnosis of human filariasis.
Use of probiotics to reduce infections and death and prevent colonization with extended-spectrum beta-lactamase (ESBL)-producing bacteria among newborn infants in Tanzania (ProRIDE Trial): study protocol for a randomized controlled clinical trial.
Use of succinic & oxalic acid in reducing the dosage of colistin against New Delhi metallo-?-lactamase-1 bacteria.
Use of ticarcillin disodium plus clavulanate potassium in the management of acute bacterial infections in children.
Validation of a Worst-Case Scenario Method Adapted to the Healthcare Environment for Testing the Antibacterial Effect of Brass Surfaces and Implementation on Hospital Antibiotic-Resistant Strains.
Vancomycin Analogue Restores Meropenem Activity against NDM-1 Gram-Negative Pathogens.
Variation of effect estimates in the analysis of mortality and length of hospital stay in patients with infections caused by bacteria-producing extended-spectrum beta-lactamases: a systematic review and meta-analysis.
Variations in amoxicillin pharmacokinetic/pharmacodynamic parameters may explain treatment failures in acute otitis media.
VEZT, a Novel Putative Tumor Suppressor, Suppresses the Growth and Tumorigenicity of Gastric Cancer.
Vicenin-2 inhibits the Helicobacterium pylori infection associated gastric carcinogenic events through modulation of PI3K/AKT and Nrf2 signaling in GES-1 cells.
VIM-1 Metallo-{beta}-Lactamase Producing Enterobacter cloacae Infections and Their Correlation With Clinical Outcome.
Virulence and genomic features of a blaCTX-M-3 and blaCTX-M-14 coharboring hypermucoviscous Klebsiella pneumoniae of serotype K2 and ST65.
Virulence and Plasmid Transferability of KPC Klebsiella pneumoniae at the Veterans Affairs Healthcare System of New Jersey.
Virulence and resistance determinants of Klebsiella pneumoniae isolated from a Portuguese tertiary university hospital centre over a 31-year period.
Virulence Factors Of Carbapenem-Resistant Pseudomonas aeruginosa In Hospital-Acquired Infections In Mansoura, Egypt.
Virulence genotype and nematode-killing properties of extra-intestinal Escherichia coli producing CTX-M beta-lactamases.
Watch Out for Wild Animals: A Systematic Review of Upper Extremity Injuries Caused by Uncommon Species.
Were all carbapenemases created equal? Treatment of NDM-producing extensively drug-resistant Enterobacteriaceae: a case report and literature review.
What do beta-lactamases mean for clinical efficacy?
Which antibiotic is better for the treatment of infections of the lower respiratory tract?
Whole Genomic analysis of a clinical isolate of Uropathogenic Escherichia coli strain of Sequence Type - 101 carrying the drug resistance NDM-7 in IncX3 plasmid.
Whole-genome sequences of multidrug-resistant Escherichia coli in South-Kivu Province, Democratic Republic of Congo: characterization of phylogenomic changes, virulence and resistance genes.
Whole-Genome Sequencing of Human Clinical Klebsiella pneumoniae Isolates Reveals Misidentification and Misunderstandings of Klebsiella pneumoniae, Klebsiella variicola, and Klebsiella quasipneumoniae.
Worldwide clinical experience with sultamicillin.
Worldwide experience with the use of doripenem against extended-spectrum-beta-lactamase-producing and ciprofloxacin-resistant Enterobacteriaceae: analysis of six phase 3 clinical studies.
Worrisome high frequency of extended-spectrum beta-lactamase-producing Escherichia coli in community-acquired urinary tract infections: a case-control study.
Yersinia enterocolitica targets cells of the innate and adaptive immune system by injection of Yops in a mouse infection model.
Zebrafish and Galleria mellonella: Models to Identify the Subsequent Infection and Evaluate the Immunological Differences in Different Klebsiella pneumoniae Intestinal Colonization Strains.
Zinc Chelation by a Small-Molecule Adjuvant Potentiates Meropenem Activity in Vivo against NDM-1-Producing Klebsiella pneumoniae.
["Staphylococcus saprophyticus": a little known Staphylococcus (author's transl)]
[5-Methyl-3-phenyl-4-isoxazolyl penicillin in infections produced by staphylococcus producing penicillinase]
[A combination of amoxycillin with clavulanic acid (Augmentin) in various types of urinary tract infections caused by microbes producing beta-lactamase]
[A comparative study of tazobactam/piperacillin and piperacillin in chronic respiratory tract infections]
[A SHV-derived extended-spectrum beta-lactamase (SHV-12) produced by an Escherichia coli recovered from wound abscess in post operative case with rectal carcinoma]
[A study of the transplacental passage of cefotaxime (author's transl)]
[Activity of fosfomycin against extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae]
[Analysis on Related Factors of Pulmonary Infection in Patients with Multiple Myeloma Treated with Bortezomib].
[Antibiotic prophylaxis for patients with joint prostheses undergoing dental treatment--a topic for discussion]
[Antibiotic prophylaxis in cesarean section -- piperacillin versus piperacillin/tazobactam in 300 cesarean sections]
[Antibiotic prophylaxis in multiple trauma patients]
[Antibiotic resistance rates of extended spectrum beta-lactamase producing Escherichia coli and Klebsiella spp. strains isolated from urinary tract infections in a private hospital]
[Antibiotic sensitivity of Branhamella catarrhalis isolated from respiratory tract infections]
[Antibiotics in uncomplicated urinary tract infections: no increase in resistance over the past 5 years.]
[Antimicrobial activities of sultamicillin against clinical isolates from upper respiratory tract infections]
[Antimicrobial activities of sultamicillin against clinical isolates obtained from outpatients]
[Bactericidal activity against P. aeruginosa in serum and bronchial secretion in patients under continuous infusion of azlocillin]
[Bacteriological and clinical evaluation tazobactam/piperacillin in infectious diseases in surgical field]
[Bacteriological and clinical study of ciprofloxacin in gonococcal urethritis]
[beta-lactam susceptibility of Escherichia coli isolates from urinary tract infections exhibiting different resistance phenotypes.]
[beta-lactamase activity in sputum of patients with community-acquired lower respiratory tract infections]
[Beta-lactamase inhibitors. I. In vivo evaluation of an amoxicillin + clavulanic acid combination in the treatment of urinary infections]
[Beta-lactamases with a wide substrate spectrum in gram negative strictly anaerobic rods]
[Broad-spectrum beta-lactamases: profile and perspectives after 3 years of systematic detection at the Main Hospital of Dakar (1 February 1992 to 1 February 1995)]
[Carbapenemases in enterobacteriaceae]
[Ciprofloxacin after clinical failure of beta-lactam antibiotics in children with salmonellosis]
[Clinical application of beta-lactamase inhibitors on urinary tract infections]
[Clinical application of mCIM and eCIM combined detection of carbapenemase-producing enterobacteriaceae].
[Clinical Characteristics of Extended-spectrum beta-lactamase Producing Shigella sonnei Infection Outbreaked in Chungju Area.]
[Clinical characterization of blaIMP positive gram-negative rods isolated cases]
[Clinical effects of piperacillin and tazobactam/piperacillin on Haemophilus influenzae lower respiratory tract infection in pediatric patients]
[Clinical efficacy of arbekacin in patients with methicillin-resistant Staphylococcus aureus infections. Research Group of MRSA Forum]
[Clinical evaluation of Augpenin (clavulanic acid-ticarcillin) in urinary tract infections: especially against beta-lactamase producing strains]
[Clinical evaluation of metallo-beta-lactamase producing bacterium]
[Clinical evaluation of sulbactam/cefoperazone for infections in the field of obstetrics and gynecology]
[Clinical evaluation of sulbactam/cefoperazone for lower respiratory tract infections. Correlation between the efficacy of sulbactam/cefoperazone and beta-lactamase]
[Clinical experience of cefotaxime (author's transl)]
[Clinical experience with Timentin]
[Clinical impact of infections with carbapenem-resistant enterobacteriaceae in liver transplant recipients].
[Clinical results with sulbactam/ampicillin in a multicenter study of 425 patients]
[Clinical review and antibacterial effect of aztreonam in infections in obstetrics and gynecology]
[Clinical significance of bacterial beta-lactamase production in the treatment of urinary tract infections with oral beta-lactam-antibiotics]
[Clinical studies of cefotaxime in perinatal infection]
[Clinical studies of tazobactam/piperacillin (TAZ/PIPC) in pediatric patients]
[Clinical studies on sultamicillin fine granules in the urological field]
[Clinical study of BRL 25000 (clavulanic acid-amoxicillin) granules in pediatric infections]
[Clinical trial of a new broad-spectrum cephalosporin: HR 756 (cefotaxime)]
[Clinical, epidemiological and microbiological characterization of bacteremia produced by carbapenem-resistant enterobacteria in a university hospital in Córdoba, Argentina].
[Community-acquired febrile urinary tract infection caused by extended-spectrum beta-lactamase-producing bacteria in hospitalised infants].
[Comparative activity of cefepime, ceftazidime and imipenem in a mouse infection caused by Klebsiella pneumoniae producing a broad spectrum beta-lactamase]
[Comparative assessment of the Vitek 2 and Phoenix systems for detection of extended-spectrum beta-lactamases.]
[Comparison of different strategies for short-term death prediction in the infected older patient].
[Current chemotherapy in urogenital infections. Part 5:Macrolide antibiotics, carbapenems, monobactams, beta-lactamase inhibitors]
[Degradation of ampicillin by urine of patients with complicated urinary tract infections and its protective effect of dicloxacillin (author's transl)]
[Description and investigation of an outbreak of extended-spectrum beta-lactamase producing Escherichia coli strain in a neonatal unit]
[Detection methods for drug-resistant bacteria in routine examination--BLNAR]
[Detection of beta-lactamase-producing bacteria from female patients with acute uncomplicated cystitis]
[Detection of beta-lactamase-producing strains isolated from urinary tract and their drug susceptibility]
[Detection of inducible beta-lactamase in sputum--clinical studies on Pseudomonas respiratory infection]
[Diffusion of sulbactam and cefoperazone into the prostatic tissue]
[Dissemination of the KPC carbapenemase producing Klebsiella pneumoniae in a hospital in Warsaw, Poland]
[Drug resistance and genotyping of Klebsiella pneumoniae in lower respiratory tract infection]
[Drug-resistance analysis of Gram-negative bacilli producing extended-spectrum beta-lactamases in lower respiratory tract infection]
[Effect of H. pylori on the expression of CCAAT enhancer binding protein ? and Cx43 and its role?in gastric carcinogenesis].
[Effect of hydrogen sulfide on the expression of CSE, NF-?B, and IL-8 mRNA in GES-1 cells with Helicobacter pylori infection].
[Efficacy of intravenous ceftazidime in childhood infections]
[Emergence of plasmid mediated AmpC ?-lactamasas: Origin, importance, detection and therapeutical options].
[Epidemiologic diagnostic of nosocomial suppurative-septic infections of Pseudomonas etiology based on intraspecies typing of causative agent].
[Epidemiologic markers of Neisseria (author's transl)]
[Epidemiological and therapeutic studies of gonorrheal infection--clinical efficacy of sultamicillin]
[Epidemiological and therapeutic studies on gonococcal infections--one shot therapy by spectinomycin--[Sapporo Clinical Research Group for STD]]
[Epidemiological characterization of Neisseria gonorrhoeae isolates from Taiwan. Part II: Distribution of auxotyping, serogrouping and plasmid profile]
[Epidemiology of community-acquired pneumonia in children. Current data]
[ESBL-producing E. coli and EHEC in dogs and cats in the Tyrol as possible source of human infection].
[Etiology of pneumonia and host defense]
[Evaluation of in vitro susceptibility of hospital bacterial isolates to piperacillin and tazocin (piperacillin/tazobactam]
[Experimental and clinical studies of sulbactam/cefoperazone in pediatric field]
[Experimental and clinical studies on BRL 25000 (clavulanic acid-amoxicillin) granules in the pediatric field]
[Experimental and clinical studies on BRL 25000 (clavulanic acid-amoxicillin) in the pediatric field]
[Extended-spectrum beta-lactamase producing gram negative rods infection]
[Fatal pneumonia caused by carbapenem resistant Klebsiella pneumoniae].
[First outbreak report of VIM-1 metallo-beta-lactamase producing Pseudomonas aeruginosa in Japan].
[Five years following of infections with extended-spectrum beta-lactamase producing enterobacteriaceae].
[Fosfomycin: past, present and future]
[Fundamental and clinical studies on beta-lactamase inhibitors]
[Gene examination methods (detection and genotyping of resistant genes)--metallo-beta-lactamase]
[Human pulmonary infection by a strain of Pasteurella multocida producing beta-lactamase]
[Ill-appearing febrile 5-week-old infant: the rule of empiric treatment]
[IMP-1 type metalo-beta-lactamase producing Serratia marcescens strains isolated from blood culture between 1991 to 2000]
[Impact of fluoroquinolone use on multidrug-resistant bacteria emergence]
[Implication of extended-spectrum beta-lactamase enterobacteriaceae in nosocomial infections in neonates]
[In vitro activity of fosfomycin against ESBL-producing enterobacteria of urinary origin.]
[In vitro and in vivo antimicrobial activities of cefmetazole against Bacteroides fragilis]
[In vitro susceptibilities of causative organisms isolated from patients with primary respiratory tract infections to BRL 25000 (clavulanic acid/amoxicillin)]
[In vivo antibacterial activity of cefoperazone in intraperitoneal infections in mice]
[Incidence and the results of treatment of beta-lactamase-positive gonorrhea with spectinomycin (trobicin)]
[Increasing prevalence of fosfomycin resistance in extended-spectrum-beta-lactamase-producing Escherichia coli urinary isolates (2005-2009-2011)].
[Infection Control from the Viewpoint of Medical Safety by Our Clinical Laboratory in TMDU Hospital].
[Interaction of bacillus anthracis with benzylpenicillin in vivo and in vitro]
[Investigation of ESBL types in community acquired urinary Escherichia coli isolates by isoelectric focusing and polymerase chain reaction.]
[Investigation of the presence of extended spectrum beta-lactamase, KPC-type carbapenemase and plasmid-mediated AmpC beta-lactamase in E.coli and K.pneumoniae strains isolated from blood cultures].
[Investigation of the presence of New Delhi metallo-beta-lactamase-1 (NDM-1) by PCR in carbapenem-resistant gram-negative isolates].
[Investigation of the Susceptibilities of Extended-Spectrum Beta-Lactamase Producing Escherichia coli and Klebsiella spp. Strains to Ertapenem and Other Carbapenems.]
[Isolation and analysis of the drug resistance of the flavobacterium and its production of beta-lactamases]
[Management of urinary tract infections in children. Evaluation of clinical practice].
[Metallo-beta-lactamase producing gram negative rods infection]
[Microorganisms isolated from urinary tract infection and their beta-lactamase production and evaluation of clinical efficacy of sulperazone]
[Molecular characterization and antimicrobial susceptibility pattern of extended-spectrum ?-lactamase-producing Escherichia coli as cause of community acquired urinary tract infection].
[Molecular epidemiology of beta-lactamases in ceftazidime-resistant Pseudomonas aeruginosa isolates].
[Multidrug-resistant organisms (MDRO) in patients in outpatient care in the Rhine-Main region, Germany, in 2014 : Prevalence and risk factors].
[New antibiotics in infection treatment].
[New antibiotics: an overview].
[Occurrence and mechanisms of resistance to beta-lactam antibiotics in clinically important species of Enterobacter]
[Odontogenic pyogenic infections. 10-year analysis]
[One case of New Delhi metallo-beta-lactamase 1 infection treated by integrative medicine].
[Outbreak of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a neonatal intensive care unit: Risk factors and key preventive measures for eradication in record time].
[Outbreak of infections of Klebsiella pneumoniae with extended spectrum beta-lactamase in a hospital unit with a long and medium stay]
[Outbreak of multiresistant and extended spectrum ?-lactamase producing Klebsiella pneumoniae in a high risk neonatal unit].
[Penicillinase and penicillin therapy of mixed staphylococcal-pneumococcal infections]
[Pharmacokinetic and clinical studies of sultamicillin granule in the pediatric field]
[Pharmacokinetic, bacteriological and clinical studies on sulbactam/ampicillin in pediatric field]
[Pharmacological studies of sulbactam and its association with semisynthetic beta-lactam antibiotics]
[Pharyngeal A-streptococcal infection encountered in the practical work of an internal medicine specialist].
[Polymicrobial infections in recurrent tonsillitis and adenoiditis in children]
[Prevalence of carbapenemase-producing bacteria in hospitals in Saxony, Germany].
[Problems of antibiotic-resistance Gram negative pathogens in the hospital environment]
[Resistance in Haemophilus influenzae in Spain. 2d study (1990)]
[Respiratory infections caused by Branhamella catarrhalis in 5 different hospitals]
[Respiratory tract infections: how frequent is antibiotic resistance? In vitro activity of older and recent antibiotics against the significant pathogens]
[Results of application of CS-1170 to pediatric infections (author's transl)]
[Risk factors for infection with extended-spectrum beta-lactamase-producing strains in children].
[Role of obligate anaerobes in infections in hospitalized patients and therapeutic options]
[Sensitivity and resistance to antimicrobial agents ESBL-producing and not producing ESBL strains of E. coli in patients with urinary tract infection.]
[Sensitivity to Fosfomycin in Extended-spectrum Betalactamase-producing Escherichia coli].
[Significance of normal oropharyngeal flora in the development of streptococcal pharyngitis and outcome of penicillin therapy]
[Studies on phage type, beta-lactamase activity and sensitivity of multiple drug-resistant Staphylococcus aureus isolated from clinical specimens to cefmetazole]
[Studies on sulbactam/ampicillin in the field of pediatrics]
[Studies on sulbactam/cefoperazone in the field of pediatrics]
[STUDY OF NEW ORAL QUINOLONES (LEVOFLOXACIN AND SITAFLOXACIN) AS PROPHYLACTIC ANTIMICROBIAL AGENTS IN TRANSRECTAL PROSTATE NEEDLE BIOPSY].
[Temocillin and urinary tract infections].
[Test evaluation and strategy proposal to detect and to characterize carbapenemase-producing gram negative bacilli].
[The efficacy of prophylactic administration of SBT/ABPC for postoperative infection in neurosurgical operations]
[The role of carbapenems in the treatment of nosocomial infection]
[The role of penicillins in the treatment of respiratory system infections]
[Tolerance of amoxicillin-clavulanic acid combination in the child]
[Transmission of multidrug-resistant bacteria in ambulatory settings.]
[Transplacental passage of cefmenoxime]
[Unasyn in severe hospital infections]
[Update on Acinetobacter baumannii]
[Urinary tract infections caused by extended-spectrum beta-lactamase (ESBL)--producing enterobacteria in outpatients from Primorsko-Goranska County, Croatia]
[Urinary tract infections due to wide spectrum beta lactamase producing enterobacteriaceae]
[Use of cephalosporins in surgical patients]
[Use of penicillinase resistant penicillins for the treatment of surgical suppurative infection]
Infertility
A STANDARD PENICILLINASE PREPARATION.
Development of a proof of principle for universal neutralization of antibiotics in cord blood by-products used for sterility testing.
Some observations on the use of penicillinase in sterility tests for penicillin.
Inflammatory Bowel Diseases
Risk Factors for Community-Associated Clostridium difficile Infection in Adults: A Case-Control Study.
Influenza, Human
Ampicillin disk diffusion susceptibility testing of Haemophilus influenzae.
An enzymatic assay for detection of viral entry.
An enzymatic virus-like particle assay for sensitive detection of virus entry.
Bacteremic Hemophilus influenzae pneumonia in the adult.
Clinical significance of serotype, biotype, and beta-lactamase production of respiratory isolates of Hemophilus influenzae.
Pandemic and seasonal influenza: therapeutic challenges.
Susceptibility of Haemophilus influenza to ampicillin as determined by use of a modified, one-minute beta-lactamase test.
The correlation of micro-organisms between tonsillar crypt culture and tonsillar core culture in chronic tonsillitis.
The genetic code constrains yet facilitates Darwinian evolution.
[Prevalence of bacteria in children with otitis media with effusion]
[Respiratory infections caused by Branhamella catarrhalis in 5 different hospitals]
Insulinoma
The role of dibasic residues in prohormone sorting to the regulated secretory pathway. A study with proneurotensin.
Intraabdominal Infections
Antimicrobial susceptibility and extended-spectrum beta-lactamase rates in aerobic gram-negative bacteria causing intra-abdominal infections in Vietnam: report from the Study for Monitoring Antimicrobial Resistance Trends (SMART 2009-2011).
Ceftazidime-Avibactam Combination Therapy Compared to Ceftazidime-Avibactam Monotherapy for the Treatment of Severe Infections Due to Carbapenem-Resistant Pathogens: A Systematic Review and Network Meta-Analysis.
Ceftazidime/avibactam: a novel cephalosporin/nonbeta-lactam beta-lactamase inhibitor for the treatment of complicated urinary tract infections and complicated intra-abdominal infections.
Clinical and economic outcomes associated with community-acquired intra-abdominal infections caused by extended spectrum beta-lactamase (ESBL) producing bacteria in China.
Efficacy of a beta-lactamase inhibitor combination for serious intraabdominal infections.
Emergence of high levels of extended-spectrum-beta-lactamase-producing gram-negative bacilli in the Asia-Pacific region: data from the Study for Monitoring Antimicrobial Resistance Trends (SMART) program, 2007.
Epidemiologic trends, occurrence of extended-spectrum beta-lactamase production, and performance of ertapenem and comparators in patients with intra-abdominal infections: analysis of global trend data from 2002-2007 from the SMART study.
Eravacycline for the treatment of intra-abdominal infections.
Ertapenem non-susceptibility and independent predictors of the carbapenemase production among the Enterobacteriaceae isolates causing intra-abdominal infections in the Asia-Pacific region: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART).
Etiology, Extended-Spectrum Beta-Lactamase Rates, and Antimicrobial Susceptibility of Gram-negative Bacilli Causing Intra-abdominal Infections in Patients in General Pediatric and Pediatric Intensive Care Units - Global Data from The Study for Monitoring Antimicrobial Resistance Trends (SMART) 2008-2010.
Increasing extended-spectrum beta-lactamase production and quinolone resistance among Gram-negative bacilli causing intra-abdominal infections in the Asia/Pacific region: data from the Smart Study 2002-2006.
Multicenter surveillance of antimicrobial susceptibilities and resistance mechanisms among Enterobacterales species and non-fermenting Gram-negative bacteria from different infection sources in Taiwan from 2016 to 2018.
Pharmacoeconomic analysis of ampicillin-sulbactam versus cefoxitin in the treatment of intraabdominal infections.
Prevotella and Porphyromonas infections in children.
Treatment Modalities and Antimicrobial Stewardship Initiatives in the Management of Intra-Abdominal Infections.
Use of carbapenems in the combined treatment of emerging ceftazidime/avibactam-resistant and carbapenem-susceptible KPC-producing Klebsiella pneumoniae infections: report of a case and review of the literature.
[Bacteriological and clinical evaluation tazobactam/piperacillin in infectious diseases in surgical field]
[Patterns of susceptibility to antibiotics of Enterobacteriaceae causing intra-abdominal infection in Spain: SMART 2003 study outcomes]
Keratitis
Extended spectrum beta-lactamase producing Klebsiella pneumoniae-related keratitis.
Keratosis
Comparison of benign keratoses using p53, bcl-1, and bcl-2.
Keratosis, Seborrheic
Comparison of benign keratoses using p53, bcl-1, and bcl-2.
Kidney Failure, Chronic
Comparison of ampicillin-sulbactam and ticarcillin-clavulanic acid in patients with chronic renal failure: effects of differential pharmacokinetics on serum bactericidal activity.
Donor feces infusion for eradication of Extended Spectrum beta-Lactamase producing Escherichia coli in a patient with end stage renal disease.
Klebsiella Infections
Fatal cross infection by carbapenem-resistant Klebsiella in two liver transplant recipients.
lactase deficiency
Effect of lactase preparations in asymptomatic individuals with lactase deficiency--gastric digestion of lactose and breath hydrogen analysis.
Laryngeal Neoplasms
Amplification of int-2 and bcl-1 genes in squamous cell carcinoma of the larynx.
Leishmaniasis
High-throughput screening of amastigotes of Leishmania donovani clinical isolates against drugs using a colorimetric beta-lactamase assay.
Leishmaniasis, Visceral
High-throughput screening of amastigotes of Leishmania donovani clinical isolates against drugs using a colorimetric beta-lactamase assay.
Lemierre Syndrome
Lemierre's syndrome: two cases of postanginal sepsis.
Leukemia
Activation of the leukemia plasmacytoid dendritic cell line PMDC05 by Toho-1, a novel IDO inhibitor.
Alleviation of chronic GVHD in mice by oral immuneregulation toward recipient pretransplant splenocytes does not jeopardize the graft versus leukemia effect.
An Uncommon ST1224 NDM-1-Producing Klebsiella pneumoniae Isolated from the Bloodstream of a Leukemia Patient in China.
Augmentation of the antileukemia potency of total-body irradiation (TBI) by a novel P-site inhibitor of spleen tyrosine kinase (SYK).
bcl-1 rearrangement. Frequency and clinical significance among B-cell chronic lymphocytic leukemias and non-Hodgkin's lymphomas.
Characterization of Klebsiella pneumoniae and Escherichia coli strains that produce CTX-M-2-type broad spectrum beta-lactamase isolated from a child with leukemia.
Cyclin D1 overexpression in non-Hodgkin's lymphoma with chromosome 11 bcl-1 rearrangement.
Distribution of VIM-2 and SSEA-1 glycoconjugate epitopes among human leukocytes and leukemia cells.
In vivo efficacy of B43 (anti-CD19)-pokeweed antiviral protein immunotoxin against BCL-1 murine B-cell leukemia.
In vivo pharmacokinetic features, toxicity profile, and chemosensitizing activity of alpha-cyano-beta-hydroxy-beta- methyl-N-(2,5-dibromophenyl)propenamide (LFM-A13), a novel antileukemic agent targeting Bruton's tyrosine kinase.
In vivo radiosensitizing effects of recombinant interleukin 6 on radiation resistant BCL-1 B-lineage leukemia cells in a murine syngeneic bone marrow transplant model system.
Janus kinase 3 inhibitor WHI-P131/JANEX-1 prevents graft-versus-host disease but spares the graft-versus-leukemia function of the bone marrow allografts in a murine bone marrow transplantation model.
Lack of intraclonal diversification in Ig heavy and light chain V region genes expressed by CD5+IgM+ chronic lymphocytic leukemia B cells: a multiple time point analysis.
Molecular hematology. Qualitative to quantitative techniques.
Oncogenes in chronic lymphocytic leukemia.
Phenotypic markers and BCL-1 gene rearrangements in B-cell chronic lymphocytic leukemia: a Cancer and Leukemia Group B study.
Phorbol esters specifically inhibit induction of immunoglobulin secretion in a murine B cell leukemia.
PRAD-1/cyclin D1 gene overexpression in chronic lymphoproliferative disorders: a highly specific marker of mantle cell lymphoma.
Rearrangement and overexpression of the BCL-1/PRAD-1 gene in intermediate lymphocytic lymphomas and in t(11q13)-bearing leukemias.
[Molecular-genetic evaluation of translocation of bcl-2 gene and locus bcl-1 in selected lymphoproliferative changes]
Leukemia, B-Cell
BCL-1 rearrangement in acute lymphocytic leukemia and its clinical significance.
In vivo efficacy of B43 (anti-CD19)-pokeweed antiviral protein immunotoxin against BCL-1 murine B-cell leukemia.
Phorbol esters specifically inhibit induction of immunoglobulin secretion in a murine B cell leukemia.
Treatment of BCL-1 murine B-cell leukemia with recombinant cytokines. Comparative analysis of the anti-leukemic potential of interleukin 1 beta (IL-1 beta), interleukin 2 (IL-2), interleukin-6 (IL-6), tumor necrosis factor alpha (TNF alpha), granulocyte colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), and their combination.
Leukemia, Hairy Cell
PRAD-1/cyclin D1 gene overexpression in chronic lymphoproliferative disorders: a highly specific marker of mantle cell lymphoma.
Leukemia, Lymphocytic, Chronic, B-Cell
Association of bcl-1 rearrangements with lymphocytic lymphoma of intermediate differentiation.
Bcl-1 gene rearrangements in B cell lymphoma.
bcl-1 rearrangement. Frequency and clinical significance among B-cell chronic lymphocytic leukemias and non-Hodgkin's lymphomas.
BCL-1 rearrangements and p53 mutations in atypical chronic lymphocytic leukemia with t(11;14)(q13;q32).
bcl-1 translocations are frequent in the paraimmunoblastic variant of small lymphocytic lymphoma.
CD23 negative chronic lymphocytic leukemia of the tonsil: report of a case.
Cyclin D1 messenger RNA overexpression as a marker for mantle cell lymphoma.
Epiglottic diffuse B-cell malignant lymphoma: A case report.
Multiple breakpoints within the BCL-1 locus in B-cell lymphoma: rearrangements of the cyclin D1 gene.
Oncogenes in chronic lymphocytic leukemia.
Phenotypic markers and BCL-1 gene rearrangements in B-cell chronic lymphocytic leukemia: a Cancer and Leukemia Group B study.
PRAD-1/cyclin D1 gene overexpression in chronic lymphoproliferative disorders: a highly specific marker of mantle cell lymphoma.
Rearrangement and overexpression of the BCL-1/PRAD-1 gene in intermediate lymphocytic lymphomas and in t(11q13)-bearing leukemias.
Rearrangement of the chromosome 11 bcl-1 locus in centrocytic lymphoma: analysis with multiple breakpoint probes.
The BCL-1, BCL-2, and BCL-3 oncogenes are involved in chronic lymphocytic leukemia. Detection by fluorescence in situ hybridization.
The molecular biology of B-cell lymphoma: clinicopathologic implications.
[Molecular-genetic evaluation of translocation of bcl-2 gene and locus bcl-1 in selected lymphoproliferative changes]
Leukemia, Lymphoid
bcl-1 rearrangement. Frequency and clinical significance among B-cell chronic lymphocytic leukemias and non-Hodgkin's lymphomas.
Cyclin D1 (Bcl-1, PRAD1) protein expression in low-grade B-cell lymphomas and reactive hyperplasia.
Oncogene rearrangements in chronic B-cell leukemia.
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
A novel carbohydrate, differentiation antigen on fucogangliosides of human myeloid cells recognized by monoclonal antibody VIM-2.
Molecular hematology. Qualitative to quantitative techniques.
Total synthesis of VIM-2 ganglioside isolated from human chronic myelogenous leukemia cells.
Leukemia, Myeloid, Acute
A novel carbohydrate, differentiation antigen on fucogangliosides of human myeloid cells recognized by monoclonal antibody VIM-2.
Cyclin D1 overexpression in non-Hodgkin's lymphoma with chromosome 11 bcl-1 rearrangement.
Distribution of VIM-2 and SSEA-1 glycoconjugate epitopes among human leukocytes and leukemia cells.
Molecular hematology. Qualitative to quantitative techniques.
Leukemia, Prolymphocytic, B-Cell
Oncogenes in chronic lymphocytic leukemia.
Leukemia, Prolymphocytic, T-Cell
Cyclin D1 overexpression in non-Hodgkin's lymphoma with chromosome 11 bcl-1 rearrangement.
Leukocytosis
Clinical characteristics of post-neurosurgical Klebsiella pneumoniae meningitis in adults and a clinical comparison to the spontaneous form in a Taiwanese population.
Liver Abscess
Beta-lactamase producing Haemophilus influenzae as causative agent of a liver abscess.
Community-acquired liver abscess caused by serotype K1 Klebsiella pneumoniae with CTX-M-15-type extended-spectrum beta-lactamase.
Transfer of CMY-2 Cephalosporinase from Escherichia coli to Virulent Klebsiella pneumoniae Causing a Recurrent Liver Abscess.
Liver Cirrhosis
Characterization of a new integron containing VIM-2, a metallo- beta-lactamase gene cassette, in a clinical isolate of Enterobacter cloacae.
Pneumococcal bacterial peritonitis in aids patient following esophageal endoscopic variceal sclerotherapy. Case report and recommendations for antibiotic prophylaxis.
Liver Diseases
Impact of host-pathogen-treatment tripartite components on early mortality of patients with Escherichia coli bloodstream infection: Prospective observational study.
Lung Abscess
[A comparative study of tazobactam/piperacillin and piperacillin in bacterial pneumonia]
Lung Neoplasms
Alkaloid Extract of Moringa oleifera Lam. Exerts Antitumor Activity in Human Non-Small-Cell Lung Cancer via Modulation of the JAK2/STAT3 Signaling Pathway.
Design, synthesis and preliminary biological evaluation of new [1,2,3]triazolo[4,5-d]pyrimidine/thiourea hybrids as antiproliferative agents.
Frequent amplification of the bcl-1 locus in poorly differentiated squamous cell carcinoma of the lung. The Lung Cancer Study Group.
Increased expression of insulin-like growth factor-II messenger RNA-binding protein 1 is associated with tumor progression in patients with lung cancer.
Lyme Disease
Cases of Lyme borreliosis resistant to conventional treatment: improved symptoms with cephalosporin plus specific beta-lactamase inhibition.
Lymphadenopathy
Cutaneous Vasculitis and Generalized Lymphadenopathy Associated with Extended-Spectrum Beta-Lactamase (ESBL)-Producing Escherichia coli Endocarditis: A Rare Case Report.
Mycobacterial excretory secretory-31 protein with serine protease and lipase activities: An immunogen and drug target against tuberculosis infection.
Sero-reactivity of two different antigenic protein fractions of M.tb H37Ra excretory-secretory antigen in pulmonary and extra-pulmonary tuberculosis.
Seroreactivity of 31 kDa and 41 kDa mycobacterial secretory proteins isolated from culture filtrate in extra pulmonary tuberculosis.
Lymphatic Metastasis
Multiple genetic lesions in laryngeal squamous cell carcinomas.
Lymphoma
A distinctive composite lymphoma consisting of clonally related mantle cell lymphoma and follicle center cell lymphoma.
A genotypic study of low grade B-cell lymphomas, including lymphomas of mucosa associated lymphoid tissue (MALT).
Abnormalities in the PRAD1 (CYCLIN D1/BCL-1) oncogene are frequent in cervical and vulvar squamous cell carcinoma cell lines.
Allogeneic hematopoietic transplantation for mantle-cell lymphoma: molecular remissions and evidence of graft-versus-malignancy.
Analysis of c-myc, bcl-1 and bcl-2 translocations in human lymphoma by pulsed-field gel electrophoresis.
B-cell lymphomas with coexpression of CD5 and CD10.
BCL-1 (PRAD-1/cyclin D-1) overexpression distinguishes the blastoid variant of mantle cell lymphoma from B-lineage lymphoblastic lymphoma.
Bcl-1 gene rearrangements in B cell lymphoma.
BCL-1 Gene Rearrangements in Iranian Non-Hodgkin Lymphoma Patients.
bcl-1 gene rearrangements in mantle cell lymphoma: a comprehensive analysis of 118 cases, including B-5-fixed tissue, by polymerase chain reaction and Southern transfer analysis.
bcl-1 rearrangement and cyclin D1 protein expression in mantle cell lymphoma.
bcl-1 rearrangement. Frequency and clinical significance among B-cell chronic lymphocytic leukemias and non-Hodgkin's lymphomas.
bcl-1, bcl-2, p53, c-myc, and lyt-10 analysis in cutaneous lymphomas.
bcl-1, t(11;14), and mantle cell-derived lymphomas.
BCL-6 and other genomic alterations in non-Hodgkin's lymphoma (NHL).
Biologic and molecular characterization of non-Hodgkin's lymphoma.
Blastoid variants of mantle cell lymphoma: frequent bcl-1 rearrangements at the major translocation cluster region and tetraploid chromosome clones.
Burkitt transformation of mantle cell lymphoma.
Carb-3 Is the Superior Anti-CD15 Monoclonal Antibody for Immunohistochemistry.
CD2 expression in murine B cell lineage.
CD5- mantle cell lymphoma.
CD5-expressing B-cell non-Hodgkin's lymphomas with bcl-1 gene rearrangement have a relatively homogeneous immunophenotype and are associated with an overall poor prognosis.
Centrocytic lymphoma: a B-cell non-Hodgkin's lymphoma characterized by chromosome 11 bcl-1 and PRAD 1 rearrangements.
Characterization of chromosome 11 translocation breakpoints at the bcl-1 and PRAD1 loci in centrocytic lymphoma.
Characterization of t(11;14) translocation in mantle cell lymphoma by fluorescent in situ hybridization.
Chromosomal translocations in lymphoid malignancies reveal novel proto-oncogenes.
Chromosome 11 translocation breakpoints at the PRAD1/cyclin D1 gene locus in centrocytic lymphoma.
Chromosome t(11;14)(q13;q32) breakpoints in centrocytic lymphoma are highly localized at the bcl-1 major translocation cluster.
Clinicopathologic study of PRAD1/cyclin D1 overexpressing lymphoma with special reference to mantle cell lymphoma. A distinct molecular pathologic entity.
Commitment of B lymphocytes to a plasma cell fate is associated with Blimp-1 expression in vivo.
Comparison of chromosome analysis and BCL-1 rearrangement in a series of patients with multiple myeloma.
Composite mantle cell and follicular lymphoma. A case report.
Conformational variants of duplex DNA correlated with cytosine-rich chromosomal fragile sites.
Correspondence Re: Chibbar R, Leung K, McCormick S, Ritzkalla K, Strickler J, Staggs R, et al. bcl-1 gene rearrangements in mantle cell lymphoma: a comprehensive analysis of 118 cases, including B-5-fixed tissue, by polymerase chain reaction and southern transfer analysis. Mod Pathol 1998;11:1089-97.
Cyclin D1 (Bcl-1, PRAD1) protein expression in low-grade B-cell lymphomas and reactive hyperplasia.
Cyclin D1 by flow cytometry as a useful tool in the diagnosis of B-cell malignancies.
Cyclin D1 messenger RNA overexpression as a marker for mantle cell lymphoma.
Cyclin D1 overexpression in malignant lymphomas.
Cyclin D1 overexpression in non-Hodgkin's lymphoma with chromosome 11 bcl-1 rearrangement.
Deletions and loss of expression of p16INK4a and p21Waf1 genes are associated with aggressive variants of mantle cell lymphomas.
Detection of bcl-1 gene rearrangement and B-cell clonality in mantle cell lymphoma using formalin-fixed, paraffin-embedded tissues.
Detection of cyclin D1 (bcl-1, PRAD1) overexpression by a simple competitive reverse transcription-polymerase chain reaction assay in t(11;14)(q13;q32)-bearing B-cell malignancies and/or mantle cell lymphoma.
Detection of single and associated lesions of the Bcl-1, Bcl-2, Bcl-6, c-myc, p53 and p16 genes in B-cell non-Hodgkin's lymphomas: value of molecular analysis for a better assignment of the histologic subtype.
Detection of the bcl-1 rearrangement at the major translocation cluster in frozen and paraffin-embedded tissues of mantle cell lymphomas by polymerase chain reaction.
Differential expression of a CD45R epitope(6B2) on murine CD5+ B cells: possible difference in the post-translational modification of CD45 molecules.
Direct visualization of dispersed 11q13 chromosomal translocations in mantle cell lymphoma by multicolor DNA fiber fluorescence in situ hybridization.
During acute graft versus host disease CD28 deletion in donor CD8+ , but not CD4+ , T cells maintain antileukemia responses in mice.
Early phase of intestinal mantle cell lymphoma: a report of two cases associated with advanced colonic adenocarcinoma.
Expression of retinoblastoma gene product (pRb) in mantle cell lymphomas. Correlation with cyclin D1 (PRAD1/CCND1) mRNA levels and proliferative activity.
Genetics of small lymphocyte disorders.
Genomic analysis of T-cell receptor and immunoglobulin antigen receptor genes and breakpoint cluster regions in gastrointestinal lymphomas.
Genotypic characterization of centrocytic lymphoma: frequent rearrangement of the chromosome 11 bcl-1 locus.
Histogenesis and pathogenesis of follicular small cleaved cell lymphoma (FSCCL), diffuse small cleaved cell lymphoma (DSCCL) and intermediate lymphocytic lymphoma/lymphocytic lymphoma of intermediate differentiation (ILL/IDL).
Histogenetic correlations between subcategories of small noncleaved cell lymphomas.
Identification of genetic lesions associated with diffuse large-cell lymphoma.
IgH partner breakpoint sequences provide evidence that AID initiates t(11;14) and t(8;14) chromosomal breaks in mantle cell and Burkitt lymphomas.
Immunostaining of PRAD1/cyclin D1 protein as a marker for the diagnosis of mantle cell lymphoma.
In situ hybridization and reverse transcription-polymerase chain reaction for cyclin D1 mRNA in the diagnosis of mantle cell lymphoma in paraffin-embedded tissues.
Induction of apoptosis and down regulation of cell cycle proteins in mantle cell lymphoma by flavopiridol treatment.
Influence of miR-30b regulating humoral immune response by genetic difference.
Intranuclear expression of cyclin D1 protein as a useful prognostic marker for mantle cell lymphoma.
Large cell variants of CD5+, CD23- B-cell lymphoma/leukemia.
Mantle cell lymphoma. A morphological, immunohistochemical and molecular genetic study.
Mantle cell lymphoma. Rapid polymerase chain reaction-based genotyping of a morphologically heterogeneous entity.
Mantle cell lymphoma: an update.
Mantle cell lymphoma: diagnostic criteria, clinical aspects and therapeutic problems.
Mantle cell lymphoma: improved diagnostics using a combined approach of immunohistochemistry and identification of t(11;14)(q13;q32) by polymerase chain reaction and fluorescence in situ hybridization.
Mantle cell/centrocytic lymphoma: molecular and phenotypic analysis including analysis of the bcl-1 major translocation cluster by PCR.
Mechanisms of chromosomal rearrangement in the human genome.
Minimal residual disease in vitro of a pre-B-lymphoma.
Molecular analysis of bcl-1/IgH junctional sequences in mantle cell lymphoma: potential mechanism of the t(11;14) chromosomal translocation.
Molecular analysis of mucosa-associated lymphoid tissue (MALT) lymphoma of ocular adnexa.
Molecular detection of t(11;14)(q13;q32) in mantle cell lymphoma.
Molecular diagnosis of mantle cell lymphoma in paraffin-embedded tissue.
Molecular features of primary mediastinal B-cell lymphoma: involvement of p16INK4A, p53 and c-myc.
Molecular genetics and lymphoproliferative disorders.
Molecular genetics of gastrointestinal non-Hodgkin's lymphomas: unusual prevalence and pattern of c-myc rearrangements in aggressive lymphomas.
Molecular hematology. Qualitative to quantitative techniques.
Multiple breakpoints within the BCL-1 locus in B-cell lymphoma: rearrangements of the cyclin D1 gene.
Multiple lymphomatous polyposis of the gastrointestinal tract: prospective clinicopathologic study of 31 cases. Groupe D'étude des Lymphomes Digestifs.
Non-Hodgkin's lymphomas of primary follicle/mantle zone origin.
Oncogene rearrangement in non-Hodgkin's lymphoma with a 14q+ chromosome of unknown origin.
Overexpression of PRAD1 in a mantle zone lymphoma patient with a t(11;22)(q13;q11) translocation.
p53 gene mutations and protein overexpression are associated with aggressive variants of mantle cell lymphomas.
Polymerase chain reaction detection of the t(11;14) translocation involving the bcl-1 major translocation cluster in mantle cell lymphoma.
PRAD-1/cyclin D1 gene overexpression in chronic lymphoproliferative disorders: a highly specific marker of mantle cell lymphoma.
PRAD1 (cyclin D1): a parathyroid neoplasia gene on 11q13.
PRAD1/Cyclin D1 gene overexpression in mantle cell lymphoma.
Primary low-grade B-cell lymphoma of mucosa-associated lymphoid tissue (MALT) arising in dura.
Proliferative fraction, bcl-1 gene translocation, and p53 mutation status as markers in mantle cell lymphoma.
Quantitation of cyclin D1 over-expression using competitive fluorescent reverse transcription polymerase chain reaction: a tool for the differential diagnosis of mantle cell lymphoma.
Rearrangement of the chromosome 11 bcl-1 locus in centrocytic lymphoma: analysis with multiple breakpoint probes.
Rearrangements of bcl-1, bcl-2, bcl-6, and c-myc in diffuse large B-cell lymphomas.
Splenic lymphoma with villous lymphocytes: analysis of BCL-1 rearrangements and expression of the cyclin D1 gene.
Structure of Bcl-1 and IgH-CDR3 rearrangements as clonal markers in mantle cell lymphomas.
Sulfhydryl-based tumor antigen-carrier protein conjugates stimulate superior antitumor immunity against B cell lymphomas.
Templated nucleotide addition and immunoglobulin JH-gene utilization in t(11;14) junctions: implications for the mechanism of translocation and the origin of mantle cell lymphoma.
The anaplastic variant of centrocytic lymphoma is marked by frequent rearrangements of the bcl-1 gene and high proliferation indices.
The molecular biology of B-cell lymphoma: clinicopathologic implications.
The presence of bcl-1 and bcl-2 gene rearrangements in diffuse small cleaved-cell lymphoma. A disease with diverse molecular and immunophenotypic findings.
The value of fluorescence in situ hybridization and polymerase chain reaction in the diagnosis of B-cell non-Hodgkin lymphoma by fine-needle aspiration.
Utility of gene rearrangements in lymphoid malignancies.
[Molecular diagnosis of leukemia and lymphoma]
[Molecular study of hematological diseases]
[Overexpression of PRAD1 gene in B-cell malignancy with t(11;14)(q13;q32) translocation]
[The role of genetic studies in the diagnosis and classification of non-Hodgkin lymphoma]
[Typing of malignant mantle zone lymphomas]
Lymphoma, B-Cell
A genotypic study of low grade B-cell lymphomas, including lymphomas of mucosa associated lymphoid tissue (MALT).
Analysis of c-myc, bcl-1 and bcl-2 translocations in human lymphoma by pulsed-field gel electrophoresis.
Association of bcl-1 rearrangements with lymphocytic lymphoma of intermediate differentiation.
Bcl-1 gene rearrangements in B cell lymphoma.
bcl-1 translocations are frequent in the paraimmunoblastic variant of small lymphocytic lymphoma.
bcl-1, bcl-2, p53, c-myc, and lyt-10 analysis in cutaneous lymphomas.
Chromosomal translocation detected by bcl-1 and bcl-2 rearrangement in low-grade B-cell lymphomas in a European population.
Commitment of B lymphocytes to a plasma cell fate is associated with Blimp-1 expression in vivo.
Cyclin D1 overexpression in non-Hodgkin's lymphoma with chromosome 11 bcl-1 rearrangement.
Detection of oncogene rearrangements in human non-Hodgkin's lymphomas.
Gene rearrangement of bcl-1 and bcl-2 is confined to distinct subgroups of high-grade malignant B-cell lymphomas.
Genomic analysis of T-cell receptor and immunoglobulin antigen receptor genes and breakpoint cluster regions in gastrointestinal lymphomas.
Large cell variants of CD5+, CD23- B-cell lymphoma/leukemia.
Mechanisms of chromosomal rearrangement in the human genome.
Molecular analysis of breaks in BCL-1 proto-oncogene in B-cell lymphomas with abnormalities of 11q13.
Multiple breakpoints within the BCL-1 locus in B-cell lymphoma: rearrangements of the cyclin D1 gene.
Rearrangements of bcl-1, bcl-2, bcl-6, and c-myc in diffuse large B-cell lymphomas.
Lymphoma, B-Cell, Marginal Zone
A genotypic study of low grade B-cell lymphomas, including lymphomas of mucosa associated lymphoid tissue (MALT).
Genomic analysis of T-cell receptor and immunoglobulin antigen receptor genes and breakpoint cluster regions in gastrointestinal lymphomas.
Molecular analysis of mucosa-associated lymphoid tissue (MALT) lymphoma of ocular adnexa.
Lymphoma, Follicular
Association of bcl-1 rearrangements with lymphocytic lymphoma of intermediate differentiation.
Blastic/blastoid transformation of follicular lymphoma: immunohistologic and molecular analyses of five cases.
Mechanisms of chromosomal rearrangement in the human genome.
Molecular hematology. Qualitative to quantitative techniques.
Oncogene rearrangement in non-Hodgkin's lymphoma with a 14q+ chromosome of unknown origin.
Overexpression of PRAD1 in a mantle zone lymphoma patient with a t(11;22)(q13;q11) translocation.
Stem-cell transplantation in non-Hodgkin's lymphoma: improving outcome.
Templated nucleotide addition and immunoglobulin JH-gene utilization in t(11;14) junctions: implications for the mechanism of translocation and the origin of mantle cell lymphoma.
The molecular biology of B-cell lymphoma: clinicopathologic implications.
The value of fluorescence in situ hybridization and polymerase chain reaction in the diagnosis of B-cell non-Hodgkin lymphoma by fine-needle aspiration.
Utility of gene rearrangements in lymphoid malignancies.
[Molecular diagnosis of leukemia and lymphoma]
Lymphoma, Large B-Cell, Diffuse
Bcl-1 gene rearrangements in B cell lymphoma.
Mechanisms of chromosomal rearrangement in the human genome.
Lymphoma, Mantle-Cell
A distinctive composite lymphoma consisting of clonally related mantle cell lymphoma and follicle center cell lymphoma.
BCL-1 (PRAD-1/cyclin D-1) overexpression distinguishes the blastoid variant of mantle cell lymphoma from B-lineage lymphoblastic lymphoma.
bcl-1 gene rearrangements in mantle cell lymphoma: a comprehensive analysis of 118 cases, including B-5-fixed tissue, by polymerase chain reaction and Southern transfer analysis.
bcl-1 rearrangement and cyclin D1 protein expression in mantle cell lymphoma.
Blastoid variants of mantle cell lymphoma: frequent bcl-1 rearrangements at the major translocation cluster region and tetraploid chromosome clones.
Burkitt transformation of mantle cell lymphoma.
CD5- mantle cell lymphoma.
Characterization of t(11;14) translocation in mantle cell lymphoma by fluorescent in situ hybridization.
Correspondence Re: Chibbar R, Leung K, McCormick S, Ritzkalla K, Strickler J, Staggs R, et al. bcl-1 gene rearrangements in mantle cell lymphoma: a comprehensive analysis of 118 cases, including B-5-fixed tissue, by polymerase chain reaction and southern transfer analysis. Mod Pathol 1998;11:1089-97.
Cyclin D1 by flow cytometry as a useful tool in the diagnosis of B-cell malignancies.
Cyclin D1 overexpression in malignant lymphomas.
Deletions and loss of expression of p16INK4a and p21Waf1 genes are associated with aggressive variants of mantle cell lymphomas.
Detection of bcl-1 gene rearrangement and B-cell clonality in mantle cell lymphoma using formalin-fixed, paraffin-embedded tissues.
Detection of cyclin D1 (bcl-1, PRAD1) overexpression by a simple competitive reverse transcription-polymerase chain reaction assay in t(11;14)(q13;q32)-bearing B-cell malignancies and/or mantle cell lymphoma.
Early phase of intestinal mantle cell lymphoma: a report of two cases associated with advanced colonic adenocarcinoma.
Identification of genetic lesions associated with diffuse large-cell lymphoma.
IgH partner breakpoint sequences provide evidence that AID initiates t(11;14) and t(8;14) chromosomal breaks in mantle cell and Burkitt lymphomas.
In situ hybridization and reverse transcription-polymerase chain reaction for cyclin D1 mRNA in the diagnosis of mantle cell lymphoma in paraffin-embedded tissues.
Induction of apoptosis and down regulation of cell cycle proteins in mantle cell lymphoma by flavopiridol treatment.
Intranuclear expression of cyclin D1 protein as a useful prognostic marker for mantle cell lymphoma.
Large cell variants of CD5+, CD23- B-cell lymphoma/leukemia.
Mantle cell lymphoma. Rapid polymerase chain reaction-based genotyping of a morphologically heterogeneous entity.
Mantle cell lymphoma: improved diagnostics using a combined approach of immunohistochemistry and identification of t(11;14)(q13;q32) by polymerase chain reaction and fluorescence in situ hybridization.
Mechanisms of chromosomal rearrangement in the human genome.
Molecular analysis of bcl-1/IgH junctional sequences in mantle cell lymphoma: potential mechanism of the t(11;14) chromosomal translocation.
Molecular detection of t(11;14)(q13;q32) in mantle cell lymphoma.
Molecular diagnosis of mantle cell lymphoma in paraffin-embedded tissue.
Molecular hematology. Qualitative to quantitative techniques.
Multiple lymphomatous polyposis of the gastrointestinal tract: prospective clinicopathologic study of 31 cases. Groupe D'étude des Lymphomes Digestifs.
Oncogene rearrangement in non-Hodgkin's lymphoma with a 14q+ chromosome of unknown origin.
Over-expression of cyclin D1 in chronic B-cell malignancies with abnormality of chromosome 11q13.
Overexpression of PRAD1 in a mantle zone lymphoma patient with a t(11;22)(q13;q11) translocation.
p53 gene mutations and protein overexpression are associated with aggressive variants of mantle cell lymphomas.
Polymerase chain reaction detection of the t(11;14) translocation involving the bcl-1 major translocation cluster in mantle cell lymphoma.
PRAD1/Cyclin D1 gene overexpression in mantle cell lymphoma.
Proliferative fraction, bcl-1 gene translocation, and p53 mutation status as markers in mantle cell lymphoma.
Quantitation of cyclin D1 over-expression using competitive fluorescent reverse transcription polymerase chain reaction: a tool for the differential diagnosis of mantle cell lymphoma.
Templated nucleotide addition and immunoglobulin JH-gene utilization in t(11;14) junctions: implications for the mechanism of translocation and the origin of mantle cell lymphoma.
[Molecular diagnosis of leukemia and lymphoma]
Lymphoma, Non-Hodgkin
BCL-1 Gene Rearrangements in Iranian Non-Hodgkin Lymphoma Patients.
Centrocytic lymphoma: a B-cell non-Hodgkin's lymphoma characterized by chromosome 11 bcl-1 and PRAD 1 rearrangements.
Characterization of chromosome 11 translocation breakpoints at the bcl-1 and PRAD1 loci in centrocytic lymphoma.
Chromosomal translocation detected by bcl-1 and bcl-2 rearrangement in low-grade B-cell lymphomas in a European population.
Cyclin D1 overexpression in non-Hodgkin's lymphoma with chromosome 11 bcl-1 rearrangement.
Detection of oncogene rearrangements in human non-Hodgkin's lymphomas.
Expression of common fragile sites in untreated non-Hodgkin's lymphoma with aphidicolin and folate deficiency.
Gene rearrangement of bcl-1 and bcl-2 is confined to distinct subgroups of high-grade malignant B-cell lymphomas.
Genomic analysis of T-cell receptor and immunoglobulin antigen receptor genes and breakpoint cluster regions in gastrointestinal lymphomas.
Identification of genetic lesions associated with diffuse large-cell lymphoma.
Induction of apoptosis and down regulation of cell cycle proteins in mantle cell lymphoma by flavopiridol treatment.
Lack of intraclonal diversification in Ig heavy and light chain V region genes expressed by CD5+IgM+ chronic lymphocytic leukemia B cells: a multiple time point analysis.
Oncogene rearrangement in non-Hodgkin's lymphoma with a 14q+ chromosome of unknown origin.
Retrospective identification of a previously undetected clinical case of OXA-48-producing K. pneumoniae and E. coli: the importance of adequate detection guidelines.
The presence of bcl-1 and bcl-2 gene rearrangements in diffuse small cleaved-cell lymphoma. A disease with diverse molecular and immunophenotypic findings.
The role of molecular monitoring in autotransplantation for non-Hodgkin's lymphoma.
Treatment of BCL-1 murine B-cell leukemia with recombinant cytokines. Comparative analysis of the anti-leukemic potential of interleukin 1 beta (IL-1 beta), interleukin 2 (IL-2), interleukin-6 (IL-6), tumor necrosis factor alpha (TNF alpha), granulocyte colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), and their combination.
[Molecular-genetic evaluation of translocation of bcl-2 gene and locus bcl-1 in selected lymphoproliferative changes]
Lymphoma, T-Cell
Detection of oncogene rearrangements in human non-Hodgkin's lymphomas.
Lymphoma, T-Cell, Cutaneous
bcl-1, bcl-2, p53, c-myc, and lyt-10 analysis in cutaneous lymphomas.
Lymphoproliferative Disorders
Cyclin D1 messenger RNA overexpression as a marker for mantle cell lymphoma.
PRAD-1/cyclin D1 gene overexpression in chronic lymphoproliferative disorders: a highly specific marker of mantle cell lymphoma.
Marek Disease
Characterization of proteins of chicken infectious anemia virus with monoclonal antibodies.
Mastitis
Analytical specificity and sensitivity of a real-time polymerase chain reaction assay for identification of bovine mastitis pathogens.
Antibiotic resistance in animals.
Antibiotic resistance of staphylococci from humans, food and different animal species according to data of the Hungarian resistance monitoring system in 2001.
Antimicrobial drug susceptibility of Staphylococcus aureus isolated from bovine mastitis.
Antimicrobial potential of Copaiba Oil (Copaifera multijuga Hayne-Leguminosae) against bubaline mastitis multiresistant isolates.
Antimicrobial susceptibility of udder pathogens from cases of acute clinical mastitis in dairy cows.
Binding of Staphylococcus aureus to milk fat globules increases resistance to penicillin-G.
Biological activities of Ocimum sanctum L. fixed oil--an overview.
Characterization of extended-spectrum beta-lactamase (ESBL)-carrying plasmids and clones of Enterobacteriaceae causing cattle mastitis in France.
CTX-M-Type Extended-Spectrum ?-Lactamase-Producing Klebsiella pneumoniae Isolated from Cases of Bovine Mastitis in Japan.
Efficacy of lincosaminide antibiotics in the treatment of experimental staphylococcal mastitis in lactating mice.
Extended-spectrum beta-lactamase production in E. coli strains isolated from clinical bovine mastitis.
Identification of staphylococci from bovine mastitis and an examination of their susceptibility to antibiotics and beta-lactamase production.
Investigation of the antibiotic resistance and biofilm formation of Staphylococcus aureus strains isolated from gangrenous mastitis of ewes.
Mastitis diagnosis in dairy cows using PathoProof real-time polymerase chain reaction assay in comparison with conventional bacterial culture in a Northern German field study.
Molecular characterization of KPC-2-producing Klebsiella pneumoniae ST258 isolated from bovine mastitis.
Occurrence of the blaZ gene in penicillin resistant Staphylococcus aureus isolated from bovine mastitis in Denmark.
[Bacterial resistance in bacteria isolated from the nasal cavity of Swiss dairy calves].
[Treatment of mastitis in general practice]
Maxillary Sinusitis
Bacteriology and beta-lactamase activity in acute and chronic maxillary sinusitis.
Mediastinitis
Development of ertapenem resistance in a patient with mediastinitis caused by an extended-spectrum beta-lactamase producing Klebsiella pneumoniae.
Melanoma
Comparison of recombinant and synthetically formed monoclonal antibody-beta-lactamase conjugates for anticancer prodrug activation.
Regressions and cures of melanoma xenografts following treatment with monoclonal antibody beta-lactamase conjugates in combination with anticancer prodrugs.
Suppression of tumor growth by Pleurotus ferulae ethanol extract through induction of cell apoptosis, and inhibition of cell proliferation and migration.
[Effects of bcl-2 antisense oligodeoxynucleotide on proliferation and apoptosis of human melanoma A375 cell line]
Melioidosis
Burkholderia pseudomallei class a beta-lactamase mutations that confer selective resistance against ceftazidime or clavulanic acid inhibition.
Pseudomonas pseudomallei resistance to beta-lactam antibiotics due to alterations in the chromosomally encoded beta-lactamase.
Meningitis
A case of fatal acute pyogenic meningitis in a neonate caused by extended-spectrum beta-lactamase producing Salmonella group B.
A Conserved Virulence Plasmidic Region Contributes to the Virulence of the Multiresistant Escherichia coli Meningitis Strain S286 Belonging to Phylogenetic Group C.
Amp C beta-lactamase-producing Escherichia coli in neonatal meningitis: diagnostic and therapeutic challenge.
Ampicillin treatment failure of apparently beta-lactamase-negative Haemophilus influenzae type b meningitis due to novel beta-lactamase.
Antimicrobial resistance in Haemophilus influenzae.
Beta-lactamase effect on ampicillin treatment of Haemophilus influenzae B bacteremia and meningitis in infant rats.
Carbapenemase producing Klebsiella pneumoniae (KPC) meningitis from chronic otitis media.
Characterization of a laboratory-derived, high-level ampicillin-resistant Salmonella enterica serovar Typhimurium strain that caused meningitis in an infant.
Clinical evaluation of aztreonam therapy for serious infections due to gram-negative bacteria.
Comparison of antibiotic resistant and sensitive strains of Haemophilus influenzae type b in The Netherlands by outer-membrane protein subtyping.
Comparison of cotrimoxazole, ampicillin, and chloramphenicol in treatment of experimental Haemophilus influenzae type B meningitis.
Determinants of beta-lactam resistance in meningitis-causing Enterobacteriaceae in Brazil.
Different ratios of the piperacillin-tazobactam combination for treatment of experimental meningitis due to Klebsiella pneumoniae producing the TEM-3 extended-spectrum beta-lactamase.
Drug transfer into cerebrospinal fluid after simultaneous administration of ampicillin with ceftriaxone or ceftazidime in rabbits with Staphylococcus aureus meningitis.
Efficacy of bacteriophage therapy in experimental sepsis and meningitis caused by a clone O25b:H4-ST131 Escherichia coli strain producing CTX-M-15.
Emergence of KPC-producing Klebsiella pneumoniae ST512 isolated from cerebrospinal fluid of a child in Algeria.
Evaluation of piperacillin-tazobactam in experimental meningitis caused by a beta-lactamase-producing strain of K1-positive Escherichia coli.
Extended-spectrum beta-lactamase Klebsiella pneumoniae meningitis treated with tigecycline.
Extended-Spectrum Beta-Lactamase-Producing Escherichia coli Meningitis and Cerebral Abscess in a Neonate: Therapeutic Challenge.
Failure of ceftazidime-amikacin therapy for bacteremia and meningitis due to Klebsiella pneumoniae producing an extended-spectrum beta-lactamase.
First Initial community-acquired meningitis due to extended-spectrum beta-lactamase producing Escherichia coli complicated with multiple aortic mycotic aneurysms.
Haemophilus influenzae type b brain abscess complicating meningitis: case report.
High prevalence of type b beta-lactamase-non-producing ampicillin-resistant Haemophilus influenzae in meningitis: the situation in Japan where Hib vaccine has not been introduced.
In vitro susceptibilities to 23 antimicrobial agents of Haemophilus influenzae from pediatric patients in Japan.
Klebsiella pneumoniae Isolates from Meningitis: Epidemiology, Virulence and Antibiotic Resistance.
Meningitis caused by Escherichia coli producing TEM-52 extended-spectrum beta-lactamase within an extensive outbreak in a neonatal ward: epidemiological investigation and characterization of the strain.
Meningitis due to beta-lactamase producing chloramphenicol resistant Haemophilus influenzae type b in Kuwait.
Meningitis due to beta-lactamase producing, chloramphenicol-resistant Haemophilus influenzae type b, in South Africa.
Molecular characterization of a small Haemophilus influenzae plasmid specifying beta-lactamase and its relationship to R factors from Neisseria gonorrhoeae.
Nosocomial meningitis caused by Klebsiella pneumoniae producing carbapenemase, with initial cerebrospinal fluid minimal inflammatory response.
Pharmacokinetics and efficacy of ceftazidime in experimental Haemophilus influenzae b meningitis.
Postneurosurgical meningitis due to Proteus penneri with selection of a ceftriaxone-resistant isolate: analysis of chromosomal class A beta-lactamase HugA and its LysR-type regulatory protein HugR.
Rapid detection in spinal fluid of beta-lactamase produced by ampicillin-resistant Haemophilus influenzae.
Septicemia, meningitis, and skull osteomyelitis complicating infected cephalhematoma caused by ESBL-producing Escherichia coli.
Successful medical treatment in a child with E. coli ESBL meningitis with acute communicating hydrocephalus and ventricular empyema: a case report.
Treatment of a meningitis due to an Enterobacter aerogenes producing a derepressed cephalosporinase and a Klebsiella pneumoniae producing an extended-spectrum beta-lactamase.
Using Therapeutic Drug Monitoring to Treat KPC-Producing Klebsiella pneumoniae Central Nervous System Infection With Ceftazidime/Avibactam.
[Description and investigation of an outbreak of extended-spectrum beta-lactamase producing Escherichia coli strain in a neonatal unit]
[Detection methods for drug-resistant bacteria in routine examination--BLNAR]
[The role of carbapenems in the treatment of nosocomial infection]
[Treatment of purulent meningitis in the child using Cefotaxime]
Meningitis, Bacterial
Diffusion of 3-quaternary ammonium cephem antibiotics into cerebrospinal fluid of patients with bacterial meningitis.
[Meropenem was effective to the bacterial meningitis due to beta-lactamase negative ampicillin-resistant Haemophilus influenzae; case report]
[The role of carbapenems in the treatment of nosocomial infection]
Multiple Endocrine Neoplasia
A radiation hybrid map of the proximal long arm of human chromosome 11 containing the multiple endocrine neoplasia type 1 (MEN-1) and bcl-1 disease loci.
Multiple Endocrine Neoplasia Type 1
A radiation hybrid map of the proximal long arm of human chromosome 11 containing the multiple endocrine neoplasia type 1 (MEN-1) and bcl-1 disease loci.
Multiple Myeloma
Bcl-1 rearrangement and cyclin D1 protein expression in multiple myeloma precursor cells.
Comparison of chromosome analysis and BCL-1 rearrangement in a series of patients with multiple myeloma.
Rearrangement of the chromosome 11 bcl-1 locus in centrocytic lymphoma: analysis with multiple breakpoint probes.
Muscle Spasticity
Degeneration of the cerebellar granule cell layer in transgenic mice expressing genes of human foamy virus.
Mycoses
Community- and healthcare-associated infections in critically ill patients: a multicenter cohort study.
Nasopharyngeal Neoplasms
Synergy of CO2-Response and Aggregation Induced Emission in A Block Copolymer: A Facile Way to "See" Cancer Cells.
Neonatal Sepsis
Acquisition of carbapenem resistance in multiresistant Klebsiella pneumoniae isolates of sequence type 11 at a university hospital in China.
Carbapenem Resistance in Acinetobacter baumannii and Other Acinetobacter spp. Causing Neonatal Sepsis: Focus on NDM-1 and Its Linkage to ISAba125.
Characterization of CTX-M-14 and CTX-M-15 Producing Escherichia coli Strains Causing Neonatal Sepsis.
Detection of blaCTX-M15 and blaOXA-48 genes in Gram-negative isolates from neonatal sepsis in central of Iran.
Early-Onset Neonatal Sepsis with Extended Spectrum Beta-Lactamase Producing Escherichia Coli in Infants Born to South and South East Asian Immigrants: A Case Series.
Evaluation of existence and transmission of extended spectrum beta lactamase producing bacteria from post-delivery women to neonates at Bugando Medical Center, Mwanza-Tanzania.
First report of a Klebsiella pneumoniae ST466 strain causing neonatal sepsis harbouring the blaCTX-M-15 gene in Rabat, Morocco.
Neoplasm Metastasis
Crocin reverses 1-methyl-3-nitroso-1-nitroguanidine (MNNG)-induced malignant transformation in GES-1 cells through the Nrf2/Hippo signaling pathway.
miR-215 promotes malignant progression of gastric cancer by targeting RUNX1.
miR-27b inhibits gastric cancer metastasis by targeting NR2F2.
Modulation of E-cadherin expression promotes migration ability of esophageal cancer cells.
Multiple genetic lesions in laryngeal squamous cell carcinomas.
The crucial role of SRPK1 in IGF-1-induced EMT of human gastric cancer.
The role of NK cells and CD39 in the immunological control of tumor metastases.
Neoplasm, Residual
Improving outcomes in transplantation.
Molecular diagnosis of B- and T-cell lymphomas: fundamental principles and clinical applications.
The role of molecular monitoring in autotransplantation for non-Hodgkin's lymphoma.
Neoplasms
(-)-Patchouli alcohol protects against Helicobacter pylori urease-induced apoptosis, oxidative stress and inflammatory response in human gastric epithelial cells.
177Lu radiolabeling and preclinical theranostic study of 1C1m-Fc: an anti-TEM-1 scFv-Fc fusion protein in soft tissue sarcoma.
A bifunctional murine::human chimeric antibody with one antigen-binding arm replaced by bacterial beta-lactamase.
A comparative trial of moxalactam plus ticarcillin and clavulanic acid or piperacillin as empiric antibiotic therapy for febrile cancer patients.
A radiation hybrid map of the proximal long arm of human chromosome 11 containing the multiple endocrine neoplasia type 1 (MEN-1) and bcl-1 disease loci.
A small deletion in the 3'-untranslated region of the cyclin D1/PRAD1/bcl-1 oncogene in a patient with chronic lymphocytic leukemia.
A Small Regulatory RNA Controls Cell Wall Biosynthesis and Antibiotic Resistance.
Absolute quantification of free tumor cells in the peripheral blood of gastric cancer patients.
Activation of the leukemia plasmacytoid dendritic cell line PMDC05 by Toho-1, a novel IDO inhibitor.
Alkaloid Extract of Moringa oleifera Lam. Exerts Antitumor Activity in Human Non-Small-Cell Lung Cancer via Modulation of the JAK2/STAT3 Signaling Pathway.
Amplification and expression of the bcl-1 gene in human solid tumor cell lines.
Amplification of 11q13 DNA markers in head and neck squamous cell carcinomas: correlation with clinical outcome.
Amplification of int-2 and bcl-1 genes in squamous cell carcinoma of the larynx.
An additional breakpoint region in the BCL-1 locus associated with the t(11;14)(q13;q32) translocation of B-lymphocytic malignancy.
Antibiotic use in 530 French hospitals: results from a surveillance network at hospital and ward levels in 2007.
Antimicrobial Resistance Pattern and Their Beta-Lactamase Encoding Genes among Pseudomonas aeruginosa Strains Isolated from Cancer Patients.
Applied molecular genetics in the diagnosis of malignant non-Hodgkin's lymphoma.
Association of bcl-1 rearrangements with lymphocytic lymphoma of intermediate differentiation.
Associations between the neuron-specific glucocorticoid receptor (NR3C1) Bcl-1 polymorphisms and suicide in cancer patients within the first year of diagnosis.
BAIAP2L2 promotes the progression of gastric cancer via AKT/mTOR and Wnt3a/?-catenin signaling pathways.
BCL-1 participates in the 11q13 amplification found in breast cancer.
bcl-1 rearrangement. Frequency and clinical significance among B-cell chronic lymphocytic leukemias and non-Hodgkin's lymphomas.
BCL-1/cyclin D1 oncoprotein oscillates and subverts the G1 phase control in B-cell neoplasms carrying the t(11;14) translocation.
Blastic mantle cell leukemia: an unusual presentation of blastic mantle cell lymphoma.
blaVIM-7, an evolutionarily distinct metallo-beta-lactamase gene in a Pseudomonas aeruginosa isolate from the United States.
Burkitt transformation of mantle cell lymphoma.
Cancer cell-specific internalizing ligands from phage displayed beta-lactamase-peptide fusion libraries.
CD19-specific triplebody SPM-1 engages NK and ?? T cells for rapid and efficient lysis of malignant B-lymphoid cells.
CD5-expressing B-cell non-Hodgkin's lymphomas with bcl-1 gene rearrangement have a relatively homogeneous immunophenotype and are associated with an overall poor prognosis.
Cell cycle-dependent expression of cyclin D1 and a 45 kD protein in human A549 lung carcinoma cells.
Cell cycle-related variation and tissue-restricted expression of human cyclin D1 protein.
Characterization of chromosome 11 translocation breakpoints at the bcl-1 and PRAD1 loci in centrocytic lymphoma.
Chromosomal translocation detected by bcl-1 and bcl-2 rearrangement in low-grade B-cell lymphomas in a European population.
Chromosome 11Q13 amplification in head and neck squamous cell carcinoma.
Chromosome 11q13 amplification in head and neck squamous cell carcinoma. Association with poor prognosis.
Chromosome 11q13, c-erbB-2, and c-myc amplification in invasive breast carcinoma: clinicopathologic correlations.
Clinical outcome of Escherichia coli bloodstream infection in cancer patients with/without biofilm formation: a single-center retrospective study.
Clinical significance of upregulation of mir-196a-5p in gastric cancer and enriched KEGG pathway analysis of target genes.
Clustering of breakpoints on chromosome 11 in human B-cell neoplasms with the t(11;14) chromosome translocation.
Colonization and infection with extended-spectrum beta-lactamase producing Enterobacteriaceae in patients with malignancy.
Conditionally cleavable radioimmunoconjugates: a novel approach for the release of radioisotopes from radioimmunoconjugates.
Construction of a general vector for efficient expression of mammalian proteins in bacteria: use of a synthetic ribosome binding site.
Convergent evolution of TEM-26, a beta-lactamase with extended-spectrum activity.
Correlation between temperature-dependent cytoplasmic solubility and periplasmic export of a heterologous protein in Escherichia coli.
Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders.
Cyclin D1 and human neoplasia.
Cyclin D1 overexpression in malignant lymphomas.
Cyclin D1/PRAD1/BCL-1 alternative transcript [B] protein product in B-lymphoid malignancies with t(11;14)(q13;q32) translocation.
D11S287, a putative oncogene on chromosome 11q13, is amplified and expressed in squamous cell and mammary carcinomas and linked to BCL-1.
De novo CD5-positive and Richter's syndrome-associated diffuse large B cell lymphomas are genotypically distinct.
Design and synthesis of isatin/triazole conjugates that induce apoptosis and inhibit migration of MGC-803 cells.
Detection of bcl-1 gene rearrangement and B-cell clonality in mantle cell lymphoma using formalin-fixed, paraffin-embedded tissues.
Detection of epithelial cells by RT-PCR targeting CEA, CK20, and TEM-8 in colorectal carcinoma patients using OncoQuick density gradient centrifugation system.
Detection of oncogene rearrangements in human non-Hodgkin's lymphomas.
Detection of single and associated lesions of the Bcl-1, Bcl-2, Bcl-6, c-myc, p53 and p16 genes in B-cell non-Hodgkin's lymphomas: value of molecular analysis for a better assignment of the histologic subtype.
Developing bifunctional beta-lactamase molecules with built-in target-recognizing module for prodrug therapy: identification of Enterobacter Cloacae P99 cephalosporinase loops suitable for randomization and phage-display selection.
Development and validation of a scoring system for predicting cancer patients at risk of extended-spectrum b-lactamase-producing Enterobacteriaceae infections.
Dextran sulfate inhibition on human gastric cancer cells invasion, migration and epithelial-mesenchymal transformation.
Discovery of 6-chloro-2-(propylthio)-8,9-dihydro-7H-purines containing a carboxamide moiety as potential selective anti-lung cancer agents.
Dissemination of ST101 blaOXA-48 producing Klebsiella pneumoniae at tertiary care setting.
Distinct melanization pathways in the mosquito Aedes aegypti.
DNA hypermethylation of the vimentin gene inversely correlates with vimentin expression in intestinal- and diffuse-type gastric cancer.
Effect of bone morphogenetic protein-2 on proliferation and apoptosis of gastric cancer cells.
Elevated levels of tumour endothelial marker-8 in human breast cancer and its clinical significance.
Engineering of Escherichia coli ?-lactamase TEM-1 variants showing higher activity under acidic conditions than at the neutral pH.
Epidemiology, Risk Factors, and Clinical Outcomes of Bloodstream Infection due to Extended-Spectrum Beta-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae in Hematologic Malignancy: A Retrospective Study from Central South China.
Expression of common fragile sites in untreated non-Hodgkin's lymphoma with aphidicolin and folate deficiency.
Extranodal noncutaneous lymphoid hyperplasias represent a continuous spectrum of B-cell neoplasia: demonstration by molecular genetic analysis.
Fisetin inhibits the proliferation of gastric cancer cells and induces apoptosis through suppression of ERK 1/2 activation.
Flow cytometric DNA analysis is useful in detecting multiple genetic alterations in squamous cell carcinoma of the esophagus.
Frequent amplification of 11q13 DNA markers is associated with lymph node involvement in human head and neck squamous cell carcinomas.
Frequent amplification of the bcl-1 locus in head and neck squamous cell carcinomas.
Frequent amplification of the bcl-1 locus in poorly differentiated squamous cell carcinoma of the lung. The Lung Cancer Study Group.
Frequent p53 gene involvement in splenic B-cell leukemia/lymphomas of possible marginal zone origin.
Genetic Alterations (Amplification and Rearrangement) of D-Type Cyclins Loci in Head and Neck Squamous Cell Carcinoma of Indian Patients: Prognostic Significance and Clinical Implications.
Genetic construction, expression, and characterization of a single chain anti-carcinoma antibody fused to beta-lactamase.
Genomic characterisation of Klebsiella michiganensis co-producing OXA-181 and NDM-1 carbapenemases isolated from a cancer patient in uMgungundlovu District, KwaZulu-Natal Province, South Africa.
Helicobacter pylori CagA promotes the malignant transformation of gastric mucosal epithelial cells through the dysregulation of the miR-155/KLF4 signaling pathway.
Hidradenocarcinoma: a histological and immunohistochemical study.
High cell kinetics is associated with amplification of the int-2, bcl-1, myc and erbB-2 proto-oncogenes and loss of heterozygosity at the DF3 locus in primary breast cancers.
High-level expression of ampC beta-lactamase due to insertion of nucleotides between -10 and -35 promoter sequences in Escherichia coli clinical isolates: cases not responsive to extended-spectrum-cephalosporin treatment.
High-throughput fluorescence anisotropy screen for inhibitors of the oncogenic mRNA binding protein, IMP-1.
Hispidin induces autophagic and necrotic death in SGC-7901 gastric cancer cells through lysosomal membrane permeabilization by inhibiting tubulin polymerization.
Identification of let-7-regulated oncofetal genes.
IMP-1 Displays Cross-Talk with K-Ras and Modulates Colon Cancer Cell Survival through the Novel Proapoptotic Protein CYFIP2.
Impact of DOTA Conjugation on Pharmacokinetics and Immunoreactivity of [177Lu]Lu-1C1m-Fc, an Anti TEM-1 Fusion Protein Antibody in a TEM-1 Positive Tumor Mouse Model.
Improved yield and stability of L49-sFv-beta-lactamase, a single-chain antibody fusion protein for anticancer prodrug activation, by protein engineering.
In vitro binding properties of tumor suppressor p53 with PUMA and NOXA.
Increased expression of IGF II mRNA-binding protein 1 mRNA is associated with an advanced clinical stage and poor prognosis in patients with ovarian cancer.
Increased expression of insulin-like growth factor-II messenger RNA-binding protein 1 is associated with tumor progression in patients with lung cancer.
Induction of microsatellite instability by oxidative DNA damage.
Infection with Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae in cancer patients.
Influence of previous antimicrobial therapy on oral carriage of beta-lactamase producing Capnocytophaga isolates.
Influence of tumor microenvironment on prognosis in colorectal cancer: Tissue architecture-dependent signature of endosialin (TEM-1) and associated proteins.
Inhibitory effects of salidroside on MCF-7 breast cancer cells in vivo.
Insights into the mevalonate pathway in the anticancer effect of a platinum complex on human gastric cancer cells.
Involvement of the CCND1 gene in hairy cell leukemia.
Larotrectinib in a Patient With Advanced Pleomorphic Liposarcoma of the Uterus.
Let-7 modulates acquired resistance of ovarian cancer to Taxanes via IMP-1-mediated stabilization of MDR1.
Long non-coding RNA NEAT1 increases the aggressiveness of gastric cancer by regulating the microRNA-142-5p/JAG1 axis.
Long-Term Tracking of Cancer Cell Nucleus and Identification of Colorectal Cancer with an Aggregation-Induced Emission-Based Fluorescent Probe.
Low-grade, malt-type, primary B-cell lymphoma of the conjunctiva.
Malignant transformation of human gastric epithelium cells via reactive oxygen species production and Wnt/?-catenin pathway activation following 40-week exposure to ochratoxin A.
Mesenchymal stem cell-based NK4 gene therapy in nude mice bearing gastric cancer xenografts.
Methotrexate-associated orbital lymphoproliferative disorder in a patient with rheumatoid arthritis: a case report.
Microbiological and Clinical Profile of Uropathogenic Escherichia coli Isolates in Kathmandu University Hospital.
MicroRNA-378 promotes cell survival, tumor growth, and angiogenesis by targeting SuFu and Fus-1 expression.
Molecular analysis of breaks in BCL-1 proto-oncogene in B-cell lymphomas with abnormalities of 11q13.
Molecular analysis of cutaneous B- and T-cell lymphomas.
Molecular characterization of IgA- and/or IgG-switched chronic lymphocytic leukemia B cells.
Molecular characterization of primary mediastinal B cell lymphoma.
Molecular hematology. Qualitative to quantitative techniques.
Molecular pathogenesis of non-Hodgkin lymphoma: a clinical perspective.
Molecular pathology of the cell cycle in human cancer cells.
Monoclonal antibody against PRAD1/cyclin D1 stains nuclei of tumor cells with translocation or amplification at BCL-1 locus.
Multiple lymphomatous polyposis of the gastrointestinal tract: prospective clinicopathologic study of 31 cases. Groupe D'étude des Lymphomes Digestifs.
Multiplexing of pathway-specific beta-lactamase reporter gene assays by optical coding with Qtracker nanocrystals.
Myxoinflammatory fibroblastic sarcoma: an immunohistochemical and molecular genetic study of 73 cases.
Nobiletin Inhibits Helicobacterium pylori Infection-Induced Gastric Carcinogenic Signaling by Blocking Inflammation, Apoptosis, and Mitogen-Activated Protein Kinase Events in Gastric Epithelial-1 Cells.
Nosocomial spread of armA-mediated high-level aminoglycoside resistance in Enterobacteriaceae isolates producing CTX-M-3 beta-lactamase in a cancer hospital in Bulgaria.
Novel beta-lactamase-random peptide fusion libraries for phage display selection of cancer cell-targeting agents suitable for enzyme prodrug therapy.
Novel IMP-1 metallo-beta-lactamase inhibitors can reverse meropenem resistance in Escherichia coli expressing IMP-1.
Outbreak of ceftazidime resistance due to a novel extended-spectrum beta-lactamase in isolates from cancer patients.
Over-expression of cyclin D1 in chronic B-cell malignancies with abnormality of chromosome 11q13.
Pediatric tumor cells express erythropoietin and a functional erythropoietin receptor that promotes angiogenesis and tumor cell survival.
Phenotypic markers and BCL-1 gene rearrangements in B-cell chronic lymphocytic leukemia: a Cancer and Leukemia Group B study.
Photodynamic treatment with cationic Ir(III) complexes induce a synergistic antimicrobial effect with imipenem over carbapenem-resistant Klebsiella pneumoniae.
Physicochemical characterization of polysaccharide from the leaf of Dendrobium officinale and effect on LPS induced damage in GES-1 cell.
PRAD-1/cyclin D1 gene overexpression in chronic lymphoproliferative disorders: a highly specific marker of mantle cell lymphoma.
Primary cutaneous perivascular epithelioid cell tumor: a clinicopathological and molecular reappraisal.
Prognostic value of tumour endothelial markers in patients with endometrial cancer.
Protective effects and mechanism of coenzyme Q10 and vitamin C on doxorubicin-induced gastric mucosal injury and effects of intestinal flora.
Quantitative analysis of TEM-8 and CEA tumor markers indicating free tumor cells in the peripheral blood of colorectal cancer patients.
RAF may induce cell proliferation through hypermethylation of tumor suppressor gene promoter in gastric epithelial cells.
Rearrangement and overexpression of the BCL-1/PRAD-1 gene in intermediate lymphocytic lymphomas and in t(11q13)-bearing leukemias.
Retraction RETRACTION of "Absolute quantification of free tumor cells in the peripheral blood of gastric cancer patients" by N. Bayat, M.M. Mokhtari, M. Rezaei-Tavirani, A. Baradaran-Rafii, S. Rahman Zadeh, S. Heidari-Keshel and F. Ghasemvand. Genet. Mol. Res. 13 (2): 4425-4432 (2014).
Risk factors for bloodstream infections due to extended-spectrum ?-lactamase producing Enterobacteriaceae in cancer patients.
Selection of TNF-alpha binding affibody molecules using a beta-lactamase protein fragment complementation assay.
Sensitization against anticancer drugs by transfection with UBE2I variant gene into ras-NIH3H3 mouse fibroblasts.
Sequence analysis of a 45-kb segment in the 19 degrees-23 degrees region of the Bacillus subtilis chromosome containing glpT and mpr loci.
Silencing of MEOX1 Gene Inhibits Proliferation and Promotes Apoptosis of LNCaP Cells in Prostate Cancer.
Site-specific prodrug activation by antibody-beta-lactamase conjugates: preclinical investigation of the efficacy and toxicity of doxorubicin delivered by antibody directed catalysis.
Stigmasterol exhibits potent antitumor effects in human gastric cancer cells mediated via inhibition of cell migration, cell cycle arrest, mitochondrial mediated apoptosis and inhibition of JAK/STAT signalling pathway.
Synthesis and anticancer evaluation of novel 1H-benzo[d]imidazole derivatives of dehydroabietic acid as PI3K? inhibitors.
Synthesis of [3?-acetoxy-urs-12-en-28-oyl]-1-monoglyceride and investigation on its anti tumor effects against BGC-823.
Synthesis, anticancer evaluation and mechanism studies of novel indolequinone derivatives of ursolic acid.
The amplification unit on chromosome 11q13 in aggressive primary human breast tumors entails the bcl-1, int-2 and hst loci.
The anaplastic variant of centrocytic lymphoma is marked by frequent rearrangements of the bcl-1 gene and high proliferation indices.
The BCL-1, BCL-2, and BCL-3 oncogenes are involved in chronic lymphocytic leukemia. Detection by fluorescence in situ hybridization.
The clinical significance of downregulation of mir-124-3p, mir-146a-5p, mir-155-5p and mir-335-5p in gastric cancer tumorigenesis.
The emergence of carbapenemase blaNDM genotype among carbapenem-resistant Enterobacteriaceae isolates from Egyptian cancer patients.
The HGF/SF antagonist NK4 reverses fibroblast- and HGF-induced prostate tumor growth and angiogenesis in vivo.
The inhibition of histone deacetylase 8 suppresses proliferation and inhibits apoptosis in gastric adenocarcinoma.
The Long Noncoding RNA MAGI1-IT1 Regulates the miR-302d-3p/IGF1 Axis to Control Gastric Cancer Cell Proliferation.
The Preventive Effect of the Phenotype of Tumour-Associated Macrophages, Regulated by CD39, on Colon Cancer in Mice.
The Role of miR-378a in Metabolism, Angiogenesis, and Muscle Biology.
The role of NK cells and CD39 in the immunological control of tumor metastases.
The role of the Epstein-Barr virus-encoded BARF1 gene expressed in human gastric epithelial cells.
The use of quinolones as therapy in granulocytopenic cancer patients. Comparison with other antimicrobials.
Towards a ligand targeted enzyme prodrug therapy: single round panning of a beta-lactamase scaffold library on human cancer cells.
Treatment of BCL-1 murine B-cell leukemia with recombinant cytokines. Comparative analysis of the anti-leukemic potential of interleukin 1 beta (IL-1 beta), interleukin 2 (IL-2), interleukin-6 (IL-6), tumor necrosis factor alpha (TNF alpha), granulocyte colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), and their combination.
TRIM59 is up-regulated in gastric tumors, promoting ubiquitination and degradation of p53.
Tumour endothelial marker 8 (TEM-8) in human colon cancer and its association with tumour progression.
Upregulation of tumour endothelial marker-8 by interleukin-1beta and its impact in IL-1beta induced angiogenesis.
Vicenin-2 inhibits the Helicobacterium pylori infection associated gastric carcinogenic events through modulation of PI3K/AKT and Nrf2 signaling in GES-1 cells.
YAP1 enhances cell proliferation, migration, and invasion of gastric cancer in vitro and in vivo.
Z-Guggulsterone Induces Apoptosis in Gastric Cancer Cells through the Intrinsic Mitochondria-Dependent Pathway.
ZNF139 promotes tumor metastasis by increasing migration and invasion in human gastric cancer cells.
[Effect of epsilon-aminocaproic acid on the accumulation of labeled fibrinogen I-131 in the transplantable tumor IMP-1]
Neoplasms, Squamous Cell
Amplification and expression of the bcl-1 gene in human solid tumor cell lines.
Neuralgia
Clavulanic Acid Attenuating Effect on the Diabetic Neuropathic Pain in Rats.
Neutropenia
The use of quinolones as therapy in granulocytopenic cancer patients. Comparison with other antimicrobials.
[Septicemia caused by beta-lactamase producing Fusobacterium nucleatum in a patient with neutropenia]
Nocardia Infections
[New effective therapy of systemic infection with Nocardia asteroides]
Noma
Case report: a rare case of NOMA (cancrum oris) in a Malian woman.
Odontogenic Cysts
Expression of cell cycle and apoptosis-related proteins in sporadic odontogenic keratocysts and odontogenic keratocysts associated with the nevoid basal cell carcinoma syndrome.
Ophthalmia Neonatorum
Ophthalmia neonatorum due to penicillinase producing Neisseria gonorrhoeae. Two case reports.
[Pseudogonococcal ophthalmia neonatorum induced by beta-lactamase positive Branhamella catarrhalis. Report of a case]
Opportunistic Infections
Host immunology and rational immunotherapy for carbapenem-resistant Klebsiella pneumoniae infection.
Osteitis
Osteitis in Systemic Sclerosis: a nationwide case-control retrospective study (SCLEROS Study).
Successful treatment and digestive decolonisation of a patient with osteitis caused by a carbapenemase-producing Klebsiella pneumoniae isolate harbouring both NDM-1 and OXA-48 enzymes.
Osteomyelitis
Antimicrobial treatment of chronic osteomyelitis.
Clinical evaluation of aztreonam therapy for serious infections due to gram-negative bacteria.
Combination of aztreonam, ceftazidime-avibactam and amikacin in the treatment of VIM-1 Pseudomonas aeruginosa ST235 osteomyelitis.
Long Term Compassionate Use of Cefiderocol to Treat Chronic Osteomyelitis Caused by XDR-Pseudomonas aeruginosa and ESBL-producing Klebsiella pneumoniae in a Pediatric Patient.
Refractory vertebral osteomyelitis due to CTX-M-14-producing Escherichia coli at ertapenem treatment in a patient with a coexisting urinary tract infection caused by the same pathogen.
Septicemia, meningitis, and skull osteomyelitis complicating infected cephalhematoma caused by ESBL-producing Escherichia coli.
Treatment failure in Haemophilus influenzae due to a beta-lactamase low-level ampicillin-resistant organism.
Two for the price of one: emerging carbapenemases in a returning traveller to New York City.
Otitis
Effective treatment and decolonization of a dog infected with carbapenemase (VIM-2)-producing Pseudomonas aeruginosa using probiotic and photodynamic therapies.
Identification of VIM-2 metallo-?-lactamase-producing Pseudomonas aeruginosa isolated from dogs with pyoderma and otitis in Korea.
New patterns in the otopathogens causing acute otitis media six to eight years after introduction of pneumococcal conjugate vaccine.
Quantitative bacterial cultures and beta-lactamase activity in chronic suppurative otitis media.
[Epidemiology of Haemophilus influenzae strains identified in 2001 in France, and assessment of their susceptibility to beta-lactams]
Otitis Media
Amoxicillin/clavulanic acid: a review of its use in the management of paediatric patients with acute otitis media.
Antimicrobial treatment of an experimental otitis media caused by a beta-lactamase positive isolate of Haemophilus influenzae.
Bacteriology and beta-lactamase activity in ear aspirates of acute otitis media that failed amoxicillin therapy.
Beta-lactamase production and bacterial tolerance in recurrent acute otitis media.
beta-Lactamase-producing Moraxella catarrhalis may prevent the emergence of penicillin-resistant Streptococcus pneumoniae in children with recurrent acute otitis media.
Carbapenemase producing Klebsiella pneumoniae (KPC) meningitis from chronic otitis media.
Characterization of Haemophilus influenzae isolated from patients with otitis media.
Clinical significance of resistant organisms in otitis media.
Comparison of the efficacy, safety and acceptability of cefixime and amoxicillin/clavulanate in acute otitis media.
Genetic diversity among strains of Moraxella catarrhalis: analysis using multiple DNA probes and a single-locus PCR-restriction fragment length polymorphism method.
Haemophilus influenzae in acute otitis media.
Impact of 2011 French guidelines on antibiotic prescription for acute otitis media in infants.
Isoelectric focusing of beta-lactamases from sputum and middle ear isolates of Branhamella catarrhalis recovered in the United States.
Isolation of nasopharyngeal beta-lactamase producing Haemophilus influenzae, in relation to antibiotic treatment of acute otitis media in infants.
Management of acute otitis media in an era of increasing antibiotic resistance.
Microbial factors leading to recurrent upper respiratory tract infections.
Microbiology of common infections in the upper respiratory tract.
Penetration of trimethoprim--sulfadiazine into middle ear fluid in secretory otitis media.
Phenoxymethylpenicillin and therapeutic failure in acute otitis media.
POM-1 metallo-?-lactamase-producing Pseudomonas otitidis isolate from a patient with chronic otitis media.
Probability of achieving requisite pharmacodynamic exposure for oral beta-lactam regimens against Haemophilus influenzae in children.
Prospective study about the incidence of B lactamase producing bacteriae in otitis media in the population of the emergency room of the University Pediatric Hospital.
Sulbactam/ampicillin in the treatment of otitis and sinusitis.
The antibiotic susceptibilities and beta-lactamase production of clinical isolated Branhamella catarrhalis from acute otitis media in children.
Trimethoprim-sulfamethoxazole in the treatment of otitis media secondary to ampicillin-resistant strains of Haemophilus influenzae.
Using antibiotic concentrations in middle ear fluid to predict potential clinical efficacy.
Variations in amoxicillin pharmacokinetic/pharmacodynamic parameters may explain treatment failures in acute otitis media.
Otitis Media with Effusion
Microbiology and management of otitis media.
[A study of concentration of ampicillin into middle ear effusion after administration of bacampicillin]
Otitis Media, Suppurative
Quantitative bacterial cultures and beta-lactamase activity in chronic suppurative otitis media.
[A study of concentration of ampicillin into middle ear effusion after administration of bacampicillin]
Otorhinolaryngologic Diseases
Investigation of normal bacterial flora in the upper respiratory tract.
Ovarian Neoplasms
Increased expression of IGF II mRNA-binding protein 1 mRNA is associated with an advanced clinical stage and poor prognosis in patients with ovarian cancer.
Let-7 modulates acquired resistance of ovarian cancer to Taxanes via IMP-1-mediated stabilization of MDR1.
Parathyroid Neoplasms
Abnormalities in the PRAD1 (CYCLIN D1/BCL-1) oncogene are frequent in cervical and vulvar squamous cell carcinoma cell lines.
Chromosomal translocations in lymphoid malignancies reveal novel proto-oncogenes.
Paresthesia
Long Term Compassionate Use of Cefiderocol to Treat Chronic Osteomyelitis Caused by XDR-Pseudomonas aeruginosa and ESBL-producing Klebsiella pneumoniae in a Pediatric Patient.
Pelvic Infection
Infection in women. Clinical experience with beta-lactamase inhibitors.
Pelvic Inflammatory Disease
Inpatient treatment for uncomplicated and complicated acute pelvic inflammatory disease: ampicillin/sulbactam vs. Cefoxitin.
Pericarditis
Pericarditis caused by beta-lactamase-producing Haemophilus influenzae: report of two cases in adults and review of the literature.
Periodontal Pocket
High prevalence of cfxA beta-lactamase in aminopenicillin-resistant Prevotella strains isolated from periodontal pockets.
Periodontitis
Antibiotic resistance in bacteria isolated from subgingival plaque in a norwegian population with refractory marginal periodontitis.
Beta-lactamase producing bacteria in the subgingival microflora of adult patients with periodontitis. A comparison between Spain and The Netherlands.
Beta-lactamase production and antimicrobial susceptibility of subgingival bacteria from refractory periodontitis.
Characterization of a beta-lactamase found in Eikenella corrodens.
Detection and characterization of beta-lactamase genes in subgingival bacteria from patients with refractory periodontitis.
Peritonitis
Broad-Spectrum ss-Lactam Antibiotics for Treating Experimental Peritonitis in Mice Due a Klebsiella pneumoniae Producing the Carbapenemase OXA-48.
Clinical outcomes of spontaneous bacterial peritonitis due to extended-spectrum beta-lactamase-producing Escherichia coli or Klebsiella pneumoniae: a retrospective cohort study.
Detection of High-Level Rifaximin Resistance in Enteric Bacteria by Agar Screen.
Early dissemination of OXA-72-producing Acinetobacter baumannii strain in Colombia: a case report.
Efficacy and safety of piperacillin/tazobactam in intra-abdominal infections.
EVOLUTION OF ANTIBIOTIC RESISTANCE MECHANISMS AND THEIR RELEVANCE TO DIALYSIS-RELATED INFECTIONS.
Expanded-spectrum beta-lactamase producing Klebsiella pneumoniae-related peritonitis in a patient on peritoneal dialysis.
Expression of CTX-M-15 limits the efficacy of ceftolozane/tazobactam against Escherichia coli in a high-inoculum murine peritonitis model.
Pharmacokinetics and pharmacodynamics of antistaphylococcal antibiotics in continuous ambulatory peritoneal dialysis patients.
Risk factors and outcomes of extended-spectrum beta-lactamase-producing E. coli peritonitis in CAPD patients.
Successful treatment of carbapenemase producing Enterobacteriaceae peritonitis: 'Old therapy for a new bug'.
[A contemporary situation in the antimicrobial treatment of the secondary peritonitis]
[Cefoperazone concentration in infected tissues and clinical effect for patients with peritonitis (author's transl)]
[Clinical studies on 6059-S for acute peritonitis. Clinical effect and tissue concentration (author's transl)]
[Clinical study of cefmenoxime in acute peritonitis: clinical effect and tissue concentration of cefmenoxime]
[Multidrug resistant gram-negative bacteria : Clinical management pathway for patients undergoing elective interventions in visceral surgery].
[Peritonitis in the course of peritoneal dialisis caused by Haemophilus influenzae with BLNAR phenotype]
[Therapeutic effect of ceftazidime in a rabbit model of peritonitis caused by Escherichia coli producing CTX-M-14 extended-spectrum beta-lactamase]
Persistent Infection
Avidity of anti-P aeruginosa antibodies during chronic infection in patients with cystic fibrosis.
Chronic infection sustained by a Pseudomonas aeruginosa High-Risk clone producing the VIM-1 metallo-?-lactamase in a cystic fibrosis patient after lung transplantation.
Induction of beta-lactamase production in Pseudomonas aeruginosa biofilm.
Persistent infection with metallo-beta-lactamase and extended spectrum ?-lactamase producer Morganella morganii in a patient with urinary tract infection after kidney transplantation.
Pharyngitis
Clindamycin in the treatment of an outbreak of streptococcal pharyngitis in a kibbutz due to beta-lactamase producing organisms.
Controversies in the treatment of streptococcal pharyngitis.
Lack of influence of beta-lactamase-producing flora on recovery of group A streptococci after treatment of acute pharyngitis.
Phenoxymethyl penicillin versus co-amoxiclav in the treatment of acute streptococcal pharyngitis, and the role of beta-lactamase activity in saliva.
Potential mechanisms for failure to eradicate group A streptococci from the pharynx.
The extended microbiology of group A streptococcal pharyngitis. Observations during a double-blind controlled study of cephalexin twice versus four-times daily.
Treatment of beta-hemolytic streptococcal pharyngitis with cefaclor or penicillin. Efficacy and interaction with beta-lactamase-producing organisms in the pharynx.
[Beta-lactamase producing bacteria in the pharyngeal flora of patients with acute pharyngitis]
Pilomatrixoma
bcl-2 expression in pilomatricoma.
Plague
[Field trial of an immunoenzyme method using beta-lactamase as the monoclonal antibody marker for the capsular antigen of the plague microbe]
[Study of the penicillinase of the plague microbe, the synthesis of which is determined by the R-episome]
[Use of beta-lactamase from Bacillus licheniformis 749/C for solid-phase immunoenzyme analysis]
[Use of immunospecific components labelled with beta-lactamase and horseradish peroxidase for immunoenzyme analysis]
Pleural Effusion
[Matrix metalloproteinases and their inhibitors in lung cancer with malignant pleural effusion]
Pneumoconiosis
[Respiratory tract infections caused by Branhamella catarrhalis in outpatients with pneumoconiosis]
Pneumonia
A rapid low-cost real-time PCR for the detection of Klebsiella pneumonia carbapenemase genes.
A unusual case of multifocal pyogenic abscess formation following ERCP procedure.
Activity of cefepime and carbapenems in experimental pneumonia caused by porin-deficient Klebsiella pneumoniae producing FOX-5 beta-lactamase.
An overview of ceftolozane sulfate + tazobactam for treating hospital acquired pneumonia.
Antibacterial and synergistic activity of 6?-hydroxy-3-oxolup-20(29)-en-28-oic acid (6?-hydroxy betunolic acid) isolated from Schumacheria castaneifolia vahl.
Antimicrobial Drug-Resistant Gram-Negative Saprophytic Bacteria Isolated from Ambient, Near-Shore Sediments of an Urbanized Estuary: Absence of ?-Lactamase Drug-Resistance Genes.
Arbekacin treatment of a patient infected with a Pseudomonas putida producing a metallo-beta-lactamase.
Assessment of two penicillins plus beta-lactamase inhibitors versus cefotaxime in treatment of murine Klebsiella pneumoniae infections.
Bacteremic Hemophilus influenzae pneumonia in the adult.
Bacteremic pneumonia caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: Appropriateness of empirical treatment matters.
Carbapenemase Genes and Multidrug Resistance of Acinetobacter Baumannii: A Cross Sectional Study of Patients with Pneumonia in Southern Vietnam.
Cefepime versus imipenem-cilastatin for treatment of nosocomial pneumonia in intensive care unit patients: a multicenter, evaluator-blind, prospective, randomized study.
Ceftazidime-Avibactam Combination Therapy Compared to Ceftazidime-Avibactam Monotherapy for the Treatment of Severe Infections Due to Carbapenem-Resistant Pathogens: A Systematic Review and Network Meta-Analysis.
Ceftobiprole medocaril (BAL5788) treatment of experimental Haemophilus influenzae, Enterobacter cloacae, and Klebsiella pneumoniae murine pneumonia.
Characterization of a multidrug-resistant Klebsiella pneumoniae ST3330 clone responsible for a nosocomial outbreak in a neonatal intensive care unit.
Characterization of blaCMY-10 a novel, plasmid-encoded AmpC-type beta-lactamase gene in a clinical isolate of Enterobacter aerogenes.
Class I Integron-Borne bla(VIM-1) Carbapenemase in a Strain of Enterobacter cloacae Responsible for a Case of Fatal Pneumonia.
Clinical characteristics of pneumonia caused by beta-lactamase negative ampicillin resistant Haemophilus influenzae (BLNAR).
Clinical effect of ampicillin with beta-lactamase inhibitor (sulbactam/ampicillin) on community-acquired pneumonia in the elderly.
Clinical evaluation of aztreonam therapy for serious infections due to gram-negative bacteria.
Construction, mechanism, and antibacterial resistance insight into polypeptide-based nanoparticles.
Contaminated handwashing sinks as the source of a clonal outbreak of KPC-2-producing Klebsiella oxytoca on a hematology ward.
Correction: Membrane-active macromolecules resensitize NDM-1 gram-negative clinical isolates to tetracycline antibiotics.
Cystatin 9 and C modulates serum biomarkers associated with inflammation and provides prophylactic as well as long-term protection against multi-drug resistant Klebsiella pneumoniae.
Detection of Carbapenemase and CTX-M Encoding Genes Directly from Bronchoalveolar Lavage Using the CRE and ESBL ELITe MGB Assays: Toward Early and Optimal Antibiotic Therapy Management of Critically Ill Patients with Pneumonia.
Detection of Carbapenemase Production in Gram-negative Bacteria.
Diaryl-substituted thiosemicarbazone: A potent scaffold for the development of New Delhi metallo-?-lactamase-1 inhibitors.
Dissemination and spread of New Delhi Metallo-beta-lactamase-1 Superbugs in hospital settings.
Distribution of Class D Carbapenemase and Extended-Spectrum ?-Lactamase Genes among Acinetobacter Baumannii Isolated from Burn Wound and Ventilator Associated Pneumonia Infections.
Effect of porins and plasmid-mediated AmpC beta-lactamases on the efficacy of beta-lactams in rat pneumonia caused by Klebsiella pneumoniae.
Effects of morphine dependence on the pathogenesis of swine herpesvirus infection.
Efficacies of cefepime, ceftazidime, and imipenem alone or in combination with amikacin in rats with experimental pneumonia due to ceftazidime-susceptible or -resistant Enterobacter cloacae strains.
Efficacies of imipenem, meropenem, cefepime, and ceftazidime in rats with experimental pneumonia due to a carbapenem-hydrolyzing beta-lactamase-producing strain of Enterobacter cloacae.
Efficacy and Pharmacokinetics of the Combination of OP0595 and Cefepime in a Mouse Model of Pneumonia Caused by Extended-Spectrum-Beta-Lactamase-Producing Klebsiella pneumoniae.
Efficacy of beta-lactams for treating experimentally induced pneumonia due to a carbapenem-hydrolyzing metallo-beta-lactamase-producing strain of Pseudomonas aeruginosa.
Efficacy of cefepime and imipenem in experimental murine pneumonia caused by porin-deficient Klebsiella pneumoniae producing CMY-2 beta-Lactamase.
Efficacy of Colistin and Its Combination With Rifampin in Vitro and in Experimental Models of Infection Caused by Carbapenemase-Producing Clinical Isolates of Klebsiella pneumoniae.
Efficacy of sulbactam-ampicillin in an induced Pasteurella haemolytica pneumonia model in calves.
Emergence of Carbapenemase Producing Klebsiella Pneumonia and Spread of KPC-2 and KPC-17 in Taiwan: A Nationwide Study from 2011 to 2013.
Emergence of colistin resistance during treatment of recurrent pneumonia caused by carbapenemase producing Klebsiella pneumoniae.
Evaluation of sulbactam plus ampicillin for treatment of experimentally induced Klebsiella pneumoniae lung infection in foals.
Expanded-spectrum beta-lactamase producing Klebsiella pneumoniae-related peritonitis in a patient on peritoneal dialysis.
First report of Klebsiella pneumonia carbapenemase-producing Pseudomonas aeruginosa isolated from burn patients in Iran: phenotypic and genotypic methods.
Frequency of Mycoplasma pneumoniae among atypical pneumonia of childhood.
IMP-1 encoded by a novel Tn402-like class 1 integron in clinical Achromobacter xylosoxidans, China.
In vitro activity of cefcanel versus other oral cephalosporins.
In vitro susceptibilities of isolates from patients with Branhamella catarrhalis pneumonia compared with those of colonizing strains.
In vivo development of ertapenem resistance in a patient with pneumonia caused by Klebsiella pneumoniae with an extended-spectrum beta-lactamase.
In vivo efficacies of combinations of beta-lactams, beta-lactamase inhibitors, and rifampin against Acinetobacter baumannii in a mouse pneumonia model.
Klebsiella pneumonia strains moderately resistant to ampicillin and carbenicillin: characterization of a new beta-lactamase.
Klebsiella pneumoniae: Development of Carbapenem Resistance due to Acquisition of bla NDM-1 During Antimicrobial Therapy in Twin Infants with Pneumonia.
Membrane-active macromolecules resensitize NDM-1 gram-negative clinical isolates to tetracycline antibiotics.
Molecular basis of NDM-1, a new antibiotic resistance determinant.
Molecular epidemiology of KPC-producing Klebsiella pneumoniae isolated from patients in two public hospitals in Carabobo and Zulia states, Venezuela.
Multicenter Evaluation of the Xpert Carba-R Assay for Detection and Identification of Carbapenemase Genes in Sputum Specimens.
N-acylhydrazones confer inhibitory efficacy against New Delhi metallo-?-lactamase-1.
Native mitral valve endocarditis associated with KPC producing Serratia marcescens bacteremia successfully treated with mitral valve replacement and ceftazidime-avibactam.
New Delhi metallo-?-lactamase-producing Acinetobacter baumannii: a novel paradigm for spreading antibiotic resistance genes.
Nosocomial bloodstream infections in a pediatric intensive care unit: 3-year survey.
Nosocomial pneumonia caused by carbapenem-resistant Raoultella planticola: a case report and literature review.
Pharmacokinetic/pharmacodynamic modelling to evaluate the efficacy of various dosing regimens of ceftazidime/avibactam in patients with pneumonia caused by Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae: a multicentre study in northern China.
Phenotypic characteristics of Branhamella catarrhalis strains.
Phenotypic detection of Klebsiella pneumoniae carbapenemase among burns patients: First report from Iran.
Pneumonia: the impact of antibiotic resistance on its management.
Polymyxin B clinical outcomes: A prospective study of patients undergoing intravenous treatment.
Population Screening Using Sewage Reveals Pan-Resistant Bacteria in Hospital and Community Samples.
Prevalence and Characterization of Carbapenem-Resistant Enterobacteriaceae Isolated from Mulago National Referral Hospital, Uganda.
Prevalence and Distribution Characteristics of blaKPC-2 and blaNDM-1 Genes in Klebsiella pneumoniae.
Randomized controlled trial of sequential intravenous (i.v.) and oral moxifloxacin compared with sequential i.v. and oral co-amoxiclav with or without clarithromycin in patients with community-acquired pneumonia requiring initial parenteral treatment.
Reappraisal of clindamycin IV monotherapy for treatment of mild-to-moderate aspiration pneumonia in elderly patients.
Sensitivity and specificity of oropharyngeal suction versus bronchoalveolar lavage in identifying respiratory tract pathogens in children with chronic pulmonary infection.
Severity of ICU-acquired pneumonia according to infectious microorganisms.
Successful medical treatment in a child with E. coli ESBL meningitis with acute communicating hydrocephalus and ventricular empyema: a case report.
Successful Treatment of Urinary Tract Infection in Kidney Transplant Recipients Caused by Multiresistant Klebsiella pneumoniae Producing New Delhi Metallo-Beta-Lactamase (NDM-1) With Strains Genotyping.
Synthesis and in vitro activity of asymmetric indole-based bisamidine compounds against Gram-positive and Gram-negative pathogens.
Synthesis and in vitro activity of dicationic indolyl diphenyl ethers as novel potent antibiotic agents against drug-resistant bacteria.
The antibiotic treatment of community-acquired, atypical, and nosocomial pneumonias.
The antimicrobial spectrum of Xeroform(®).
The clinical relevance of in-vitro resistance to penicillin, ampicillin, amoxycillin and alternative agents, for the treatment of community-acquired pneumonia caused by Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis.
The frequency of Klebsiella pneumonia encoding genes for CTX-M, TEM-1 and SHV-1 extended-spectrum beta lactamases enzymes isolated from urinary tract infection.
The IncP-6 Plasmid p10265-KPC from Pseudomonas aeruginosa Carries a Novel ?ISEc33-Associated bla KPC-2 Gene Cluster.
The rising problem of antimicrobial resistance in the intensive care unit.
The role of fluoroquinolones in respiratory tract infections: community acquired pneumonia.
Treatment of acute exacerbations of chronic bronchitis: antibiotic therapy.
Treatment of experimental pneumonia in rats caused by a PER-1 extended-spectrum beta-lactamase-producing strain of Pseudomonas aeruginosa.
Treatment of respiratory tract infections with cephalosporin antibiotics.
Use of cefepime for the treatment of infections caused by extended spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli.
Validation of a Prediction Score for Drug-resistant Microorganisms in Community-Acquired Pneumonia.
Whole-genome analysis of EC129, an NDM-5-, CTX-M-14-, OXA-10- and MCR-1-co-producing Escherichia coli ST167 strain isolated from Japan.
Xpert CARBA-R Assay for the Detection of Carbapenemase-Producing Organisms in Intensive Care Unit Patients of a Korean Tertiary Care Hospital.
[Drug sensitivity and beta-lactamase producibility of various types of bacteria clinically isolated during the period from December 1999 to February 2000]
[Laboratory-based surveillance of antibacterial drug-resistant bacteria in the Kinki region].
[Microbiological evaluation of antibiotics for empirical therapy of community-acquired infections of the lower respiratory tract]
[Microflora formation in the newborn in maternity hospitals and neonatal abnormality units]
[Penicillinase activity in young infants with pneumonia]
[Susceptibility of gramnegative carbapenemase-producing bacteria to various group antibiotics].
[The problem of antibiotic resistance in patients with urinary tract infection].
[The Transmission of KPC-2 Gene in Klebsiella Species].
[Utilization of antibiotics according to most frequent indications at Hungarian hospitals and results of surveys]
Pneumonia, Aspiration
Pneumonia in the elderly.
Reappraisal of clindamycin IV monotherapy for treatment of mild-to-moderate aspiration pneumonia in elderly patients.
Pneumonia, Bacterial
Efficacy and safety of loracarbef in the treatment of pneumonia.
Efficacy of Sulbactam, a B-lactamase Inhibitor, Combined with Ampicillin in the Therapy of Ampicillin-resistant Pneumonic Pasteurellosis in Veal Calves.
[A comparative study of tazobactam/piperacillin and piperacillin in bacterial pneumonia]
Pneumonia, Ventilator-Associated
Co-production of MCR-1 and NDM-1 by Escherichia coli sequence type 31 isolated from a newborn in Moscow, Russia.
Doripenem: a review of its use in the treatment of bacterial infections.
Emergence and molecular characterization of multidrug-resistant Klebsiella pneumoniae isolates harboring blaCTX-M-15 extended-spectrum ?-lactamases causing ventilator-associated pneumonia in China.
Emergence of blaNDM-1 and blaVIM producing Gram-negative bacilli in ventilator-associated pneumonia at AMR Surveillance Regional Reference Laboratory in India.
Emergence of Klebsiella pneumoniae ST273 Carrying blaNDM-7 and ST656 Carrying blaNDM-1 in Manila, Philippines.
Impact of systematic screening for AmpC-hyperproducing Enterobacterales intestinal carriage in intensive care unit patients.
Semi-quantitative cultures of throat and rectal swabs are efficient tests to predict ESBL-Enterobacterales ventilator-associated pneumonia in mechanically ventilated ESBL carriers.
Ventilator-associated pneumonia caused by carbapenem-resistant Enterobacteriaceae carrying multiple metallo-beta-lactamase genes.
Ventilator-associated pneumonia caused by colistin-resistant KPC-producing Klebsiella pneumoniae: a case report and literature review.
Pouchitis
Extended spectrum beta-lactamase-producing bacteria and Clostridium difficile in patients with pouchitis.
Precursor Cell Lymphoblastic Leukemia-Lymphoma
BCL-1 (PRAD-1/cyclin D-1) overexpression distinguishes the blastoid variant of mantle cell lymphoma from B-lineage lymphoblastic lymphoma.
BCL-1 rearrangement in acute lymphocytic leukemia and its clinical significance.
Molecular hematology. Qualitative to quantitative techniques.
Rearrangement of the chromosome 11 bcl-1 locus in centrocytic lymphoma: analysis with multiple breakpoint probes.
Treatment of BCL-1 murine B-cell leukemia with recombinant cytokines. Comparative analysis of the anti-leukemic potential of interleukin 1 beta (IL-1 beta), interleukin 2 (IL-2), interleukin-6 (IL-6), tumor necrosis factor alpha (TNF alpha), granulocyte colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), and their combination.
Prostatic Neoplasms
First clinical cases of NDM-1-producing Klebsiella pneumoniae from two hospitals in Bulgaria.
Identification and functional analysis of a novel tryptophyllin peptide from the skin of the red-eye leaf frog, Agalychnis callidryas.
Nucleases of the metallo-beta-lactamase family and their role in DNA and RNA metabolism.
Prostatitis
Bacterial prostatitis due to Pseudomonas aeruginosa harbouring the blaVIM-2 metallo-{beta}-lactamase gene from Saudi Arabia.
Incidence of acute prostatitis caused by extended-spectrum beta-lactamase-producing Escherichia coli after transrectal prostate biopsy.
New Delhi metallo-beta-lactamase from traveler returning to Canada.
Successful Treatment of Acute Prostatitis Caused by Multidrug-Resistant Escherichia coli With Tigecycline Monotherapy.
[Laboratory and clinical study of sulbactam/cefoperazone (SBT/CPZ) on bacterial prostatitis]
Pseudolymphoma
Polymerase chain reaction detection of the t(11;14) translocation involving the bcl-1 major translocation cluster in mantle cell lymphoma.
Rearrangements of immunoglobulin gene and oncogenes in ocular adnexal pseudolymphoma.
Pseudomonas Infections
A unique case report of a high-pressure paint injection injury of the hand with associated carbapenemase resistant Pseudomonas aeruginosa infection.
Carriage of two carbapenem-resistance genes in Pseudomonas aeruginosa isolated from hospital-acquired infections in children from Costa Rica: the importance of local epidemiology.
Co-existence of OXA-48 and NDM-1 in colistin resistant Pseudomonas aeruginosa ST235.
First nosocomial outbreak of Pseudomonas aeruginosa producing an integron-borne metallo-beta-lactamase (VIM-2) in the United States.
Inactivation of the glycoside hydrolase NagZ attenuates antipseudomonal {beta}-lactam resistance in Pseudomonas aeruginosa.
Novel bacteriophage therapy for controlling metallo-beta-lactamase producing Pseudomonas aeruginosa infection in catfish.
Outbreak of Pseudomonas aeruginosa infections with PER-1 extended-spectrum beta-lactamase in Warsaw, Poland: further evidence for an international clonal complex.
Stepwise upregulation of the Pseudomonas aeruginosa chromosomal cephalosporinase conferring high-level beta-lactam resistance involves three AmpD homologues.
The influence of metallo-beta-lactamase production on mortality in nosocomial Pseudomonas aeruginosa infections.
Treatment of infections caused by metallo-beta-lactamase-producing Pseudomonas aeruginosa in the Calgary Health Region.
What do beta-lactamases mean for clinical efficacy?
[Comparative antibacterial activity of carbapenems against P. aeruginosa (1)]
Pseudorabies
A differential ELISA based on recombinant immunodominant epitopes of the gE gene of SHV-1 in a baculovirus-insect cell system to discriminate between pigs infected naturally with pseudorabies and vaccinated pigs.
Antigens involved in vaccination of swine against Aujeszky's disease (pseudorabies) virus.
Introduction of foreign strains of Suid herpesvirus 1 (Aujeszky's disease virus) documented by restriction fragment pattern (RFP) analysis.
Pulmonary Disease, Chronic Obstructive
Amoxicillin concentrations in relation to beta-lactamase activity in sputum during exacerbations of chronic obstructive pulmonary disease.
Prevalence of Escherichia coli Resistant to Beta-Lactam Antibiotics among Patients with Chronic Obstructive Pulmonary Disease and Urinary Tract Infection.
Relation between beta-lactamase producing bacteria and patient characteristics in chronic obstructive pulmonary disease (COPD).
[Microbiological evaluation of antibiotics for empirical therapy of community-acquired infections of the lower respiratory tract]
[Respiratory tract infections caused by Haemophilus influenzae in adults]
Pyelonephritis
Doripenem: a review of its use in the treatment of bacterial infections.
Efficacy and Cost Comparison of Ertapenem as Outpatient Parenteral Antimicrobial Therapy in Acute Pyelonephritis due to Extended-spectrum Beta-lactamase-producing Enterobacteriaceae.
Emphysematous pyelonephritis and septic shock in an elderly male patient caused by extended-spectrum beta-lactamase producing Klebsiella pneumoniae.
Impact of Extended-Spectrum Beta-Lactamase on Acute Pyelonephritis Treated with Empirical Ceftriaxone.
New Delhi metallo-beta-lactamase from traveler returning to Canada.
Pharmacokinetics/Pharmacodynamics of Vaborbactam, a Novel Beta-Lactamase Inhibitor, in Combination with Meropenem.
Recurrent pyelonephritis due to NDM-1 metallo-beta-lactamase producing Pseudomonas aeruginosa in a patient returning from Serbia, France, 2012.
Renal vein thrombosis complicating severe acute pyelonephritis with renal abscesses and associated bacteraemia caused by extended-spectrum beta-lactamase producing Escherichia coli.
Pyoderma
Identification of VIM-2 metallo-?-lactamase-producing Pseudomonas aeruginosa isolated from dogs with pyoderma and otitis in Korea.
Pyomyositis
Pyomyositis caused by extended-spectrum beta-lactamase-producing Escherichia coli in a patient with acute myeloid leukemia.
Renal Insufficiency
[Beta-lactamase inhibitors. II. Pharmacokinetics of an amoxicillin + clavulanic acid combination in renal insufficiency and during hemodialysis]
Renal Insufficiency, Chronic
Risk Factors for Community-Associated Clostridium difficile Infection in Adults: A Case-Control Study.
Status Epilepticus and Delirium Associated with Ertapenem in a Very Elderly Patient with Chronic Kidney Disease and Silent Ischaemic Cerebrovascular Disease.
Respiratory Insufficiency
Expanded-spectrum beta-lactamase producing Klebsiella pneumoniae-related peritonitis in a patient on peritoneal dialysis.
Respiratory Tract Diseases
Isoelectric focusing of beta-lactamases from sputum and middle ear isolates of Branhamella catarrhalis recovered in the United States.
[Pathogenesis of beta-lactam-resistant Haemophilus influenzae isolated from sputum]
Respiratory Tract Infections
A comparison of ampicillin/sulbactam versus cefotaxime in the therapy of lower respiratory tract infections in hospitalized patients.
Activity of erythromycin against Haemophilus influenzae from respiratory tract infections.
Antimicrobial use in European acute care hospitals: results from the second point prevalence survey (PPS) of healthcare-associated infections and antimicrobial use, 2016 to 2017.
Bacteraemia due to extensively drug-resistant Pseudomonas aeruginosa sequence type 235 high-risk clone: Facing the perfect storm.
Bacterial agents of lower respiratory tract infections (LRTIs), beta-lactamase production, and resistance to antibiotics in elderly people. DEDALO Study Group.
beta-Lactamase activities and resistance to antibiotics of Haemophilus influenzae, H. parainfluenzae and H. aphrophilus strains identified in throat cultures from children.
beta-Lactamase activity in sputum and indirect pathogenicity.
Branhamella catarrhalis respiratory infections in The Netherlands.
Cefetamet pivoxil. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
Clarithromycin. A review of its efficacy in the treatment of respiratory tract infections in immunocompetent patients.
Clinical features of patients with beta-lactamase producing Haemophilus influenzae isolated from sputum.
Comparative evaluation of efficacy and safety of cefotaxime-sulbactam with amoxicillin-clavulanic acid in children with lower respiratory tract infections.
CTX-M and PER-1 group extended spectrum ?-lactamases-producing Pseudomonas aeruginosa from the patients of lower respiratory tract infection.
Decreasing prevalence of beta-lactamase production among respiratory tract isolates of Haemophilus influenzae in the United States.
Evaluation of the Antimicrobial Activity of Sparfloxacin, Relative to Other Oral Antibiotics Against 1,125 Bacterial Isolates from 10 Medical Centers in Brazil.
Global distribution of TEM-1 and ROB-1 beta-lactamases in Haemophilus influenzae.
Hemophilus influenzae bronchitis and pneumonia.
Hemophilus influenzae respiratory infection in adults. 2. Treatment guidelines.
Importance of beta-lactamase stability in treating today's respiratory tract infections.
In vitro activity of cefpodoxime in comparison with other oral beta-lactam antibiotics.
In-vitro activity of FCE 22101 against respiratory tract pathogens with reference to production of beta-lactamases.
Increasing prevalence of ampicillin- resistant, non-beta-lactamase-producing strains of Haemophilus influenzae in children in Japan.
Macrolide susceptibility and beta-lactamase production among haemophilus influenzae isolates in the United States, 1996-1997.
Metallo-beta-lactamase-producing Pseudomonas putida as a reservoir of multidrug resistance elements that can be transferred to successful Pseudomonas aeruginosa clones.
Microbial factors leading to recurrent upper respiratory tract infections.
Moraxella catarrhalis in upper respiratory tract of healthy Yemeni children/adults and paediatric patients: detection and significance.
Multicenter surveillance of antimicrobial susceptibilities and resistance mechanisms among Enterobacterales species and non-fermenting Gram-negative bacteria from different infection sources in Taiwan from 2016 to 2018.
Prevalence of extended spectrum beta-lactamase producing Klebsiella spp. causing nosocomial respiratory infections.
Prevalence of Extended-Spectrum Beta-Lactamase/Carbapenemase Genes and Quinolone-Resistance Determinants in Klebsiella pneumoniae Clinical Isolates from Respiratory Infections in Myanmar.
Probability of achieving requisite pharmacodynamic exposure for oral beta-lactam regimens against Haemophilus influenzae in children.
Resistance of Haemophilus influenzae isolates in children under 5 years old with acute respiratory infections in China between 2000 and 2002.
Respiratory tract infections caused by beta-lactamase producing organisms treated with augmentin.
Role of sultamicillin and ampicillin/sulbactam in the treatment of upper and lower bacterial respiratory tract infections.
Study of the diffusion of cefmenoxime into the bronchial secretions.
The antibiotic susceptibilities and beta-lactamase production of clinical isolated Branhamella catarrhalis from acute otitis media in children.
The beta-lactamases of Moraxella (Branhamella) catarrhalis isolated from Danish children.
The emergence of resistance to beta-lactam antibiotics during treatment of Pseudomonas aeruginosa lower respiratory tract infections: is combination therapy the solution?
The role of epidemic resistance plasmids and international high-risk clones in the spread of multidrug-resistant Enterobacteriaceae.
The use of oral antibiotics in daily clinical practice.
Treatment of respiratory tract infections with cephalosporin antibiotics.
Upper respiratory tract infections. Ecological and therapeutic aspects of beta-lactamase production with special reference to Branhamella catarrhalis.
Which antibiotic is better for the treatment of infections of the lower respiratory tract?
[A comparative study of tazobactam/piperacillin and piperacillin in chronic respiratory tract infections]
[Antibiotic sensitivity of Branhamella catarrhalis isolated from respiratory tract infections]
[Antibiotic therapy in the outpatient setting: update 2009]
[Antimicrobial activities of sultamicillin against clinical isolates from upper respiratory tract infections]
[beta-lactamase activity in sputum of patients with community-acquired lower respiratory tract infections]
[Clinical effects of piperacillin and tazobactam/piperacillin on Haemophilus influenzae lower respiratory tract infection in pediatric patients]
[Clinical evaluation of sulbactam/cefoperazone for lower respiratory tract infections. Correlation between the efficacy of sulbactam/cefoperazone and beta-lactamase]
[Detection of inducible beta-lactamase in sputum--clinical studies on Pseudomonas respiratory infection]
[Drug resistance and genotyping of Klebsiella pneumoniae in lower respiratory tract infection]
[Drug-resistance analysis of Gram-negative bacilli producing extended-spectrum beta-lactamases in lower respiratory tract infection]
[In vitro susceptibilities of causative organisms isolated from patients with primary respiratory tract infections to BRL 25000 (clavulanic acid/amoxicillin)]
[Molecular characterization of BRO beta-lactamases of Moraxella catarrhalis strains isolated from carrier children]
Retinoblastoma
Flow cytometric DNA analysis is useful in detecting multiple genetic alterations in squamous cell carcinoma of the esophagus.
Immunohistochemical expression of cyclin D1, E2F-1, and Ki-67 in benign and malignant thyroid lesions.
Molecular genetic demonstration of the diverse evolution of Richter's syndrome (chronic lymphocytic leukemia and subsequent large cell lymphoma).
Oncogene rearrangements in chronic B-cell leukemia.
Salmonella Infections
Detection of a bla(SHV) extended-spectrum {beta}-lactamase in Salmonella enterica serovar Newport MDR-AmpC.
Emergence of domestically acquired ceftriaxone-resistant Salmonella infections associated with AmpC beta-lactamase.
Human Salmonella infection yielding CTX-M beta-lactamase, United States.
Multiple outbreaks of nosocomial salmonellosis in Russia and Belarus caused by a single clone of Salmonella enterica serovar Typhimurium producing an extended-spectrum beta-lactamase.
The Role of Ceftiofur in the Selection and Dissemination of blaCMY-2 - Mediated Cephalosporin Resistance in Salmonella enterica and Commensal Escherichia coli Isolated from Cattle.
[Ciprofloxacin after clinical failure of beta-lactam antibiotics in children with salmonellosis]
Sarcoma
177Lu radiolabeling and preclinical theranostic study of 1C1m-Fc: an anti-TEM-1 scFv-Fc fusion protein in soft tissue sarcoma.
Development of 89Zr-Ontuxizumab for in vivo TEM-1/endosialin PET applications.
Molecular pathology of the cell cycle in human cancer cells.
[Electrophoretic study of the blood serum of rats with IMP-1 sarcoma during radiation and combined therapy]
Scarlet Fever
Penicillinase producing straphylococci interfering with penicillin treatment in scarlet fever.
Scoliosis
Prevention of spinal fusion post-operative wound infections in pediatric patients with scoliosis: a quality improvement initiative.
Seizures
Clinical characteristics of post-neurosurgical Klebsiella pneumoniae meningitis in adults and a clinical comparison to the spontaneous form in a Taiwanese population.
Motor and electrical signs of epileptiform activity induced by penicillin in the spinal cords of decapitate cats.
Status Epilepticus and Delirium Associated with Ertapenem in a Very Elderly Patient with Chronic Kidney Disease and Silent Ischaemic Cerebrovascular Disease.
Sepsis
A case of septicemia due to Chyresobacterium indologenes producing blaNDM-1.
A change for the antibacterial treatment policy to decrease carbapenem consumption at a haematopoietic stem cell transplantation centre.
A comparison of extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae bloodstream infections in Alberta using a provincial surveillance system.
A retrospective analysis of risk factors and outcomes in patients with extended-spectrum beta-lactamase ESBL-producing Escherichia coli bloodstream infections.
An Immunocompromised Child with Bloodstream Infection Caused by Two Escherichia coli Strains, One Harboring NDM-5 and the Other Harboring OXA-48-Like Carbapenemase.
Antibiotic Adjuvant Therapy for Multi-Drug Resistant Carbapenemases Producing Klebsiella pneumoniae Associated Sepsis: A Case Study.
Antibiotic resistance patterns in gram-negative and gram-positive bacteria causing septicemia in newborns in León, Nicaragua: correlation with environmental samples.
Antibiotic-resistant hypervirulent Klebsiella pneumoniae causing community- acquired liver abscess: an emerging disease.
Autochthonous ST405 NDM-5 producing Escherichia coli causing fatal sepsis in Northern Italy.
Aztreonam plus ceftazidime-avibactam as treatment of NDM-1-producing Klebsiella pneumoniae bacteraemia in a neutropenic patient: Last resort therapy?
Bacteremia caused by Escherichia coli producing extended-spectrum beta-lactamase: a case-control study of risk factors and outcomes.
Bloodstream infection by two subpopulations of Klebsiella pneumoniae ST1685 carrying KPC-33 or KPC-14 following ceftazidime/avibactam treatment: considerations regarding acquired heteroresistance and choice of carbapenemase detection assay.
Bloodstream infection caused by KPC-producing Klebsiella pneumoniae resistant to ceftazidime/avibactam: epidemiology and genomic characterization.
Bloodstream Infection Due to CTX-M-15 and TEM-1 Extended-Spectrum ?-Lactamase-Producing Salmonella enterica serovar Virchow ST16.
Bloodstream infection due to extended-spectrum beta-lactamase (ESBL)-positive K. pneumoniae and E. coli: an analysis of the disease burden in a large cohort.
Bloodstream infections by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in children: epidemiology and clinical outcome.
Bloodstream infections caused by extended-spectrum-beta-lactamase- producing Escherichia coli: risk factors for inadequate initial antimicrobial therapy.
Bloodstream infections caused by extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae: risk factors, molecular epidemiology, and clinical outcome.
Bloodstream Infections caused by Klebsiella pneumoniae and Serratia marcescens isolates co-harboring NDM-1 and KPC-2.
Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase 2-producing K. pneumoniae at a Hematology Department in Wenzhou, China.
Bloodstream infections caused by multidrug-resistant Klebsiella pneumoniae producing the carbapenem-hydrolysing VIM-1 metallo-beta-lactamase: first Italian outbreak.
Bloodstream Infections Caused by Pseudomonas spp.: How To Detect Carbapenemase Producers Directly from Blood Cultures.
Bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy.
Capnocytophaga canimorsus - a potent pathogen in immunocompetent humans - systematic review and retrospective observational study of case reports.
Carbapenem Resistance in Acinetobacter baumannii and Other Acinetobacter spp. Causing Neonatal Sepsis: Focus on NDM-1 and Its Linkage to ISAba125.
Ceftolozane-tazobactam versus meropenem for definitive treatment of bloodstream infection due to extended-spectrum beta-lactamase (ESBL) and AmpC-producing Enterobacterales ("MERINO-3"): study protocol for a multicentre, open-label randomised non-inferiority trial.
Characterization of an IMP-4-Producing Klebsiella pneumoniae ST1873 Strain Recovered from an Infant with a Bloodstream Infection in China.
Characterization of ESBL-producing Escherichia coli and Klebsiella pneumoniae from bloodstream infections in three hospitals in Bucharest, Romania: a preliminary study.
Clinical and epidemiological characteristics of KPC-producing Klebsiella pneumoniae from bloodstream infections in a tertiary referral center in Italy.
Clinical and Molecular Description of a High-Copy IncQ1 KPC-2 Plasmid Harbored by the International ST15 Klebsiella pneumoniae Clone.
Clinical and molecular epidemiology of community-onset bacteremia caused by extended-spectrum ?-lactamase-producing Escherichia coli over a 6-year period.
Clinical characteristics and epidemiology of sepsis in the neonatal intensive care unit in the era of multi-drug resistant organisms: A retrospective review.
Clinical characteristics of bloodstream infections due to ampicillin-sulbactam-resistant, non-extended- spectrum-beta-lactamase-producing Escherichia coli and the role of TEM-1 hyperproduction.
Clinical Prediction Score for Community-Onset Bloodstream Infections Caused by Extended-Spectrum Beta-Lactamase-Producing Escherichia coli and Klebsiella Species.
Clinical prediction tool for extended-spectrum beta-lactamase-producing enterobacterales as the etiology of a bloodstream infection in solid organ transplant recipients.
Cluster of bloodstream infections caused by KPC-2 carbapenemase-producing Klebsiella pneumoniae in Manhattan.
Co-Occurrence of mcr-9 and blaNDM-1 in Enterobacter cloacae Isolated from a Patient with Bloodstream Infection.
Coexistence of mcr-9 and blaNDM-1 in a multidrug-resistant Enterobacter hormaechei strain recovered from a bloodstream infection in China.
Coexistence of two blaCTX-M-14 genes in a blaNDM-5-carrying multidrug-resistant Escherichia coli strain recovered from a bloodstream infection in China.
Colonisation with extended-spectrum beta-lactamase (ESBL) not detected in a prevalence study.
Combined Molecular and Phenotypic Antimicrobial Susceptibility Testing Is Beneficial in Detection of ESBL and AmpC Beta-Lactamase Producing Isolates of Enterobacteriaceae in Pediatric Patients with Bloodstream Infections.
Community-onset bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli: risk factors and prognosis.
Complete genome sequencing and genomic characterization of two Escherichia coli strains co-producing MCR-1 and NDM-1 from bloodstream infection.
Coproduction Of MCR-9 And NDM-1 By Colistin-Resistant Enterobacter hormaechei Isolated From Bloodstream Infection.
Correction for Hasassri et al., An Immunocompromised Child with Bloodstream Infection Caused by Two Escherichia coli Strains, One Harboring NDM-5 and the Other Harboring OXA-48-Like Carbapenemase.
Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy.
Current evidence for therapy of ceftriaxone-resistant Gram-negative bacteremia.
Detection of OXA-1 ?-Lactamase Gene of Klebsiella pneumoniae from Blood Stream Infections (BSI) by Conventional PCR and In-Silico Analysis to Understand the Mechanism of OXA Mediated Resistance.
Discovery of thiosemicarbazone derivatives as effective New Delhi metallo-?-lactamase-1 (NDM-1) inhibitors against NDM-1 producing clinical isolates.
Dissemination of extensively drug-resistant and KPC-2 producing Klebsiella pneumoniae isolated from bloodstream infections.
Draft genome sequence of Escherichia coli ST977: A clinical multidrug-resistant strain harbouring blaNDM-3 isolated from a bloodstream infection.
EARLY ONSET MORGANELLA MORGANII SEPSIS IN A NEWBORN INFANT WITH EMERGENCE OF CEPHALOSPORIN RESISTANCE CAUSED BY DEREPRESSION OF AMPC beta-LACTAMASE PRODUCTION.
Effect of PMX-DHP for sepsis due to ESBL-producing E. coli in an extremely low-birthweight infant.
Efficacies of calcium-EDTA in combination with imipenem in a murine model of sepsis caused by Escherichia coli with NDM-1 ?-lactamase.
Efficacy of Colistin and Its Combination With Rifampin in Vitro and in Experimental Models of Infection Caused by Carbapenemase-Producing Clinical Isolates of Klebsiella pneumoniae.
Efflux pumps expression and its association with porin down-regulation and beta-lactamase production among Pseudomonas aeruginosa causing bloodstream infections in Brazil.
Emergence of a ST2570 Klebsiella pneumoniae isolate carrying mcr-1 and blaCTX-M-14 recovered from a bloodstream infection in China.
Emergence of bla NDM-1 associated with the aac(6')-Ib-cr, acrB, cps, and mrkD genes in a clinical isolate of multi-drug resistant Klebsiella pneumoniae from Recife-PE, Brazil.
Emergence of Resistance to Colistin During the Treatment of Bloodstream Infection Caused by Klebsiella pneumoniae Carbapenemase-Producing Klebsiella pneumoniae.
Epidemiological investigation of bloodstream infections by extended spectrum cephalosporin-resistant Escherichia coli in a Taiwanese teaching hospital.
Epidemiology and Burden of Bloodstream Infections Caused by Extended-Spectrum Beta-Lactamase Producing Enterobacteriaceae in a Pediatric Hospital in Senegal.
Epidemiology, Risk Factors, and Clinical Outcomes of Bloodstream Infection due to Extended-Spectrum Beta-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae in Hematologic Malignancy: A Retrospective Study from Central South China.
Evaluation of a Novel Culture System for Rapid Pathogen Identification and Detection of Cephalosporin Resistance in Neonatal Gram-negative Sepsis at a Tertiary Referral Unit in Harare, Zimbabwe.
Evaluation of the FilmArray Blood Culture Identification Panel on Detection of Pathogenic Microorganisms in Positive Blood Cultures: the First Clinical Report in Japan.
Experimental model for treatment of extended spectrum betalactamase producing-Klebsiella pneumoniae.
Extended spectrum beta-lactamase producing Enterobacteriaceae causing bloodstream infections in rural Ghana, 2007-2012.
Extended-spectrum beta-lactamase gram-negative sepsis following prostate biopsy: implications for use of fluoroquinolone prophylaxis.
Extended-spectrum beta-lactamase-conferring transferable resistance to different antimicrobial agents in Enterobacteriaceae isolated from bloodstream infections.
Extended-spectrum beta-lactamase-type SHV-12-producing Enterobacteriaceae causing septicemia in Tanzanian children: vectors for horizontal transfer of antimicrobial resistance.
First case of New Delhi metallo-?-lactamase in Klebsiella pneumoniae from Ecuador: An update for South America.
First clinical cases of NDM-1-producing Klebsiella pneumoniae from two hospitals in Bulgaria.
First detection of autochthonous extensively drug-resistant NDM-1 Pseudomonas aeruginosa ST235 from a patient with bloodstream infection in Italy, October 2019.
First Indian report of IncX3 plasmid carrying blaNDM-7 in Escherichia coli from bloodstream infection: potential for rapid dissemination.
First Indian report on B4/H24RxC ST410 multidrug-resistant Escherichia coli from bloodstream infection harbouring blaOXA-181 and blaCTX-M-15.
Fluoroquinolone resistance in pediatric bloodstream infections because of Escherichia coli and Klebsiella species.
Fluoroquinolone-Resistant Escherichia coli Sequence Type 131 Isolates Causing Bloodstream Infections in a Canadian Region with a Centralized Laboratory System: Rapid Emergence of the H30-Rx Sublineage.
Fulminant endocarditis and disseminated infection caused by carbapenem-resistant Acinetobacter baumannii in a renal-pancreas transplant recipient.
Handwashing sinks as the source of transmission of ST16 carbapenem-resistant Klebsiella pneumoniae, an international high-risk clone, in an intensive care unit.
Health and economic outcomes of the detection of Klebsiella pneumoniae-produced extended-spectrum beta-lactamase (ESBL) in a hospital with high prevalence of this infection.
Healthcare-associated Klebsiella pneumoniae carbapenemase producing K. pneumoniae bloodstream infection: the time has come.
High mortality of bloodstream infection outbreak caused by carbapenem-resistant P. aeruginosa producing SPM-1 in a bone marrow transplant unit.
Implications of beta-lactamase-inhibitor combinations.
In vitro and in vivo activities of AM-112, a novel oxapenem.
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies.
Increase in hospital-acquired bloodstream infections caused by extended spectrum beta-lactamase-producing Escherichia coli in a large French teaching hospital.
Infections with extended-spectrum beta-lactamase-producing enterobacteriaceae: changing epidemiology and drug treatment choices.
KPC-2 producing Pseudomonas putida as an unexpected pathogen of catheter-associated bloodstream infection.
KPC-2 producing ST101 Klebsiella pneumoniae from bloodstream infection in India.
Long-term, low-dose tigecycline to treat relapsing bloodstream infection due to KPC-producing Klebsiella pneumoniae after major hepatic surgery.
Longitudinal Analysis of Risk Factors for Clinical Outcomes of Enterobacteriaceae Meningitis/Encephalitis in Post-Neurosurgical Patients: A Comparative Cohort Study During 2014-2019.
Metallo-beta-lactamase Producing Pseudomonas aeruginosa in Neonatal Septicemia.
Microbiological Characterization of VNRX-5236, a Broad-Spectrum ?-Lactamase Inhibitor for Rescue of the Orally Bioavailable Cephalosporin Ceftibuten as a Carbapenem-Sparing Agent against Strains of Enterobacterales Expressing Extended-Spectrum ?-Lactamases and Serine Carbapenemases.
Molecular characterization of carbapenem-resistant Klebsiella pneumoniae ST14 and ST512 causing bloodstream infections in ICU and surgery wards of a tertiary university hospital of Verona (northern Italy): co-production of KPC-3, OXA-48, and CTX-M-15 ?-lactamases.
Molecular epidemiology of Escherichia coli producing CTX-M beta-lactamases: the worldwide emergence of clone ST131 O25:H4.
Molecular epidemiology of extended-spectrum beta-lactamase (ESBL)-positive Klebsiella pneumoniae from bloodstream infections and risk factors for mortality.
Monitoring Ceftazidime-Avibactam (CAZ-AVI) and Aztreonam (ATM) Concentrations in the Treatment of a Bloodstream Infection Caused by a Multidrug-Resistant Enterobacter sp. Carrying both KPC-4 and NDM-1 Carbapenemases.
Mother to Child Transmission of Extended Spectrum Beta-Lactamase Producing Enterobacteriaceae.
Multidrug resistant NDM-1 metallo-beta-lactamase producing Klebsiella pneumoniae sepsis outbreak in a neonatal intensive care unit in a tertiary care center at central India.
New Delhi Metallo-Beta-Lactamase (NDM-1)-Producing Klebsiella Pneumoniae Isolated from a Burned Patient.
Nosocomial bloodstream infections caused by Klebsiella pneumoniae: impact of extended-spectrum beta-lactamase (ESBL) production on clinical outcome in a hospital with high ESBL prevalence.
Nucleotide sequence and characterization of a novel cefotaxime-hydrolyzing beta-lactamase (CTX-M-10) isolated in Spain.
Pharmacokinetics of Ceftazidime-Avibactam in Two Patients With KPC-Producing Klebsiella pneumoniae Bacteremia and Renal Impairment.
Plasmid-mediated carbapenem-hydrolyzing enzyme KPC-2 in an Enterobacter sp.
Plasmid-mediated quinolone resistance among extended-spectrum beta-lactamase producing Enterobacteriaceae from bloodstream infections.
Post-MERINO trial: Any role for piperacillin-tazobactam in treating bloodstream infections caused by extended-spectrum beta-lactamase producing Enterobacteriaceae?
Predictors of mortality from community-onset bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae.
Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment.
Prevalence and distribution of beta-lactamase coding genes in third-generation cephalosporin-resistant Enterobacteriaceae from bloodstream infections in Cambodia.
Prolonged fecal shedding of CTX-M-15-producing Escherichia coli and recurrent sepsis in a patient after cord blood stem-cell transplantation.
Prospective observational study of the impact of VIM-1 metallo-beta-lactamase on the outcome of patients with Klebsiella pneumoniae bloodstream infections.
Pseudomonas aeruginosa bloodstream infections: risk factors and treatment outcome related to expression of the PER-1 extended-spectrum beta-lactamase.
Pseudomonas aeruginosa may accumulate drug resistance mechanisms without losing its ability to cause bloodstream infections.
Risk factors and clinical outcomes of extended spectrum beta-lactamase (ESBL)-producing Escherichia coli septicemia at Srinagarind University Hospital, Thailand.
Risk factors for and mortality of extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli nosocomial bloodstream infections.
Risk factors for bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli in a Turkish hospital.
Risk factors for bloodstream infection with Klebsiella pneumoniae producing VIM-1 metallo-beta-lactamase.
Risk factors for bloodstream infections due to colistin-resistant KPC-producing Klebsiella pneumoniae: results from a multicenter case-control-control study.
Risk factors for extended-spectrum beta-lactamase-producing Enterobacterales bloodstream infection among solid organ transplant recipients.
Risk-factors for emerging bloodstream infections caused by extended-spectrum beta-lactamase-producing Escherichia coli.
Role of Horizontal Gene Transfer in the Development of Multidrug Resistance in Haemophilus influenzae.
Scope and limitations of antimicrobial therapy of sepsis in surgery.
Screening for extended-spectrum beta-lactamase-producing Enterobacteriaceae among high-risk patients and rates of subsequent bacteremia.
Sepsis Caused by Extended-Spectrum Beta-Lactamase (ESBL)-Positive K. pneumoniae and E. coli: Comparison of Severity of Sepsis, Delay of Anti-Infective Therapy and ESBL Genotype.
Sepsis caused by Salmonella Paratyphi B producing an OXA-48 carbapenemase in a traveller.
Sepsis in neonates due to imipenem-resistant Klebsiella pneumoniae producing NDM-1 in India.
Septicemia, meningitis, and skull osteomyelitis complicating infected cephalhematoma caused by ESBL-producing Escherichia coli.
Severe community onset healthcare-associated Clostridium difficile infection complicated by carbapenemase producing Klebsiella pneumoniae bloodstream infection.
Simultaneous presence of blaTEM and blaSHV genes on a large conjugative plasmid carried by extended-spectrum beta-lactamase-producing Klebsiella pneumoniae.
Successful outcome after treatment with a combination of meropenem and fosfomycin for VIM-1 and CTX-M-15 producing Klebsiella pneumoniae bloodstream infection.
Superior vena caval thrombosis after a neonatal arterial switch procedure.
Systematic review of carbapenem-resistant Enterobacteriaceae causing neonatal sepsis in China.
The role of interleukin-6 as an early predictor of sepsis in a murine sepsis model.
Time to appropriate antibiotic therapy is a predictor of outcome in patients with bloodstream infection caused by KPC-producing Klebsiella pneumoniae.
Unravelling the genome sequence of NDM-1 and KPC-2 co-producing Klebsiella pneumoniae ST11 isolated from a bloodstream infection.
Vancomycin Analogue Restores Meropenem Activity against NDM-1 Gram-Negative Pathogens.
Virulence of a Klebsiella pneumoniae strain carrying the New Delhi metallo-beta-lactamase-1 (NDM-1).
Whole genome analysis of cephalosporin-resistant Escherichia coli from bloodstream infections in Australia, New Zealand and Singapore: high prevalence of CMY-2 producers and ST131 carrying blaCTX-M-15 and blaCTX-M-27.
Whole genome sequence of an Escherichia coli ST131 strain isolated from a patient with bloodstream infection in China co-harbouring blaKPC-2, blaCTX-M-3, blaCTX-M-14, qnrS1, aac(3)-IIa and aac(6')-Ib-cr genes.
Whole genome sequence of an Escherichia coli ST410 isolate co-harbouring blaNDM-5, blaOXA-1, blaCTX-M-15, blaCMY-2, aac(3)-IIa and aac(6')-Ib-cr genes isolated from a patient with bloodstream infection in China.
[A case of sepsis caused by Enterobacter cloacae producing both type SHV-12 and type CTX-M-14 ESBLs in a post bone-marrow transplantation patient]
[Excess mortality and prolongation of stay due to bloodstream infections caused by multiresistant pathogens in Germany].
[Looking back 2018--focused on surgical infection].
[Mortality risk factors for bloodstream infections caused by extended-spectrum beta-lactamase-producing microorganisms.]
[Multiresistant Haemophilus influenzae. Beta-lactamase producing, chloramphenicol and tetracycline resistant Haemophilus influenzae as a cause of septicemia]
[One year of infectious diseases in review].
[Risk factors and prognosis in 31 patients with extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae bloodstream infection]
[Septicemia caused by beta-lactamase producing Fusobacterium nucleatum in a patient with neutropenia]
Serum Sickness
[Penicillin allergy in the form of serum sickness; its treatment with penicillinase.]
Severe Combined Immunodeficiency
Nucleases of the metallo-beta-lactamase family and their role in DNA and RNA metabolism.
Sexually Transmitted Diseases
Beta-lactamase-producing isolates of Neisseria gonorrhoeae in Cape Town.
Cefoperazone (Cefobid) for treating men with gonorrhoea caused by penicillinase producing Neisseria gonorrhoeae.
Imported penicillinase producing Neisseria gonorrhoeae becomes endemic in London.
Penicillin resistant Neisseria gonorrhoeae in low prevalence areas: implications for cost-effective management.
Spectinomycin as initial treatment for gonorrhoea.
[Antimicrobial resistance of Neisseria gonorrhoeae strains isolated from sex workers in Ankara]
[Resistance surveillance of Neisseria gonorrhoeae in a hospital in Santa Fe province, Argentina: 1997-2004]
Shock, Septic
A change for the antibacterial treatment policy to decrease carbapenem consumption at a haematopoietic stem cell transplantation centre.
Capnocytophaga canimorsus - a potent pathogen in immunocompetent humans - systematic review and retrospective observational study of case reports.
Emphysematous pyelonephritis and septic shock in an elderly male patient caused by extended-spectrum beta-lactamase producing Klebsiella pneumoniae.
Enterocolitis caused by methicillin-resistant Staphylococcus aureus: molecular characterization of respiratory and digestive tract isolates.
Glycerol monolaurate inhibits the production of beta-lactamase, toxic shock toxin-1, and other staphylococcal exoproteins by interfering with signal transduction.
Successful prone positioning after recent caesarean section in severe ARDS with postpartum pulmonary haemorrhage.
[Antibiotics susceptibilities and other biological properties of methicillin-resistant Staphylococcus aureus: observation in the last 2 years in our university hospital]
[Epidemiological study of Arbekacin-resistant, methicillin resistant Staphylococcus aureus in Saitama Medical School Hospital]
Sinusitis
Bacteriology and beta-lactamase activity in acute and chronic maxillary sinusitis.
Genetic diversity among strains of Moraxella catarrhalis: analysis using multiple DNA probes and a single-locus PCR-restriction fragment length polymorphism method.
Microbial factors leading to recurrent upper respiratory tract infections.
Microbiology and antimicrobial management of sinusitis.
Microbiology and management of sinusitis.
Microbiology of common infections in the upper respiratory tract.
Pharmacokinetic and therapeutic trial of sultamicillin in acute sinusitis.
Pilot study of outcomes in pediatric rhinosinusitis.
Probability of achieving requisite pharmacodynamic exposure for oral beta-lactam regimens against Haemophilus influenzae in children.
Sulbactam/ampicillin in the treatment of otitis and sinusitis.
[Bacteriological study of chronic maxillary sinusitis in adults and observation of susceptibility to antibiotics]
[Epidemiology of bacterial ENT and bronchopulmonary infection in 1998]
[Evaluation of microorganisms ability to beta-lactamase production in exacerbation of chronic sinusitis treated with beta-lactam antibiotics]
Skin Diseases
[Penicillinase activity of Staphylococci isolated from normal subjects (carriers) and also isolated from patients with dermatoses and gonorrhea]
Soft Tissue Infections
Clinical evaluation of aztreonam therapy for serious infections due to gram-negative bacteria.
Methicillin-resistant S. aureus (MRSA), extended-spectrum (ESBL)- and plasmid-mediated AmpC ß-lactamase -producing Gram-negative bacteria associated with skin and soft tissue infections in hospital and community settings.
Prevotella and Porphyromonas infections in children.
Staphylococcal resistance revisited: community-acquired methicillin resistant Staphylococcus aureus--an emerging problem for the management of skin and soft tissue infections.
Therapy of soft tissue infections with piperacillin/tazobactam.
USE OF AMOXICILLIN AND CLAVULANIC ACID (AUGMENTIN) IN THE TREATMENT OF SKIN AND SOFT TISSUE INFECTIONS IN CHILDREN.
Spinal Cord Injuries
Chondroitinase ABCI improves locomotion and bladder function following contusion injury of the rat spinal cord.
Squamous Cell Carcinoma of Head and Neck
Amplification of int-2 and bcl-1 genes in squamous cell carcinoma of the larynx.
Frequent amplification of 11q13 DNA markers is associated with lymph node involvement in human head and neck squamous cell carcinomas.
Frequent amplification of the bcl-1 locus in head and neck squamous cell carcinomas.
Overexpression of cyclin-D1, bcl-2, and bax proteins, proliferating cell nuclear antigen (PCNA), and DNA-ploidy in squamous cell carcinoma of the oral cavity.
Staphylococcal Infections
Antibiotic resistance in Staphylococcus aureus and its relevance in therapy.
Biological activities of Ocimum sanctum L. fixed oil--an overview.
Evaluation in an animal model and in vitro of the combination clavulanic acid and cephalosporins against beta-lactamase producing and nonproducing Staphylococcus aureus strains.
The distribution of pathogens and their antimicrobial susceptibility patterns among canine surgical wound infections in Sweden in relation to different risk factors.
THE ROLE OF PENICILLINASE IN STAPHYLOCOCCAL INFECTIONS.
[Action in staphylococcal infections of benzylpenicillin combination with penicillinase inhibitors (Phenoxymethylpenicillin sulfoxide and benzylpenicillin sulfone)]
[Considerations on MRSA infections in relation to modern chemotherapy]
[Decisive effect on a serious staphylococcal infection of a synthetic penicillin which is unaffected by penicillinase.]
[Intensification of the severity of staphylococcal infection and transduction of determinants of penicillinase activity in experiments on albino mice]
[Observations on staphylococcal infections. Effects of a penicillin insensitive to penicillinase. I. Clinical discussion.]
Stevens-Johnson Syndrome
[Staphylogenous Lyell's syndrome]
Stomach Neoplasms
A Cell-based Single-stranded DNA Aptamer Specifically Targets Gastric Cancer.
A cell-based single-stranded DNA aptamer specifically targetsgastric cancer.
A novel ent-kaurane diterpenoid analog, DN3, selectively kills human gastric cancer cells via acting directly on mitochondria.
A novel HDAC6 inhibitor exerts an anti-cancer effect by triggering cell cycle arrest and apoptosis in gastric cancer.
A novel long noncoding RNA-LOWEG is low expressed in gastric cancer and acts as a tumor suppressor by inhibiting cell invasion.
A Polysaccharide Isolated from Mycelia of the Lion's Mane Medicinal Mushroom Hericium erinaceus (Agaricomycetes) Induced Apoptosis in Precancerous Human Gastric Cells.
Adenovirus-directed expression of TIPE2 suppresses gastric cancer growth via induction of apoptosis and inhibition of AKT and ERK1/2 signaling.
AMPK/mTOR-mediated inhibition of survivin partly contributes to metformin-induced apoptosis in human gastric cancer cell.
An increase in integrin-linked kinase non-canonically confers NF-¿B-mediated growth advantages to gastric cancer cells by activating ERK1/2.
Andrographolide inhibits the adhesion of gastric cancer cells to endothelial cells by blocking E-selectin expression.
ANGPTL2 expression in gastric cancer tissues and cells and its biological behavior.
Anti-proliferation effects of interferon-gamma on gastric cancer cells.
Antitumor activity of ginseng sapogenins, 25-OH-PPD and 25-OCH3-PPD, on gastric cancer cells.
Artesunate inhibits the growth of gastric cancer cells through the mechanism of promoting oncosis both in vitro and in vivo.
Aspeterreurone A, a Cytotoxic Dihydrobenzofuran-Phenyl Acrylate Hybrid from the Deep-Sea-Derived Fungus Aspergillus terreus CC-S06-18.
Attenuation of enoyl coenzyme A hydratase short chain 1 expression in gastric cancer cells inhibits cell proliferation and migration in vitro.
Autophagy-mediated HMGB1 release promotes gastric cancer cell survival via RAGE activation of extracellular signal-regulated kinases 1/2.
Bidirectional regulation between TMEFF2 and STAT3 may contribute to Helicobacter pylori-associated gastric carcinogenesis.
Biosynthesis of gold nanoparticles using chloroplasts.
CCDC134 is down-regulated in gastric cancer and its silencing promotes cell migration and invasion of GES-1 and AGS cells via the MAPK pathway.
Chondromodulin-1 functions as a tumor suppressor in gastric adenocarcinoma.
Chronic CagA-positive Helicobacter pylori infection with MNNG stimulation synergistically induces mesenchymal and cancer stem cell-like properties in gastric mucosal epithelial cells.
Cimetidine inhibits the adhesion of gastric cancer cells expressing high levels of sialyl Lewis x in human vascular endothelial cells by blocking E-selectin expression.
Clinical significance of upregulation of mir-196a-5p in gastric cancer and enriched KEGG pathway analysis of target genes.
Collapsin response mediator protein 4 isoforms (CRMP4a and CRMP4b) have opposite effects on cell proliferation, migration, and invasion in gastric cancer.
Conversion of cadherin isoforms in cultured human gastric carcinoma cells.
Da0324, an inhibitor of nuclear factor-?B activation, demonstrates selective antitumor activity on human gastric cancer cells.
Decreased expression of hsa_circ_0001895 in human gastric cancer and its clinical significances.
Design, synthesis, and biological evaluation of new thiazolo[5,4-d]pyrimidine derivatives as potent antiproliferative agents.
Down-Regulated miRNA-214 Induces a Cell Cycle G1 Arrest in Gastric Cancer Cells by Up-Regulating the PTEN Protein.
Effect of bone morphogenetic protein-2 on proliferation and apoptosis of gastric cancer cells.
Effect of histone modifications on hMLH1 alternative splicing in gastric cancer.
Effects of Birinapant on Proliferation and Invasion of MGC-803 Gastric Cancer Cells and Mechanism Underlying These Effects.
Effects of IL-1? on the proliferation and apoptosis of gastric epithelial cells and acid secretion from isolated rabbit parietal cells.
Effects of miR-362 in Regulating the Proliferation, Invasion and Apoptosis of Gastric Cancer by Inhibiting the Expression of Tumor-Promoting Factor PRDM2.
Effects of miR-384 and miR-134-5p Acting on YY1 Signaling Transduction on Biological Function of Gastric Cancer Cells.
Efficient isolation and proteomic analysis of cell plasma membrane proteins in gastric cancer reveal a novel differentiation and progression related cell surface marker, R-cadherin.
Enhancement of radiotherapy efficacy by miR-200c-loaded gelatinase-stimuli PEG-Pep-PCL nanoparticles in gastric cancer cells.
Epigenetic regulation of CDH1 exon 8 alternative splicing in gastric cancer.
Establishment and characterization of a GES-1 human gastric epithelial cell line stably expressing miR-23a.
Exosomal miR-155-5p promotes proliferation and migration of gastric cancer cells by inhibiting TP53INP1 expression.
Expression and regulatory function of miRNA-34a in targeting survivin in gastric cancer cells.
Expression and role of grainyhead-like 2 in gastric cancer.
Expression and significance of TWIST basic helix-loop-helix protein over-expression in gastric cancer.
Expression of a LINE-1 endonuclease variant in gastric cancer: its association with clinicopathological parameters.
Expression of miR-141 and YAP1 in gastric carcinoma and modulation of cancer cell proliferation and apoptosis.
Expression of pituitary homeobox 1 gene in human gastric carcinogenesis and its clinicopathological significance.
Expression of seven main Rho family members in gastric carcinoma.
Expression of tumor necrosis factor ?-induced protein 8 is upregulated in human gastric cancer and regulates cell proliferation, invasion and migration.
Functions of the AP-2? gene in activating apoptosis and inhibiting proliferation of gastric cancer cells both
GATA-3 augmentation down-regulates Connexin43 in Helicobacter pylori associated gastric carcinogenesis.
GKN2 increases apoptosis, reduces the proliferation and invasion ability of gastric cancer cells through down-regulating the JAK/STAT signaling pathway.
Gold@Silica Nanoparticles Functionalized with Oligonucleotides: A Prominent Tool for the Detection of the Methylated Reprimo Gene in Gastric Cancer by Dynamic Light Scattering.
Gramicidin inhibits human gastric cancer cell proliferation, cell cycle and induced apoptosis.
H. pylori modifies methylation of global genomic DNA and the gastrin gene promoter in gastric mucosal cells and gastric cancer cells.
HAI-178 antibody-conjugated fluorescent magnetic nanoparticles for targeted imaging and simultaneous therapy of gastric cancer.
Helicobacter pylori induces malignant transformation of gastric epithelial cells in vitro.
High expression of GM? is associated with poor prognosis of gastric cancer patients.
HTRA1 gene expression in gastric epithelial cells.
Hydrotalcite Can Prevent the Damaging Effects of Helicobacter Pylori on Gastric Epithelial Cells.
Identification of volatile biomarkers of gastric cancer cells and ultrasensitive electrochemical detection based on sensing interface of Au-Ag alloy coated MWCNTs.
Increased expression of long intergenic non-coding RNA LINC00152 in gastric cancer and its clinical significance.
Inhibition of Proliferation of SGC7901 and BGC823 Human Gastric Cancer Cells by Ursolic Acid Occurs Through a Caspase-Dependent Apoptotic Pathway.
Inhibition of Vav3 could reverse the drug resistance of gastric cancer cells by downregulating JNK signaling pathway.
JWA reverses cisplatin resistance via the CK2-XRCC1 pathway in human gastric cancer cells.
KLK6 Promotes Growth, Migration, and Invasion of Gastric Cancer Cells.
Long intergenic non-protein coding RNA 1006 used as a potential novel biomarker of gastric cancer.
Long non-coding RNA NEAT1 increases the aggressiveness of gastric cancer by regulating the microRNA-142-5p/JAG1 axis.
Long noncoding RNA NEAT1-modualted miR-506 regulates gastric cancer development through targeting STAT3.
Low expression of hsa_circ_0006633 in human gastric cancer and its clinical significances.
Low expression of lncRNA-HMlincRNA717 in human gastric cancer and its clinical significances.
Mesenchymal stem cell-based NK4 gene therapy in nude mice bearing gastric cancer xenografts.
MicroRNA-134 suppresses cell proliferation in gastric cancer cells via targeting of GOLPH3.
MicroRNA-137 Contributes to Dampened Tumorigenesis in Human Gastric Cancer by Targeting AKT2.
MicroRNA-140 Inhibits Cell Proliferation in Gastric Cancer Cell Line HGC-27 by Suppressing SOX4.
MicroRNA-183 inhibits gastric cancer proliferation and invasion via directly targeting Bmi-1.
MicroRNA-23 regulates the growth, metastasis and chemosensitivity of human gastric cancer cells by targeting MAP3K9.
MicroRNA-30a-5p inhibits the proliferation and invasion of gastric cancer cells by targeting insulin-like growth factor 1 receptor.
MicroRNA-3178 ameliorates inflammation and gastric carcinogenesis promoted by Helicobacter pylori new toxin, Tip-?, by targeting TRAF3.
MicroRNA-335 acts as a metastasis suppressor in gastric cancer by targeting Bcl-w and specificity protein 1.
MicroRNA-495 Inhibits Gastric Cancer Cell Migration and Invasion Possibly via Targeting High Mobility Group AT-Hook 2 (HMGA2).
MicroRNA-524-5p suppresses the growth and invasive abilities of gastric cancer cells.
miR-129-5p attenuates cell proliferation and epithelial mesenchymal transition via HMGB1 in gastric cancer.
MiR-129-5p inhibits proliferation of gastric cancer cells through targeted inhibition on HMGB1 expression.
MiR-135a targets JAK2 and inhibits gastric cancer cell proliferation.
miR-148a suppresses cell invasion and migration in gastric cancer by targeting DNA methyltransferase 1.
miR-199a-3p targets ETNK1 to promote invasion and migration in gastric cancer cells and is associated with poor prognosis.
miR-218 inhibits proliferation, migration, and EMT of gastric cancer cells by targeting WASF3.
MiR-221 affects proliferation and apoptosis of gastric cancer cells through targeting SOCS3.
MMP-9 is increased in the pathogenesis of gastric cancer by the mediation of HER2.
Molecular mechanisms of MCM3AP-AS1 targeted the regulation of miR-708-5p on cell proliferation and apoptosis in gastric cancer cells.
Notch1 and PI3K/Akt signaling blockers DAPT and LY294002 coordinately inhibit metastasis of gastric cancer through mutual enhancement.
NRAGE confers poor prognosis and promotes proliferation, invasion, and chemoresistance in gastric cancer.
Over-expression of FRZB in gastric cancer cell suppresses proliferation and induces differentiation.
PCDH17 gene promoter demethylation and cell cycle arrest by genistein in gastric cancer.
PCDHGA9 acts as a tumor suppressor to induce tumor cell apoptosis and autophagy and inhibit the EMT process in human gastric cancer.
Phosphorylation of TOB1 at T172 and S320 is critical for gastric cancer proliferation and progression.
Pin1 is overexpressed and correlates with poor prognosis in gastric cancer.
Piperine Inhibits Cell Proliferation and Induces Apoptosis of Human Gastric Cancer Cells by Downregulating Phosphatidylinositol 3-Kinase (PI3K)/Akt Pathway.
Pre-treatment of human umbilical cord-derived mesenchymal stem cells with interleukin-6 abolishes their growth-promoting effect on gastric cancer cells.
Propofol inhibited gastric cancer proliferation via the hsa-miR-328-3p/STAT3 pathway.
Quercetin from Polygonum capitatum Protects against Gastric Inflammation and Apoptosis Associated with Helicobacter pylori Infection by Affecting the Levels of p38MAPK, BCL-2 and BAX.
Reduced expression of PTEN and increased PTEN phosphorylation at residue Ser380 in gastric cancer tissues: A novel mechanism of PTEN inactivation.
RhoC is essential for the metastasis of gastric cancer.
Rosmarinic Acid Analogue-11 Induces Apoptosis of Human Gastric Cancer SGC-7901 Cells via the Epidermal Growth Factor Receptor (EGFR)/Akt/Nuclear Factor kappa B (NF-?B) Pathway.
RUNX3-mediated transcriptional inhibition of Akt suppresses tumorigenesis of human gastric cancer cells.
Serum Interleukin-33 Levels in Patients with Gastric Cancer.
Silenced PITX1 promotes chemotherapeutic resistance to 5-fluorocytosine and cisplatin in gastric cancer cells.
Silencing the YB-1 gene inhibits cell migration in gastric cancer in vitro.
Stigmasterol exhibits potent antitumor effects in human gastric cancer cells mediated via inhibition of cell migration, cell cycle arrest, mitochondrial mediated apoptosis and inhibition of JAK/STAT signalling pathway.
Stress-induced cytotoxicity of chiral Ag nanoclusters.
Suppression of PTP1B in gastric cancer cells in vitro induces a change in the genome-wide expression profile, and inhibits gastric cancer cell growth.
Suppression of tumor growth by Pleurotus ferulae ethanol extract through induction of cell apoptosis, and inhibition of cell proliferation and migration.
The clinical significance of downregulation of mir-124-3p, mir-146a-5p, mir-155-5p and mir-335-5p in gastric cancer tumorigenesis.
The effect of antisense inhibitor of miRNA 106b?25 on the proliferation, invasion, migration, and apoptosis of gastric cancer cell.
The interaction between RACK1 and WEE1 regulates the growth of gastric cancer cell line HGC27.
The Role of Tumoral FOXP3 on Cell Proliferation, Migration, and Invasion in Gastric Cancer.
Thymoquinone induces cytotoxicity and reprogramming of EMT in gastric cancer cells by targeting PI3K/Akt/mTOR pathway.
TIPE2 functions as a metastasis suppressor via negatively regulating ?-catenin through activating GSK3? in gastric cancer.
Totarol, a natural diterpenoid, induces selective antitumor activity in SGC-7901 human gastric carcinoma cells by triggering apoptosis, cell cycle disruption and suppression of cancer cell migration.
Transcription Factor Myeloid Zinc-Finger 1 Suppresses Human Gastric Carcinogenesis by Interacting with Metallothionein 2A.
Umbelliprenin isolated from Ferula sinkiangensis inhibits tumor growth and migration through the disturbance of Wnt signaling pathway in gastric cancer.
Xiao Tan He Wei Decoction reverses MNNG-induced precancerous lesions of gastric carcinoma in vivo and vitro: Regulation of apoptosis through NF-?B pathway.
YAP promotes gastric cancer cell survival and migration/invasion via the ERK/endoplasmic reticulum stress pathway.
ZNF139 promotes tumor metastasis by increasing migration and invasion in human gastric cancer cells.
[Decreased expression of Cx32 and Cx43 and their function of gap junction intercellular communication in gastric cancer]
[Differentially expressed circular RNAs in human gastric cancer cells].
[Effect and mechanism of Vav3 on the proliferation of human gastric cancer SGC7901 cells].
[Effect of Abl-interacting protein 1 overexpression upon human gastric cancer cell proliferation in vitro]
[Effect of miR-513a-3p targeting MDM2 on proliferation, migration and invasion of gastric cancer cells].
[Effects of ginsenoside Rg5 on cell cycle and invasion of gastric cancer].
[Effects of Helicobacter pylori and Helicobacter pylori-related cytokines on apoptosis of gastric epithelial cells and mechanisms thereof]
[Expression and clinical significance of cancer-related gene MPS-1 in gastric cancer]
[Expression and intracellular localization of FRZB gene in gastric cancer and its significance.]
[Expression of NEK-6 in gastric cancer and its clinical significance].
[Expression of OCT4 in gastric cancer cell lines and its significance].
[miR-449a/b negatively regulates E2F1 to suppress proliferation of gastric cancer cells].
[P28GANK is a novel marker for prognosis and therapeutic target in gastric cancer].
[Polyadenylation signal-deficient retroviruses transformation of human gastric epithelial GES-1 cells]
[Preparation of PHF10 antibody and analysis of PHF10 expression gastric cancer tissues.]
Stomach Ulcer
A unique polysaccharide purified from Hericium erinaceus mycelium prevents oxidative stress induced by H2O2 in human gastric mucosa epithelium cell.
Streptococcal Infections
Activity of a broad-spectrum cephalosporin (Ro 48-8391) alone and in combination with two novel beta-lactamase inhibitors (Ro 48-5545 and Ro 48-8724).
Subphrenic Abscess
Meropenem-Vaborbactam as Salvage Therapy for Ceftazidime-Avibactam-Resistant Klebsiella pneumoniae Bacteremia and Abscess in a Liver Transplant Recipient.
Superinfection
Infectious morbidity in gynecologic cancer.
Surgical Wound Infection
High carriage rate of extended-spectrum beta-lactamase-producing Enterobacteriaceae among patients admitted for surgery in Tanzanian hospitals with a low rate of endogenous surgical site infections.
Membrane-active macromolecules kill antibiotic-tolerant bacteria and potentiate antibiotics towards Gram-negative bacteria.
Wound infection in head and neck surgery: implications for perioperative antibiotic treatment.
Syphilis
A novel beta-lactamase activity from a penicillin-binding protein of Treponema pallidum and why syphilis is still treatable with penicillin.
Tetanus
Adjuvant activity of Mycobacterium bovis BCG expressing CRM197 on the immune response induced by BCG expressing tetanus toxin fragment C.
Development of a nonantibiotic dominant marker for positively selecting expression plasmids in multivalent Salmonella vaccines.
Generation of an expression library in the baculovirus expression vector system.
Study of anti tetanus IgG and IgM levels in maternal and cord sera by enzyme linked immunosorbent assay (ELISA).
Thrombosis
Meropenem-Vaborbactam as Salvage Therapy for Ceftazidime-Avibactam-Resistant Klebsiella pneumoniae Bacteremia and Abscess in a Liver Transplant Recipient.
Renal vein thrombosis complicating severe acute pyelonephritis with renal abscesses and associated bacteraemia caused by extended-spectrum beta-lactamase producing Escherichia coli.
Tics
Resistance to beta-lactams in Enterobacteriaceae: distribution of phenotypes related to beta-lactamase production.
Tonsillitis
Acute Tonsillitis.
Bacteriology of normal and diseased tonsils assessed by fine-needle aspiration: Haemophilus influenzae and the pathogenesis of recurrent acute tonsillitis.
Comparison of the surface and core bacteria in tonsillar and adenoid tissue with Beta-lactamase production.
Emergence of beta-lactamase producing anaerobic bacteria in the tonsils during penicillin treatment.
Evaluation of beta-lactamase activity and microbial interference in treatment failures of acute streptococcal tonsillitis.
In vitro protection of group A beta-hemolytic streptococci from penicillin and cephalothin by Bacteroides fragilis.
Management of tonsillitis by the general practitioner.
Microbial factors leading to recurrent upper respiratory tract infections.
Microbiology of obstructive tonsillar hypertrophy and recurrent tonsillitis.
The role of beta-lactamase producing bacteria and bacterial interference in streptococcal tonsillitis.
Tonsil surface and core cultures in recurrent tonsillitis: prevalence of anaerobes and beta-lactamase producing organisms.
Treatment of patients with acute recurrent tonsillitis due to group A beta-haemolytic streptococci: a prospective randomized study comparing penicillin and amoxycillin/clavulanate potassium.
[Bacteriological and clinical evaluation of BRL 25000 (clavulanic acid-amoxicillin) granules in the pediatric field]
[Beta-lactamase-producing bacteria in recurrent childhood tonsillitis]
Toxoplasmosis
Enzyme linked immunosorbent assay using penicillinase in serodiagnosis of toxoplasmosis.
Usage of penicillinase as an enzyme marker in enzyme linked immunosorbent assay for the detection of IgG antibodies to Toxoplasma gondii.
Travel-Related Illness
Molecular Characteristics of Travel-Related Extended-Spectrum {beta}-lactamase producing Escherchia coli from the Calgary Health Region.
Tuberculosis
"Roar" of blaNDM-1 and "silence" of blaOXA-58 co-exist in Acinetobacter pittii.
Amoxicillin-clavulanic acid for treating drug-resistant Mycobacterium tuberculosis.
Antimicrobial activity of pomegranate fruit constituents against drug-resistant Mycobacterium tuberculosis and ?-lactamase producing Klebsiella pneumoniae.
Beta-lactamase can function as a reporter of bacterial protein export during Mycobacterium tuberculosis infection of host cells.
beta-Lactamase inhibitors and the inducibility of the beta-lactamase of Mycobacterium tuberculosis.
Beta-lactamases of Mycobacterium tuberculosis and Mycobacterium kansasii.
Biochemical and structural characterization of Mycobacterium tuberculosis beta-lactamase with the carbapenems ertapenem and doripenem.
Can penicillins and other beta-lactam antibiotics be used to treat tuberculosis?
Cloning and sequence analysis of a class A beta-lactamase from Mycobacterium tuberculosis H37Ra.
Comparison of four beta-lactamase inhibitors in combination with ampicillin against Mycobacterium tuberculosis.
Contribution of beta-lactamases to beta-lactam susceptibilities of susceptible and multidrug-resistant Mycobacterium tuberculosis clinical isolates.
Crystal structure and activity studies of the Mycobacterium tuberculosis beta-lactamase reveal its critical role in resistance to beta-lactam antibiotics.
Detection of free and immune-complexed serine protease and its antibody in TB patients with and without HIV co-infection.
Detection of New Delhi metallo-beta-lactamase enzyme gene blaNDM-1 associated with the Int-1 gene in Gram-negative bacteria collected from the effluent treatment plant of a tuberculosis care hospital in Delhi, India.
Diagnostic potential of fractionatedMycobacterium tuberculosis H(37)R(a) excretory-secretory (EST-DE(1)) antigen in pulmonary tuberculosis.
Distribution and characterization of beta-lactamases of mycobacteria and related organisms.
Emergence of potential superbug mycobacterium tuberculosis, lessons from new delhi mutant-1 bacterial strains.
Ertapenem and Faropenem against Mycobacterium tuberculosis: in vitro testing and comparison by macro and microdilution.
Genetic analysis of the beta-lactamases of Mycobacterium tuberculosis and Mycobacterium smegmatis and susceptibility to beta-lactam antibiotics.
Genome-wide regulon and crystal structure of BlaI (Rv1846c) from Mycobacterium tuberculosis.
Identification of functional Tat signal sequences in Mycobacterium tuberculosis proteins.
Identification of Mycobacterium tuberculosis signal sequences that direct the export of a leaderless beta-lactamase gene product in Escherichia coli.
Imaging tuberculosis with endogenous beta-lactamase reporter enzyme fluorescence in live mice.
Immunodiagnosis of childhood pulmonary and extrapulmonary tuberculosis using Mycobacterium tuberculosis ES antigen by penicillinase ELISA.
Impact of ?-lactamase inhibition on the activity of ceftaroline against Mycobacterium tuberculosis and Mycobacterium abscessus.
In vitro and in vivo efficacy of beta-lactams against replicating and slowly growing/non replicating M. tuberculosis.
In vitro released antigens in diagnosis and immunomonitoring of filaria and tuberculosis.
Irreversible Inhibition of the Mycobacterium tuberculosis beta-Lactamase by Clavulanate.
Meropenem-clavulanate is effective against extensively drug-resistant Mycobacterium tuberculosis.
Molecular cloning, overexpression and biochemical characterization of hypothetical beta-lactamases of Mycobacterium tuberculosis H37Rv.
Penicillinase ELISA for detection of tubercular antigen in tuberculosis.
Recombinant expression and characterization of the major beta-lactamase of Mycobacterium tuberculosis.
Sero-reactivity of two different antigenic protein fractions of M.tb H37Ra excretory-secretory antigen in pulmonary and extra-pulmonary tuberculosis.
Serodiagnosis of childhood tuberculosis by ELISA.
Seroreactivity of 31 kDa and 41 kDa mycobacterial secretory proteins isolated from culture filtrate in extra pulmonary tuberculosis.
Structure of the covalent adduct formed between Mycobacterium tuberculosis beta-lactamase and clavulanate.
Susceptibility of multidrug-resistant strains of Mycobacterium tuberculosis to amoxycillin in combination with clavulanic acid and ethambutol.
Syntheses and Biological Evaluations of Highly Functionalized Hydroxamate Containing and N-Methylthio Monobactams as Anti-Tuberculosis and ?-Lactamase Inhibitory Agents.
Synthesis and biological evaluation of indole core-based derivatives with potent antibacterial activity against resistant bacterial pathogens.
Tackling Threats and Future Problems of Multidrug-Resistant Bacteria.
The effect of the penicillinase-resistant penicillins and other chemotherapeutic substances on the penicillinase of the R1Rv strain of Mycobacterium tuberculosis.
The in vitro activity of beta-lactamase inhibitors in combination with cephalosporins against M. tuberculosis.
The Mycobacterium tuberculosis protein LdtMt2 is a nonclassical transpeptidase required for virulence and resistance to amoxicillin.
The vitro efficacy of beta-lactam and beta-lactamase inhibitors against multidrug resistant clinical strains of Mycobacterium tuberculosis.
Tuberculosis and beta-lactam antibiotics.
Use of beta-lactam/beta-lactamase-inhibitor combinations as antimycobacterial agents.
Virtual screening and repositioning of inconclusive molecules of beta-lactamase Bioassays-A data mining approach.
[A study of beta-lactamase activity of mycobacteria and clinical trial of penicillin/beta-lactamase inhibitor combinations in the treatment of drug-resistant Mycobacterium tuberculosis]
[Cephalosporins as possible methods of etiotropic therapy of tuberculosis]
Tuberculosis, Meningeal
Mycobacterial excretory secretory-31 protein with serine protease and lipase activities: An immunogen and drug target against tuberculosis infection.
Penicillinase ELISA for detection of tubercular antigen in tuberculosis.
Sero-reactivity of two different antigenic protein fractions of M.tb H37Ra excretory-secretory antigen in pulmonary and extra-pulmonary tuberculosis.
Seroreactivity of 31 kDa and 41 kDa mycobacterial secretory proteins isolated from culture filtrate in extra pulmonary tuberculosis.
Tuberculosis, Multidrug-Resistant
New experimental drugs for the treatment of tuberculosis.
Tuberculosis, Osteoarticular
Sero-reactivity of two different antigenic protein fractions of M.tb H37Ra excretory-secretory antigen in pulmonary and extra-pulmonary tuberculosis.
Seroreactivity of 31 kDa and 41 kDa mycobacterial secretory proteins isolated from culture filtrate in extra pulmonary tuberculosis.
Tuberculosis, Pulmonary
Diagnostic potential of fractionatedMycobacterium tuberculosis H(37)R(a) excretory-secretory (EST-DE(1)) antigen in pulmonary tuberculosis.
Mycobacterium tuberculosis H(37)Ra ESAS-7-An excretory-secretory antigen fraction of immunodiagnostic potential in pulmonary tuberculosis.
Penicillinase ELISA for detection of tubercular antigen in tuberculosis.
Seroreactivity of 31 kDa and 41 kDa mycobacterial secretory proteins isolated from culture filtrate in extra pulmonary tuberculosis.
Tularemia
The Bla2 beta-lactamase from the live-vaccine strain of Francisella tularensis encodes a functional protein that is only active against penicillin-class beta-lactam antibiotics.
[Isolation and purification of penicillinase from Francisella tularensis]
[Mechanism of natural penicillin resistance in the causative agent of tularemia]
Typhoid Fever
Clinical isolates of Salmonella enterica serovar Agona producing NDM-1 metallo-?-lactamase: first report from Pakistan.
Emergence of multi-drug resistance among beta-lactamase producing Salmonella.
ESBL-producing strains isolated from imported cases of enteric fever in England and Wales reveal multiple chromosomal integrations of blaCTX-M-15 in XDR Salmonella Typhi.
Urethritis
A comparison of penicillin G plus a beta-lactamase inhibitor (sulbactam) with spectinomycin for treatment of urethritis caused by penicillinase-producing Neisseria gonorrhoeae.
Efficacy of pefloxacin in acute gonococcal urethritis.
Evaluation of a DNA-hybridization method for detection of African and Asian strains of Neisseria gonorrhoeae in men with urethritis.
Haemophilus parainfluenzae causing sexually transmitted urethritis. Report of a case and evidence for a beta-lactamase plasmid mobilizable to Escherichia coli by an Inc-W plasmid.
Norfloxacin in the treatment of gonorrhea due to penicillinase and non-penicillinase producing Neisseria gonorrheae: a review.
Purification and characterization of beta-lactamase from Neisseria gonorrhoeae from clinical samples.
Single dose piperacillin in treating uncomplicated gonococcal urethritis in men.
Single dose treatment of gonococcal urethritis with augmentin in Ibadan.
Single oral dose of azithromycin for therapy of susceptible sexually transmitted diseases: a multicenter open evaluation.
Sultamicillin in the treatment of gonorrhoea caused by penicillin sensitive and penicillinase producing strains of Neisseria gonorrhoeae.
Treating gonococcal urethritis in men: oral amoxycillin potentiated by clavulanate compared with intramuscular procaine penicillin.
[Gonococci producing beta-lactamase in male urethritis]
Urinary Tract Infections
A case of New Delhi metallo-beta-lactamase 1 (NDM-1)-producing Klebsiella pneumoniae from the Balkan in the Netherlands with putative secondary transmission.
A new case report of urinary tract infection due to KPC-3-producing klebsiella pneumoniae (ST258) in Spain.
A rare emergence of resistance to ceftolozane/tazobactam in Klebsiella pneumoniae causing urinary tract infection.
A report on the presence of GES-5 extended spectrum beta-lactamase producing Pseudomonas aeruginosa associated with urinary tract infection from north-east India.
A trial with IgY chicken antibodies to eradicate faecal carriage of Klebsiella pneumoniae and Escherichia coli producing extended-spectrum beta-lactamases.
Activity of ertapenem and other antimicrobials against ESBL-producing enterobacteria isolated from urine in patients from Madrid.
Activity of fosfomycin alone or combined with cefoxitin in vitro and in vivo in a murine model of urinary tract infection due to Escherichia coli harbouring CTX-M-15-type extended-spectrum ?-lactamase.
Antibacterial activities of essential oils from Iranian medicinal plants on extended-spectrum ?-lactamase-producing Escherichia coli.
Antibacterial Activity of Some Plant Extracts Against Extended- Spectrum Beta-Lactamase Producing Escherichia coli Isolates.
Antibacterial activity of Syzygium aromaticum (clove) against uropathogens producing ESBL, MBL, and AmpC beta-lactamase: Are we close to getting a new antibacterial agent?
Antimicrobial resistance and beta-lactamase production of Escherichia coli causing canine urinary tract infections: Passive surveillance of laboratory isolates in Saskatoon, Canada, 2014.
Antimicrobial susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in health care-associated urinary tract infection: focus on susceptibility to fosfomycin.
Antimicrobial susceptibility, risk factors and prevalence of bla cefotaximase, temoneira, and sulfhydryl variable genes among Escherichia coli in community-acquired pediatric urinary tract infection.
Bacterial Profiles and Their Associated Factors of Urinary Tract Infection and Detection of Extended Spectrum Beta-Lactamase Producing Gram-Negative Uropathogens Among Patients with Diabetes Mellitus at Dessie Referral Hospital, Northeastern Ethiopia.
Bactericidal activity of oral beta-lactam antibiotics in plasma and urine versus isogenic Escherichia coli strains producing broad- and extended-spectrum beta-lactamases.
Beta-lactam resistance in clinical isolates of Escherichia coli caused by elevated production of the ampC-mediated chromosomal beta-lactamase.
beta-lactamase production by strains of Escherichia coli of intermediate susceptibility to beta-lactam antibiotics. A study of their clinical significance in urinary tract infection.
Carbapenem versus fosfomycin tromethanol in the treatment of extended-spectrum beta-lactamase-producing Escherichia coli-related complicated lower urinary tract infection.
Carriage of Extended-Spectrum-Beta-Lactamase- and AmpC Beta-Lactamase-Producing Escherichia coli Strains from Humans and Pets in the Same Households.
Cefepime versus carbapenems for the treatment of urinary tract infections caused by extended-spectrum beta-lactamase producing enterobacteriaceae.
Ceftazidime-Avibactam Combination Therapy Compared to Ceftazidime-Avibactam Monotherapy for the Treatment of Severe Infections Due to Carbapenem-Resistant Pathogens: A Systematic Review and Network Meta-Analysis.
Ceftazidime/avibactam: a novel cephalosporin/nonbeta-lactam beta-lactamase inhibitor for the treatment of complicated urinary tract infections and complicated intra-abdominal infections.
Challenges to Early Discharge of Patients with Upper Urinary Tract Infections by ESBL Producers: TMP/SMX as a Step-Down Therapy for Shorter Hospitalization and Lower Costs.
Characterization of a NDM-7 carbapenemase-producing Escherichia coli ST410 clinical strain isolated from a urinary tract infection in China.
Characterization of a new plasmid-mediated extended-spectrum beta-lactamase from Serratia marcescens.
Characterization of blaCMY-11, an AmpC-type plasmid-mediated beta-lactamase gene in a Korean clinical isolate of Escherichia coli.
Ciprofloxacin and co-trimoxazole resistance and extended spectrum beta-lactamase production in Escherichia coli strains isolated from urinary tract infections.
Clavulanate combinations with mecillinam, cefixime or cefpodoxime against ESBL-producing Enterobacterales frequently associated with blaOXA-1 in a paediatric population with febrile urinary tract infections.
Clinical and bacteriological efficacy of amikacin in the treatment of lower urinary tract infection caused by extended-spectrum beta-lactamase-producing Escherichia coli or Klebsiella pneumoniae.
Clinical and Economic Impact of Community-Onset Urinary Tract Infections Caused by ESBL-Producing Klebsiella pneumoniae Requiring Hospitalization in Spain: An Observational Cohort Study.
Clinical and economic impact of urinary tract infections caused by ESBL-producing Escherichia coli requiring hospitalization: A matched cohort study.
Clinical and laboratory profiles of urinary tract infections caused by extended-spectrum beta-lactamase-producing Escherichia coli in a tertiary care center in central Saudi Arabia.
Clinical and molecular analysis of extended-spectrum {beta}-lactamase-producing enterobacteria in the community setting.
Clinical features of multidrug-resistant organism infections in early postoperative solid organ transplantation in a single center.
Clinical outcomes of urinary tract infection caused by extended spectrum beta-lactamase producing Enterobacteriaceae: a retrospective observational study comparing patients with and without systemic inflammatory response syndrome.
Clinical patterns, epidemiology and risk factors of community-acquired urinary tract infection caused by extended-spectrum beta-lactamase producers: a prospective hospital case-control study.
Clonal dissemination of highly virulent extended-spectrum beta-lactamase-producing Escherichia coli strains isolated from the urine of non-hospitalised patients in Zagreb region.
Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum beta-lactamases in the UK.
Comparison of community-onset healthcare-associated and hospital-acquired urinary infections caused by extended-spectrum beta-lactamase-producing Escherichia coli and antimicrobial activities.
CTX-M-producing Escherichia coli and Klebsiella pneumoniae isolated from community-acquired urinary tract infections in Valledupar, Colombia.
Daptomycin for a complicated urinary tract infection with vancomycin-resistant Enterococcus faecium in a renal transplant recipient.
Detection of extended-spectrum beta-lactamase production in Enterobacteriales from patients with suspected urinary tract infections, Tabora region, Rural Tanzania.
Differences in the antibiotic susceptibility of human Escherichia coli with poultry-associated and non-poultry-associated extended-spectrum beta-lactamases.
Differential effects of chromosome and plasmid blaCTX-M-15 genes on antibiotic susceptibilities in extended-spectrum beta-lactamase-producing Escherichia coli isolates from patients with urinary tract infection.
Distribution of Pathogenicity Island Markers and H-Antigen Types of Escherichia coli O25b/ST131 Isolates from Patients with Urinary Tract Infection in Iran.
Editorial Comment to Differential effects of chromosome and plasmid blaCTX-M-15 genes on antibiotic susceptibilities in extended-spectrum beta-lactamase-producing Escherichia coli isolates from patients with urinary tract infection.
Effect of clavulanic acid and amoxycillin formulation against beta-lactamase producing Gram-negative bacteria in urinary tract infections.
Effect of tannin extract against Pseudomonas aeruginosa producing metallo beta-lactamase.
Efficacy of BRL 25000 against Serratia marcescens, Enterobacter cloacae, and Citrobacter freundii in urinary tract infections.
Efficacy of cefoxitin for the treatment of urinary tract infection due to extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates.
Efficacy of cefoxitin versus carbapenem in febrile male urinary tract infections caused by extended spectrum beta-lactamase-producing Escherichia coli: a multicenter retrospective cohort study with propensity score analysis.
Efficacy of non-carbapenem antibiotics for pediatric patients with first febrile urinary tract infection due to extended-spectrum beta-lactamase-producing Escherichia coli.
Emergence of metallo-beta-lactamase producing Pseudomonas aeruginosa in Pakistan.
Emergence of NDM-1- and IMP-14a-producing Enterobacteriaceae in Thailand.
Emergence of New Delhi metallo-?-lactamase 1 (NDM-1) Producing and Multidrug Resistant Uropathogens Causing Urinary Tract Infections in Andaman Islands, India.
Epidemiological and clinical complexity of amoxicillin-clavulanate-resistant Escherichia coli.
Epidemiology of urinary tract infections caused by extended-spectrum beta-lactamase-producing Escherichia coli.
Epidemiology, risk factors and comorbidity for urinary tract infections caused by extended-spectrum beta-lactamase (ESBL)-producing enterobacteria.
Escherichia coli belonging to ST131 rarely transfers blactx-m-15 to fecal Escherichia coli.
Experience with fosfomycin in the treatment of complicated urinary tract infections caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae.
Extended spectrum beta-lactamase production and fluorquinolone resistance in pathogens associated with community acquired urinary tract infection.
Extended spectrum beta-lactamase urinary tract infections.
Extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae and urinary tract infections in pregnant/post-partum women: a systematic review and meta-analysis.
Extended-spectrum beta-lactamase Escherichia coli and Klebsiella pneumoniae urinary tract infections.
Extended-spectrum beta-lactamase-positive Escherichia coli causing complicated upper urinary tract infection: Urologist should act in time.
Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae from urinary tract infections: Evolution of antimicrobial resistance and treatment options.
Extended-spectrum beta-lactamases in urinary isolates of Escherichia coli, Klebsiella pneumoniae and other gram-negative bacteria in a hospital in Eastern Province, Saudi Arabia.
Extended-spectrum-Beta-lactamase producing bacteria related urinary tract infection in renal transplant recipients and effect on allograft function.
First clinical cases of NDM-1-producing Klebsiella pneumoniae from two hospitals in Bulgaria.
First detection of CTX-M and SHV extended-spectrum beta-lactamases in Escherichia coli urinary tract isolates from dogs and cats in the United States.
Frequency assessment of ?-lactamase enzymes in Escherichia coli and Klebsiella isolates in patients with urinary tract infection.
Genome Sequence of Escherichia coli Clone O25:H4 Sequence Type 131, Isolated from a Sudanese Patient with Urinary Tract Infection.
Genomics and Virulence of Klebsiella pneumoniae Kpnu95 ST1412 Harboring a Novel Incf Plasmid Encoding Blactx-M-15 and Qnrs1 Causing Community Urinary Tract Infection.
Genotypic and Phenotypic Characterization of IncX3 Plasmid Carrying blaNDM-7 in Escherichia coli Sequence Type 167 Isolated From a Patient With Urinary Tract Infection.
Genotypic to Phenotypic Resistance Discrepancies Identified Involving ?-Lactamase Genes, blaKPC, blaIMP, blaNDM-1, and blaVIM in Uropathogenic Klebsiella pneumoniae.
Healthcare costs doubled when children had urinary tract infections caused by extended-spectrum ?-lactamase-producing bacteria.
High occurrence of blaCMY-1 AmpC lactamase producing Escherichia coli in cases of complicated urinary tract infection (UTI) from a tertiary health care centre in north India.
High prevalence of CTX-M-15 and first report of CTX-M-3, CTX-M-22, CTX-M-28 and plasmid-mediated AmpC beta-lactamase producing Enterobacteriaceae causing urinary tract infections in Bosnia and Herzegovina in hospital and community settings.
High Prevalence of Extended-Spectrum Beta-Lactamases in Escherichia coli Strains Collected From Strictly Defined Community-Acquired Urinary Tract Infections in Adults in China: A Multicenter Prospective Clinical Microbiological and Molecular Study.
Identity of blaCTX-M Carrying Plasmids in Sequential ESBL-E. coli Isolates from Patients with Recurrent Urinary Tract Infections.
Impact of reflex fosfomycin E-testing on the utilization of carbapenems for definitive extended-spectrum beta-lactamase Escherichia coli urinary tract infection treatment.
In vitro activity of fosfomycin and other antimicrobials against uropathogenic Escherichia coli and Klebsiella pneumoniae at a tertiary care center in Lebanon.
In vitro activity of temocillin against extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae strains isolated from urinary tract infections in France.
Incidence of beta-lactamase producing E. coli in urinary tract infections.
Incidence of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in patients with urinary tract infection.
Incidence of multidrug resistance and extended-spectrum beta-lactamase expression in community-acquired urinary tract infection among different age groups of patients.
Increase resistant rates and ESBL production between E. coli isolates causing urinary tract infection in young patients from Iran.
Infection Control Following an Outbreak of Extended-Spectrum Beta-Lactamase-Producing Klebsiella pneumoniae Isolated from Catheter-Associated Urinary Tract Infection.
Infections with extended-spectrum beta-lactamase-producing enterobacteriaceae: changing epidemiology and drug treatment choices.
Intestinal carriage of Extended Spectrum Beta-Lactamase producing E. coli in women with urinary tract infections, Cameroon.
Investigation of risk factors for community-acquired urinary tract infections caused by extended-spectrum beta-lactamase Escherichia coli and Klebsiella species.
Klebsiella pneumoniae carbapenemase (KPC) in urinary infection isolates.
Long-term outcomes of inappropriate antibiotic therapy for upper urinary tract infections caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae: a retrospective cohort study.
Low relapse rate of urinary tract infections from extended-spectrum beta-lactamase-producing bacteria in young children.
Management of Extended-Spectrum Beta-Lactamase Urinary Tract Infections: Diagnostic and Treatment Considerations for the Older Adult.
Managing ESBL-producing Enterobacteriaceae-related urinary tract infection in primary care: a tool kit for general practitioners.
Maternal antibiotic exposure during pregnancy is a risk factor for community-acquired urinary tract infection caused by extended-spectrum beta-lactamase-producing bacteria in infants.
Metallo beta-lactamase producing pseudomonas species--a major cause of concern among hospital associated urinary tract infection.
Molecular characteristics of extended-spectrum beta-lactamase-producing Escherichia coli from the Chicago area: high prevalence of ST131 producing CTX-M-15 in community hospitals.
Molecular epidemiology of multiresistant Escherichia coli isolates from community-onset urinary tract infections in Cornwall, England.
Multicategory interpretive reporting of susceptibility testing with selected antimicrobial concentrations. Ten years of laboratory and clinical experience.
Multidrug resistant and carbapenemase producing Enterobacteriaceae among patients with urinary tract infection at referral Hospital, Northwest Ethiopia.
Multidrug-resistant and extended-spectrum beta-lactamase-producing uropathogens in children in Bhaktapur, Nepal.
Multiomics Assessment of Gene Expression in a Clinical Strain of CTX-M-15-Producing ST131 Escherichia coli.
NDM-1 producers as causative agents of nosocomial urinary tract infections.
Nosocomial bacteremia and urinary tract infections caused by extended-spectrum beta -lactamase-producing Klebsiella pneumoniae with plasmids carrying both SHV-5 and TLA-1 genes.
Nosocomial urinary tract infections caused by extended-spectrum beta-lactamase uropathogens: Prevalence, pathogens, risk factors, and strategies for infection control.
Persistent extended-spectrum beta-lactamase urinary tract infection.
Persistent infection with metallo-beta-lactamase and extended spectrum ?-lactamase producer Morganella morganii in a patient with urinary tract infection after kidney transplantation.
Pharmacokinetics/Pharmacodynamics of Vaborbactam, a Novel Beta-Lactamase Inhibitor, in Combination with Meropenem.
Phenotypic and genotypic evaluation of beta-lactamases (ESBL and KPC) among enterobacteria isolated from community-acquired monomicrobial urinary tract infections.
Pivmecillinam compared to other antimicrobials for community-acquired urinary tract infections with Escherichia coli, ESBL-producing or not - a retrospective cohort study.
Population Analysis and Epidemiological Features of inhibitor-resistant-TEM (IRT) {beta}-lactamases Producing Escherichia coli from both Community and Hospital Settings in Madrid, Spain.
Predictive utility of prior positive urine culture of extended- spectrum ? -lactamase producing strains.
Predominance of SHV-5 beta-lactamase in enteric bacteria causing community-acquired urinary tract infections in Bosnia and Herzegovina.
Prevalence and pathogenesis of extended-spectrum beta-lactamase producing Escherichia coli causing urinary tract infection in hospitalized patients.
Prevalence and risk factors for extended spectrum Beta-lactamase-producing uropathogens in patients with urinary tract infection.
Prevalence of extended spectrum beta lactamase producing Escherichia coli and Klebsiella pneumoniae urinary isolates in a tertiary care hospital in Kathmandu, Nepal.
Prevalence of Extended Spectrum Beta-Lactamase Producing Klebsiella Pneumoniae Isolated From Urinary Tract Infected Patients.
Prevalence of extended-spectrum beta-lactamase producing Escherichia coli in community-onset urinary tract infections in France in 2013.
Prevalence of ST1193 clone and IncI1/ST16 plasmid in E-coli isolates carrying blaCTX-M-55 gene from urinary tract infections patients in China.
Prevalence, antimicrobial properties and beta-lactamase production of haemolytic enterobacteria in patients with diarrhoea and urinary tract infections in Legos, Nigeria.
Refractory vertebral osteomyelitis due to CTX-M-14-producing Escherichia coli at ertapenem treatment in a patient with a coexisting urinary tract infection caused by the same pathogen.
Relationship between ciprofloxacin resistance and extended-spectrum beta-lactamase production in Escherichia coli and Klebsiella pneumoniae strains.
Retrospective evaluation of the patients with urinary tract infections due to carbapenemase producing Enterobacteriaceae.
Risk factors for extended-spectrum beta-lactamase positivity in uropathogenic Escherichia coli isolated from community-acquired urinary tract infections.
Risk factors for extended-spectrum beta-lactamase-producing Escherichia coli urinary tract infection in the community in Denmark: a case-control study.
Risk factors for urinary tract infection caused by Enterobacteriaceae with extended-spectrum beta-lactamase resistance in patients admitted to internal medicine departments.
Risk factors in community-acquired/onset urinary tract infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae.
Service evaluation of selected risk factors for extended-spectrum beta-lactamase Escherichia coli urinary tract infections: a case-control study.
Single-dose amikacin plus 7 days of amoxicillin/clavulanate to treat acute cystitis caused by extended-spectrum beta-lactamase-producing Escherichia coli: A retrospective cohort study.
Status Epilepticus and Delirium Associated with Ertapenem in a Very Elderly Patient with Chronic Kidney Disease and Silent Ischaemic Cerebrovascular Disease.
Study of family physicians' practices in case of urinary tract infections caused by enterobacteriaceae secreting extended-spectrum-beta-lactamase.
Successful medical treatment in a child with E. coli ESBL meningitis with acute communicating hydrocephalus and ventricular empyema: a case report.
Successful treatment of lower urinary tract infections with oral fosfomycin: a report of three cases.
Successful Treatment of Urinary Tract Infection in Kidney Transplant Recipients Caused by Multiresistant Klebsiella pneumoniae Producing New Delhi Metallo-Beta-Lactamase (NDM-1) With Strains Genotyping.
Sultamicillin (CP-49, 952): evaluation of two dosage schedules in urinary infection.
Susceptibility to penicillins and cephalosporins in beta-lactamase producing strains of E. coli and relative amount of beta-lactamase produced from these strains.
Synthesis and Characterization of Carbon Dots Coated CaCO3 Nanocarrier for Levofloxacin Against Multidrug Resistance Extended-Spectrum Beta-Lactamase Escherichia coli of Urinary Tract Infection Origin.
Temporal trends and risk factors for extended-spectrum beta-lactamase-producing Escherichia coli in adults with catheter-associated urinary tract infections.
The Amino Acid Changes T55A, A273P and R277C in the Beta-Lactamase CTX-M-14 Render E. coli Resistant to the Antibiotic Nitrofurantoin, a First-Line Treatment of Urinary Tract Infections.
The characteristics of NDM-1-producing Escherichia coli that belong to the successful and virulent clone ST131.
The efficacy of cefmetazole against pyelonephritis caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae.
The frequency of Klebsiella pneumonia encoding genes for CTX-M, TEM-1 and SHV-1 extended-spectrum beta lactamases enzymes isolated from urinary tract infection.
Transmission of meropenem in breast milk.
Treatment duration of complicated urinary tract infections by extended-spectrum beta-lactamases producing enterobacterales.
Treatment Failure in Urinary Tract Infections: A Warning Witness for Virulent Multi-Drug Resistant ESBL- Producing Escherichia coli.
Treatment of acute uncomplicated urinary tract infections with single daily doses of cefuroxime axetil.
Treatment options for new delhi metallo-Beta-lactamase-harboring enterobacteriaceae.
Urinary tract infection caused by ESBL- producing bacteria: Risk factors and antibiotic resistance.
Urinary tract infection in infants caused by extended-spectrum beta-lactamase-producing Escherichia coli: comparison between urban and rural hospitals.
Urinary tract infections caused by extended-spectrum betalactamase-producing bacteria in children: a matched casecontrol study.
Use of a non-radioactive hybridisation assay for direct detection of gram-negative bacteria carrying TEM beta-lactamase genes in infected urine.
Virulence genotype and nematode-killing properties of extra-intestinal Escherichia coli producing CTX-M beta-lactamases.
Worrisome high frequency of extended-spectrum beta-lactamase-producing Escherichia coli in community-acquired urinary tract infections: a case-control study.
[A combination of amoxycillin with clavulanic acid (Augmentin) in various types of urinary tract infections caused by microbes producing beta-lactamase]
[Activity of fosfomycin against extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae]
[Antibiotic resistance rates of extended spectrum beta-lactamase producing Escherichia coli and Klebsiella spp. strains isolated from urinary tract infections in a private hospital]
[Antibiotics in uncomplicated urinary tract infections: no increase in resistance over the past 5 years.]
[beta-lactam susceptibility of Escherichia coli isolates from urinary tract infections exhibiting different resistance phenotypes.]
[Clinical application of beta-lactamase inhibitors on urinary tract infections]
[Clinical evaluation of Augpenin (clavulanic acid-ticarcillin) in urinary tract infections: especially against beta-lactamase producing strains]
[Clinical significance of bacterial beta-lactamase production in the treatment of urinary tract infections with oral beta-lactam-antibiotics]
[Clinical studies on sultamicillin fine granules in the urological field]
[Community-acquired febrile urinary tract infection caused by extended-spectrum beta-lactamase-producing bacteria in hospitalised infants].
[Degradation of ampicillin by urine of patients with complicated urinary tract infections and its protective effect of dicloxacillin (author's transl)]
[Detection of beta-lactamase-producing bacteria from female patients with acute uncomplicated cystitis]
[Detection of beta-lactamase-producing strains isolated from urinary tract and their drug susceptibility]
[Experimental and clinical studies of sulbactam/cefoperazone in pediatric field]
[Ill-appearing febrile 5-week-old infant: the rule of empiric treatment]
[In vitro activity of fosfomycin against ESBL-producing enterobacteria of urinary origin.]
[Increasing prevalence of fosfomycin resistance in extended-spectrum-beta-lactamase-producing Escherichia coli urinary isolates (2005-2009-2011)].
[Investigation of ESBL types in community acquired urinary Escherichia coli isolates by isoelectric focusing and polymerase chain reaction.]
[Management of urinary tract infections in children. Evaluation of clinical practice].
[Microorganisms isolated from urinary tract infection and their beta-lactamase production and evaluation of clinical efficacy of sulperazone]
[Molecular characterization and antimicrobial susceptibility pattern of extended-spectrum ?-lactamase-producing Escherichia coli as cause of community acquired urinary tract infection].
[Pharmacokinetic, bacteriological and clinical studies on sulbactam/ampicillin in pediatric field]
[Sensitivity and resistance to antimicrobial agents ESBL-producing and not producing ESBL strains of E. coli in patients with urinary tract infection.]
[Temocillin and urinary tract infections].
[Urinary tract infections caused by extended-spectrum beta-lactamase (ESBL)--producing enterobacteria in outpatients from Primorsko-Goranska County, Croatia]
[Use of cephalosporins in surgical patients]
Urologic Diseases
[Detection of beta-lactamase-producing strains isolated from urinary tract and their drug susceptibility]
Urticaria
Chronic penicillin urticaria from dairy products, proved by penicillinase cures.
Uterine Cervical Neoplasms
High-throughput screening compatible cell-based assay for interrogating activated notch signaling.
Synergy of CO2-Response and Aggregation Induced Emission in A Block Copolymer: A Facile Way to "See" Cancer Cells.
Uterine Cervicitis
Norfloxacin in the treatment of gonorrhea due to penicillinase and non-penicillinase producing Neisseria gonorrheae: a review.
Vaccinia
Characterization of human foamy virus proteins expressed by recombinant vaccinia viruses.
Vasculitis
Cutaneous Vasculitis and Generalized Lymphadenopathy Associated with Extended-Spectrum Beta-Lactamase (ESBL)-Producing Escherichia coli Endocarditis: A Rare Case Report.
[MRI in a dog with confirmed pseudorabies infection].
Virus Diseases
The tyrosine kinase inhibitor genistein blocks HIV-1 infection in primary human macrophages.
Whooping Cough
Adjuvant activity of Mycobacterium bovis BCG expressing CRM197 on the immune response induced by BCG expressing tetanus toxin fragment C.
Recombinant Mycobacterium bovis BCG expressing pertussis toxin subunit S1 induces protection against an intracerebral challenge with live Bordetella pertussis in mice.
[Antimicrobial activities of clarithromycin against clinical isolates]
[Development of an immunoenzyme test system for the diagnosis of pertussis using penicillinase conjugates]
Wound Infection
Antibiotic prophylaxis in major head and neck surgery when clean-contaminated wounds are established.
Association of borderline oxacillin-susceptible strains of Staphylococcus aureus with surgical wound infections.
Beta-lactamase production diminishes the prophylactic efficacy of ampicillin and cefazolin in a guinea pig model of Staphylococcus aureus wound infection.
BUT-1: a new member in the chromosomal inducible class C beta-lactamases family from a clinical isolate of Buttiauxella sp.
Community acquired staphylococcal skin infections in rural areas of Zimbabwe.
Complete genome sequence of an IMP-8, CTX-M-14, CTX-M-3 and QnrS1 co-producing Enterobacter asburiae isolate from a patient with wound infection.
Drug resistance profile and molecular characterization of extended spectrum beta-lactamase (ES?L)-producing Pseudomonas aeruginosa isolated from burn wound infections. Essential oils and their potential for utilization.
Extended-spectrum Beta-lactamase Orthopedic Wound Infections in Nigeria.
Genome-based insights into the resistome and mobilome of two clinical wound-pathogens Providencia rettgeri strains isolated in Madagascar.
Genomic analysis reveals the presence of a class D beta-lactamase with broad substrate specificity in animal bite associated Capnocytophaga species.
Microbiology of gastrostomy site wound infections in children.
Study of genetic diversity, biofilm formation, and detection of Carbapenemase, MBL, ESBL, and tetracycline resistance genes in multidrug-resistant Acinetobacter baumannii isolated from burn wound infections in Iran.
Whole genome sequence analysis of NDM-1, CMY-4, and SHV-12 coproducing Salmonella enterica serovar Typhimurium isolated from a case of fatal burn wound infection.
Yersinia pseudotuberculosis Infections
[Penicillinase activity of Pasteurella pestis, Pasteurella pseudotuberculosis and Pasteurella X]
Zika Virus Infection
New Antibacterial Peptides from the Freshwater Mollusk Pomacea poeyana (Pilsbry, 1927).
Zoonoses
Efficacy of six disinfection methods against extended-spectrum beta-lactamase (ESBL) producing E. coli on eggshells in vitro.